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Summary
Light-dark cycles are considered the most important synchroniser of the 
human circadian pacemaker. To better understand the effect of light input and the lack 
thereof on the circadian timing system, 12 healthy blind subjects with no light 
perception (NLP) were studied for ~4 months during field and laboratoiy conditions. 
In three NLP subjects who all had at least one eye, light exposure induced melatonin 
suppression [NLP(+); E-POS group]. In seven NLP subjects, melatonin suppression 
did not occur [NLP(-)]; four of them had at least one eye (E-NEG group) and three 
were bilaterally enucleated (BE group). In two NLP subjects melatonin suppression 
was not assessed [NLP(<>)]. The findings reported in this thesis show that:
(1) The observed period of the melatonin rhythm measured under field 
conditions was not significantly longer than the obseiwed period measured under the 
forced desynchrony condition in the non-entrained totally blind subjects. This shows 
that, contraiy to previous suggestions, that average period measured in NLP blind 
subjects during field studies is an accurate reflection of the endogenous period.
(2) The phase and amplitude of the plasma melatonin rhythm exhibited a 
significantly greater modulation by the sleep-wake cycle and associated stimuli in the 
BE group compared to that observed in the E-POS and E-NEG NLP blind groups and 
sighted subjects studied under the same FD conditions. This indicates that the eyes 
may play an additional role in the human circadian system independent of its role as a 
light transducer.
(3) Homeostatic and circadian processes are intact and regulate sleep and 
waking performance in NLP blind subjects, like that observed in sighted subjects. 
This demonstrates that these processes function independent of conscious image- 
forming and non-image-fonning (circadian) photoreception.
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Chapter 1
Introduction
CHAPTER 1 -  INTRODUCTION 
1.1 Dynamics of Circadian Rhythms
1.1.1 Daily Rhythmicity on Earth
Most fixed points on the Earth’s surface with the exception of north and south 
poles experience a cycle between light (subjective day) and dark (subjective night). 
The geophysical light-dark (LD) cycle is produced by the Earth’s rotation and its 
exposure to the sun’s radiance. A complete axial rotation of the planet relative to the 
position of the sun occurs with a frequency or period of 24-hours (h). Local 
environmental light levels change gradually during daily transitions, increasing at 
dawn and decreasing at dusk when the sun ascends and descends in the sky, 
respectively. The light-dark ratio (L:D; hours of light and dark) changes slightly each 
day as a result of the Earth’s fixed tilt angle and its elliptical revolution around the sun 
(i.e., seasons). For example, in the northern hemisphere the LD ratio is maximal 
(-15:9) on the day of the summer solstice when the Earth’s north pole is tilted toward 
the sun, minimal (-9:15) on the day of the winter solstice when the Earth’s north pole 
is tilted away from the sun and is relatively equal (12:12) on the day of the spring and 
autumnal equinox when the Earth’s north pole is tilted sideways relative to the sun.
Features of the geophysical environment and most life on the planet usually 
exhibit daily rhythms or predictable, recurring changes and events that coincide with 
the LD cycle. For instance, air, water and surface temperatures typically oscillate 
every 24-h, gradually rising during the subjective day and gradually falling during the 
subjective night. In mammals, including humans, various biological processes and 
behaviour such as core body temperature and activity level usually oscillate in a 
similar temporal fashion. However, in comparison to environmental cycles, the 
generation of daily biological and behavioural rhythms is not dependent upon the LD
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cycle. For example, environmental temperatures usually change after dawn, whereas 
mammalian biological processes and behaviour usually change in an anticipatory 
manner prior to dawn. Moreover, daily environmental temperature cycles are usually 
abolished in constant darkness (DD), where as biological and behavioural rhythms 
usually persist with a period near to 24-h. Biological and behavioural events that recui* 
or cycle in about a day under constant environmental conditions are referred to as 
circadian (Latin, circa dies) rhythms (Halberg, 1959).
1.1.2 Circadian Rhythmicity
Circadian rhythms are endogenously driven by a central biological time­
keeping system called the circadian pacemaker (Pittendrigh, 1960). They usually 
exhibit a precise, stable “free-running” period near to, but slightly shorter or longer 
than 24-h for as many cycles as are measured under constant conditions, especially 
DD (Pittendrigh and Daan, 1976a). Interestingly, the free-mnning period of the 
circadian pacemaker is temperature compensated and does not shorten much (i.e., 
speed up the clock) when constant temperatures are increased by 10°C (Qio 
temperature coefficient) over time (Pittendrigh, 1954; Sweeney and Hastings, 1960).
Despite its endogenous nature, the circadian pacemaker is not impervious to 
daily environmental cycles, particularly the 24-h solar LD cycle. Light is undoubtedly 
the strongest, most significant environmental factor that can influence the observed 
period of the mammalian and human circadian pacemaker (Daan and Pittendrigh, 
1976a; Czeisler and Wright Jr., 1999). The daily LD cycle primarily adjusts or 
entrains the phase of circadian pacemaker each day relative to the phase of the 
environmental cycle, such that the observed period of the pacemaker equals 24-h 
(Pittendrigh and Daan, 1976b). However, other periodic “nonphotic” time-cues
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(environmental or behavioural) can also influence the observed period of the circadian 
pacemaker, but most are much weaker than light (Mistlberger and Skene, 2004).
The predictable 24-h changes in the geophysical environment can alter the 
timing of circadian rhythms, but they do not drive circadian rhythmicity. Circadian 
rhythms usually exhibit an anticipatory temporal relationship with the 24-h day as a 
result of their endogenous periodicity and the exogenous influence of environmental 
cycles. For example, most mammals usually make many transitions between two 
physiological-behavioural states known as the rest-activity (or sleep-wake) cycle. The 
timing of a particular state usually coincides with a particular phase of daily LD cycle 
with some exceptions. The majority of rest/sleep bouts or active/wake bouts are 
usually consolidated during either the subjective day or subjective night of the 24-h 
day. This temporal relationship between the rest-activity state and the LD phase is 
species-specific. In a diurnal animal the active/wake state usually begins slightly 
before and mostly occupies the light phase, where as in a nocturnal animal the 
active/wake state usually begins slightly before and mostly occupies the dark phase. 
In contrast, a crepuscular animal exhibits two separate active/wake bouts during the 
24-h day, one centred around dawn and another centred around dusk.
1.1.3 Parameters of Circadian Rhythms
In general, an oscillation or rhythm is characterized by three distinct, required 
parameters; (I) the phase ((j) -  0° to 359°), the state of the rhythm at any given time 
along a single oscillation; (2) the amplitude (a), half the total distance between the 
maximum and minimum units o f a recurring rhythm across a complete oscillation and
(3) the period [tau (x)], the frequency of the oscillation, or the average time between 
corresponding phases, over multiple successive or intermittent oscillations across
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time. Rhythms in mammalian physiology and behaviour may exhibit periods that are: 
(1) near-24-h (circadian), such as rest-activity, feeding behaviour, core body 
temperature and pineal melatonin secretion; (2) less than 24-h (ultradian), such as 
heart rate and the NREM/REM sleep cycle; (3) greater than 24-h (infradian), such as 
the human menstrual cycle; and (4) yearly (circannual) or seasonal, such as 
hibernation and reproduction behaviour. Circadian rhythms are assessed by direct, 
physiological measurements of the pacemaker or of pacemaker-controlled variables 
(circadian markers). The core body temperature rhythm and pineal melatonin 
secretion are commonly used as markers of the human circadian pacemaker. The 
phase of these rhythms may be defined as the (clock) time of the minimum (nadir, 
bathyphase) or maximum (peak, acrophase) of a recurring sinusoidal wave or the 
onset, midpoint or offset of a square wave. If a circadian marker no longer exhibits 
discernable parameters over the course of many days, it may be defined as 
arrhythmic. However, under certain conditions the underlying endogenous rhythm 
may persist despite the absence of obseiwable overt rhythms. In this case, the 
underlying endogenous rhythm is masked.
1.1.4 Circadian Entrainment
1.1.4.1 Entrainment to the 24-h Day
The endogenous circadian phase ((|)i) of a rhythm can also be described by its 
temporal relationship to the timing of a particular phase of the T-cycle ((jiy) relative to 
the period of the T-cycle (i.e., rest-activity or LD cycle), known as the phase angle 
(\j/) o f the rhythm. For instance, the timing of a particular phase of the circadian cycle 
(i.e., the onset time of a particular rhythm) may occur earlier, later or coincide with 
the onset time of sleep during the rest-activity cycle or with darkness during the LD
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cycle [i|/ = [((|)/ “ (j)T)-^T] X 360°]. Therefore, for example, when the phase of the 
circadian cycle and the phase o f the T-cycIe coincide each cycle of T, the two rhythms 
are said to exhibit a 0° phase angle. However, when the phase of the circadian cycle 
and the phase of the T-cycle remain ~12-h apart each cycle of T, the two rhythms are 
said to exhibit a 180° phase angle.
The endogenous period or tan (x) of the circadian pacemaker under DD 
conditions usually deviates slightly from the exogenous period or T-cycle (T) of the 
recurring environmental or an imposed LD cycle, or the photoperiod. As a result, the 
pacemaker free-runs and the phase angle (\}/) or temporal relationship between the 
endogenous phase ((j),) and the exogenous phase ((j)T) changes every cycle of the each 
rhythm as a function of their disproportionate periods [if x T; A\}/ = F(x,T) = T -  x]. 
The endogenous phase ((|)/) of the non-24-h pacemaker drifts to an earlier time (x < 24- 
h) or later time (x > 24-h) relative to the exogenous phase (<j)T) of the geophysical 
photoperiod. This daily change in phase of the circadian pacemaker relative to the 
phase of the geophysical environmental time under DD conditions is known as 
external desynchronization (Aschoff, 1969). To establish and maintain a stable phase 
angle each day with the environment (e.g., if  \|/i =(]),— (])t then \|/i = Yn), either the 
phase o f the pacemaker must be reset or adjusted (Acj),} daily to an appropriate phase 
of the LD cycle or the intrinsic period of the pacemaker must be shortened or 
lengthened (Ax) to the period of the LD cycle. This process is refeixed to as 
entrainment. Under entrainment to the geophysical LD cycle, the timing of 
endogenous phase conesponds with the timing of a particular phase of the LD cycle 
the day following release into DD. When the observed period (Xobs) of the endogenous 
rhythm equals the period of the exogenous rhythm with a stable phase angle over 
many consecutive T-cycles, the endogenous circadian rhythm is defined as being
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“entrained” to the exogenous rhythm. When the observed period of the endogenous 
rhythm does not equal the period of the exogenous rhythm, the endogenous circadian 
rhythm is defined as being “not entrained” to the exogenous rhythm.
1.1.4.2 Entrainment Models: Discrete vs. Continuous
Based on the discrete (nonparametric) model of entrainment, the geophysical 
photoperiod evokes discrete phase shifts (A(j)) that entrain the phase of the endogenous 
rhythm to the phase of the exogenous rhythm (Pittendi'igh and Daan, 1976b). As a 
result o f these daily adjustments, the recumng phase of the endogenous rhythm 
exhibits an observed period equal to the exogenous 24-h rhythm. The A(|) required to 
achieve entrainment is basically the functional difference in period between the 
endogenous or intrinsic rhythm (xi) and the exogenous rhythm (T) [A^  F(xi) = Xi -  T]. 
For example, animals with periods longer than the 24-h day require a net phase- 
advance shift (+A(|)), and animals with periods shorter than the 24-h day require a net 
phase-delay shift (~A(j)) each day to entrain to the geophysical photoperiod ( I  = 24-h). 
In contrast, based on the continuous (parametric) model of entrainment, the 
geophysical photoperiod alters the intrinsic period (Ax,) of the circadian pacemaker 
(Aschoff, 1960; Daan and Aschoff, 2001). In this manner, the intrinsic period of the 
circadian pacemaker is synchronised to the geophysical photoperiod. For instance, the 
daily 24-h LD cycle may either shorten (-Ax, when x, > 24-h) or lengthen (+Ax; when 
Xi < 24-h) the intrinsic period of the circadian pacemaker nearer or equal to 24-h.
1.1.4.3 Range of Entrainment
Ocular exposure to the daily geophysical LD cycle resets or entrains the phase 
o f human circadian pacemaker to an observed period of 24-h (Czeisler et al., 1981).
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The circadian pacemaker can be entrained to various imposed T-cycles (day length, 
LD or scheduled rest-activity) that are shorter or longer than the intrinsic circadian 
period. However, the range of imposed T-cycles to which the circadian pacemaker 
will attain and maintain circadian entrainment, or its range of entrainment, is 
dependent upon (1) the intrinsic period o f the circadian pacemaker, (2) the sensitivity 
of the pacemaker to the resetting or synchronising stimulus, and (3) the maintenance 
of an imposed LD or rest-activity schedule (Pittendrigh and Daan, 1976b; Klerman et 
al., 1996; Wright et al., 2001; Scheer et al., 2007; Gronfier et al., 2007). For instance, 
when the intrinsic circadian period is closer to the period of the imposed T-cycle (1) 
shorter daily phase adjustments are required and (2) weaker resetting stimuli (i.e., dim 
light or nonphotic stimuli) may be sufficient to achieve and maintain circadian 
entrainment. Thus, the circadian pacemaker with a given intrinsic circadian period 
and under certain periodic environmental conditions may only entrain within a certain 
range of T-cycle lengths. Similarly, a certain range of intrinsic periods within a 
species may only entrain during continued exposure to a particular T-cycle length.
1.1.4.4 Relative Coordination
The circadian pacemaker usually can no longer exhibit entrainment when it is 
exposed to a weaker periodic time cue under imposed 24-h or non-24-h T-cycles that 
are outside the range of entrainment. As a result, the endogenous circadian rhythm 
will exhibit a period different to the period of the exogenous T-cycle, creating a 
change in the temporal phase relationship between the two each cycle. Therefore, the 
phase angle becomes unstable, the endogenous and exogenous phase, which 
conesponded under entrainment, disassociate and the phase relationship or distance in 
time between the two phases increases until they are -12 h (\|/=180°) apart from each
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other. However, as the two rhythms continue to cycle, the distance in time between 
the endogenous and exogenous phase eventually decreases until the two intersect 
again (\|/=0°). Over many complete oscillations of each of the two rhythms, the phase 
relationship between the two rhythms will intersect, increase, decrease and intersect 
again. Each time the phases of the two rhythms with different periods intersect they 
complete 1 beat cycle (B-cycle). A beat cycle is defined as the period or duration of 
time that it takes the conesponding phases of two concurrent rhythms with different 
periods to coincide or intersect again [xb = (x x T) / |(x -  T)| ]. When the observed 
periods of the two rhythms are equal (i.e., 24-h) and the phase relationship between 
the two rhythms correspond, they are considered synchronised, and thus the beat 
period between the two rhythms is equal to the observed period. However, when the 
observed periods of the two rhythms are not equal and the phase relationship between 
the two rhythms continually changes, they are not considered synchronised. The beat 
period between the two rhythms can be lengthened by increasing the absolute 
difference between x and T (i.e., imposing a shorter or longer T-cycle relative to x).
The phase and observed period of the non-entrained endogenous rhythm may 
be affected by the presence of weak periodic time cues, based on the pacemaker’s 
phase-dependent sensitivity to photic or particular nonphotic time cues. Periodic time 
cues linked to the exogenous rhythm may elicit small, but significant phase shifts or 
amplitude changes only across a particular range of phases of the beat cycle and not 
others. Such effects may potentially alter the obseiwed period of the endogenous 
rhythm, whereby a shortening or lengthening of period under non-entrained 
conditions may only be observed when the phase relationship between the 
endogenous and exogenous rhythm is farthest from (phase angle greater; 91° to 270°) 
or nearest to intersection (phase angle shorter; 271° or -91° to 90°). For instance, when
the phase relationship between the endogenous rhythm and the exogenous rhythm is 
farthest, the non-entrained endogenous rhythm may exhibit a period similar to the 
period obseiwed under DD conditions. However, when the phase relationship between 
the endogenous rhythm and the exogenous rhythm is nearest to intersection, the non- 
entrained endogenous rhythm may exhibit a period shorter or longer than the period 
observed under DD conditions. The intermittent, periodic change in observed period 
of one rhythm in the presence of another rhythm across a beat cycle is known as 
relative coordination. In some spontaneous desynchronized free-running human 
subjects, the period and phase relationship between the endogenous and exogenous 
rhythm remained the same for several cycles before dissociating again, a phenomenon 
referred to as phase-trapping (Kronauer et al., 1982). Under phase-trapping, the two 
coinciding oscillations with disproportionate periods interact, such that the period of 
one oscillation alters the obseiwed period o f the other at certain phase angles.
1.1.5 Photic Sensitivity of the Circadian Pacemaker
1.1.5.1 Circadian Phase Dependent Sensitivity
In mammals, light infoiTnation is transmitted to the circadian pacemaker 
through a specific, non-visual pathway to the pacemaker. A phase response curve 
(PRC) for light describes the direction (advance or delay) and magnitude (time; 
minutes/hours) of the shift in relation to the circadian phase at which the light 
exposure occurs (Hastings and Sweeney, 1958). In general, phase shifts are greater 
when light exposure occurs during the mid-subjective night compared to exposure 
during the mid-subjective day. For instance, in humans, ocular bright light exposure 
centred in the early subjective night before the temperature minimum or peak of 
melatonin secretion causes phase-delay shifts, whereas, ocular bright light exposure
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centred in the early subjective day shortly after the temperature minimum or peak of 
melatonin secretion causes phase-advance shifts in circadian rhythms (Czeisler et a l, 
1986; Honma & Honma, 1988; Jewett et al., 1991; Minors et al., 1991; Duffy et al., 
1996; Klialsa et al., 2003). Light exposure centred in the middle of the subjective day 
usually does not elicit significant phase shifts in some mammalian species {dead 
zone), although this may not be true in humans (Jewett et a l, 1997). It is the 
pacemaker’s PRC to light that predominantly elicits photic entrainment, while also 
considering the endogenous period of the organism. Again, to entrain to the 24-h day 
organisms with a period shorter or longer than 24-h require a phase-delay or phase- 
advance shift, respectively,
1.1.5.2 Types of Circadian Phase Resetting
The shape and magnitude of the PRC to light is dependent on the phase of the 
light exposure and the intensity, duration, and the number of light pulse cycles. Two 
distinct types of light-induced circadian phase resetting have been defined to describe 
the pacemaker’s sensitivity to light, “weak Type 1” and “strong Type 0” resetting 
(Winfree, 1980). The characteristic of each type is based upon a phase-transition plot, 
where the initial phase and final phase of the rhythm are plotted across a full range of 
circadian phases that the pacemaker was exposed to light pulses (Czeisler et al., 1989; 
Jewett et al., 1994). The differences between weak Type 1 and strong Type 0 resetting 
are (1) the average slope of the line between the greatest phase delays and phase 
advances and (2) the shift-magnitude at the critical region, the cross-over point 
between phase-delay and phase-advance shifts. For instance, the light PRC for Type 1 
resetting is a continuous low amplitude sinusoidal curve that displays relatively small 
phase shifts of up to 3 to 6 hours following exposure to a single light pulse. The
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amplitude o f the phase shifts on either side of the critical region are relatively similar 
in some cases, thus the slope of the line between them on the phase transition curve is 
approximately equal to ‘1’. Conversely, the light PRC for Type 0 resetting is a 
discontinuous high amplitude exponential cuiwe that displays much larger phase shifts 
up to 12 h (Jewett et al., 1991). The larger phase shifts occur nearest to or at the 
critical region, thus the slope of the line between them on the phase transition cuiwe is 
approximately equal to ‘O’. The human PRC to light is mostly characterized by a 
Type I resetting, however Type 0 resetting has been demonstrated in response to 
consecutive 3-cycle bright light exposures, such that the results were not consistent 
with the sum of three Type 1 responses (Czeisler et al., 1989; Czeisler et al., 1990).
1.1.5.3 Light-Dependent Characteristics of the PRC
In addition to the timing of the light exposure, the characteristics of the light 
exposure, such as the intensity, wavelength and duration may determine the type and 
magnitude of the resetting response to light. For example, a Dose Response Curve 
(DRC) describes the shift-magnitude of various intensities of light administered at 
particular circadian phases (Hastings and Sweeney, 1958). Exposure to lower- 
intensities of light across circadian phases may change the type of resetting or 
amplitude of the PRC compared to higher intensities. In humans, exposure to dim 
light levels equivalent to normal room lighting as low as -50  to 200 lux can induce 
significant phase shifts (Boivin et al., 1994; Boivin et al., 1996; Boivin et a l, 1998; 
Zeitzer et al., 1997), yet they are not equal to phase shifts elicited by much higher 
intensities between 5000 and 10,000 lux, achieving saturation between -600 and 1000 
lux (Zeitzer et al., 2000b). The human circadian pacemaker is also sensitive to short 
wavelength light (-460-480 nm), consistent with the peak sensitivity for melatonin
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suppression by light (Brainard et al., 2001; Thapan et al., 2001; Lockley et al., 2003; 
Wamian et al., 2003). Multiple inteimittent light exposures can phase shift the 
rhythm, such that a non-linear relationship exists between total duration of exposure 
and phase shift (Rimmer et al., 2000; Gronfier et al., 2004). Moreover, an organism 
exposed to periodic short duration light pulses (i.e., a 30 to 60 minute pulse eveiy 12 
h) under DD conditions, known as skeleton photoperiods, is sufficient to entrain the 
organism to the period o f the light pulse (Gronifler et al., 2007).
1.1.6 Nonphotic Sensitivity of the Circadian Pacemaker
The influence of most nonphotic time cues on the pacemaker is usually much 
weaker than light as described by nonphotic PRCs in rodents. However, some 
nonphotic PRCs are similar to photic PRCs, such that the timing of exposure across 
the corresponding circadian phases elicits phase shifts in the similar direction and 
with similar magnitude. Not suiprisingly, these nonphotic PRCs are usually created 
by experimental manipulations of the physiological photic input pathways to the 
pacemaker or to the pacemaker itself. For instance, electrical stimulation of either the 
primaiy photic input pathway (optic nerve or retinohypothalamic tract) to the 
pacemaker or electrical stimulation of the mammalian pacemaker (suprachiasmatic 
nuclei) across circadian phases usually produce a photic PRC (Rusak and Groos,
1982). In addition, pharmacological administration of neurotransmitter agonists that 
mediate light-induced stimulation of the primary retinohypothalamic pathway or the 
mammalian pacemaker will also produce a similar photic PRC (Prosser and Gillette, 
1989; Rusak et al., 1990).
In contrast to the PRC to light, the PRC produced by some nonphotic stimuli 
is inverted relative to the direction of shift. Compared to light, exposure to nonphotic
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time cues usually produces lower amplitude PRCs. Phase shifts may be only up to 1 
hour or less. In addition, nonphotic PRCs may not be symmetrical, such that phase 
advances may be greater than phase delays or vice versa. Phase shifts in certain 
mammals (i.e., nocturnal) may be greatest when nonphotic exposure occurs nearer to 
the mid-subjective day compared to the mid-subjective night, but in other mammals 
(i.e., diurnal), like humans, phase shifts may be greatest when nonphotic exposure 
occurs during the subjective night. For instance, in humans, bouts of exercise 
occurring in the early subjective night before the temperature minimum elicit 
circadian phase-advance shifts (Buxton et al., 2003), while bouts of exercise occurring 
in the late subjective night just after the temperature minimum elicit circadian phase- 
delay shifts (Barger et al., 2004). Timed 24 h exogenous melatonin administration has 
been shown to entrain the rhythms of non-entrained blind animals (Redman et al.,
1983) and blind humans (Arendt et al., 1988; Lockley et al., 2000; Sack et al., 2000). 
In addition, there is strong evidence of a food entrainable oscillator, in which shifting 
the timing of restricted food availability shifts the timing of the rest-activity rhythm 
without shifting the timing of pacemaker (i.e., the core body temperature) in rodents 
(Rusak et al., 1988; Gooley et al., 2006). The neirral pathway(s) responsible for 
mediating nonphotic phase shifts are not well understood, but brain areas controlling 
arousal levels are thought to be involved (Mistlberger and Skene, 2004).
1.2. Neurophysiology of the Mammalian Circadian Pacemaker
The mammalian circadian system is composed of three major functional 
components; (1) a central oscillator or pacemaker; (2) an output pathway from the 
pacemaker; and (3) an input pathway or pathways to the pacemaker. As stated, the 
circadian pacemaker generates internal near-24-h rhythmicity, oscillating slightly
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slower or faster than the geophysical day. A distinct retinal input pathway conveys 
environmental time from external photic cues to the circadian pacemaker. The 24-h 
LD cycle resets the endogenous phase o f non-24-h pacemaker to an appropriate, 
stable environmental phase o f LD cycle. However, there are other, nonphotic 
pathways that may convey additional environmental infonnation and contribute to 
entrainment in combination with or independent of photic input. In addition, these 
nonphotic pathways may even mediate changes in circadian phase or entrainment in 
the absence of light under conditions of either DD or blinding.
The pacemaker conveys circadian timing to other brain areas, organs, glands 
and tissues through various output pathways. Output pathways from the pacemaker 
coordinate and couple the 24-h timing of various physiological and behaviour 
rhythms across the circadian cycle. The phase relationship between overt rhythms 
remains the same during each subsequent circadian cycle. This is referred to as 
internal synchronization. Under the natural 24-h LD, the obseiwed period and the 
phase relationship between endogenous rhythms and the 24-h day usually remains the 
same during each subsequent circadian cycle. This is referred to as external 
synchronization or entrainment. In humans, the nadir of core body temperature 
rhythm and the peak of the pineal melatonin rhythm during entrainment to 24-h day 
usually occur during the later half of the subjective night prior to habitual wake time. 
In humans, the core body temperature rhythm and pineal melatonin rhythm are highly 
coupled (Shanahan and Czeisler, 1991; Czeisler et al., 1999). For example, during 
sleep deprivation under dim light constant conditions in entrained individuals who 
sleep at night, the onset of melatonin secretion typically occurs in the late subjective 
day before habitual bedtime and just after the peak of CBT. Thereafter, melatonin 
levels rise throughout the subjective night as CBT gradually declines and then peak
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before habitual wake time and just before the minimum of CBT rhythm. Thereafter, 
melatonin levels decline and remain low throughout the subjective day and CBT 
gradually rises.
1.2.1 Circadian Pacemaker: Suprachiasmatic Nuclei (SON)
Mammalian circadian rhythms are endogenously generated by the paired 
suprachiasmatic nuclei (SCN), known together as the circadian pacemaker (Klein, 
Moore and Reppert, 1991). The SCN are located in the anterior hypothalamus at the 
base of the third ventricle and dorsal to the optic chiasm (Figure 1-1 A). A similar 
location of the SCN in humans has been identified (Lydie et al., 1980). Electrically 
stimulating the region of the SCN in vivo in bilaterally enucleated rats and hamsters 
causes similar phase shifts and changes in the observed period of feeding and the 
activity rhythms, respectively, like those observed with timed light exposure in intact 
animals (Rusak and Groos, 1982). Each paired SCN contribute equally to generating 
circadian rhythmicity, such that a unilateral SCN lesion does not abolish physiological 
and behavioural circadian rhythmicity in DD (Donaldson and Stephan, 1982; Davis 
and Gorski, 1984; Harrington et al., 1990). However, a number of physiological and 
behavioural variables, such as adrenal corticosterone production (Moore and Eichler, 
1972), pineal melatonin secretion (Reppert et al., 1981), drinking and locomotor 
activity (Stephan and Zucker, 1972) and the sleep-wake cycle (Edgar et al., 1993) 
become arrhythmic in DD after bilateral SCN lesions. Circadian locomotor activity 
can be restored by transplanting donor fetal SCN tissue into the third ventricle of an 
arrhythmic, SCN-lesioned host (Sawaki et al., 1984) and into a genetically arrhythmic 
host (Sujino et al., 2003). The period of locomotor activity in the host animal is 
equivalent to the donor animal (Ralph et al., 1990). In addition, a wild-type host with
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Figure 1-1. Diagram of general (A) mammalian circadian system and (B) SCN input and 
output pathways, cell types and neurotransmitters.
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a partial SCN-lesion and a partial mutant donor SCN transplant displays bi-modal 
locomotor activity rhythms (Vogelbaum and Menaker, 1992). Although, donor 
transplanted SCN tissue usually restores circadian rest-activity rhythms in arrhythmic 
hosts, it does not necessarily restore rhythmicity to all biological processes (Meyer- 
Bernstein et al., 1999) or restore circadian responses to photic cues (Hakim et a l, 
1991). Moreover, the location of the SCN grafts in the host’s brain (Silver et a l, 
1996; LeSauter et a l , 1997) and the host’s age (Romero et a l , 1993) will determine 
restoration and precision of circadian locomotor activity rhythms.
1.2.1.1 SCN Electrical Activity
Most SCN neurons exhibit an autonomous circadian rhythm of firing rate in 
vivo in LD or DD (Inouye and Kawamura, 1979), as well as in vitro (Green and 
Gillette, 1982; Groos and Hendriks, 1982; Groos et a l, 1983; Shibata et a l , 1984a). 
Spontaneous, circadian electrical activity can persist for multiple days in culture in 
neurons throughout the SCN (Nakamura et a l, 2001). The firing rate o f SCN cells is 
usually high during the light phase and low during the dark phase in both nocturnal 
(Inouye and Kawamura, 1979; Green and Gillette, 1982; Deboer et a l , 2003) and 
diurnal mammals (Sato and Kawamura, 1984). Ocular light exposure increases SCN 
cell firing rates in vivo in a phase and light intensity dependent manner (Meijer et a l, 
1986; Nakamura et a l , 2004). The circadian period of rhythmic firing rates between 
individual SCN neurons in cultured SCN slices exhibit similar periods around 24-h 
(Honma et a l , 2004). Conversely, uncoupled and dispersed individual SCN neurons 
exhibit desynchronised peak firing rates and a wider range of circadian periods 
(Welsh et a l , 1995). However, the average of those disproportionate periods is quite 
similar to the obseiwed period of behavioural rhythms (Liu et a l, 1997a). Thus
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functional synapses between SCN cells are required to maintain synchronised 
spontaneous neural firing rates (Honma et al., 1998a; Long et al., 2005).
The circadian period of electrical activity in individual SCN neurons is 
temperature compensated (Ruby et al., 1999; Herzog et al., 2003). For example, the 
period changes veiy little when SCN cells are exposed to constant temperatures 
increased by 10°C (Qio), however a minute percentage of SCN cells may display 
some temperature sensitivity (Burgoon and Boulant, 2001). The pattern of electrical 
activity in other neurons in surrounding hypothalamic tissue is predominately 
influenced by the SCN (Inouye and Kawamura, 1979). However, the electrical 
activity of SCN neurons may be influenced by unknown brain areas involved in the 
control of sleep-wake states independent of their rhythmicity (Glotzbach et al., 1987; 
Deboer et al., 2003). How these nonphotic changes in SCN electrical activity between 
sleep-wake states affect circadian output is not yet known.
1.2.1.2 SON Ceils and Neurotransmitters
Each lateral SCN contains a dense multioscillator cell population, which 
varies in number between mammalian brains, especially rodents and humans. Each 
nucleus is comprised of approximately 8,000 to 10,000 neurons in the rat (Moore et 
al., 2002; Van den Pol, 1980) and approximately 20,000 neurons in the human 
(Hofman et al., 1996). Each paired SCN is usually subdivided into two distinct 
segments, dorsomedial or shell and ventrolateral or core (Moore, 1996). These 
subdivisions are based on the difference between the number, type and distribution of 
SCN neurons, the origin of SCN afferents projections, as well as the existence of SCN 
efferent projections (Figure 1-lB). Similar SCN subdivisions have been described in 
many mammalian species, yet specific moiphological and neurochemical
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characteristics and afferent-efferent SCN projections may differ significantly between 
species (Morin and Allen, 2006). In general, vasoactive intestinal peptide (VIP), 
gastrin-releasing peptide (GRP) and enkephalin (ENK) neurons occupy the 
dorsomedial subdivision, and vasopressin (VP), arginine-vasopressin peptide (AVP) 
and neuropeptide Y (NPY) neurons occupy the ventrolateral in the mammalian SCN 
(Van den Pol, 1980; Moore et al., 2002). In addition, many neurons throughout the 
mammalian SCN produce the inhibitory neurotransmitter Gamma (y)-aminobutyric 
acid (GABA) (Van den Pol and Gores, 1986; Okamura et al., 1989; Moore and Speh, 
1993). However, GAB A containing neurons are usually more abundant in the 
dorsomedial region of the SCN. A similar morphology has been obseiwed in humans 
SCN (Stopa et al., 1984; Gao and Moore, 1996; Hofman et al., 1996; Romijn et al., 
1999). In addition, human SCN contain a larger population of neurotensin (NT) 
neurons and neuropeptide-Y (NPY) throughout (Mai et al., 1991; Moore, 1992), yet it 
is uncertain whether GRP neurons are present in human SCN.
Both dorsomedial A VP neurons and ventrolateral VIP neurons exhibit 
spontaneous, circadian electrical activity in culture (Nakamura et al., 2001). 
Communication between the paired nuclei occurs across ventrolateral and 
dorsomedial neurons in either direction, however communication between regions 
mostly flows from ventrolateral to dorsomedial (Leak et al., 1999). Ventrolateral SCN 
neurons receive most, if not all, direct photic input from distinct retinal projections 
and transmit to neurons in the dorsomedial region, while dorsomedial SCN neurons 
transmit mostly within the SCN and send efferents to nearby brain areas (Figure 1- 
IB).
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1.2.2 Pacemaker Output -  Efferent Pathways
A majority of SCN efferents project internally within the cluster of SCN cells 
(Watts et al., 1987; Watts and Swanson, 1987; Watts, 1991). Neurons of the paired 
SCN project contralaterally in the core (i.e., VIP) and shell (i.e., AVP) subdivisions, 
yet there is a greater number of core to shell than shell to core projections (Leak et al., 
1999). Although the SCN act as the master clock, the outward expression and 
synchronization of behavioural and physiological circadian rhythmicity rely heavily 
on the various direct and indirect SCN efferents. Ventrolateral and dorsomedial 
regions of the SCN project to adjacent hypothalamic areas. Areas of particular 
importance include the subparaventricular zone (sPVZ), dorsomedial hypothalamus 
(DMH), median preoptic (MnPO) and ventrolateral preoptic (VLPO) area and 
paraventricular nucleus (PVN). The sPVZ, which receives dense efferent projections 
from the SCN, is cmcial for conveying or amplifying much of the circadian signal to 
nearby areas. Ventral and dorsal sPVZ efferents appear to target different 
hypothalamic regions responsible for the regulation of particular overt rhythms. For 
example, ventral sPVZ lesions dismpt or abolish the circadian rest-activity, but not 
body temperature rhythm, while dorsal sPVZ lesions disrupt or abolish the body 
temperature, but not rest-activity rhythm (Lu et al., 2001; Abrahamson and Moore,
2006). The DMH, which receives direct and indirect projections from the SCN, is 
vital for the expression o f sleep-wake, locomotor activity, feeding and corticosteroid 
circadian rhythmicity (Chou et al., 2003). In addition, the DMH has been shown to be 
necessary for food-entrainment (Gooley et al., 2006). The VLPO, which is heavily 
involved in the sleep-wake regulatory system, receives few direct projections from the 
SCN (Novak and Nunez, 2002). However, indirect SCN input to the VLPO may be 
conveyed through its projections to DMH (Chou et al, 2002; Deurveilher et al., 2002;
1-20
Deurveilher and Semba, 2003). Lastly, a major SCN projection via the PVN to the 
pineal gland, is responsible for the production the daily melatonin rhythm (see section 
1.5).
1.2.3 Pacemaker Input -  Afferent Pathways
1.2.3.1 Anatomy of the Eye: Classical Photoreceptors
Photoreceptor cells in the retina transduce luminance for conscious image- 
forming visual perception, as well as for non-image forming responses (i.e., pupil 
reflex, circadian photoreception). The human retina lines the inner orbital wall 
between the outer layers of the sclera, choroids and pigment epithelium and the inner 
space filled with the fluid-like vitreous humor (Figure 1-2A). The retina has several 
well defined inner and outer layers composed of distinct cell types and synapses 
(plexiform) between them (Figure 1-2B). Light entering thiough the pupil is projected 
onto the retina thiough the lens. Light falling upon the retina passes through the inner­
most ganglion cell layer. Light then passes tlirough the inner nuclear layer, which is 
composed of amacrine, bipolar and horizontal cells, before being absorbed by rod and 
cone photoreceptors in outer-most cell layer adjacent to the pigment epithelium. Rods 
are roughly homologous to each other, react to low light intensities, and are very 
abundant, since they are spread across the most of the retinal field like the cells in the 
ganglion and inner nuclear layers. In contrast, cones are separated into (short, mid and 
long) wavelength dependent types, react better to brighter light intensities, and are 
fewer in number, since they are heavily concentrated mostly in the fovea, a small area 
of the retina where the cornea and lens mainly focus light entering the eye. Due to 
there anatomical differences, rods are more responsible for dim-light (night) and 
peripheral visual perception, where as cones are more responsible for colour and acute
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Figure 1-2. Anatomy of the eye (A) and cell layers of the retina (B).
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visual perception. The rods and cones transmit photic signals to the ganglion cell layer 
via the inner nuclear cell layers. The optic nerve is formed in the nei*ve fibre layer by 
the axons of the retinal ganglion cells (RGCs) (Figure I-2B).
The retina in each eye is subdivided laterally between nasal and temporal 
fields. Light rays (pure white or spectiaim) and particles (photons) entering the eye 
from the right field of vision project onto the temporal retinal field in the left eye and 
the nasal retinal field in the right eye. Conversely, rays and particles of light from the 
left field of vision project onto the nasal retinal field in the left eye and temporal 
retinal field retina in the right eye. ROC axons in the temporal retinal field in each eye 
form the two primaiy optic nerves that project to the optic tract on the ipsilateral side 
of the brain. ROC axons in the nasal retinal field in each eye form the two accessory 
optic nerves that cross over and project to the optic tract on the contralateral side of 
the brain. The accessory optic nerves criss-cross at the optic chiasm ventral to the 
SCN. The primary and accessory optic tracts project heavily to the striate cortex, 
which is predominantly responsible for image-forming light perception (Figure 1-1 A).
1.2.3.2 Melanopsin: Novel/Ciroadian Photopigment
Non-image forming responses to light, such as pupil reflex, melatonin 
suppression and circadian phase shifting, do not depend on the presence of functional 
rods and cones. A small percentage of blind humans lacking functional rods and cones 
(Czeisler et al., 1995; Klemian et al., 2002, Zaidi et al., 2007), primates (Gamlin et 
al., 2007) and homogenous rodless/coneless mice (Foster et al., 1991; Freedman et al., 
1999; Lucas et al., 1999; Lucas et al., 2001; Peirson and Foster, 2006) continue to 
exhibit non-image forming responses to light with a peak sensitivity near 480nm. A 
novel opsin photopigment called melanopsin (Provencio et al., 1998) was identified in
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human retina (Provencio et ah, 2000) and in most RGCs that project to the SCN 
(Gooley et ah, 2001; Hannibal et ah, 2004). Melanopsin-containing RGCs are 
intrinsically photosensitive (zpRGC) with a peak sensitivity of 480nm as compared to 
non-melanopsin containing RGCs (Hattar et ah, 2002; Berson et ah, 2002). In 
addition, when melanopsin is expressed in cells that are not inherently sensitive to 
light, those cells become light sensitive and also have a peak sensitivity of 480nm 
(Meylan et ah, 2005; Qui et ah, 2005; Panda et ah, 2005). Homozygous 
rodless/coneless melanopsin knockout (KO) animals do not entrain to LD cycle 
(Hattar et ah, 2003; Beaulé et ah, 2003). However, homozygous melanopsin KG 
animals exhibit attenuated phase shifting (Panda et ah, 2002; Ruby et ah, 2002) and 
pupillary light reflexes in response to light exposure (Lucas et ah, 2003) compared to 
wild-type animals, concluding that rods and cones may contribute to non-image 
forming responses to light. A similar spectral sensitivity of non-image forming 
responses in blind humans with no functional rods or cones has been reported (Zaidi 
et ah, 2007). Melanopsin-expressing RGCs project to the SCN, as well as other 
circadian-related brain areas, such as the ventrolateral preoptic area (VLPO) involved 
in sleep-wake regulation, ventral subparaventricular zone (vSPV) involved in 
amplifying the circadian signals from the SCN, pretectal area (PTA) involved in 
ocular reflex behaviour such as pupillary diameter in response to light and automatic 
eye movements, and the intergeniculate leaflet (IGL) involved in circadian responses 
to photic and nonphotic stimuli (Gooley et ah, 2003).
1.2.3.3 Ocular Disorders: Circadian Photoreception
Certain eye diseases and disorders may affect retinal photic transmission at or 
between the pathway from the eyes to the SCN. In general, bilateral absence of the
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eyes, bilateral retinal degeneration, or bilateral optic nerve or optic chiasm lesions are 
usually the primary physiological reasons for total vision loss. Total loss of light 
perception may be acute, occurring instantaneously, or progressive, occurring over a 
matter of days, weeks, months or years.
In humans, the absence of both eyes can be the result o f a prenatal condition 
called anophthalmia, in which initial formation of the eyes does not occur during early 
stages of embryonic development. Similarly, in bilateral microphthalmia, continued 
development ceases after initial orbital formation, leaving only small vestibular eyes. 
The destmction/removal of the eyes or bilateral enucleation can be the result of ocular 
trauma or surgery to treat chronic ocular diseases or conditions, such as 
retinoblastoma, which is a cancer or a malignant tumor growth on the retina. 
However, ocular trauma or retinoblastoma may not always result in the loss of both 
eyes, but may result in a total loss of light perception.
Retinal degeneration can result from numerous conditions, either as the result 
of ocular or non-ocular disease, infection, trauma, exposure, aging, and heredity. 
Depending on the cause or magnitude of the underlying cause, retinal degeneration 
may be complete or partial, affecting all or only certain cell layers. For example, 
retinopathy of prematurity (ROP), which was first known as retrolental fibroplasia, is 
a common cause of retinal degeneration visual impairment in individuals who were 
bom prematurely in North American and western European countries during the 
1940s and 1950s. It was believed that maintaining premature infants in oxygen-rich 
incubators would help support their growth and increase their chances of survival. 
Under these conditions, the high oxygen concentrations caused abnormal blood vessel 
growth across the retina, which can cause retinal scaning. The vasculature of the 
developing eye is dependent on oxygen for growth, but if the eyes are exposed to high
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concentrations of oxygen, the blood vessels begin to grow and elongate at a faster 
rate. This abnormal growth essentially causes the blood vessels to spread 
indiscriminately, rooting their way through all cell layers of the retina.
In some cases, the abnomial vascular growth related to ROP can cause retinal 
detachment, itself a separate cause o f vision loss all its own. Retinal detachments can 
also be the result of head trauma and infection. Vision loss due to retinal detachments 
occurs when the retina becomes separated from the pigment epithelium either by 
retinal scarring and/or tearing due to abrupt (accelerating/decelerating) forces of 
motion. Under these circumstances, fluid seeps in and accumulates in the space 
produced between the outer retinal layer and the pigment epithelium causing further 
quadrants of the retina to pull away. This separation usually causes damage to rod and 
cone cells in the outer photoreceptor layer.
Non-ocular diseases can indirectly cause retinal degeneration and visual 
impairment. For instance, individuals who contract measles and are malnourished 
usually exhibit a Vitamin A deficiency. Vitamin A is a vital nutrient necessary for 
photoreceptor function. Chronic Vitamin-A deficiency can result in bilateral retinal 
degeneration and eventually complete loss of light perception. In addition, the globe 
of the eyes will shrink over time in individuals who have no light perception as a 
result of measles. This shrinking or atrophy of the eyes, called phthisis bulbi, can 
cause further damage to the retina. Despite this, there is some evidence that a small 
proportion of functional RGCs and their axons persist in atrophic eyes (Cursiefen et 
al., 2003).
Usher’s syndrome, juvenile retinoschisis, Leber’s congenital amaurosis and 
retinitis pigmentosa are common forms of hereditary-based eyes disorders that cause 
retinal degeneration. The gene-mutations responsible for causing retinal degeneration
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of this kind are different, yet the outcome is usually similar. Retinitis pigmentosa (RP) 
is a bilateral degeneration of the retinas caused by inheritance of an autosomal- 
recessive, autosomal-dominant, or X-linked gene. Retinal degeneration starts in the 
outer photoreceptor layer and progresses slowly over a matter of months to years. 
Initially peripheral and night vision diminishes due to the predominant degeneration 
of rods, which eventually leads to tunnel vision. Over time cones in the fovea 
eventually degenerate until the individual experiences a complete loss of light 
perception. Despite the loss o f light perception due to the preliminary degeneration of 
rods and cones in the outer retinal layer, RGCs and their axons within inner retinal 
layer can remain unaffected (Stone et al., 1992).
Vision loss due to optic nerve damage can be caused by retinoblastoma or a 
condition called glaucoma. Congenital glaucoma is more common, but it can be 
acquired later in life during adulthood. Glaucoma is caused by an abnormal increase 
in intraocular pressure (lOP) of aqueous humor fluid. The lOP is essential for 
maintaining a proper shape and function of the eye. Aqueous humor fluid is routinely 
drained from the anterior and posterior chambers between the cornea and lens through 
specialized ducts. Wlien these ducts become blocked, fluid drainage ceases and the 
lOP may increase. Small, reversible increases in lOP can alter the shape of the eye 
and may even affect visual acuity temporarily. However, if this blockage persists and 
TOP levels rise and remain above normal for too long, the inner retinal layer and optic 
nerve become compressed under the intense pressure. Chronic elevated lOP levels can 
gradually cause RGC and optic nerve damage and degeneration if left untreated, 
resulting in degraded visual acuity and peripheral vision and eventually a complete 
loss of light perception. However, there is evidence that some RGCs may survive 
despite the loss of light perception (Pavlidis et al., 2003).
1-27
The importance of the eyes in circadian physiology is underlined by 
comparative observations between sighted and blind individuals. A significantly 
greater percentage of blind individuals with no light perception (NLP) are more likely 
to report sleep-wake disturbances (Sasaki et al., 1992; Tabandeh et al., 1998; Leger et 
al., 1999a; Leger et al., 1999b) or exhibit abnoi*mally entrained or non-entrained 
melatonin rhythms (Lewy and Newsome, 1983; Sack et al., 1992; Lockley et al., 
1997a; Lockley et al., 1997b; Skene et al., 1999) compared to sighted or legally blind 
individuals who have minimal light perception. One functional retina is sufficient for 
both conscious visual perception and circadian photoreception and can entrain to a LD 
cycle. Bilaterally enucleated animals exhibit free-running locomotor activity rhythms 
in the presence of a LD cycle similar to that observed in sighted animals under DD 
conditions (Stephan and Zucker, 1972). However, specific retinal-layer degeneration, 
such as observed in rodless/coneless mice (Foster et al., 1991; Freedman et al., 1999; 
Lucas et al., 1999; Lucas et a l , 2001; Peirson and Foster, 2006) and a small 
percentage of blind humans (Czeisler et a l , 1995; Kleiman et a l, 2002; Zaidi et a l,
2007), may lead to the loss of image-forming light perception, but not a loss of non- 
image-forming responses to light.
In a comprehensive review of the literature, in which circadian period 
estimates in NLP blind individuals living in society were reported (Miles et a l, 1977; 
Orth et a l, 1979; Lewy and Newsome, 1983; Arendt et a l, 1988; Nakagawa et a l, 
1992; Sack et a l, 1992; Klein et a l ,  1993; Lockley et a l, 1997a; Klerman et a l, 1998; 
Lockley et a l, 2000; Sack et a l, 2000; Kendall et a l, 2001; Hack et a l , 2003; Lewy 
et a l , 2004; Emens et a l, 2005), approximately 65% of the total population [n=103; 
does not include 4 NLP blind individuals who exhibit light-induced melatonin 
suppression (Czeisler et a l , 1995; Klerman et a l , 2002)] exhibited periods
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significantly different from 24-h and were categorized as non-entrained or “free- 
mnning”; 30% exhibited periods not significantly different from 24-h and are 
categorized as “enti'ained” and 5% exhibited no discernable rhythm and are 
categorized as “unstable” (not included below). When NLP blind subjects were 
separated by cause of blindness (if reported), the following exhibited non-entrained 
rhythms while living in society: 75% of bilaterally enucleated (n=24); 82% ocular 
trauma with at least one eye intact (n= ll); 88% with ROP (n=17); 38% with retinal 
detachments (n=8); 25% with hereditaiy gene mutation like RP (n=4); 100% with 
glaucoma (n=8); 88% with non-ocular related disease (n=8); 55% of those in which 
diagnosis was not reported (n= ll). Note that NLP blind individuals with vision loss 
diagnoses that usually result in significant, complete damage to the retina and/or optic 
nerve (i.e., bilateral enucleation and glaucoma) are more likely to exhibit non- 
entrained rhythms, compared to disorders which may only result in specific 
degeneration to the classical photoreceptor layer of the retina (i.e., hereditary gene 
mutation and retinal detachments).
1.2.3.4 Direct Photic Input Pathway to SCN:
The retinohypothalamic tract (RHT) (see Figure 1-lB) is a distinct 
monosynaptic pathway that projects bilaterally to the ventrolateral region of the SCN 
from a subset of RGCs (Hendrickson et ah, 1972; Moore and Lenn, 1972; Moore et 
al., 1995). The RHT projects from a dense population of melanopsin-containing 
RGCs (Gooley et al., 2001; Hannibal et al., 2004). The RHT is primarily responsible 
for transmitting photic information from the environment to the SCN and is essential 
for entrainment. Animals with bilateral transects of the RHT exhibit free-running 
rhythms in the presence o f a 24-h LD cycle, similar to the rhythms of sighted animals
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in DD (Johnson et al., 1988). Electrical stimulation of the RHT via the optic nerve 
during the subjective night increases the firing rate and shifts the timing of peak 
electrical activity in SCN cells (Cahill and Menaker, 1989; Shibata and Moore, 1993) 
and the animal’s activity rhythm (de Vries et al., 1994). Photic transmission via the 
RHT is mediated by two neurotransmitters, glutamate (Meijer et al., 1988; Shirakawa 
and Moore, 1994) and pituitary-adenylate-cyclise-activating-polypeptide (PACAP) 
(Hannibal et al., 1997; Hannibal et al., 2000).
1.2.3.5 Nonphotic/lndirect Photic Input Pathways
Photic input is indirectly conveyed to the SCN from the intergeniculate leaflet 
(IGL) via the geniculohypothalamic tract (GHT). The GHT originates from the IGL 
located in the lateral geniculate nucleus (LGN) (Moore and Card, 1994). The LGN is 
a major processing area for incoming visual information, which is then transmitted to 
the striate cortex. The striate cortex is located in the occipital lobe and is the brain 
region primarily responsible for image-foiining visual perception. The LGN receives 
major retinal projections from both the primary and accessory optic tracts, including 
projections from the RHT. Many of these projections to the IGL originate from RGCs 
containing melanopsin (Morin et al., 2003; Dacey et al., 2005). The IGL contains 
NPY and G ABA neurons which project to the SCN along the GHT (Hanington et al., 
1985; Card and Moore, 1989; Moore and Speh, 1993; Moore and Card, 1994). 
Lesions to the IGL do not abolish circadian rhythmicity or photic entrainment, but 
may alter the observed period and PRC to light of the pacemaker (Pickard et al., 
1987). In addition, the LGN also receives serotonergic input from the dorsal raphe 
nucleus.
1-30
1.3 Molecular-Genetic Basis of Circadian Rhythm Generation
Initially, the endogenous nature, precision and distribution of free-mnning 
periods within and between species suggested the notion of an underlying genetic 
component to circadian rhythm generation. SCN electrical activity is merely the initial 
output pathway for conveying the endogenous circadian period to the rest of the 
system (Davies and Mason, 1994), since endogenous circadian timing continues to 
oscillate even in the absence of spontaneous neural firing in SCN cells (Schwartz et 
al., 1987). It is now definitively known that endogenous circadian rhythmicity within 
individual SCN cells is generated at a molecular level by specific ‘clock’ genes and 
the proteins that they produce (Albrecht, 2002; Morse and Sassone-Corsi, 2002; 
Piggins, 2002; Reppert and Weaver, 2002; Hofman, 2004). However, the biochemical 
pathway(s) that transmit molecular rhythmicity into spontaneous, rhythmic electiical 
activity in SCN cells is not yet known.
Circadian clock genes were first identified in the fruit fly. Drosophila 
melanogaster (Konopka and Benzer, 1971). Mammalian and human homologues (a 
gene having the same relative position, value, or structure on DNA) o f Drosophila 
clock genes have been identified, yet there may be more than one. A mutation of a 
single gene within SCN cells has helped identify and deteiinine the significance and 
individual contribution of each clock gene and protein in the molecular circadian 
clock. Artificial clock gene mutations are established by deleting, duplicating, 
inverting, substituting or inserting genetic code in DNA. Some gene mutations may 
abolish or knockout (KO) the expression of a gene along with the protein product it 
encodes. In other mutations, the gene is still expressed, but the protein it encodes may 
have an abnormal molecular stmcture which does not allow that particular protein to 
interact properly with other proteins.
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In comparison to a wild-type (WT) animal, a particular mutation may result in 
a lengthening or shortening of period, diminished temperature compensation, altered 
light sensitivity or an anhythmic molecular and behavioural clock altogether. For 
example, a single gene mutation called tau was described in Golden hamsters 
(Mesocricetus auratus), in which the locomotor activity of tau mutant hamsters 
exhibited an abnormally shorter average circadian period compared to wild-type 
hamsters and exhibited atypical or no entrainment to a 24-h LD cycle (Ralph and 
Menaker, 1988). The tau allele is encoded by a gene called Casein kinase I  epsilon 
(Ckis), a homologue to the Drosophila double-time {dbt) gene (Lowrey et al., 2000). 
Wild-type hamsters exhibit an average circadian period of -24-h, whereas, 
homozygous and heterozygous Tau mutants exhibit an average circadian period o f 20 
h and 22 h, respectively. Transplanting fetal SCN tissue of a donor tau mutant into the 
SCN region of an SCN-lesioned wild-type animal restores circadian locomotor 
activity rhythmicity with an observed period similar to that of the tau mutant donor 
(Ralph et al., 1990). In addition, although wild-type and tau mutant hamsters exhibit 
similar phase shifts to 1 h light pulses, the amplitude of the PRC is much greater in 
tau mutants (Shimomura and Menaker, 1994; Grosse et al., 1995). The amplitude on 
one side of the PRC increases in the tau mutant hamsters as elapsed time in DD 
increases, yet both phase delays (Shimomura and Menaker, 1994) and phase advances 
(Grosse et al., 1995) have been reported to be greater.
1.3.1 Mechanisms of Molecular Circadian Clock
The endogenous characteristics of circadian rhythmicity, including phase and 
period, are controlled by genes. Various genes are found along particular sections of 
DNA (deoxyribonucleic acid; double helix) on a particular chromosome within the
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nucleus of a cell. A gene is a subunit of DNA that contains a specific genetic 
sequence of pairing of four bases (adenine - thymine and cytosine - guanine) or a 
distinct code of instructions for producing a specific protein (protein-products), a 
chain of amino-acids. Proteins are mostly responsible for maintaining a cell’s 
stmcture and function in single cell organisms and in tissue or organ cells of complex 
organisms. Protein-products include hormones, which stimulate the production of 
other proteins in other cell tissues, and enzymes, which usually breakdown other 
proteins or hormones. The DNA gene sequence for making a protein is copied or 
transcribed by messenger ribonucleic acid (mRNA), a process called gene 
transcription. The cellular presence of a particular gene’s mRNA or protein is called 
gene expression.
The post-transcriptional clock gene, or mRNA, travels outside of the nucleus 
or translocates into the cytoplasm of the cell where it then binds to ribosomes. 
Ribosomes read the mRNA gene sequence and produce the protein specified or 
encoded by the mRNA, a process called gene translation. Many circadian clock genes 
encode for a particular type of protein, members of the basic Helix-Loop-Helix-PER- 
ARNT-SIM (bHLH-PAS) transcription factor family (Sheamian et al., 1999). Many 
post-translational protein-products will bind (dimerize) and form paired complexes 
called dimers. Dimers may be formed between proteins with a similar molecular 
structure, called homodimers, or between proteins with a different molecular 
structure, called heterodimers. Depending on the protein-protein combination, a dimer 
may or may not translocate inside the nucleus (Yagita et al., 2000). Some dimers that 
are able to translocate inside the nucleus function as transcription factors. A 
transcription factor either enhances or represses gene expression by binding to a 
particular section of DNA, called an E-box element. An E-box element is a specific
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DNA sequence of the promoter (expression enhancer) region of a gene. Transcription 
factor “enhancers” actively increase a gene’s transcription rate at the E-box element. 
In contrast, transcription factor “repressors” decrease a gene’s transcription rate by 
inhibiting transcription factor enhancer-binding by either (1) competing for E-box 
binding sites or (2) by binding to transcription rate enhancers. The amount of 
enhancer or repressor transcription factors is regulated by either the inhibition of (1) 
dimer translocation inside the nucleus due to inappropriate dimer partners or (2) 
protein dimerization due to phosphoiylation (adding a phosphate group to a protein), 
which alters the proteins structure and its ability to dimerize.
The molecular circadian clock is composed of a bi-directional feedback loop 
containing a positive and negative limb. The positive limb of the molecular circadian 
clock is represented by particular transcription factors that enhance gene expression in 
the negative limb. They drive or enhance the transcription rate of other clock genes, or 
in few cases, they may even drive their own transcription. Transcription factors that 
repress gene expression represent the negative limb of the molecular circadian clock. 
They decrease or repress the transcription rate of other clock genes by interfering with 
transcription factor E-box element binding in the positive limb. The build up and 
translocation of transcription factors in the negative limb blocks transcription factors 
in the positive limb either (1) by competing for binding sites on their own E-box 
element promoter regions with positive-limb dimers or (2) by inhibiting positive 
dimer binding on their own E-box element promoter regions by binding to positive- 
limb dimers (Honma et al., 2002). As mentioned, phosphoiylation actively interrupts 
protein dimerization and translocation in the negative limb, eventually leading to the 
breakdown and degradation of these proteins. There are particular genes that are not 
directly part of the negative or positive limb, but they encode for proteins that
1-34
phosphorylate specific protein-products in the cytoplasm. These are referred to as 
transcription rate “regulators”. They influence the amount of dimerization, which 
influences the amount of dimer-translocation into the nucleus, and eventually the 
amount of transcription factor E-box binding in either the positive or negative limb of 
the cycle (Eide et al., 2002).
Taken together, enhanced gene mRNA transcription, expression and 
cytoplasmic-translocation in the positive limb is followed by protein translation, 
dimerization or degradation (phosphoiylation), dimer nucleic-translocation and 
repressed gene expression in the negative limb. As cytoplasmic negative limb proteins 
degrade, the amount of negative feedback on their own tianscription drops, allowing 
the positive limb to begin again. The elapsed time between these steps within the loop 
is determined by transcription-rate-regulating genes, which either decrease or increase 
the rate of dimer translocation. Overall, the period of the circadian clock is dependent 
upon the time-lag between components within the positive-negative feedback loop 
(Lee et al., 2001).
1.3.2. Mammalian Circadian Clock Genes
In general, circadian clock genes are characterized by whether or not they; (1) 
exhibit a circadian rhythm in peak expression; (2) exhibit direct phase-dependent, 
light-induced change in expression rate; (3) are expressed in body tissues (i.e., 
peripheral clocks) other than the SCN; and (4) are required for a functional clock and 
entrainment. In addition, many clock genes are subdivided between positive and 
negative limbs. However, there are additional clock genes that are not directly 
included within either limb, but they help maintain the stability of the period of the 
circadian clock.
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1.3.2.1 Positive Limb of Feedback Loop
The positive limb of the molecular circadian clock is composed of two main 
homologues of Drosophila clock genes, Clock (Vitatema et al., 1994; Antoch et a l, 
1997; King et a l, 1997) and Bmalî (also called MopS) (Gekakis et a l , 1998; 
Hogenesch et a l, 1998; Jin et a l, 1999; Bunger et a l, 2000; Avivi et a l , 2001). 
Mammalian Clock {mClock) gene expression is not rhythmic (Maywood et a l , 2003), 
but may exhibit light-induced changes in expression rate (Abe et a l ,  1999). In mice, a 
mutation of the Clock gene, lengthens the period of locomotor activity and disrupts 
the persistence o f locomotor activities rhythmicity in DD (Vitaterna et a l, 1994). The 
Clock mutant exhibits arrhythmic gene expression which also exhibits arrhythmic 
electrical activity in the SCN (Herzog et a l, 1998). In contrast, mammalian Sm all 
{mSmall) expression exhibits 24-h rhythmicity, peaking during the subjective night 
(Honma et a l, 1998b; Maywood et a l , 2003). Sm all does not exhibit any light- 
induced changes in expression rate (Abe et a l , 1998; von Gall et a l, 2003). 
Homozygous Sm all KO do not exhibit circadian locomotor activity in DD and do not 
phase shift to a 6 h light pulse (Bunger et a l, 2000). The mRNA of Clock and Sm all 
encode for particular bHLH-PAS proteins, CLOCK and BMALl, which dimerize 
with each other in the cytoplasm (Gekakis et a l, 1998; Hogenesch et a l , 1998; 
Sheaiman et a l, 1999; Avivi et a l , 2001; see Figure 1-3). Another gene Npas2 (also 
called Mop4) encodes for a protein NPAS2 that also dimerizes with BMAL1 (Reick et 
a l, 2001; Kaasik and Lee, 2004). This protein is not necessary for circadian rhythm 
generation in the SCN, but it can maintain rhythmicity in the absence of CLOCK 
(Debmyne et a l, 2007) and may be necessaiy in peripheral oscillators (Dudley et a l, 
2003). When CLOCK-BMAL 1 dimers translocate into the nucleus they act as 
transcription rate enhancers, increasing the transcription rate of clock genes in the
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negative limb of the feedback loop. Clock and Email genes have been found in many 
other peripheral tissues and are necessaiy for rhythm generation in those tissues.
1.3.2.2 Negative Limb of Feedback Loop
The negative limb of the mammalian molecular circadian clock is composed 
of thiee homologues of the Drosophila period  gene, Perl (Shigeyoshi et al., 1997; 
Sun et al., 1997; Tei et al., 1997; Shigeyoshi et al., 2002), Per2 (Albrecht et al., 1997; 
Shearman et al., 1997; Takumi et al., 1998; Shigeyoshi et al., 2002) m àP erS  (Zylka 
et al., 1998a; Shearman et al., 2000a) and two homologues of the Drosophila 
cryptochrome gene, Cryl and Cry2 (Thresher et al., 1998; Griffin Jr et al., 1999; 
Kume et al., 1999; Okamura et al., 1999; van der Horst et al., 1999; Vitatema et al., 
1999). A mammalian homologue of Drosophila timeless {tim) was also identified, 
Timeless (Tim) (Sangoram et al., 1998; Zylka et al., 1998b; Hastings et al., 1999; 
Takumi et al., 1999; Gotter et al., 2000), However, in studies that assessed the 
relevance of the mammalian Tim gene, it has been reported, with one exception 
(Tischkau et al., 1999), that Tim exhibits little expression or circadian rhythmicity in 
the SCN, as well as no light induced changes in expression. In addition, the bHLH- 
PAS protein TIM has been reported to have no significant role in the mammalian 
clock feedback loop. It has been postulated that during mammalian evolution, the 
additional PER proteins may have taken the place of (Drosophila) TIM in the 
mammalian circadian feedback loop (Zylka et al., 1998b).
A single Per or Cry gene is not sufficient for a functioning circadian clock in 
DD. Circadian rhythm generation is dependent upon multiple genes and their protein 
interactions (Oster et al., 2003b). For example, homozygous Perl KO, Per2 KO or 
Perl/Per2  double KO animals exhibit arrhythmic locomotor activity in LD and DD,
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Figure 1-3. The Circadian Post-Transcriptional, Post-Translational Positive-Negative 
Feedback Loop. In the positive limb, Clock and Bmall m RNA translocates to the cytoplasm  
(dashed-lines, arrows) to form their respective proteins (centre to #1) and dimerize (dashed  
box, two-way arrows). CL0C K:BM A L1 heterodimers (dashed box joined symbols) 
translocate into the nucleus (short dashed-line, arrow), bind to E-box elements of Per/Cry 
genes enhancing (solid line, circled '+') their transcription rate on the negative limb (centre 
to #2). CL0CK:BM AL1 drive the 8m a/f-transcription repressor, Rev-erba (#6 to #5). In 
addition, D EC 1/D E C 2 proteins regulate the rate of BMAL1:CL0CK-induced transcription of 
P er by inhibiting cytoplasmic BM AL1:CLOCK dimerization (#1 to #6). Cytoplasmic PER and 
C R Y  dimerization inhibits immediate protein degradation and maintains nuclear protein 
accumulation. CKIe and M APK phosphorylate PER /C R Y  proteins in the cytoplasm (#4). 
Nuclear translocation of P ER :PER  and PE R iC R Y  represses Per and Cry transcription by 
(1) forming complexes with CL0C K:BM A L1 (centre to #2) or (2) competing with 
CL0C K:BM A L1 for PerlCry E-box binding sites (short dash line, circled '-'). PER 2 activates 
Small transcription with another unknown dimerization partner (just above centre). 
Enhanced transcription of Rev-erba by CL0CK:BM AL1 is repressed by P ER 2:C R Y  
competing for binding to Rev-erba E-box (centre to #5). As Small transcription decreases, 
PER  and C R Y transcription decreases, and cytoplasmic degradation increase, negative 
feedback ceases and the cycle begins again.
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but homozygous PerS KO animals are similar to WT (Shearman et ai., 2000a; Bae et 
ai., 2001; Lee et al., 2004). The locomotor activity rhythms of Perl/Per3 or 
Per2/Per3 double KO mice are also similar to PerJ KO mice or Per2 KO mice. This 
indicates that Per3 is not necessaiy for generating circadian rhythmicity, but may be 
important for other regulatory processes. For example, polymorphisms in the human 
PER3 gene have been shown to related to sleep-wake time preference and differences 
in homeostatic mechanisms (Archer et al., 2003; Viola et al., 2007; Jones et al., 2007).
In regards to Cry genes, both homozygote Cryl or Cry2 KO animals have 
been shown to exhibit circadian locomotor activity in DD. The average period of 
locomotor activity is -1  h shorter in homozygous Cfyl  KO and -1  h longer in 
homozygous Cry2 KO compared to WT (Thresher et al., 1998; van der Horst et al., 
1999; Vitatema et a l, 1999). Initially, both “homozygous-Cry7/heterozygous-Oy2” 
KO and “homozygoous-C/y2/hetereozygoous-Oy/” KO animals exhibit similar free- 
mnning rhythms of locomotor activity in DD, but eventually both become arrhythmic 
after many days in DD (van der Horst et a l, 1999). In addition, the locomotor activity 
of homozygous Cryl/Cry2 double KO is amhythmic in DD (Vitaterna et a l, 1999). 
Cry deficient animals continue to exhibit photic phase shifts and entrainment, yet they 
have altered light sensitivity (van der Horst et a l , 1999). For example, homozygous 
Cryl KO, Ciy2 KO and Ciyl/Cry2  double KO can entrain by light, but each genotype 
has a reduced sensitivity to acute light induction of the Period gene (Vitaterna et a l, 
1999; Albus et a l, 2002). The amplitude of the PRC is significantly different between 
Cry2 WT, heterozygote KO and homozygote KO. Homozygote Cry2 KO animals 
exhibited a larger amplitude PRC compared to WT. CryUCry2 double KO mutants 
have been shown to exhibit high levels of PER1/PER2 at all times of day, yet 
Perl!Per2 still increase their expression in response to brief light pulse (Vitaterna et
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al., 1999; Okamura et al., 1999). CRY proteins negatively affect Per transcription in 
SCN cells, but do not mediate photic entrainment mechanisms o f the clock (Okamura 
et al., 1999).
Clock genes Perl, Per2, Per3, C iyl and Cry2 exhibit a circadian rhythm in 
peak expression that is in antiphase with Bmall peak expression. Their mRNA levels 
are high during the subjective day and low during the subjective night. Mammalian 
Perl expression peaks during the early subjective day, while Per2, Per3, Cryl and 
Cty2 peak during the latter subjective day or evening (Takumi et al., 1998; Okamura 
et al., 1999). Perl and Per2 are the only known light sensitive genes and are mostly 
responsible for photic entrainment (Zylka et al., 1998a; Griffin Jr et al., 1999; Yan et 
al., 1999a; Miyake et al., 2000; Albrecht et al., 2001). In a phase-dependent manner, 
light exposures during the subjective night can increase and shift the timing of Perl 
and Per2 expression in the SCN, and a LD cycle can entrain their peak timing (Oishi 
et al., 2002). However, following a brief light exposure Perl expression significantly 
increases within 30 minutes while Per2 expression does not significantly increase 
until after 2 h (Albrecht et al., 1997; Shearman et al., 1997). The light-induced 
increase in Perl expression coincides with light-induced increases in electrical 
activity in retino-recipient SCN cells (Kuhlman et al., 2003). Ventral subpopulation 
gastrin-releasing peptides convey photic signals to the dorsal subpopulation of output 
SCN cells via induction of Perl gene expression (Aida et al., 2002). Light induction 
of Perl and Per2 expression is somehow mediated through signal cascades of light- 
dependent transcription factors related to light-induced early immediate gene c-fos 
expression and CREB phosphorylation in SCN cells (Obrietan et al., 1998; Oster et 
al., 2003a). In general, the phase shifts observed in the timing of peak Perl expression
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are similar to the phase shifts in the timing mammalian rest-activity behaviour 
(Shigeyoshi et al., 1997).
Per genes may also mediate nonphotic effects to the molecular clock. In 
contrast to light-induced increases in Per gene expression during the subjective night, 
nonphotic stimuli repress Per gene expression dining the subjective day (Maywood et 
al., 1999). For example, split mice exhibited delayed Perl and Per2 expression in 
relation to activity onsets (Abe et al., 2001). In addition, Neuropeptide Y within the 
intergeniculate leaflet, which is speculated to cause behavioural induced phase shifts, 
can reduce the expression of Perl and Per2 in the SCN (Fukuhara et al., 2001). These 
examples illustrate the differences between photic and many nonphotic effects at the 
molecular level of the clock in respect to the mammalian Period genes. It also 
demonstrates that photic and nonphotic inputs affect the same core components, 
which are necessaiy for clock function and resetting.
After CLOCK: BMAL 1 E-box element activation of Per and Q y  transcription, 
mRNA levels increase within the nucleus of the cell and then translocate to the 
cytoplasm to form their respective protein (see Figure 1-3). Per genes encode for 
particular bHLH-PAS proteins PERI, PER2 and PER3, and Cry genes encode for 
photolyase-like/blue-light photopigment proteins CRYl and CRY2. These proteins 
form complexes with each other, either PER:PER homodimers or CRY:PER 
heterodimers (Griffin Jr et al., 1999; Kume et al., 1999; Field et al., 2000; Yagita et 
al., 2000; Vielhaber et al., 2001; Yagita et al., 2002). Binding between PER and PER 
or CRY inhibits immediate degradation and maintains nuclear accumulation of these 
proteins. PERiPER and PER:CRY dimers translocate into the nucleus where they 
repress the action of CL0CK:BMAL1 mediated transcription of Per and Cry. 
Repression occurs either by (1) fonning complexes with CL0CK:BMAL1 or (2)
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competing with CL0CK:BMAL1 heterodimers for binding sites of the E-box 
promoter region on Per genes (Griffin Jr et al., 1999). However, PER2 can directly 
activate a positive component of the clock, where by it can increase Bmall 
transcription with another dimerization partner, either with CRY (Yu et a l, 2002), 
itself (Sheaiman et a l , 2000b; Bae et a l ,  2001) or with an unknown protein co­
activator.
1.3.2.3 Transcription Rate Regulators
Six additional genes, Dbp, Ckis, Mapk, Rev-erba and D ecl and Dec2 
intertwined between the positive-negative limbs act as transcription rate regulators. 
They are generally insensitive to light and mostly act as “timing gears” within the 
molecular circadian clock. They regulate the rate of nuclear transcription by either 
direct E-box element binding in the nucleus and/or by influencing the rate of 
dimerization in the cytoplasm. In general, they determine the lag time between 
positive and negative limbs and thus influence the overall circadian period of the cell.
The Dbp gene encodes for DBP (albumin D-element binding protein; a PAR 
leucine zipper transcription factor family) and is expressed heavily in the SCN and 
other brain areas. Dbp expression exhibits circadian rhythmicity in the SCN, peaking 
in the early subjective day and is driven by CL0CK:BMAL1 heterodimer binding 
(Yan et a l, 1999b). DBP may have dual roles, where by (1) it exhibits feedback on 
the negative limb of the clock as binding element in promoter region of Perl 
enhancing the transcription of Perl through the same E-box promoter region along 
with CLOCK:BMALl heterodimers (Yamaguchi et a l , 2000), and (2) it is thought to 
be a component of the output pathway of the molecular clock (Lopez-Molina et a l, 
1997; Ripperger et a l , 2000).
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The CkIs gene encodes for CKIs (Casein kinase I epsilon; a serine/theonine 
protein kinase), which blocks the inhibitoiy effects of PER proteins on 
CL0CK:BMAL1 mediated transcription of Per and O y  genes (Lowrey et al., 2000; 
Vielhaber et al., 2000; Lee et al., 2001; Eide et al., 2002; Akashi et al., 2002; Lee et 
al., 2004; Takano et al., 2004; Gallego et al., 2006). CKIs phosphoiylates PER in the 
cytoplasm regulating the amount o f PER dimerization and PER translocation into the 
nucleus (Figure 1-3). CKIs may also be able to phosphoiylate both CRYl and CRY2 
if bound to PER proteins, and may regulate the amount of BMAL 1, but not CLOCK, 
in the cytoplasm (Eide et al., 2002). The Tau mutant, which is encoded by Ckis, is a 
semidominant autosomal allele that shortens the free-running period locomotor 
activity in hamsters (Ralph and Menaker, 1988; Lowrey et al., 2000). In the Tau 
mutant, the negative limb of feedback loop has a shorter lag time during the molecular 
cycle which causes the circadian clock to run faster compared to wild-types. The Tau 
mutant CKIe enzyme was initially thought to be less active, causing less PER 
phosphorylation, greater PER accumulation, and a higher rate of PER negative 
feedback, which would close the negative limb of the cycle (Lowrey et al., 2000). It is 
now understood that the Tau mutant CKIe enzyme is more active, causing more PER 
phosphoiylation, less PER accimiulation, and a higher rate of PER degradation, which 
is then responsible for closing the negative limb of cycle (Gallego et al., 2006). 
Another protein, MAPK (P-ERK) may also function as a dimerization regulator, like 
CKIe. It degrades (phosphorylation) the availability of cytoplasmic CRY (Sanada et 
al., 2004), as well as BMALl (Sanada et al., 2002). In addition, MAPK appears to be 
an active component during light-induced changes in gene expression and protein 
regulation within the molecular clock (Obrietan et al., 1998).
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Rev-erba, D ecl and Dec2 regulate transcription factors in the positive limb. 
The gene Rev-erba encodes for REV-ERBa (part of thyroid/steroid hormone 
receptor family; encoded by opposite strand of c-erbAa). REV-ERBa represses 
Bmall transcription through a ROR response element (RORE). Rev-erba  expression 
is in phase with Bmall during the night, which is in anti-phase with Per2 expression 
(Ueda et al,, 2002). Rev-erba transcription is enhanced by CL0CK:BMAL1 
heterodimers and repressed by PER2;CRY heterodimers competing with 
CL0CK:BMAL1 for binding to Rev-erba E-box elements (Preitner et al., 2002; see 
Figure 1-3). In Rev-erba KO mice, Bmall expression exhibits no circadian rhythm 
and remains high across the day. In addition, Rev-erba KO mice exhibit a 
significantly shorter average period and a wider distribution of periods of locomotor 
activity, and they exhibit larger light-induced phase advances compared to WT. Decl 
and Dec2 encode for bHLH-PAS proteins, DECl and DEC2 (Differentially Expressed 
in Chondrocytes). DECl and DEC2 regulate the formation and availability of 
CL0CK:BMAL1 heterodimers (Honma et al., 2002). Decl and Dec2 expression both 
exhibit a circadian peak during the subjective day near the peak o f P eriO y  
expression. D ecl and Dec2 expression may be increased in the presence of Clock in 
the nucleus (Butler et al., 2004). D ecl has been reported to exhibit phase dependent 
responses to light (Honma et al., 2002). DECl and DEC2 repress CLOCK-BMALl 
transcription enhancement of Perl via direct protein-protein interactions with 
BMALl and CLOCK (Honma et al., 2002), and may also compete with Bmall E-box 
element binding (Sato et al., 2004). Dec2 transcription is regulated by DECl and/or 
both may auto-regulate themselves (Li et al., 2003; Kawamoto et al., 2004), which 
may increase the availability of CLOCK:BMALl dimers. This interaction regulates 
the dimerization of CLOCK and BMALl, which drive negative clock components.
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1.3.2.4 Peripheral Clock Genes
Most circadian clock genes identified in SCN cells have been identified in 
other tissues outside the nervous system. Within other cells of various tissues 
throughout the body, peripheral clock genes, as they are called, exhibit rhythmic 
expression similar to that obseiwed in SCN cells. For example, circadian Perl 
expression is found in liver, lung, and muscle tissues, yet the timing and amplitude of 
peak Perl expression is not similar to its expression in SCN cells (Yamazaki et al.,
2000). Rhythmicity and synchronisation of peripheral clock genes is mainly regulated 
by the master pacemaker in the SCN. Phase shifts elicited in SCN cells will evoke 
phase shifts to peripheral oscillators, but shifts in peripheral clocks are not immediate. 
For example, when a LD cycle was advanced or delayed by 6 hours, P erl expression 
in SCN tissue rapidly shifts within one cycle, but Perl expression in peripheral tissues 
shifted after —7 cycles or more in some instances, such as in liver cells (Yamazaki et 
al., 2000). Similarly, Per2 is also expressed in peripheral tissues, like the retina 
(Okamura et al., 1999) and heart and skeletal muscle (Shearman et al., 1997). There is 
synchronous expression of Perl and Per2 in other tissue, but their peaks are later in 
the subjective day as compared to their peak expression in the SCN. Although Perl 
appears to be more highly expressed than Per2 in many tissues, Per2 is also vital for 
generating and maintaining rhythmicity and may also be involved in photic phase 
shifting and entrainment of peripheral circadian clocks.
1.4 Measurement of Circadian Period
1.4.1 Diurnal vs. Nocturnal Rodents
In most mammalian studies in mice, rats and hamsters, period is measured 
under DD conditions to remove the most significant environmental stimulus, light.
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The endogenous rhythms of some mammalian species (e.g., the rat or hamster) can 
easily be observed by measuring the animal’s rest-activity cycle. Studies of this kind 
measure the animal’s wheel-running activity across the 24-h day over many days, 
weeks or even months. Under such conditions the free-running circadian period can 
be estimated using the onset of activity as a circadian marker. The circadian period of 
the activity onset under DD conditions has been found to be highly stabile and 
precise. However, variation in the observed period in DD within the same animal can 
be produced with even moderate changes to the experimental conditions, such as the 
animal’s access to a running wheel (Edgar et al., 1991) or the type of mnning wheel 
device used to measure locomotor activity (Yamada et al., 1985; Yamada et al., 
1988).
The range of individual free-mnning circadian periods within a given species 
under DD conditions usually exhibits a normal distribution. In many cases, the 
distribution may be narrower or wider if the average period of the species is nearest to 
or farthest from the period of the natural LD cycle, respectively (Pittendrigh and 
Daan, 1976a). However, the average and/or distribution of individual circadian 
periods may differ between the young and old in some (Witting et al., 1994), but not 
all species (Davis and Viswanathan, 1989; Duffy et al., 1999). Both diurnal and 
nocturnal mammalian species exhibit near-24-h rest-activity rhythms in DD. 
However, the free-mnning period is usually longer than 24-h in diurnal mammals and 
shorter than 24-h in nocturnal mammals, but exceptions to this rule have been 
reported (Pittendrigh, 1960). Conversely, the observed period of the rest-activity 
rhythm under LL conditions usually shortens or lengthens with increasing light 
intensity relative to the free-mnning period in DD in diurnal or nocturnal mammals, 
respectively {Aschoffs Rule: Aschoff, 1952; Pittendrigh, 1960; Daan and Pittendiigh,
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1976b). In addition, a light pulse during the subjective night can decrease and 
suppress locomotor activity in nocturnal rodents, but it can usually elicit arousal and 
locomotor activity in diurnal rodents. Despite these differences, diurnal and nocturnal 
mammals do exhibit similarities in the temporal relationship between the timing of 
other internal biological processes and the timing of the 24-h LD cycle. For instance, 
the production and release of the pineal-hormone melatonin usually rises and peaks 
during the dark phase of the 24-h day or the subjective night regardless of whether the 
animal is nocturnal or diurnal (Arendt, 1995).
Prior photic history has been shown to elicit prolonged effects on observed 
circadian period. For example, prior photic entrainment to various LD cycles can 
induce aftereffects on the observed free-running period of the circadian pacemaker. 
Aftereffects have been demonstrated in the free-running rest-activity rhythms in 
nocturnal rodents in DD upon release from photic entrainment to both extremely 
shorter and longer than 24-h day lengths (Pittendrigh and Daan, 1976a). Animals 
usually exhibit shorter and longer free-running periods in DD upon release from 
entrainment. However, these ‘aftereffects’ on observed period slowly dissipated over 
so many days (>50-100 days) in DD and gradually lengthen or shorten until a more 
stable free-running period is established. Another example of the effects of prior 
photic histoiy on circadian period has been demonstrated in hamsters blinded 
(bilateral enucleation) 1, 7, and 28 days after birth while raised in LD (Yamazaki et 
al., 2002). The range of observed periods in locomotor activity was wider in all 
enucleated groups compared to controls, hamster blinded after 7 or 28 days exhibited 
significantly longer periods than controls and hamsters blinded on day 1.
Factors other than light are also known to influence the timing of circadian 
rhythms in mammals (Mistlberger and Skene, 2004), as well as humans (Klemian,
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2001; Mistlberger and Skene, 2005). Nonphotic time cues have been shown to affect 
period, eliciting phase shifts and entraining circadian rhythms in animals. Such 
nonphotic time cues include, feeding (Rusak et al., 1988), social interaction 
(Mrosovsky et al., 1988), locomotor activity or arousal (Reebs and Mrosovsky, 1989; 
Mrosovsky et al., 1989; Yamada et al., 1990; Mistlberger et al, 2003), ambient 
temperature (Janik and Mrosovsky, 1993) and phannacological agents such as, 
benzodiazepine (Van Reeth and Tuiek, 1989) melatonin administration (Redman et 
al., 1983), alcohol (Mistlberger and Nadeau, 1992) and nicotine (Trachsel et al., 
1995; Ferguson et al., 1999).
1.4.2 Circadian Period in Humans
The human circadian pacemaker generates -24-h rhythmicity in many 
physiological and behavioural variables, such as body temperatuie, hormone secretion 
and sleep-wake regulation. The earliest human studies examined the daily body 
temperature across the 24-h day. It was reported that body temperature is usually 
highest during the subjective day and lowest during the subjective night (Gibson, 
1905; Toulouse and Pieron, 1907), even when the sleep-wake schedule was inverted 
(Benedict, 1904). Nathaniel Kleitman’s pioneering work conducted in Mammoth 
Cave demonstrated that the 24-h rhythm of core body temperature persisted even 
when he lived on 28-h day schedule, which imposes or forces desynchrony between 
the sleep-wake cycle and the endogenous rhythm (Kleitman, 1939). Further studies 
reported the rhythmicity of body temperature and renal function in individuals living 
in isolation in underground caves shielded from the environmental 24-h LD cycle 
(Colin et al., 1968; Mills, 1964) or living on abnoimal day lengths similar to 
Kleitman’s protocol (Lewis and Lobban, 1956; Lewis et al., 1956).
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However, assessments of human circadian period have yet to be measured for 
long durations under DD conditions in sighted subjects due to the ethical and 
logistical problems inherent in such studies. For this reason, alternative methods have 
been devised to assess human circadian period, such as the classical free-mnning 
studies, field studies of blind individuals with no light perception and studies using 
Kleitman’s “forced desynchrony” (FD) protocol. These methods differ in regards to 
the subject population’s exposure to photic time cues and nonphotic time cues before 
or during assessments. As mentioned earlier, the observed period of the pacemaker 
may be shortened or lengthened under different environmental and behavioural 
conditions. Not surprisingly, the average circadian period reported between methods 
is relatively different (Figuie 1-4). However, the average period estimates derived 
from other studies using one of these methods is similar across those reported in the 
literature (Figure 1-5).
1.4.2.1 Classical Free-Running Studies
Aschoff and Wever conducted the first of many long duration (-1 -month or 
longer) studies in humans in isolation in underground bunkers, shielding them from 
exposure to the natural environmental LD cycle (Wever, 1979). During these isolation 
studies, subjects self-selected their sleep and wake episodes and core body 
temperature and other physiological and cognitive variables were measured 
throughout. The core body temperature rhythm usually exhibited a longer than 24-h 
period during isolation upon release from entiainment, yet the rest-activity cycle in 
some instances exhibited a much longer period, ranging from -25 to 60-h. As a result, 
the phases of the core body temperature and rest-activity rhythm, which conesponded 
during entrainment, disassociated. Over days o f the study, the temporal phase
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DISTRIBUTION OF HUMAN CIRCADIAN PERIODS
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Figure 1-4. The distribution (m ean ± S D ) of reported individual circadian period in 
humans measured under classical free-running conditions in sighted individuals (A; 
reproduced from Wever, 1979), uncontrolled field conditions in NLP blind individuals (B) 
and under forced desynchrony (T=20-h or 28-h) conditions in sighted individuals, 
including two totally blind individuals (0 )  who are not included in the sighted average. 
Data are plotted by number of subjects (y-axis) and estimated circadian period (x-axis).
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Figure 1-5. Average (± SD) circadian period estimates in humans measured under: classical free- 
running studies In A. sighted [filled triangles: Wever, 1979; Endo et al., 1999; Campbell et al., 1993, 
(a) non-nappers and (b) nappers; Monk and Moline, 1989] and S. blind subjects (open triangle: 
Lund, 1971): C. non-entrained NLP blind (open circles) reported by Harvard Medical School (HMS) 
(Klein et al., 1993; Klerman et al., 1998), Vanderbilt (VU) (Orth et al., 1979) and Stanford University 
(SU) (Miles et al., 1977); the University of Surrey (Arendt et al., 1988; Lockley et al., 1997a; Lockley 
et al., 2000; Hack et al., 2003] and Oregon Health & Science University (OHSU) (Lewy and 
Newsome, 1983; Nakagawa et al., 1992; Sack et al., 1992; Sack et al., 2000; Kendall et al., 2001; 
Lewy et al., 2004; Emens et al., 2005); D. dim LD controlled forced desynchrony studies [filled 
squares: Czelsler et al., 1999, (a) young and (b) old; Gronfier et al., 2007; Wright Jr. et al., 2001; 
Carskadon et al., 1999, adolescents; Koorengevel et al., 2003, (a) winter and (b) summer controls]; 
E. LD uncontrolled forced desynchrony studies with knowledge of time [Kelly et al., 2003; 
Waterhouse et al., 1998; (a) 27 h and (b) 30 h FD day length]; F. dim LD controlled forced 
desynchrony studies with bedtime melatonin administration [Wyatt et al., 2006; ( la )  placebo, (1b) 
0.3mg, (1c) 5.0 mg], caffeine administration [Wyatt et al., 2004; (2a) placebo and (2b) caffeine] or 
exercise within [Cain et al., 2007; (a) control and (b) exercise] and between [Beersma et al., 1998; 
(a) control, (b) moderate exercise, (c) intense exercise] subjects; G. dim light laboratory studies 
(filled downward triangle) during a time-free habitual (Cajochen et al., 2003) or inverted (Barger et 
al., 2004; controls) 24-h LD or with knowledge of time of day in constant dim light (LL), self-select 
schedule (Middleton et al., 1996).
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relationship between the core body temperature rhythm and rest-activity rhythm 
continued to change, Aschoff called this loss of synchrony between the two rhythms, 
“spontaneous internal desynchronization”.
The average (± SD) circadian period of the core body temperature rhythm 
derived from the classical free-mnning studies (n=147; Aschoff and Wever, 1962; 
Wever, 1979), was around 25.00 ± 0.50 h (range 23.8 to 27.1 h; Figure 1-4A). It is 
now understood that the circadian period was measured in the presence of non- 
unifoim or unequal distribution of ocular light exposure across circadian phase in 
individuals studied under these self-select conditions, which systematically 
lengthened the observed period (Klerman et al., 1996; Czelsler et al., 1999). At the 
time of these experiments, it was believed that social interaction, and not light, was 
the strongest synchroniser of human circadian rhythms. As described earlier, ocular 
light exposure in the early part o f the subjective night elicits phase-delay shifts, while 
ocular light exposure in the later subject night or early subjective day elicits phase- 
advance shifts (Czelsler et al., 1986; Czelsler et al., 1989; Minors et al., 1991; Khalsa 
et al., 2003), even at low intensities of light (Boivin and Czelsler, 1998; Zeitzer et al., 
2000b). The transition between light induced delay shifts and advance shifts is usually 
close to the phase (fitted minimum) of the core body temperature. Under entrained 
conditions to the 24-h day, the core body temperature minimum usually occurs shortly 
before habitual wake time during the second half of the subjective night. Under free- 
running conditions, subjects usually choose to go to bed at a later circadian phase. As 
a result, the phase relationship between both rhythms changed each cycle, such that 
subjects tended to initiate bed time and sleep (turning off the lights and closing their 
eyes) nearer to the core body temperature minimum (Figure 1-6). Consequently, this 
behaviour exposed subjects to light in the phase-delay portion of the photic PRC and
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Figure 1-6. Example of circadian rhythms and spontaneous internal desynchronization of 
one subject studied during the classical free-running study. The course of the experiment 
is arbitrarily divided into two sections: internally synchronized rhythms in the 1st section 
(A) and internally desynchronized rhythms in the 2nd second section (8), with 
spontaneous transitions. Presented are the rhythms of sleep-wake (bars: black: wake; 
white: sleep) and rectal temperature (upward triangles indicate maximum temperature 
values and downward triangles indicate minimum temperature values). 
Desynchronization occurs with a lengthening in period of the sleep-wake rhythm. 
(Adapted from W ever R, 1975 and W ever RA, 1984).
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darlcness in the phase-advance portion of the photic PRC. Due to these daily light- 
induced phase-delay shifts, the observed period of core body temperature rhythm was 
systematically lengthened in these sighted individuals.
The potential feedback effects of self-selected light exposure on the observed 
period during the classical free-running studies is apparent when considering the 
difference in observed periods between “free-running” nappers and non-nappers 
(Campbell et al., 1993). In this case, the core body temperature in subjects allowed to 
nap freely exhibited a significantly shorter period (-24.2 h) compared to the period 
observed in non-nappers (-24.7 h). As previous studies have shown, non-napping 
“free-running” subjects tended to initiate their single sleep bouts later each day 
compared to napping subjects. In addition, the rhythms of individuals living during 
the mostly dark winter days in Antarctica (Kennaway et al., 1991) and sighted 
individuals who exhibit non-24-h sleep-wake disorder while living in society exhibit 
similar non-24-h periods close to 25-h (McArthur et al, 1996; Klerman, 2001; 
Hayakawa et al., 2005) despite the knowledge of time of day and social interaction.
1.4.2.2 Field Studies in NLP Blind Subjects
A majority of blind individuals with no conscious light perception have been 
reported to exhibit non-entrained circadian rhythms while living in society. The non- 
entrained rhythms observed in NLP blind individuals in society is related their 
impaired vision (Tabandeh et al., 1998; Skene et al., 1999), in which direct photic 
input from the retina to the SCN is absent (Czeisler et al., 1995; Klerman et a l , 2002). 
This single obseiwation demonstrates that daily ocular light exposure is primarily 
responsible for human circadian entrainment. This lack of light input to the 
pacemaker has provided a means with which to measure circadian period without the
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Field Study (NLP blind)
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Figure 1-7. Timing of daily self-reported sleep (horizontal bars: gray=night time sleep; 
black=day time naps) and weekly urinary aMTBs acrophases (circled stars) in two NLP  
blind subjects during 1-month assessments while living in society (Adapted from Lockley 
St/% PhD Thesis, 1997). Data for Subject 36 (A) and Subject 13 (B) are plotted by clock 
time (x-axis) and study day (y-axis). Subject 36 maintained a relatively typical 24-h rest- 
activity pattern, yet their urinary aM T6s rhythm exhibited a period significantly longer than 
24-h (24.6  h) and, thus, their rhythm was defined as “not entrained” to 24-h (Note: Subject 
3 6 ’s aM T6s acrophase times occurred ~4-h later each week). In contrast. Subject 13 
exhibited an atypical rest-activity pattern, however their urinary aM T6s rhythm did not 
exhibit a period significantly different than 24-h. As a result. Subject 13’s rhythm was 
defined as “entrained” to 24-h, even though acrophase times appear to have occurred 
slightly later each week at atypical (daytime) clock hours (between 12:00 to 16:00).
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confounding effects of light. Despite this, many of these assessments have been 
performed under field studies without controlling for possible nonphotic effects on the 
pacemaker (Figure 1-7).
In a review of the literature, circadian rhythms (i.e., determination of period or 
entrainment) have been measured in 103 NLP blind individuals (Miles et al., 1977; 
Orth et al., 1979; Lewy and Newsome, 1983; Arendt et al., 1988; Nakagawa et al., 
1992; Sack et al., 1992; Klein et al., 1993; Lockley et al., 1997a; Klerman et al., 1998; 
Lockley et al., 2000; Sack et al., 2000; Kendall et al., 2001; Hack et al., 2003; Lewy 
et al., 2004; Emeus et al., 2005; Figure 1-4B). In this population, 67 NLP subject’s 
(3:1) exhibited periods significantly different from 24-h, and thus their rhythms are 
considered non-entrained. The average circadian period in core body temperature or 
melatonin or cortisol secretion obseiwed in non-entrained NLP blind individuals 
assessed under uncontrolled field conditions while living in society is 24.48 ± 0.22 h 
(range 23.9 to 25.1 h). This average only includes (1) period estimates that were 
significantly distinguishable from 24-h [5 NLP blind subjects excluded: period 
estimates were reported as “unstable” (Sack et al., 1992, n=3), “unclassified” 
(Lockley et al., 1997a, n=l) or there was insufficient data to determine period (Lewy 
et al., 2004, n=l)], (2) baseline period estimates before experimental inteiwentions; (3) 
initial period estimates of those subjects who were studied and/or reported more than 
once in the literature (i.e., Kendall et al., 2001), (4) period estimates from subjects 
living mostly in society [does not include period estimates of 2 NPL blind subjects 
studied under FD conditions (-24.1 h period measure in both subjects 1415 and 1451 
in Klerman et al., 1998) or period estimates of 7 blind subjects studied under the 
classical free-mnning protocol (Lund, 1974; average period was -24.5 h)]. A similar 
average, range and distribution of periods have been reported when subjects are
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DISTRIBUTION OF PERIODS IN NLP BLIND
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Figure 1-8. The distribution of individual circadian period estimates of nonentrained 
NLP blind humans measured under uncontrolled field conditions as reported from (A) 
the University of Surrey, (B) the Oregon Health and Science University (O H S U ) and 
(C ) a collective from Harvard Medical School (HMS; n=7), Vanderbilt University (VU; 
n=1) and Stanford University (SU; n=1).
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separated between the three groups based on the similarity of methods used by the 
institution that produced individual estimates (Figure 1-8). However, the percentage 
of NLP blind subjects categorized as “non-entrained” (period significantly different 
from 24-h) is not similar between these research groups (U. of Surrey, 69%, n=39; 
OHSU, 86%, n=37; HMS/VU/SU, 50%, n=18).
The remaining quarter of the total population studied exhibited 24.0 h periods 
in society (n=26) and are not included into the overall average [Lewy and Newsome, 
1983; Sack et al., 1992; Lockley et al., 1997a; Klerman et al., 1998 (including 
subjects 1415 and 1451)]. Half of NLP blind subjects with 24.0 h rhythms exhibit 
abnormal phase relationships with the 24-h day (i.e., melatonin peak between 9am to 
11pm during the daytime), but it could not be determined whether the observed 24.0 h 
rhythms reflect period, continuous entrainment (photic or nonphotic), or even phase- 
trapping. The latter suggests a temporary shortening of observed period during 
particular or range of phase relationships between the endogenous rhythm and the LD 
or rest-activity cycle. For example, the melatonin rhythm, assessed bi-weekly for ~6 
months in a subset of non-entrained NLP blind individuals, exhibited relative 
coordination with the 24-h day (Emens et al., 2005). The majority of circadian 
assessments in NLP blind individuals are between 4 to 8 weeks in duration with phase 
estimates sampled weekly, bi-weekly or longer. Therefore, factors such as duration of 
the study, number of circadian phase estimates and elapsed time between phase 
estimates may contribute to the inability to distinguish between circadian or entrained 
period or to detect periods slightly shorter or longer than 24.0 h.
Comprehensive evaluations conducted in a few of these NLP blind subjects 
have determined that some of these 24.0 h period estimates may reflect an ‘entrained’ 
period (t =T) mediated by either photic or nonphotic stimuli, rather than intrinsic
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period (Czeisler et al., 1995; Klerman et al., 1998, Klerman et al., 2002). For instance, 
4 NLP blind individuals who retain at least one natural eye exhibited 24.0 h rhythms 
and light-induced melatonin suppression (i.e., circadian photoreception) (subject 1, 2 
and 3 in Czeisler et al., 1995; subject 5 in Klerman et al., 2002), and another NLP 
individual not tested for light-induced melatonin suppression but still retained 
pupillary reflexes to light (subject 2; Sack et al., 1992). Daily ocular light exposure 
can elicit phase shifts in these individuals thus explaining their observed 24.0 h 
rhythms. Their 24.0 h rhythms reflect photic entrainment, and thus their period 
estimates are rightfully not included in the NLP blind group average. Surprisingly, 
nine totally blind subjects exhibited 24.0 h rhythms, including two subjects who were 
bilaterally enucleated (subjects 1268 and 1337 in Klerman et al., 1998) and seven 
subjects who retain at least one natural eye, but did not exhibit light-induced 
melatonin suppression (subjects 1415, 1451, 1473, 14B0, 1516, 1573 and 1612 in 
Klerman et al., 1998). Four additional bilaterally enucleated subjects have also been 
reported to exhibit 24.0 h rhythms (subject ‘F ’ in Lewy and Newsome, 1983; subjects 
1 and 4 in Sack et al., 1992; subject 34 in Lockley et al., 1997a). This may suggest 
that the observed 24.0 h rhythms in these particular NLP blind individuals reflects 
intrinsic period. However, evidence from further comprehensive assessments in two 
of these subjects (1451 and 1415 in Klerman et al., 1998) showed that nonphotic 
stimuli could also explain the 24.0 h rhythms observed in these NLP blind 
individuals. The rhythms of subject 1451 entrained to a shorter than 24-h day (23.8 h) 
in a laboratory protocol and exhibited a circadian period significantly longer than 24-h 
during a 28 h FD protocol (24.1 h). However, further study of subject 1415, who was 
apparently entrained in society and exhibited a circadian period significantly longer
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than 24-h during a 28-h FD protocol (24.1 h), was not entrained after the laboratory 
protocol while living in society.
While these comprehensive assessments show that nonphotic cues can 
significantly phase shift and entrain human circadian rhythms independent of light, 
the greater proportion of non-entrained NLP blind individuals indicates that nonphotic 
cues; (1) are much weaker than photic cues; (2) can only entrain the non-24-h 
pacemaker to the 24-h day within a certain range of periods (i.e., tau within 0.2 h, and 
only 8 of 67 non-entrained NLP blind subjects exhibit periods within 24 ± 0.2 h); and 
(3) may only be effective when exposme occms at a certain phases of the pacemaker 
(Klerman, 2001). Unfortunately, photic and nonphotic entrainment was not 
experimentally determined in the majority o f studies that reported 24.0-h rhythms in 
NLP blind subjects. Due to the uncertainty described above, 24.0-h periods observed 
in the rhythm NLP blind individuals were categorised as ‘entrained’ and excluded 
from the group average. As a result of excluding shorter periods nearer to 24-h (24.0 
to 24.3 h), the group average in NLP blind subjects under field conditions may appear 
longer compared to sighted individuals under FD conditions (Czeisler et al., 1999).
The longer average circadian period in non-entrained NLP blind individuals 
may also be related to a systematic lengthening of observed period similar to that 
observed during classical free-running studies. For instance, most assessments of NLP 
blind subjects occur under uncontrolled field conditions while the subject lives in 
society during a social 24-h day length (i.e., in bed at night and active during the day). 
The rhythms in a majority of NPL blind subjects are unable to entrain to the 24-h 
solar day mostly due to a lack of circadian photoreception and a non-24-h intrinsic 
period. During these assessments, the phase relationship between internal circadian 
timing and external environmental time changes each day relative to the difference
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between the non-24-h period of the circadian pacemaker and the forced 24-h rest- 
activity. Under these experimental conditions, photic and nonphotic time cues linked 
to the 24-h rest-activity cycle are unable to entrain and are unevenly distributed across 
circadian phases.
As described above, exposure to photic and nonphotic time cues can entrain 
the pacemaker in some NLP blind individual, and therefore it is likely that they also 
could feed-back on the circadian pacemaker, elicit small phase shifts, and lengthen the 
observed period. Self-selected light exposure may still be a significant factor in a 
small proportion of non-entrained NLP blind individuals who retain at least one 
original eye. As noted before, most assessments o f non-entrained NLP blind subjects 
did not determine if any of these individuals retained circadian photoreception despite 
the lost of conscious vision. Photic-lengthening of observed period has been reported 
in some sighted individuals who exhibit non-entrained, non-24-h rhythms while living 
in the society. For instance, during a clinical assessment, one sighted individual 
exhibited a 25.0 h period in society, yet exhibited a 24.5 h period during a laboratory 
FD protocol (Klerman et al., 2001). The rhythms in this sighted individual were not 
entrained to the 24-h day, despite retaining ocular light-induced melatonin 
suppression.
During most assessments of non-entrained NLP blind individuals, nonphotic 
time cues linked to the 24-h rest-activity cycle in society were not experimentally 
controlled. Individual subjects lived freely in society and not asked to change 
anything about their daily routines, including the timing of: (1) rest-activity/sleep- 
wake state; (2) use of any prescription or non prescription medications and/or dmgs 
(caffeine, nicotine, alcohol); (3) meals; or (4) exercise. Some of these behaviours may 
have direct effects on the pacemaker (Deboer et al., 2004). In the same manner that
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they are capable of shortening the period or entraining the phase of the pacemaker to 
the 24-h day, they may also be capable of eliciting phase shifts that lengthen the 
observed period of non-entrained NLP blind individuals. The direction of the phase 
shifts (advance or delay) may be phase dependent, yet characteristics o f a phase 
response curve for specific nonphotic time cues has yet to be established. In addition, 
specific nonphotic time cues, other than exercise (Buxton et al., 1997; Buxton et al., 
2003; Barger et al,, 2004) and phannacological substances, like exogenous melatonin 
administration (Arendt et al., 1988; Lewy et al., 1992; Lockley et a l, 2000; Sack et 
a l , 2000; Rajaratnam et a l ,  2003), have yet to be identified as proficient circadian 
phase shifting agents compared to other stimuli in humans. It is possible that the 
strength of nonphotic time cues may also be dependent upon the intrinsic period of the 
individual, as with the range of entrainment. For instance, a particular sensitive phase 
of the pacemaker will be exposed longer to nonphotic time cues linked to the T-cycle 
(i.e., 24-h) if the period o f the pacemaker is nearer to, rather than farther from the 
period of the T-cycle. As a result, the observed period of some NLP blind individuals 
living on the 24-h day in society may be shortened while others are lengthened. This 
may explain the apparent dual peak in the distribution of observed periods (at 24.4 
and 24.7 h) in non-entrained NLP blind individual (Figure 1-4B). A majority of 
studies assessing the rhythms in NLP blind individual did not experimentally control 
subjects’ exposure to nonphotic time cues during their assessments. In addition, 
except for sleep or napping (Lockley et a l, 1997b; Lockley et a l , 1999) the type and 
daily or sporadic timing of nonphotic exposure for each NLP blind subject was not 
assessed or reported. In this respect, the type, timing and periodicity of exposure to 
nonphotic time cues may be significantly different between NLP blind subjects and 
the period estimates in this population may not be comparable.
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1.4.2.3 Forced Desynchrony Studies in Sighted Subjects
In contrast to the classical free-mnning studies and field studies in the NLP 
blind individuals, both photic and nonphotic stimuli linked to the sleep-wake cycle 
(i.e., sleep-wake state, meals, activity, showers and posture) are diminished, removed 
or evenly distributed across circadian phases during the FD protocol. Under FD 
conditions, the pacemaker in sighted subjects is exposed to extreme non-24-h day 
lengths (i.e., 11, 20, 28, 42.85 h) of scheduled bed-rest in darkness and scheduled 
wakefulness in dim-light that are well outside of the range of entrainment. As a result, 
the pacemaker cannot entrain and continues to oscillate with a near-24-h period. This 
method was first demonstrated by Kleitman (1939) who devised the FD protocol. He 
lived on a 28 h day length for a over a week shielded from the solar LD cycle inside 
Mammoth Cave, Kentucky. Despite the imposed longer-than-24-h day length, 
Kleitman’s body temperature exhibited seven oscillations even though he experienced 
only 6 rest-activity days.
The average (± SD) circadian period in melatonin and core body temperature 
observed in healthy sighted individuals (n=42) assessed under strictly-controlled, 
laboratoiy forced desynchi'ony (LFD) conditions is 24,12 ±0.15 h (range 23.8 to 24.5 
h) (Czeisler et al., 1999; Wyatt et al., 1999; Wright Jr. et al., 2001; Figure 1-4C). It 
was demonstrated in one individual (subject 1111) that the observed period is similar 
(24.3 h) under either a 20- or 28-h imposed day length, but significantly longer under 
classical free-mnning conditions (-25.1 h) (Figure 1-9; Czeisler et al., 1999). These 
studies demonstrated that the period of the human circadian pacemaker is much closer 
to 24-h than previously believed, and that self-selected light exposure may lengthen 
the obseiwed period under classical free-running conditions upon release from 
entrainment.
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Figure 1-9. Experimental results from a 22-year-old man (subject 1111) living in an 
environment free of time cues on a 20-hour forced desynchrony protocol (left 
panel), a classical free-running protocol (centre panel), and a 28-hour forced 
desynchrony protocol (right panel). The rest-activity cycle is plotted in a double 
raster format, with successive days plotted both next to and beneath each other 
and clock hour indicated on the abscissa. Baseline sleep episodes were scheduled 
at their habitual times (based on an average of their schedule during the week 
before laboratory admission). Thereafter, sleep/dark episodes (solid bars, light 
intensity, 0.03 lux) were scheduled for 6.67 hours (33% of imposed day) in the 20- 
hour protocol, self-selected by subject (averaging 28% of cycle) in the free-running 
protocol, and scheduled for 9.33 hours (33% of imposed day) in the 28-hour 
protocol. During wake episodes, the light intensity was 15 lux (20- and 28-hour 
protocols) or 150 lux (free-running protocol). Constant routines (open bars) for 
phase assessments of the endogenous circadian temperature nadir (0) and the 
fitted melatonin maximum ( A)  were conducted before and after forced 
desynchrony. The temperature period estimates are nearly equivalent under both 
forced desynchrony protocols (20-hour protocol, 24.29 hours; 28-hour protocol, 
24.28 hours), independent of the imposed rest-activity cycle. However, the 
estimated temperature period (25.07 hours) observed during free-running 
conditions (with self-selected rest-activity cycle averaging 27.07 hours) was much 
longer. Adapted From Czeisler et al., 1999.
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Ill FD studies that exposed subjects to a particular non-photic time cue across 
circadian phases, a similar average period has been reported. These include FD 
studies that studied subjects with (Waterhouse et al., 1998; Kelly et al., 1999) and 
without (Hiddinga et al., 1997; Carskadon et al., 1999; Koorengevel et al., 2002; 
Wyatt et al., 2004, Wyatt et al., 2006, Wright Jr. et al., 2006) knowledge of time of 
day, with and without scheduled bouts of exercise (Beersma and Hiddinga, 1998; 
Cain et al., 2007), with and without hourly caffeine ingestion during scheduled 
wakefulness (Wyatt et al., 2004) and with and without melatonin ingestion prior to 
scheduled bed-rest (Wyatt et al., 2006). In other laboratory studies in sighted subjects 
assessed under dim light conditions, it has been reported that circadian phase 
exhibited an average drift o f approximately +0.2-0.3 h per day. This has been 
observed in subjects studied with knowledge of time of day and self-selected bed-rest 
(Middleton et al., 1996) and in subjects studied without knowledge of time of day 
while scheduled to a 24-h day length at their habitual bed and wake time (Cajochen et 
al., 2003) or scheduled to an inverted, nightshift schedule relative to their habitual bed 
and wake time (Boivin et al., 1994; Duffy et al., 1996; Barger et al., 2004).
It has been suggested that that prior photic entrainment to the 24-h day might 
induce aftereffects on the circadian pacemaker which may shorten the observed 
circadian period (Ax) under LFD in sighted subjects upon release from entrainment 
(Czeisler et al., 1999). The aftereffects that have been reported in the free-mnning 
rest-activity rhythms in nocturnal rodents usually continue for many days or weeks in 
DD (>50-100 days) before a shorter or longer, stable free-running period is 
established (Pittendrigh and Daan, 1976a). For ~3 weeks prior to entering the LFD 
protocol, sighted subjects maintain a vigilant 8-h bed-rest schedule during the night in 
darkness and a normal 16-h of daytime wakefiilness in artificial and nature light
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confirmed by continuous activity wrist monitors. These pre-laboratory sleep-wake 
restrictions expose sighted subjects to a more precise 24-h LD cycle, which may 
ultimately refine the individual’s natural 24-h photic entrainment. Preliminary 
evidence from two studies of one sighted subject provided support for the possible 
role of aftereffects of prior entrainment on the observed period under LFD conditions 
in sighted subjects (subject 1793, Wright Jr. et al., 2006). In this subject, the observed 
period of the melatonin and core body temperature rhythm during a two-week LFD 
protocol was significantly longer (Ax = +0.1 h) following 25 days of photic 
entrainment to a 24.6-h day compared to the observed period following 25 days of 
photic entrainment to a 24.0-h day. In another study (n=7; within-subjects design), the 
observed period of the melatonin rhythm during a two-week LFD protocol was also 
significantly longer (mean Ax = +0.1 h) following 14 days of photic entrainment to a 
24.65 h day compared to the observed period following 14 days of photic entrainment 
to a 23.50-h day (Scheer et al., 2007).
In general, the LFD is a useful protocol for controlling photic and nonphotic 
feedback onto the pacemaker, but most LFD studies are only a month or less in 
duration. This may not allow sufficient time to allow aftereffects to fully dissipate. As 
a result, the period observed in sighted subjects under LFD conditions may only 
reflect the period of the pacemaker during entrainment or during transients, and not 
actually depict the free-running, intrinsic period. Moreover, the tight distribution of 
periods obseiwed in sighted subjects studied under LFD may also represent 
aftereffects of entrainment on period. If  aftereffects of entrainment explain the 
observed period in sighted subjects, it may provide insight to an inherent circadian 
property of the pacemaker, such that aftereffects of entrainment may help facilitate a 
narrower range of entrainment to the 24-h day. A naiTOwer range would require less
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(photic) resetting strength (e.g., light intensity) and amount of phase shift (minutes) 
each day to maintain entrainment. However, the narrower range of periods may also 
be related to the exclusion of sighted subjects based on momingness-eveningness 
preference (Horne-Osberg M-E Questionnaire). ME preference has been shown to be 
highly correlated to the obseiwed period under LFD in sighted subjects (Duffy et al.,
2001), such that subjects who exhibited periods shorter or longer than 24-h were more 
likely to be categorised as a morning- or evening-type, respectively. In the LFD 
protocols described above, extreme morning- and evening-types were excluded from 
participation. Therefore, the exclusion of extreme evening-types may have eliminated 
sighted subjects with much longer-24-h periods.
1.5 Human Pineal Melatonin Rhythm
1.5.1 Melatonin Synthesis and Metabolism
The mammalian SCN generates the daily pineal melatonin rhythm. The pineal 
gland is a small, pine cone shaped stmcture located on the midline, posterior portion 
of the third ventricle. Melatonin (indoleamine, N-acetyl-5-methoxytryptamine) is 
synthesized from tryptophan in pineal cells called pinealocytes (Figure 1-10). 
Tryptophan hydroxylase converts tryptohan into 5-hydroxyltryptophan, aromatic 
amino acid decarboxylase (AADC) converts 5-hydroxyltryptophan into serotonin (5- 
hydroxytryptamine), aiylalkylamine A-acetyltransferase (AA-NAT) converts 
serotonin into N-acetylserotonin and hydroxyndole-O-methyltransferase (HIOMT) 
converts N-acetylserotonin into melatonin. Most of the melatonin secreted into the 
blood stream is metabolized in the liver, producing the metabolite, 6- 
sulphatoxymelatonin (aMT6s), which is mainly excreted in urine. As a result, 
continuous plasma melatonin and urinary aMT6s are highly correlated and sampling
1-67
Melatonin Synthesis
Hypothalamus
LIGHT
RHT HindbrainEYE 4  SCN
entrainment
Spinal cord
SCO
P-adrenergic
receptor
Pinealocyte
ATP
N A
cA M P
Protein
synthesis
C-kinase N A
a-adrenergic
receptor
Figure 1-10. Pineal melatonin is produced rhythmically in pinealocytes. The daily 
melatonin rhythm is generated by the circadian pacem aker, the paired S C N . Daily ocular 
exposure to the environmental light-dark cycle entrains the non-24-h period of the 
pacem aker via the retina-R H T-SC N  pathway. The S C N  elicits pineal melatonin production 
by stimulating a - and p- adrenergic receptors on pinealocytes via the PVN and superior 
cervical ganglion in the spinal cord Adapted from Arendt, 1995.
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either over 24-h is a useful method for assessing the melatonin period, phase and 
amplitude in humans (Arendt, 1986).
1.5.2 SCN Regulation of the Melatonin Rhythm
Removing or lesioning the bilateral SCN abolishes pineal melatonin synthesis 
(Klein and Moore, 1979) or its daily periodicity (Reppert et al., 1981). The SCN 
stimulate pineal melatonin synthesis along a sympathetic noradrenergic (NA) 
pathway, including the paraventricular nucleus (PVN), via paired superior ceiwical 
ganglia (SCO) located in the upper thoracic spinal column eveiy 24-h (Snyder et al., 
1965). Pinealectomy, lesioning the pineal (Neuwelt and Lewy, 1983) or transection 
along the SCN-SCG-pineal pathway, as observed in tétraplégie humans (Zeitzer et al., 
2000; Zeitzer et al., 2005), abolishes melatonin synthesis.
1.5.3 Melatonin Feedback
The pineal melatonin rhythm has been shown to feed back onto the 
reproductive system (mostly in rodents) and circadian system. For example, the ratio 
of LD exposure influences the duration of melatonin secretion (Axelrod et al., 1965). 
Gradual change in the ratio of LD across seasons of the year will elicit gradual 
shortening or lengthening of elevated melatonin secretion duration (i.e., melatonin 
duration lengthens as dark episodes expand during the months approaching the winter 
solstice and shortens as dark episodes contract during the months approaching the 
summer solstice). Extreme LD ratios, blinding and pinealectomy abolish seasonal 
reproductive growth of hamster gonads (Hoffinan and Reiter, 1965). In addition, 
pinealectomy attenuates the amplitude of neural firing rate in the SCN across the 
cycle (Rusak and Yu, 1993). Melatonin can also inhibit SCN firing rate particularly
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during the subjective day when SCN firing rate is usually high and melatonin levels 
are usually at their lowest 24-h levels (Liu et al., 1997b). Melatonin feedback on the 
pacemaker is mediated by melatonin receptor binding sites found on the mammalian 
SCN (Williams and Morgan, 1988; Weaver et al., 1989), including humans (Weaver 
et al., 1993). Two main subtypes of melatonin receptors have been identified in the 
SCN, Melia and Melib (Reppert et al., 1994; Reppert et al., 1995). Melatonin-induced 
phase-shifts and entrainment are mediated at these binding sites at the level of the 
SCN (Liu et al., 1997b; McArthur et al., 1997; Dubocovich et al., 1998). However, 
the Melia receptor-type represented in humans appears to be more responsible for the 
effects of melatonin on the SCN (Weaver and Reppert, 1996).
1.5.4 Photic Effects on the Meiatonin Rhythm
In most intact mammalian species and humans, plasma melatonin levels are 
usually high during the dark phase and are relatively low or undetectable during the 
light phase of the 24-h geophysical day (Klein et al., 1971; Wehr, 1991). The 
temporal relationship between the melatonin phase (peak) and the dark phase is 
maintained by the 24-h transitions between light and darkness via entrainment of the 
circadian pacemaker. In addition, ocular light exposure will suppress melatonin 
synthesis (Klein and Weller 1972; Wurtman et al., 1963; Lewy et al., 1980). The 
magnitude and duration of light-induced melatonin suppression is dependent upon the 
duration, intensity, and wavelength of the light exposure (Blinkley et al., 1973; 
Bojkowski et al., 1987; Zeitzer et al., 2000b; Brainard et al., 2001; Thapan et al., 
2001; Lockley et al., 2003). In addition, the pineal melatonin rhythm can also be 
phase-shifted by ocular light exposure in phase-dependent manner relative to dose, 
duration, wavelength of the light and prior photic history (Honma and Honma, 1988;
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Czeisler et al., 1989; Jewett et al., 1991; Minors et al., 1991; Boivin et al., 1996; 
Zeitzer et al., 2000b; Khalsa et al., 2003; Lockley et al., 2003; Smith et al., 2004). 
Ocular light exposure occurring before or after the daily peak of melatonin secretion 
elicits phase-delay or phase-advance shifts, respectively in the melatonin rhythm.
The light-induced phase and amplitude changes in the melatonin rhythm are 
mediated by the SCN via the RHT (Moore and Lenn, 1972). Ocular photic 
transmission via the RHT-SCN pathway originates from a subset of retinal ganglion 
cells (Klein and Moore, 1979) containing the light-sensitive photopigment melanopsin 
(Gooley et al., 2003; Hannibal et al., 2004). The RHT is composed of glutamatergic 
retinal afferents that are responsible for inducing phosphoiylation of the transcription 
factor CREB, increased c-Fos expression and release of the neurotransmitter GAB A 
(Albus et al., 2005), Rhythmic and acute GAB A release increases clock gene 
expression and electrical activity within the SCN (Liu and Reppert, 2000), and 
decreases pineal melatonin secretion via inhibition of PVN neurons (PeiTeau-Lenz et 
a l, 2003; PeiTeau-Lenz et a l , 2004; Isobe and Nishino, 2004). The mechanism 
through which light information is conveyed to the pacemaker in the SCN may be 
separate from and independent of the mechanism through which light information is 
conveyed to the SCN cells whose efferent projections elicit suppression of pineal 
melatonin secretion (Paul et a l , 2003; Paul et a l , 2004).
In humans, the classical photoreceptors (i.e., rods and cones) are not required 
to elicit these non-image-foiining photic responses in melatonin secretion. The 
specificity of this non-visual pathway is underscored by obsei-vations made in a small 
percentage o f NLP blind individuals (3/11) who exhibited acute light-induced 
melatonin suppression during a melatonin suppression test protocol (Czeisler et a l, 
1995). The melatonin rhythm in these same NLP blind individuals (plus one) also
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exhibited phase-dependent phase-resetting similar to that observed in sighted 
individuals in response to appropriately time light exposure (Klerman et ah, 2002). In 
addition, wavelength-dependent melatonin suppression has been demonstrated in a 
recently discovered NLP blind individual who exhibited non-image forming 
responses to bright white light ocular exposure (Zaidi et ah, 2007). In this case, 
monochromatic ocular light exposure at 460 nm elicited significant melatonin 
suppression, where as monochromatic ocular light exposure at 555 nm, the peak 
sensitivity of the 3-cone photopic system, did not.
Complete retinal degeneration, including the RGC layer, bilateral optic nei*ve 
transection or bilateral enucleation render animals and humans totally blind (i.e., no 
conscious image-fbrming-light perception or circadian photoreception), but does not 
abolish circadian rhythmicity of SCN neural firing, rest-activity rhythms (Inouye and 
Kawamura, 1979; Green and Gillette, 1982) or the melatonin rhythm (Klein et ah, 
1971; Ralph et ah, 1971). Due to the loss of photic input to the pacemaker the 
melatonin rhythm usually exhibits a non-24-h period in animals (Stephan and Zucker, 
1972), including humans (Arendt et ah, 1988; Lockley et ah, 1997b) in the presence 
of a LD cycle. However, it has been reported that the duration and amplitude of 
melatonin secretion in totally blind individuals assessed in constant conditions is 
similar to the melatonin secretion in sighted individuals (Klemian et ah, 2001).
1.5.5 Nonphotic Effects on the Melatonin Rhythm
In addition to circadian regulation (Lockley et ah, 1997a; Czeisler et ah, 1999) 
and ocular light exposure, nonphotic responses are also capable of affecting the SCN 
and therefore the melatonin rhythm. Nonphotic responses may be mediated acutely by 
direct anatomical or physiological alterations to the pineal itself, such as pinealectomy
1-72 I
I
(Lewy et al., 1980b; Neuwelt and Lewy, 1983) or genetic mutation within pineal cells 
(Ebihara et al., 1986). In addition, changes in daily melatonin synthesis or obseiwed 
plasma levels can be mediated at the level of the SCN and SCN-pineal pathway. 
These effects are produced by causing an absence, decrease or blockage of SCN to 
pineal signalling, such as bilateral lesions to either the SCN (Reppert et al., 1981) or 
the PVN-SCG-Pineal pathway (Klein et al., 1983; Zeitzer et al., 2000a; Zeitzer et al., 
2005), which dismpt or abolish rhythmic melatonin production. Melatonin 
suppression can be produced by injecting or administering pharmacological agents 
that inhibit melatonin synthesis, such as beta blockers (Deacon et al., 1998). Reduced 
melatonin levels have been produced by acute (Wright Jr. et al., 1997), but not 
chronic (Wyatt et al., 2004) caffeine administration. Elevated melatonin levels have 
been produced by an increased availability of melatonin precursors (Namboodiri et 
al., 1983). In particular, observed melatonin levels can be elevated by daily 
administration of a melatonin pill [acute-release (Wyatt et al., 2006) or prolonged- 
release (Rajaratnam et al., 2003)] prior to bedtime. Daily administration o f melatonin 
has also been shown shift the timing of the endogenous melatonin rhythm 
(Rajaratnam et al., 2003) and the endogenous sleep-wake timing (Rajaratnam et al., 
2004) in sighted subjects, as well as entrain the non-24-h endogenous melatonin 
rhythm to the 24-h day in some NLP blind subjects who typically exhibit non- 
entrained rhythms while living in society (Lockley et al., 2000; Sack et al., 2000). The 
magnitude of phase-shift elicited by exogenous melatonin administration is phase- 
dependent, but is much weaker than the magnitude of light depending on the type of 
melatonin used (over-the-counter dietaiy supplements or melatonin agonist); in 
sighted subjects under dim-light conditions, a dietaiy supplement melatonin brand has 
been shown to produce phase advance/delay shifts of up to 1-h or less (Lewy et al..
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1992), where as a melatonin agonist (i.e., tasimelteon), has been shown to produce 
phase-advance shifts of up to 3-h (Rajaratnam et al., 2009). However, light may still 
have potential effects during these observations and may mask or confound the 
obseiwed magnitude of effects that melatonin administration has on the pacemaker, 
particularly since sighted subjects are usually exposed to LD cycles during these 
assessments (Arendt et al. 1999).
Certain behaviours or states, such as activity level, posture changes, sleep 
deprivation and sleep, have also been reported to affect the melatonin rhythm. For 
example, moderate to intense bouts of exercise have been reported to both increase 
and decrease melatonin levels and phase shift melatonin levels in a phase dependent 
manner (Van Reeth et al., 1994; Buxton et al., 1997a; Buxton et al., 1997b; Leproult 
et al., 1997; Barger et al., 2004). In addition, daily bouts of exercise were sufficient to 
phase-advance and entrain (delayed phase angle) the melatonin rhythm to an imposed 
23.8-h rest-activity schedule in a totally blind subject (Klennan et al., 1998). Simple 
posture changes influence the melatonin rhythm, such that levels are slightly higher 
when subjects are standing compared to sitting and supine positions (Deacon and 
Arendt, 1994; Nathan et al., 1998; Cajochen et al., 2003). In addition, sleep-wake 
state and age have also been reported to affect the obsei*ved melatonin levels. For 
example, it was reported that peak melatonin levels increased in young male subjects 
as a function of time awake during >50-h total sleep deprivation (Zeitzer et al., 2007). 
In addition, age differences in melatonin levels during appropriately phased sleep and 
sleep deprivation have also been reported, such that melatonin levels were higher in 
younger subjects and lower in older subjects during sleep (Zeitzer et al., 2007).
Assessments of the melatonin rhythm in sighted subjects during LFD have 
shown a similar elevation in melatonin during scheduled sleep (Wyatt et al., 1999;
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PINEAL MELATONIN UNDER FORCED DESYNCHRONY
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Figure 1-11. Plasma melatonin during 28 h forced desynchrony. Panel A  shows 
circadian and time In 28 h day variation of plasm a melatonin (pmol/L) in one subject. 
Data are double-plotted by circadian phase (top graph; 0° =m idpeak melatonin rhythm) 
derived from period ( t ) of plasma melatonin and desynchrony phase (bottom graph; 0° 
=scheduled wake tim e) derived from the imposed 28 h period (T ) of scheduled rest- 
activity. Note (bottom graph) that there is a decrease in melatonin levels that begins 
just after scheduled w aketim e and continues for about 8 to 10 hours, but melatonin 
levels are above average throughout the scheduled sleep episode (Adapted from  
Shanahan and Czeisler, 2000). Panel B shows average circadian wave-form  of plasma 
melatonin during forced desynchrony between scheduled w ake and bed-rest (sleep). 
Circadian wave-form of plasma melatonin was educed separately for data collected 
during scheduled w ake (open circles) and scheduled sleep (filled circles). Data are  
double-plotted by circadian phase at the midpoints of the 30 degree bins derived from 
plasma melatonin [N=7 with the following exceptions: plasma melatonin during sleep, 
phase bins 0 and 30 degrees (n=4), 60 degrees (n=6), 240 degrees (n=5)j. Note that 
melatonin levels are lower during scheduled w ake and higher during scheduled bed­
rest (sleep) between -2 4 0  and 30“ (Adapted from Dijk, 1999).
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Dijk, 1999; Shanahan and Czeisler, 2000; Ritz-De Cecco, 2004). Under these 
conditions, the melatonin rhythm cannot entrain, but continues to exhibit a non-24-h 
period. Scheduled bed-rest in darkness and wake in dim light occurs ~4 h later each 
day relative to the daily peak of melatonin. As a result, subsequent episodes of 
scheduled bed-rest occur across all phases of the melatonin rhythm on more than one 
occasion. When melatonin data are (1) averaged by the imposed rest-activity period 
(elapsed time in imposed day) melatonin levels rise during scheduled bed-rest (sleep) 
and fall dramatically during scheduled wake (Wyatt et al., 1999; Shanahan and 
Czeisler, 2000; see Figure 1-1 lA). When the melatonin data during scheduled wake 
and bed-rest (sleep) are separated and then averaged by circadian phase, melatonin 
levels during the circadian rise and peak appear higher during scheduled bed-rest 
compared to levels during scheduled wake (Dijk, 1999; see Figure 1-1 IB). Further 
analysis has shown a similar corresponding effect of elevated melatonin levels during 
scheduled bed-rest and diminished melatonin levels during scheduled wake while also 
controlling for the phase relationship between the melatonin and imposed rest-activity 
rhythm (Ritz-De Cecco et al., 1999; Ritz-De Cecco et al., 2002; Ritz-De Cecco, 
2004). However, the magnitude of these effects were dependent upon the length of the 
imposed FD day, such that melatonin phase and amplitude modulation was greatest in 
subjects studied under the 20 h FD protocol and least in subject studied under the 28 h 
FD protocol. The evoked effects of sleep-wake state on the secretion patterns of 
various horaiones that are under circadian control are well documented (reviewed in 
Czeisler and Klerman, 1999). For example, cortisol secretion, which exhibits episodic 
pulses superimposed across a 24-h rhythm, is slightly suppressed during habitual 
sleep compared to secretion observed during constant wake conditions at the same 
time during the subjective night. In addition, the daily surge in growth hormone
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secretion, which usually occurs just prior to habitual bed time, is significantly 
diminished if habitual sleep does not occur. Although melatonin FD assessments 
occuiTed under dim LD conditions and photic and nonphotic time cues linked to the 
rest-activity cycle were distributed evenly across circadian phase, the influence of 
nonphotic time cues such as sleep and wake could not be determined. For instance, 
the elevated melatonin levels during schedule bed-rest compared to wake could not be 
concluded to be the affect o f sleep. Conversely, the modulation of phase and 
amplitude obseiwed in these assessments was consistent with the phase-dependent 
effects of light, such that melatonin levels were reduced during schedule wake due to 
the exposure to dim light and elevated in response to darkness. In other words, prior 
light exposure during scheduled wake may have masked the potential effects of the 
imposed non-24- LD schedule on the melatonin rhythm.
1.6 Sleep-Wake Regulation
1.6.1 Measuring Sleep-Wake States During Sleep Opportunities
During sleep the brain continues to be active as shown by polysomnography 
(PSG) recordings. A PSG recording measures changes in cortical neural activity 
(electroencephalogram; EEG) and the presence or absence of muscle activity 
(electromyogram; EMG) and eye movements (electrooculogram; EGG). Together 
these thi'ee measurements are used to determine whether an individual is awake or 
asleep (sleep-wake state) during bed-rest. The PSG recording is also used to 
determine various, distinct sleep states across total sleep time. PSG-defined sleep is 
divided into two general states. The state of sleep is determined by the presence or 
absence of a particular PSG pattern, rapid eye movement (REM) and non-rapid eye 
movement (NREM) sleep, respectively. REM sleep itself is a stage of sleep and
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NREM sleep is separated into four distinct stages based upon PSG-defined criteria 
established by Rechtschaffen and Kales (1968). In the PSG recording, short blocks of 
time, called epochs, are individually scored as wakefulness, REM or a particular 
NREM sleep stage. Epochs during PSG recordings are usually scored across every 30 
second segment.
Under entrained conditions, episodes of REM and NREM sleep cycle during 
consolidated sleep. Episodes o f REM sleep interchange with episodes of both NREM 
sleep and usually short intermittent awakenings. The wake-state is simply 
characterized by low amplitude, high frequency brain wave activity (13-30 Hz waves) 
in the EEG, (2) high muscle activity in the EMG, and (3) the presence of rapid eye 
movements in the EOG. REM sleep usually occupies approximately 15-20% of the 
total sleep time in young healthy adults under entrained conditions. In addition, the 
duration of each REM sleep bouts usually increases over the course o f 8-h in bed at 
night, such that the last REM sleep bout is longer than the first. REM sleep is 
characterized by the presence of (1) low amplitude, mixed frequency brain wave 
activity relative to wake and the occunence of “saw tooth” waves in the EEG, (2) a 
complete absence of muscle activity in the EMG, and (3) usually the presence of rapid 
eye movements (left to right, right to left, up and down, down and up) in the EOG. 
REM sleep was initially called paradoxical sleep, because the EEG and EOG activity 
in the PSG recording resembled that observed during PSG recordings during quiet 
wakefulness, with the exception o f muscle paralysis.
There are four distinct NREM sleep stages numerically denoted as. Stage-one, 
Stage-two, Stage-three and Stage-four. NREM Stage-one sleep usually occurs during 
the transition from wake to sleep, and it usually occupies approximately 10-15% of 
the total sleep time in young healthy adults under entrained conditions. It is
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characterized by (1) increased amplitude and reduced frequency in brain wave activity 
relative to wake and the occurrence of theta waves (8-12 Hz waves) in the EEG, (2) 
decreased muscle activity in the EMG, and usually slow rolling eye movements in the 
EOG. NREM Stage-two sleep usually follows shortly after Stage-one sleep. Stage- 
two sleep usually occupies approximately 40-50% of the total sleep time in young 
healthy adults under entrained conditions. NREM Stage-two sleep is characterized by 
(1) increased amplitude and reduced frequency in brain wave activity relative to wake 
and the occurrence of K-complex (sharp, negative, high-voltage EEG wave, followed 
by a slower, positive component) and sleep spindles (12-14 Hz waves with a duration 
of 0.5-1.5 seconds) in the EEG, (2) relatively low muscle activity in the EMG and an 
absence of eye movements in the EOG. Finally, NREM Stage-three and Stage-four 
sleep usually follow Stage-two sleep, approximately 15 to 45 minutes after the onset 
o f sleep. Both stages are characterized by the presence of delta brain wave activity 
(between 0.5 to 4.5 Hz and 75 pV waves) in the EEG, low muscle activity in the 
EMG, the absence of eye movements in the EOG. An epoch is scored as NREM 
stage-three or four based on the percentage of the epoch that contains of delta waves, 
25-50% is stage-three and 50% or more is stage-four sleep. Together NREM Stage- 
three and Stage-four sleep are referred to as deep sleep, delta wave sleep or Slow 
Wave Sleep (SWS) and the presence of these waves is referred to as Slow Wave 
Activity (SWA). REM sleep. Stage-one sleep and Stage-two sleep are considered 
lighter sleep compared to SWS. Depth of sleep has been determined by measuring the 
arousal threshold of a sleeping individual. For example, the duration of time to 
awaken a sleeping individual from stage REM sleep is usually shorter than the 
duration of time to awaken a sleeping individual from SWS sleep.
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1.6.2 Neurophysiology of Sleep-Wake States
The transition between sleep-wake states is a neurobehavioiiral response to 
changes in neuronal activity (firing rate; synchronization and desynchronization) 
across the cerebral cortex via input from the thalamus and basal forebrain. The 
thalamus, located at the top of the brainstem, superior to the hypothalamus, serves as 
a relay information-processing station for incoming signals from the peripheral 
nervous system via the “ascending reticular activating system” (Momzzi and Magoun, 
1949). It is responsible for generating cortical arousal and wakefulness, and damage 
to areas along this pathway can cause chronic, prolonged bouts of sleep (Von 
Economo, 1939).
In the current model of the sleep-wake system described by Saper and 
collègues (2005), there are ascending and descending inhibitoiy pathways that are 
both mediated by hypothalamic nuclei, which regulate the consolidation and temporal 
organization of sleep-wake states. The ascending reticular activating pathway is 
composed of cholinergic (acetylcholine) neurons in the basal forebrain and in the 
dorsal pons, including the pedunculopontine tegmental nuclei (PPT) and laterodorsal 
tegmental nuclei (LDT). Cholinergic neurons in the basal forebrain project directly to 
the cortex, and they exhibit rapid firing rate activity during wake and REM sleep and 
are almost inactive during NREM (Szymusiak et al., 2000; Lee et al., 2005a). The 
PPT and LDT send excitatory projections to thalamic relay neurons, which allow the 
transmission of somatosensory information from the peripheral nervous system to the 
cortex when activated (Hallanger et a l , 1987; Steriade et a l , 1988). Thus it is not 
surprising that the firing rates of neurons in these nuclei are higher during wake than 
during REM and NREM sleep (Steriade et a l ,  1990; Datta and Siwek, 1997; Datta 
and Siwek, 2002). Additional projections in the ascending reticular activating system
1-80
originate from monoaminergic neurons, including the locus coemleus (LC; 
norepinephrine), the dorsal raphe nucleus (DRN; serotonin), the median raphe nucleus 
(MnRN; serotonin), the tuberomammilaiy neurons (TMN; histamine) and the ventral 
periaqueductal grey matter (vPAG; dopamine) (Fuller et ah, 2006). These nuclei are 
more active during wake than during NREM and inactive during REM. Many of the 
nuclei in the ascending arousal system (i.e., LC, DRN, MnRN, TMN) receive 
excitatory inputs from orexin (hypocretin) neurons in the lateral hypothalamus. 
Orexrn neurons are more active during wake than during either NREM or REM (Lee 
et ah, 2005b). MCH (melanin-concentrating homione)-containing neurons send 
inhibitory projections to orexin neurons and are more active during REM (Verret et 
ah, 2003).
The ventral lateral preoptic nucleus (VLPO; GABA-producing) sends a 
descending inhibitory projection to cholinergic, monoaminergic and orexin neurons in 
the ascending arousal system (Sherin et ah, 1996; Sherin et ah, 1998; Lu et ah, 2000; 
Lu et ah, 2002) and is mostly responsible for inducing sleep. In general, VLPO 
neurons are more active during sleep (Szymusiak et ah, 1998), but specific cell 
regions of the VLPO are more active during different sleep states. For example, 
VLPO neurons identified as “extended” are mostly active during REM, and VLPO 
neurons identified as “cluster” VLPO neurons are mostly active dining NREM (Lu et 
ah, 2002). In addition, VLPO neurons exhibit higher firing rates during recovery 
compared to baseline sleep in response to sleep deprivation (Szymusiak et ah, 1998). 
This response to sleep deprivation indicates that the neurons in the VLPO are 
involved in homeostatic regulation of sleep. Other factors, such as the build up of 
adenosine levels in the brain during wakefulness and their decline during sleep 
(Strecker et ah, 2000), may also contribute to this sleep-wake dependent mechanism.
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The VLPO receives inputs from neurons in the ascending arousal system, 
including sparse direct and dense indirect projections via the SPZ (Lu et al., 2001) and 
DMH from the SON (Chou et ah, 2002; Chou et ah, 2003) and even a retinal 
projection (Lu et ah, 1999). The SCN is the site of the circadian pacemaker, which 
coordinates and consolidates the timing of many endogenous and behavioural daily 
rhythms, including the sleep-wake cycle. Daily consolidated sleep-wake rhythmicity 
is abolished by complete SCN lesions (Moore and Lenn, 1972; Stephan and Zucker, 
1972; Mistlberger et ah, 1983; Tobler et ah, 1983; Trachsel et ah, 1992; Edgar et ah,
1993). Daily light-dark exposure entrains the sleep-wake rhythms in humans, such 
that sleep is consolidated in the subjective night and wake is consolidated during the 
day time. A wake promoting signal from the ascending arousal system, including the 
SCN and orexin neurons, inhibit VLPO neurons to generate arousal and sustain 
wakefulness. Increasing time awake increases VLPO firing rates during sleep, 
strengthening inhibitory signals on nuclei in the ascending arousal system. A 
decreasing wake (or increasing sleep) promoting signal from the SCN and inhibition 
of arousal systems in the basal forebrain, hypothalamic and midbrain nuclei induce 
and sustain sleep.
1.6,3 Two-Process Model of Sleep-Wake Regulation
In humans, sleep and neurobehavioiiral function, including subjective 
alertness, vigilance and cognitive performance, are maintained and controlled by 
various areas of the brain. Although they may be affected by various environmental 
and behavioural factors, the daily patterns of sleep-wake state and neurobehavioiiral 
fiinction have been described by a two process model of sleep-wake regulation 
(Borbély, 1982; Daan et al., 1984; Dijk et al., 1987b; Achermann and Borbély, 1990;
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Achermann and Borbély, 2003). The two-process model maintains that Process S, a 
wake-sleep dependent or homeostatic component, interacts with Process C, a 
circadian component. Process S  is regulated by the duration of prior sleep and the 
duration of prior wakefulness. For example, sleep pressine rises as elapsed time 
awake increases and dissipates during sleep. Process C is regulated by circadian 
timing generated by the circadian pacemaker and functions independent of the 
duration of prior sleep and wake. The interaction between Process S  and Process C 
regulate the timing and structure of sleep during bed-rest in the subjective night, as 
well as maintain optimal alertness, vigilance and performance levels during wake in 
the subjective day (Daan et al., 1984). Under entrained conditions, an increasing wake 
drive from the circadian pacemaker pressure in the latter half of the subjective day 
counteracts the high homeostatic sleep, which has built up during the wake-state 
maintained throughout the subjective day (Borbély et al,, 1989; Edgar et al., 1993). 
Similarly, during sleep in the subjective night, decreasing homeostatic sleep pressure 
is compensated by an increasing circadian sleep propensity in the latter half of the 
subjective night (Dijk and Czeisler, 1994; Dijk and Czeisler, 1995). However, the 
sleep promotion in the latter half of the night alternatively may be due to a 
significantly diminished wake drive from the circadian pacemaker, so whether the 
circadian pacemaker actively promotes both wake and sleep at opposite phases of its 
cycle is still debated (Mistlberger, 2005).
1.6.4 Measuring Homeostatic and Circadian Components
Infomiation regarding the magnitude of homeostatic and circadian processes is 
ascertained by measuring one or more variables repeatedly and quantifying variations 
of those variables over time. Variables measured for Process S are simply assessed in
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a linear manner as a fonction of elapsed or cumulative time (i.e., minutes, hours) 
either (1) during the course of time awake or time asleep or (2) after particular 
durations of time awake or time asleep, respectively. Variables measured for Process 
C are assessed in a circular manner by circadian phase (i.e., 0 to 360°) over one or 
more complete circadian cycles. The core body temperature (CBT) and melatonin 
rhythm, which are highly coupled (Shanahan and Czeisler, 1991; Czeisler et al., 
1999), are widely used as reference markers of circadian phase in human studies. 
Therefore one or both of these rhythms are measured simultaneously during sleep- 
wake assessments.
Determining the relative contribution of homeostatic and circadian 
components on sleep-wake regulation cannot be deduced from measurements of 
entrained individuals during habitual -8-h sleep episodes during the night time and/or 
~16-h wake episodes during the day time. In this case, the initiation, course and 
termination of sleep and wake episodes usually occur at one particular, narrow range 
of circadian phases after 16-h of wake or 8-h of sleep. During 8-h of habitual sleep, 
the duration of SWS and intensity of SWA usually decrease, while REM propensity 
increases. These changes in SWS/SWA and REM propensity across habitual sleep 
could be related to the duration of prior time awake, a function of time asleep, the 
circadian phase that sleep begins, or more importantly, an interaction between sleep- 
wake dependent and circadian components. Similarly, after 8-h of sleep (excluding 
the effects of sleep inertia and factors that affect cognition, such as time-on-task or 
practice effects) subjective and objective measures of neurobehavioural function 
exhibit little or no decrements or improvements over the course of 16-h of 
wakefulness from which to detect either wake-dependent or circadian variation.
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1.6.5 Homeostatic and Circadian Components within Sleep
The cuiTent knowledge of the impact of homeostatic and circadian processes 
on human sleep-wake regulation comes from numerous studies assessing the effects 
of various experimental conditions, including sleep deprivation, naps, sleep 
restriction, sleep extension, ultra-short sleep-wake schedules, and long-term time 
isolation free-running and LFD studies. More importantly, they have identified 
variables within sleep that are more dependent upon one component than the other. 
For example, because of its “hourglass” response to time awake and time asleep, 
NREM-SWS, or in particular SWA, is commonly used as marker of homeostatic sleep 
pressure. First, the amount of SWA observed after the initiation of sleep is directly 
related to the duration of prior wakefulness. For example, if a nap is scheduled after 2 
hours of wakefulness following habitual sleep, SWA within sleep during that nap is 
relatively low, but duration of wakefulness before the nap is increased incrementally 
each day, SWA increases monotonically within sleep during naps occuiTing 4, 6, 8, 
10, 14, and 20 hours after waking from habitual sleep (Dijk et al., 1987a). In addition, 
SWA is significantly higher during recovery sleep after missing one night of sleep 
(i.e., total sleep deprivation) compared to baseline sleep (Dijk and Beersma, 1989). 
Second, after ~16 hours of wakefulness, SWA after sleep onset is highest during the 
first NREM-REM cycle and decreases exponentially during sleep. However, the 
dissipation of SWA during sleep is not solely a sleep-dependent process. Indeed, 
SWA decreases as a function of time in SWS during sleep. For example, inducing 
SWS deprivation without inducing wake during the first few hours of habitual sleep 
increases the amount of SWA relative to the same hours during baseline sleep on the 
preceding night (Dijk et al., 1987b). In addition, partial sleep deprivation over 3
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nights (habitual bed time; 4-h sleep opportunity) increases SWA during the recovery 
sleep relative to baseline sleep (Brunner et al., 1993).
Conversely, REM propensity in humans is not dependent upon the amount of 
prior sleep and wake. In studies assessing sleep in synchronised and desynchronised 
free-running subjects, it was reported that the duration of sleep and REM propensity 
within sleep change relative to the circadian phase of the body temperature rhythm 
that subjects chose to go to sleep (Czeisler et al., 1980a; Czeisler et al., 1980b; 
Weitzman et al., 1980; Zulley et al., 1980; Zulley et al., 1981). First, the duration of 
sleep was significantly longer when sleep was initiated before or nearer to the body 
temperature rhythm peak independent of the amount of prior wakefulness. Second, 
under entrained conditions during 8-h of habitual sleep, subjects exhibited more REM 
sleep in the latter half of sleep (Zulley et al., 1980). However, after release from 
entrainment, both synchronised and desynchronised free-running subjects tended to 
initiate a significantly greater number of sleep episodes nearer to the core body 
temperature minimum. Synchronised free-running subjects exhibited more REM sleep 
in the first half of these sleep episodes compared to those under entrainment. 
Compared to synchronised free-mnning subjects, desynchronised free-mnning 
subjects initiated sleep across a wider range of circadian phases, yet they also initiated 
sleep more often nearer to the temperature minimum. Desynclu'onised subjects 
exhibited more REM sleep earlier or later in the sleep episode when the temperature 
minimum occurred earlier or later in the sleep episode, respectively. Furthermore, 
REM sleep propensity was highest ~2 hours after core body temperature rhythm 
minimum and was lowest nearer to the core body temperature peak. This variation in 
REM propensity across circadian body temperature phases occurred independent of 
prior wake or sleep, indicating that REM sleep is mostly under circadian regulation.
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Conversely, SWA declined during all sleep episodes in both syncluonised and 
desynchronised subjects, but showed no significant variation relative to the phase of 
the temperature rhythm.
1.6.6 Interaction Between Homeostatic and Circadian Components
The two-process model of human sleep-wake regulation does not describe the 
interaction between homeostatic and circadian processes. In addition, the interaction 
between the two processes cannot be determined from the studies mentioned above. 
This can be attributed to unbalanced experimental conditions, such as controlling for 
prior wake-sleep and not circadian phase, or vice versa. The LFD protocol has been 
shown to an effective method for resolving this issue by scheduling subjects to 
shorter- or longer-than-24-h day lengths (i.e., 20 or 28 h) over many days or circadian 
cycles in a dim LD environment free of time cues. The human circadian pacemaker 
cannot entrain to the exti'eme LD cycles particular under the dim light levels 
maintained during scheduled wake episodes. As a result scheduled bed-rest (sleep) 
and wake opportunities occur across all circadian phases. Subsequently, 
polysomnographic measurement during fixed duration scheduled bed-rest episodes 
can be perfoimed to assess the effects homeostatic and circadian components on sleep 
regulation, and neurobehavioural assessments during fixed duration scheduled wake 
episodes can be performed to measure the effects of homeostatic and circadian 
components on subjective and objective measures of alertness and vigilance.
The results from sleep assessments from initial LFD protocols were consistent 
with the two-process model (Dijk and Czeisler, 1994; Dijk and Czeisler, 1995). These 
studies determined the individual contribution of homeostatic and circadian processes, 
as well as describing the interaction between these two processes in promoting
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Consolidated sleep during the night and alert-wakefulness across the day. Moreover, 
further assessments of both sleep and neurobehavioural function in young and old 
subjects under LFD support this finding (Johnson et ah, 1992; Dijk and Czeisler, 
1994; Dijk and Czeisler, 1995; Boivin et ah, 1997; Dijk et ah, 1997; Wyatt et ah, 
1999; Dijk, 1999; Dijk et ah, 1999; Dijk et ah, 2001; Klialsa et ah, 2002; Wright et ah, 
2002; Hull et ah, 2003; Klerman et ah, 2004; Wyatt et ah, 2004; Wyatt et ah, 2006).
As had been previously demonstrated, the homeostatic process promotes sleep 
in a wake-dependent manner and wakefulness in a sleep-dependent matter. Across 
scheduled sleep opportunities under LFD, subjects are able to fall asleep at all 
circadian phase particularly due to the amount of homeostatic sleep pressure 
accumulated during wake. The percentage of SWS and the intensity of SWA declines 
exponentially over the course of all scheduled sleep oppoitunities regardless of the 
circadian phase that scheduled lights out occurred. There is a slight circadian variation 
in SWS/SWA. However, this obseiwation has been attributed to a decline in 
SWS/SWA obseiwed just before the core body temperature minimum (near the peak 
of melatonin) when circadian sleep propensity is highest. In addition, elderly subjects 
tend to exhibit a diminished SWS/SWA, lower sleep efficiency and a greater 
frequency of awakening from sleep compared to younger subjects (Dijk et al., 1999; 
Dijk et al., 2001; Klerman et al., 2004), As SWS decreases, both the percentage of 
wakefulness and the duration of wakefulness after awakening from sleep increase 
with time in bed during scheduled sleep opportunities. In contrast, as time spent 
awake increase across scheduled wake episodes, measures of neurobehavioural 
function worsen. For example, subjective sleepiness increases, reaction time to a 
simple visual stimulus slows, and cognitive throughput (number of coixect addition
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calculation responses) declines as function of time awake (Wyatt et al., 1999; Wright 
Jr. et al., 2002; Hull et al., 2003).
The circadian process promotes sleep and wakefulness relative to the phase of 
the core body temperature (CBT) rhythm (as well as melatonin rhythm). For example, 
when sleep initiation occurs across all circadian phases, sleep latency varied across 
circadian phase. Sleep latency is shortest when the schedule sleep opportunity begins 
near the nadir of CBT rhytlun (after the peak of melatonin secretion) and gradually 
increases throughout the biological day as CBT rises. It is longest near the crest of the 
CBT rhythm (prior to the onset of melatonin secretion) and decreases rapidly on the 
falling slope of the CBT rhythm (rising melatonin secretion) across the biological 
night. Total sleep time is longest when the scheduled sleep opportunity begins near 
the crest of the CBT rhythm (near the onset of melatonin secretion), and it is shortest 
when it begins after the nadir of CBT rhythm (after the offset of melatonin secretion) 
(Dijk and Czeisler, 1994). The percentage of REM sleep is highest and REM sleep 
latency is shortest when sleep opportunity begins near the nadir of CBT rhythm.
Conversely, the percentage of wakefulness is lowest near the nadir of the CBT 
rhythm. The duration of wakefulness after awakening from sleep increases across the 
biological day, peaking just prior to and then rapidly decreasing just after the crest of 
the CBT rhythm. In addition, measures of neurobehavioral fimction during scheduled 
wake episodes also varied as a function of circadian phase. Subjective sleepiness was 
lowest, reaction time fastest and cognitive throughput optimal near the crest of the 
CBT rhythm, and decline during the biological night during the falling slope of the 
CBT rhythm. Subjective sleepiness was highest, reaction time slowest and cognitive 
throughput worse just after the peak of melatonin, but increase during the biological 
day after the melatonin levels decline and are low. However, the magnitude of
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INTERACTION OF HOMEOSTATIC AND CIRCADIAN 
COMPONENTS ON SLEEP CONSOLIDATON
3  60  ^
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Circadian Phase (degrees)
#  22  6 14 22
Corresponding Time of Day
Figure 1-12. Interaction of homeostatic and circadian components on sleep consolidation 
as a simultaneous function of circadian phase and time since start of sleep episode 
under forced desynchrony. Three-dimensional plot of wakefulness within scheduled 
sleep episodes, circadian phase and time elapsed since start of sleep episode. Data  
w ere assigned to 12 circadlan-phase bins (30 degrees each) and five time-since-start-of- 
the-sleep-episode bins (112 min each). Each point represents wakefulness as a 
percentage of total recording time. During a sleep episode, circadian phases and time 
since start of sleep episode change simultaneously along a trajectory. Under entrained 
conditions, a trajectory for a nocturnal sleep episode (dashed line) initiated at 270  
degrees (approximately midnight) is indicated. Adapted from Dijk and Czeisler, 1994.
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the circadian component on sleep-wake regulation is somewhat dependent upon time 
awake and time asleep. For example, sleep can be initiated at any circadian phase and 
the percentage of wakefulness within the first quarter of bed-rest usually remains low 
across circadian phase. However, a circadian variation in the percentage of 
wakefulness becomes more and more prominent as the time spent in bed increases 
(Figure 1-12). Under entrained conditions, homeostatic and circadian processes 
interact to promote consolidated sleep during the night when melatonin is high and 
alert-wakefulness during the day time when melatonin is low. For instance, 
homeostatic sleep drive is relatively low upon awakening in the morning after ~8 
hours of sleep. It then builds as elapsed time awake increases during the subjective 
day, and is relatively high in the evening prior to habitual bedtime after -16  h or more 
of continuous wakefulness. However, over the course of the biological day when 
melatonin levels are low, an increasing circadian wake-promoting signal counteracts 
the cumulative homeostatic sleep pressure in the later part of the subjective day. The 
circadian wake-promoting signal usually peaks in the evening prior to habitual 
bedtime shortly before the onset o f pineal melatonin secretion. Upon falling asleep at 
night, homeostatic sleep pressure accumulated over the course of wakefulness during 
the subjective day, declines over the course of sleep. Conversely, circadian sleep 
propensity rises over the course of habitual sleep and peaks in the latter part of sleep 
just after the peak of melatonin secretion and before habitual wake time. The high 
circadian sleep propensity in the later part of the sleep compensates for the diminished 
homeostatic drive producing further sleep continuity for the remainder of the 
subjective night.
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1.7, Aims of Thesis
CuiTent knowledge of the dominant influence of ocular light exposuie on 
human circadian rhythms and the specificity of the non-image visual pathway that 
mediates photic input to the pacemaker is attributed to the results from various 
laboratory and field studies in both sighted and NLP blind subjects. Despite this 
conformity, the circadian pacemaker’s sensitivity to light and exposure to various LD 
cycles is a potential confounding factor in regards to determining aspects of human 
circadian organization in studies of sighted subjects. For instance, prior photic history 
or exposure to various LD cycles under LFD may: (1) have profound effects on the 
observed period of the pacemaker, such as shortening of period as the result of 
aftereffects of prior photic entrainment upon release from entrainment (i.e., LFD 
assessments in sight subjects); (2) mask or attenuate circadian responses (i.e., period, 
phase and amplitude of melatonin rhythm) to acute or periodic exposure non-photic 
time cues (i.e., sleep-wake cycle); or (3) drive or enhance the amplitude of 
homeostatic wake-dependent responses during sleep and circadian sleep propensity.
The aim of this thesis was to better understand the effects of photic input and 
the lack thereof on the human circadian timing system. To address this, melatonin, 
rest-activity, sleep and neurobehavioural function were measured for over four 
months during similar field and LFD assessments in twelve healthy NLP blind 
subjects, including 3 newly discovered subjects who retain non-image-forming 
responses to light, to test the following three aims:
AIM 1: The period of urinaiy melatonin was measured in both similar uncontrolled 
(free) and semi-controlled (prohibitions) field conditions and compared to the period 
o f urinary melatonin measured under a strictly-controlled LFD condition to test the 
hypothesis that the period observed under field conditions is significantly longer
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compared to the period observed under LFD conditions in totally blind subjects 
(Chapter 3).
AIM 2 : Plasma melatonin was assessed under a strictly-controlled LFD condition to 
test the hypotliesis that the systematic modulation of the melatonin rhythm (phase and 
secretion duration and levels) is significantly greater in NLP blind subjects who 
exhibit light-induced melatonin suppression (E-POS) compared to NLP blind subjects 
with (E-NEG) and without eyes (BE, bilaterally enucleated) who do not exhibit light- 
induced melatonin suppression (Chapter 4).
AIM 3: Polysomnography-sleep and neurobehavioural-wake assessments were 
perfonued under a strictly-controlled LFD condition in NLP blind subjects to test the 
hypothesis that the homeostatic and circadian processes regulate sleep and wake 
function through the same interaction described in sighted subjects independent of 
photic input or the presence of the eyes (Chapter 5).
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Chapter 2
General
Methodology
CHAPTER 2 -  GENERAL METHODOLOGY 
2.1 Subjects
2.1.1 Subject Descriptions and Screening
Subjects were recmited from the community via newspaper, newsletter and 
radio advertisements placements through 500 institutions, associations and groups for 
visually impaired people across North America (Canada and USA) and the United 
Kingdom. Each subject provided written informed consent for both screening and 
protocol procedures for the research study. All procedures for this study were 
approved by the Partners Health Care System’s Investigational Review Board and 
were in accordance with the guidelines outlined in the Declaration of Helsinki.
Thirteen blind subjects, 10 males and 3 females, age 27 to 68 yrs (mean ± SD,
49.1 ± 11.3 yrs) participated in the study to assess human circadian period under both 
field and laboratory conditions (Table 2-1). Ten subjects completed the entire study. 
Two subjects were studied previously, subject 1451 (subject 9 in Czeisler et al., 1995; 
subject 1451 in Kleiman et al., 1998; subject 2 in Klerman et al., 2002) and subject 
22K4 (subject 45 in the following: Lockley et a l , 1997; Lockley et a l , 2000; Hack et 
a l, 2003). Two subjects (22F1 and 22L5) were disempaneled from the laboratoiy 
protocol due to minor medical issues unrelated to the study procedures, and one 
subject (22N5) was found to have minimal light perception in one eye just prior to the 
laboratoiy study and is not reported here. Therefore, 12 subjects are reported in 
chapter 3, 10 subjects in chapter 4 (including data from 1451’s previous study; 
Kleiman et a l , 1998) and 10 subjects in chapter 5.
Volunteers were required to be ambulatoiy and have no major handicaps other 
than visual impairment. Subjects were excluded if they were taking any prescription 
medications or diagnosed with any major health or psychological conditions. Subjects
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were not taking any other hypnotics or sleep aids or any wake-promoting dmgs during 
the study. Subjects were healthy based upon a comprehensive physical and 
psychological examination, blood and urine tests, and ECG. Subjects reported no 
histoiy of working during the overnight hours or long distance travel across one or 
more time zones in the last thiee years prior to the study. This information ensured 
that subjects did not undergo any major shifts in their regular in-bed (sleep) and out of 
bed (wake) times recently.
2.1.2 Ophthalmology -  Diagnosis of NLP
Upon initial screening, subjects reported having no conscious light perception 
(NLP). Subjects were included regardless o f ophthalmologic diagnosis, age and 
rapidity of vision loss, presence or absence of eyes, or self-reported sleep 
disturbances. An ophthalmologic assessment was preformed in all subjects who 
possessed at least one eye. Ophthalmologic assessments were performed by the 
subject’s local ophthalmologist after completing the study. As part of the eye exam, 
the following descriptions were noted for each eye: histoiy of blindness, description 
of appearance, visual acuity, nature of eye movements, a fundoscopic exam, and 
pupillaiy reflexes examined with a slit lamp with the brightest light of an indirect 
ophthalmoscope. All subjects with at least one eye did not exhibit a pupillary light 
reflex in either eye using these standard tests, and only one of these subjects (22CS) 
exhibited voluntaiy eye movements. Details of each subject’s Ophthalmologic 
diagnosis are provided in Table 2-1. Subject’s 22K4, 22CS and 22J7 were the only 
NLP blind individuals who had approximate 20/20 visual acuity for at least the first 
20 years of life.
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2.1.3 Consumption of Foreign Substances
During initial screening procedures, subjects were not excluded for use of 
certain foreign substances, including caffeine-containing products (such as coffee, tea, 
or chocolate), nicotine-containing products (such as chewing tobacco, cigarettes, 
cigars, pipe tobacco), alcohol (beer, wine or liquor, unless deemed excessive), 
marijuana, over-the-counter medication (e.g., aspirin, ibuprofen), health-food 
supplements and/or herbal remedies (HFS/HR), however they were informed that they 
would be asked to refrain from consuming all foreign substances for most of the 
study. Subjects varied in their self-reported use of foreign substances and the 
regularity of use (Table 2-2). However all subjects reported regular use of caffeine- 
containing products.
In addition, since exogenous melatonin has been shown to phase-shift the 
circadian rhythms, subjects were ask to refrain from ingesting melatonin during the 
entire study. Two subjects (22K4 and 2306) reported regular use of melatonin over 
the past year during the initial screening procedures. Subject 22K4 ceased taking his 
daily melatonin pill (5.0 mg) a month prior to beginning of his study, and subject 
2306 took one melatonin pill (1.0 mg) on day 2 (22:40) and day 6 (01:00) of the initial 
field study. During the field portions of the study, subjects were asked to report the 
consumption of any foreign substances, and they were told that their urine would be 
tested for any foreign substances on a weekly basis. Urine toxicology confinned that 
all subjects were dmg free at the time of the pre-study screening process, and all 12 
subjects were drug free at the beginning and end of the 38-day laboratoiy protocol.
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2.2 Protocol -  Schedules and Procedures
Subjects were studied under four segregated parts or study conditions in the 
following order (Figure 2-1): (1) approximately 4 weeks or more at home during a 
FIELD-FREE; (2) approximately 4 weeks or more during a FIELD-PROHIBITED-1 
protocol (modified from Lockley et ah, 1997a); (3) during a 38-day LABORATORY- 
FORCED DESYNCHRONY protocol used in prior studies of the sighted (modified 
from Czeisler et al., 1999); and (4) during another 4 week FIELD-PROHIBITED-2 
follow-up protocol. The study conditions occurred consecutively and the duration of 
the entire study was approximately 4-months.
2.2.1 Part 1: FIELD-FREE Condition
Each subject’s rest-activity and melatonin rhythm was assessed whilst they 
lived at home for at least 4 weeks during part 1 of the study, the FIELD FREE 
condition (FF). During this home-based field condition, subjects self-select daily 
bedtimes (i.e., in-bed and out of bed). In addition, subjects were free to sleep during 
the daytime (nap), and they were free to continue habitual use of caffeine-containing 
products, nicotine-containing products, alcohol, marijuana, over-the-counter 
medication, health-food supplements and/or herbal remedies, and were allowed to 
engage in any type of strenuous exercise (i.e., aerobic exercise and/or weight lifting). 
This home-based assessment has been used in numerous studies to measure rest- 
activity and melatonin rhythms in blind individuals living in society (Arendt et al. 
1988; Aldhouse and Arendt, 1991; Lockley et al., 1997a; Lockley et al,, 1997b; 
Lockley et al., 2000; Hack et al., 2003). One subject, 22A6, completed less than the 
target amount o f weeks in this condition (-25 days).
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FIELD AND LABORATORY CONDITIONS
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Figure 2-1. Raster plot of field and laboratory study segregated between four study 
conditions denoted on the right y-axis. Raster plot is double plotted for relative clock time 
(24-h, x-axis) on the abscissa (i.e., the second day is plotted to the right and below the 
first day) and day of study on the ordinate (y-axis).
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2.2.2 Part 2: FIELD-PROHIBITED-1 Condition
Each subject’s rest-activity and melatonin rhythms were assessed whilst they 
lived at home for at least another 4 weeks during part 2 of the study, the FIELD- 
PROHIBITED-1 condition (FPl). In contrast to part 1, subjects were asked to change 
certain aspects of their daily life, including; (1) maintaining the same 8 -h (± 0.50 h) 
elapsed time in bed (TIB) eveiy night; (2) refraining from sleeping outside their self­
selected 8 -h TIB schedule (i.e., no napping during the daytime); (3) refraining from 
consuming any caffeine-containing products, nicotine-containing products, alcohol, 
marijuana, over-the-counter medication, HFS / HR; and (4) refraining from engaging 
in any type of strenuous exercise (i.e., aerobic exercise and/or weight lifting). This 
self-imposed daily regime was used to ( 1) remove or control for certain potential 
periodic non-photic time-cues and (2) to reproduce the same 2-3 weeks pre-laboratoi*y 
forced desynchrony conditions that sighted subjects were exposed to prior to entering 
the laboratory. If  the beginning (spring season) or end (fall season) of “day light 
saving time” (DLST) occurred during FPl, subjects were asked to adjust their 8 -h TIB 
by minus or plus 1 hour, respectively, to ensure that subjects maintained a consistent 
daily 8 -h TIB relative to pre- or post- DLST clock time. One subject, 22CS, 
completed less than the target amount of weeks in this condition ( - 2 0  days).
2.2.3 Part 3: LAB-FORCED DESYNCHRONY Condition
Following the FPl condition, each subject’s melatonin rhythm was assessed 
whilst they lived on an imposed non-24-h day schedule in a sleep-circadian laboratoiy 
during most of part 3 of the study, the LABORATORY FORCED DESYNCHRONY 
condition (LFD). Subjects were admitted to the Intensive Physiological Monitoring 
Unit (IPM) of the General Clinical Research Center (GCRC) at Brigham and
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Women’s Hospital (BWH), Boston, Massachusetts, USA for a 38-day inpatient 
laboratoiy forced desynchrony protocol (figure 2-2). Urine toxicology assessments 
determined that each subject was drug-free upon admission. A second abbreviated 
physical assessment perfonued by a GCRC registered nurse and physician detenuined 
that each subject’s health status had not changed since their initial screening-physical 
examination ~2 months earlier. Subject 1451’s melatonin rhythm was assessed in 
1995 under the same forced desynchrony protocol (Klerman et al., 1998). As a result, 
subject 1451’s data from the previous forced desynchrony was added to the analysis 
reported in chapter 4 (with peiuiission from E.B. Klerman, MD, PhD).
2.2.3.1 Description of Time-Free Environment
Subjects lived individually and continuously in one of five time-free, sound 
proof rooms. Subjects were provided a bathroom, closet, desk and bed. Two doors 
separated the inside laboratory room and the outside staff room. The rooms contained 
white walls and were devoid of any windows, clocks, live TV or radio, phones, or 
internet access. Personal electronic devices, such as GPS, watches, cell phones, 
personal or laptop computer or pocket planners were confiscated from subjects upon 
entering the laboratoiy on day 1 and not returned until the day of discharge. Subjects 
were provided a desktop or laptop computer in which the clock was disabled. Two 
computer monitors with speakers were placed at the desk and on small table next to 
the bed for neurobehavioural testing. Throughout the laboratory study subjects did not 
have direct contact with personal acquaintances (i.e., phone calls) or receive personal 
visitors, but email or messages were given at a random time after being received.
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Figure 2-2. Raster plot of 38-day inpatient laboratory forced desynchrony protocol 
(subject 22A 6’s laboratory protocol). The timing of schedule bed-rest, 2 constant routines 
(OR) and the melatonin suppression test (M S I;  light exposure) are double plotted by 
clock time on the abscissa (x-axis) relative to subject’s habitual time-zone and day of 
study on the ordinate (y-axis), such that the second day is plotted to the right and below 
the first day. The schedule between the start of CR2 on days 34 and discharge on day 38 
are not the same across subjects (i.e., C R 2 duration not the similar between subjects).
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Laboratory rooms were equipped with hand-held terminals for on-line (time­
stamp) event recording (Ronda et al., 1985), a porthole to allow continuous 24-h 
blood sample collection without disturbing the subjects during scheduled bed-rest 
(sleep opportunity), and a closed-circuit camera and a voice-activated microphone for 
continuous subject monitoring. Room temperature was monitored and maintained (70 
- 75 °F) by means of a permanent air temperature theimistor attached to the wall 
inside the room and collected by a real-time, on-line data acquisition. Ambient room 
lighting was generated using standard, broad-spectmm ceiling-mounted fluorescent 
lamps (4100K, Philips Lighting, The Netherlands), controlled with digital ballasts and 
transmitted through a UV-stable filter (Lextran 9030 with prismatic lens; GE Plastics, 
Pittsfield, MA). Light settings for baseline days (150 lux max vertical and 90 lux 
horizontal angle of gaze) and for CR and FD experimental days (15 lux max vertical 
and 4 lux horizontal angle of gaze) were pre-calibrated by measuring light intensity 
with a light meter fixed at the top of a pole 183 cm from the floor in the vertical 
(-90°) angle of gaze at various points across each room. Daily light intensity readings 
were taken and recorded by technicians - 2  hours after scheduled wake time to verify 
predetermined light settings in the room for all baseline days (1-3, 37-38), constant 
routine days (4-5, 34-35), forced desynchrony days (6-33) and the light exposure day 
(36). Four light readings were taken at the centre of the room pointing at each 
quadrant of the square room with the light meter fixed to a pole 183 cm from the floor 
pointing in the horizontal (-0°) angle of gaze. Light intensity levels (lux) were 
measured with an IL-1400 photometer (International Light, Inc., Newbuiy, MA, 
USA).
IPM/GCRC laboratory technicians and nurses were present 24-h a day to caiTy 
out the protocol, including monitoring data acquisition systems, collecting biological
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specimens, and recording sleep-wake state polysomnographically during scheduled 
bed-rest and wakefulness. The IPM/GCRC nurses inserted and maintained the 
intravenous blood sampling system and monitor subjects’ general health and safety. 
All IPM/GCRC staff members were trained in the process of maintaining an 
environment free of time-cues, including; ( 1) removing all time-pieces or watches 
from their person while in the laboratory; (2 ) avoiding any communication regarding 
either the time of day, the current weather conditions or the nature of the experimental 
conditions to the subjects; and (3) using of the 2-doorway system for entering the 
room. Throughout the laboratoiy study, subjects received a controlled diet (nutrition 
and fluid-intake) designed and monitored by the GCRC Dietician staff.
2.2.3.2 Scheduled Wakefulness and Bed-rest
During the 38-day laboratoiy protocol, subjects experienced a total -31 days 
of scheduled wakefulness (lights on) and bed-rest (in bed; lights off). During 
scheduled wakefulness, subjects were free to move around the room at will, but they 
were instructed not to lie down or sit on their bed, meditate, nap or undertake 
vigorous exercise. Subjects’ activity and wake-state were monitored and verified for 
compliance by means of interactions with laboratoiy technicians and nurses and 
closed-circuit television (not recorded) monitoring outside the room. During all 
scheduled bed-rest, subjects’ were instructed to remain supine in bed and make eveiy 
attempt to sleep. Before entering the laboratoiy, subjects were informed of the 
possibility that they might experience bouts of insomnia (i.e., unable to fall back or 
remain asleep) during scheduled bed-rest. They were instmcted that if they are unable 
to fall back or remain asleep, they should remain in bed, in a supine position and 
make every attempt to sleep until a technician entered the room at scheduled wake
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time. Subjects were also instructed not to eat, listen to books on tape or read Braille 
books or magazines during scheduled sleep opportunities. If subjects needed to void 
or have a bowel movement during scheduled bed-rest, they alerted technicians outside 
the room sending an on-line computer prompt to technicians outside in the control 
room computer via a hand-held teiininal placed next to the bed. Once prompted, 
technicians; ( 1) entered the room using the 2  door system; (2 ) handed subjects a urinal 
bottle or bedpan as needed; and (3) left the room using the 2 door system until 
prompted to enter again to remove urinal bottle or bedpan from room. The lights 
remained off during urine voids and bowel movements during scheduled bed-rest. 
Approximately 15-20 minutes prior to lights-out at scheduled bedtime subjects sat in 
bed and then were supine. Following scheduled lights-on at scheduled wake time 
subjects remained in bed in a semi-recumbent posture, with the head of the bed at a 
45°angle for at least 1.67 hours while they performed neurobehavioural tests.
2.2.3.3 Laboratory Days 1-3: Baseline
Subjects were first scheduled to tliree baseline days (16 h :8  h) in medium 
room light (150 lux max vertical and 90 lux horizontal) during scheduled wakefulness 
and in darkness during scheduled bed-rest. The average (±SD) light intensity was 94.8 
± 12.7 lux in the horizontal angle of gaze (n=10) during scheduled wakefulness on 
baseline days. Each subject was scheduled to predetermined bed-wake time schedule. 
The timing of baseline scheduled bed-rest and scheduled wakefulness was determined 
by averaging the total time-in-bed reported by subjects during the week prior to 
admission. If the average time in bed was slightly higher or lower than 8  hours during 
the week prior to admission, the difference between the target (8 -h) and the actual 
average time in bed was divided by two and then subtracted or added to the average
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“in bed” and “out of bed” clock times, respectively. The clock times were based on 
the habitual time zone clock times of each individual subject. Breakfast, lunch, dinner 
and a small snack [150 mEq Na+/100 mEq K+ (± 20%) controlled nutrient; 2000 cc's 
fluid isocaloric; BEE x 1.4 activity for calculated diet] were given during scheduled 
wakefulness at predetermined hours after scheduled wake time (-1.83, 6.50, 11.50 
and 14.50 h, respectively). Subjects showered -2.33 hours after wake time on baseline 
days.
2.2.3.4 Laboratory Days 4-5: Constant Routine 1
After scheduled wake time on day 4 of the inpatient protocol, subjects were 
assessed during a 40-h constant routine (CRl) protocol in dim light (15 lux max 
vertical and 4 lux horizontal). The average (±SD) light intensity during CRl was 3.1 ± 
0.9 lux the horizontal angle of gaze (n=10). The CR was used to assess the circadian 
phase of the core body temperature and melatonin rhythm under constant 
environmental and behavioural conditions. Overt rhythms driven by the circadian 
pacemaker are influenced by changes in environmental and behavioural factors 
related to the rest-activity cycle, including changes in sleep-wake state, ocular light 
exposure, posture, activity level, and food-fluid intake. Under CR conditions, these 
factors are removed, reduced or equally distributed across a full circadian oscillation, 
thereby unmasking the endogenous circadian core body temperature and honnonal 
output. During the CR protocol subjects remained awake, in bed, semi-recumbent, 
with the head of the bed at a 45°angle. Food and fluid were given in small isocaloric 
meals [150 mEq Na+/100 mEq K+ (± 20%) controlled nutrient; 2000 cc's fluid 
isocaloric; BEE x 1.4 activity for calculated diet] every hour starting 2 hours after
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scheduled wake time. Constant posture and wakefulness were maintained and verified 
by a technician who sat with the subject at all times.
2.2.3.5 Laboratory Days 6-33: 28-h Day FD Protocol
Following the constant routine, subjects were scheduled to a 28-h forced 
desynchrony protocol for 4 weeks (24 cycles). Subjects were scheduled in dim light 
(15 lux max vertical and 4 lux horizontal) during scheduled wakefulness (18.67 h) and 
in darkness during scheduled bed-rest (9.33 h). The average (±SD) light intensity 
across 24 scheduled FD wake episodes was 2.8 ± 0.7 lux in the horizontal angle of 
gaze (n=10). During the forced desynchrony protocol, the timing of scheduled bed­
rest and wakefulness occurred 4 hours later each day. In sighted subjects, under these 
dim light conditions the imposed 28-h T-cycle is well outside the range of 
entrainment of the circadian pacemaker, and therefore the pacemaker continues to 
oscillate at its near-24-h period. As a result, overt circadian rhythms desynclnonize 
from the sleep-wake schedule, thus environmental and behavioural factors linked to 
the forced rest-activity schedule are distributed evenly across all circadian phases. 
Breakfast, lunch, dinner and snack [150 mEq Na+/100 mEq K+ (± 20%) controlled 
nutrient; 2000 cc's fluid isocaloric; BEE x 1.4 activity for calculated diet] were given 
at predetermined hours (-1.83, 6.50, 12.50 and 16.00 h, respectively) during 
scheduled wakefulness of the forced desynchrony protocol. Subjects showered 
following breakfast each scheduled forced desynchrony day.
2.2.3.6 Laboratory Days 34-35: Constant Routine 2
After scheduled wake time on day 34, subjects were assessed again during a 
<40-h constant routine (CR2) protocol in dim light (15 lux max vertical and 4 lux
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horizontal). The average (±SD) light intensity dining CR2 was 3.1 ± 0 .7  lux in the 
horizontal -0° angle of gaze (n=10). Subjects were assessed under the same 
conditions described in Section 2.2.1.3.4. In contrast, CR2 was used to determine the 
appropriate timing of the bright light exposure for the melatonin suppression test on 
the subsequent day. The phase estimate of the core body temperature was calculated 
from this constant routine to determine the appropriate clock time to administer a 6.5 
hour bright light exposure the following day. Once the phase estimate was calculated, 
CR2 ended, and each subject was given an 8 -h recovery sleep opportunity. The 
diaation of CR2 varied between subjects (mean duration, 29.15 h; range 21.33 to 
39.97 h) due to differences between each subject’s individual phase angle of the core 
body temperature minimum and habitual wake time at the end of the forced 
desynchrony.
2.2.3.7 Laboratory Day 36: Melatonin Suppression Test (MST)
The Melatonin Suppression Test (MST) was used to determine whether each 
NLP subjects possessed a functional circadian axis from the retina to the pineal. 
Specifically, the MST deteiinines whether melatonin secretion in NLP subjects is 
suppressed by bright ocular light exposure. After an 8 -h recovery sleep following the 
second constant routine, subjects were scheduled to a 24-h day (16:8) in dim light 
before and after a 6.5 hour bright light exposure light during scheduled wakefulness 
and in darkness during scheduled bed-rest. The average (±SD) background light 
intensity was 3.0 ± 0.9 lux in the horizontal -0° angle of gaze (n=10). Breakfast, 
lunch, dinner and snack [150 mEq Na+/100 mEq K+ (± 20%) controlled nutrient; 
2000 cc's fluid isocaloric; BEE x 1.4 activity for calculated diet] was given during 
scheduled wakefulness at predetermined hours after scheduled wake time (-1.83,
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4.00, 11.50 and 14.50 h, respectively). Lunch was given earlier during this particular 
day so that subjects were not disturbed during the 6.5 hour light exposure.
Subjects showered and were then seated in a chair -2  and -3.15 hours after 
scheduled wake time, respectively. All furniture and belongings were covered with 
white bed sheets. The overhead ceiling lights were increased to a bright light setting 
(9,500 lux max pre-calibrated setting; measured with the light meter fixed 90° at the 
top a pole 183 cm from the floor in the vertical 90° angle of gaze) exactly 4.75 hours 
after the scheduled wake time and maintained for 6.5 hours. The experimental light 
exposure for one subject, 23BP was 10.75 hours in duration as the result of core body 
temperature minimum calculation error from CR2. During the experimental light 
exposure, subjects remained seated with their eyelids open at all times verified by a 
technician sitting in the room with the subject. Subjects wore U-Vex goggles during 
the 6.5 hour light exposure to block any UV light (U-Vex, Boston, MA). Subjects 
were instructed by the technician to maintain a fixed or free gaze at pre-detennined, 
equal intervals during the 6.5 hour bright light exposure (18 min fixed, 18 min free, 6  
min fixed, 6  min free, 6  min fixed, 6  min). During the fixed gaze intervals, subjects 
were instructed to orient their visage in the same direction that they were sitting with 
their chin slightly elevated upward without moving their head to the left or to the right 
or up or down. During the fixed-gaze interval of the bright light exposure, subjects 
were instructed to cease conversation or reading; this was done to ensure that the 
subject did not become distracted from holding the position of their head. These steps 
were taken to insure that each subject received sufficient ocular light exposure, since 
most subjects were unable to voluntarily fix their eyes at a target point at the top the 
wall. During the free-gaze interval of the bright light exposure, subjects were allowed 
to move their heads in any direction, but were asked to remain seated. Subjects knew
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that the light intensity could be increased at a certain point during the laboratory 
protocol, but they were not informed that it would occur on the day of or at the start of 
the light exposure.
The technician sitting in the room measured light intensity levels with two IL- 
1400 photometers (International Light, Inc., Newbiuy, MA, USA) after fixed and free 
gazes. Light intensities were measured from the subject’s forehead in the direction of 
the subject’s fixed gaze and average free gaze holding the light sensor above (brow) 
between the subject’s eyes. The average (±SD) light intensity (n=10) was 7919 ± 
1055 lux measured after fixed gazes and 7503 ± 932 lux measured after free gazes. 
Average light intensities during the 6.5 hour light exposure were not significantly 
different between fixed and free gazes (Student’s f-test, one tailed; P=0.14). In 
addition, light intensities were measured after eveiy other fixed gaze with a light 
meter fixed on pole 137 cm from the floor at a horizontal -0° angle at -64  cm from 
the subject’s face. The average (±SD) light intensity was 7309 ± 817  lux after eveiy 
other fixed gaze from the light meter fixed on the pole. After the 6.5 hour bright light 
exposure, the ceiling lights returned to the pre-light exposure dim light setting for the 
remainder of scheduled wakeftilness. Subjects remained seated for 1.5 hours after the 
light exposure. See section 2.3.2 .2 . 2  for details regarding blood sampling during the 
melatonin suppression test.
2.2.3.8 Laboratory Day 37, 38: Readjustment, Discharge
On day 37 subjects were scheduled to a modified baseline day. Following the 
MST day, each subject’s schedule was readjusted so that the final 8 -h schedule bed­
rest opportunity on day 37 was the same as baseline days 1-3, and thus scheduled 
wakefulness on day 37 could be shorter or longer than 16 hours. On day 38 the IV
2 -1 8
catheter was removed and subjects were discharged and returned home. The final 
bedtime on day 37 for subject 22K4, whose habitual time zone was GMT, was 
scheduled 5 hours later than his habitual bedtime. In addition, subject 22K4 remained 
in EST for 5 days following his discharge.
2.2.4 Part 4: FIELD-PROHIBITED-2 Condition
After the conclusion of the laboratory protocol, the subjects’ rest-activity and 
melatonin rhythms were again assessed whilst they lived at home for at least another 4 
weeks during part 4 o f the study, the FIELD-PROHIBITED-2 condition (FP2). 
Subjects were assessed under the same conditions described in section 2 .2 .1.2. Again, 
if the beginning (spring season) or end (fall season) of “day light saving time” 
(DLST) occurred during the laboratoiy protocol, subjects were asked to adjust their 8 - 
h TIB by minus or plus 1 hour, respectively, to ensure that subjects maintained a 
consistent daily 8 -h TIB relative to pre- or post- DLST clock time.
2.3 Data Collection
2.3.1 Rest-Activity Assessments -  Field
The subjects’ activity and light exposure were recorded daily throughout the 
entire study by the Actiwatch-L (Minimitter, Inc., Bend, OR) wrist activity-light 
monitor at 1-minute intervals. Subjects were instmcted to wear the Actiwatch-L on 
the wrist of their non-dominant hand and over clothing so that the light-intensity 
recordings would be obtained. All subjects switched between two Actiwatch-L 
devices during their study. Subjects were asked to record the clock times that they 
removed the Actiwatch-L devices (i.e., showers or swimming) during field conditions.
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In addition, subjects were asked to keep daily diaries recording the timing of 
their “night time” sleep, naps, dnig and food intake, and exercise during all field 
conditions. Subjects reported the clock times relative to their habitual time zone. In 
the sleep diaiy, subjects were instmcted to record the clock times and the duration of 
their longest sleep of the day in which they followed their normal “night time” sleep 
behaviour/routine (e.g., sleeping in the bedioom). They recorded the following 
information: (1) clock time in bed, (2) clock time they tried to sleep, (3) duration of 
time it took to fall asleep (sleep latency), (4) number, clock time and duration of 
awakenings, (5) clock time of final awakening, (6 ) clock time out o f bed, (7) total 
amount of sleep lost (minutes), and (8 ) a sleep quality rating [1  (best sleep ever) to 9  
(the worst sleep ever)]. In the nap diaiy, subjects recorded the clock times of any 
daytime naps or sleep outside bedtime. Subjects also were instmcted to record clock 
times of instances of excessively sleepiness. In the intake diary, subjects were 
instmcted to record the clock times of any large meals (i.e., breakfast, lunch, dinner 
and snacks). They were not instmcted to record the type of food or amount. They also 
were asked to record the foreign substances that they consumed, if any, during the 
day. They were asked to record the type substance consumed, the amount consumed 
and/or dosage per serving and the clock time consumed. In the exercise/activity diary, 
subjects were instmcted to record any time they engaged in any strenuous exercise, 
including the type, the clock time it started and ended. The Raster Plot Program V 2.0 
(Complete Computer Consulting, MA, USA) was used to plot self-reported clock 
times for in-bed, sleep, nap and tired (excessive sleepiness) for each subject. Two 
subject, 22A6  and 1451 were not asked to or did not complete the intake or exercise 
diaries.
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2.3.2 Urinary 6-Sulphatoxymelatonin (aMT6s) Sampling -  Field/Laboratory
Urine samples were collected during all study conditions to measure a 
metabolite of the pineal hormone melatonin, 6 -sulphatoxymelatonin (aMT6 s), These 
measurements were used to calculate circadian phase and period during all field and 
laboratory assessments as reported in chapter 3. During all field assessments, subjects 
were asked to collect sequential -4-hourly urine samples during the daytime, plus - 8 - 
hour overnight samples over 48 hours each week (-10 samples per weekly collection). 
Subjects recorded the collection start and end clock time and recorded the weight of 
all urine collected during each ~4 or 8  hour collection. Subjects weighed (grams) the 
urine they collected in a collection jug using a speaking kitchen scale. After weighing 
the urine, subjects transferred some of urine into a pre-labelled 7nil sample vial using 
a new disposable pipette. Subjects placed each urine-sample vial into its own small 
individual zip-lock bag and then placed the zip-locked sample vial into a larger zip- 
lock bag in the subject’s freezer (< 0°C). Most of the subjects shipped the urine 
samples each week to Brigham and Women’s Hospital in Boston, USA. Subjects 
1451 and 2306 shipped weekly samples at the end of each field condition, and subject 
22K4 shipped all urine samples collected during the field study to the University of 
SuiTey for aMT6 s assay at the end of the entire study. Urine samples thawed at least 
once for 1 to 2 days before being stored at —20°C prior to assay.
During the laboratory protocol technicians collected sequential -4-hourly 
urine samples during scheduled wakefulness, plus a ~ 8  to 1 0  hour “overnight” sample 
during scheduled bed-rest each day. At the end of each collection period, technicians 
used a graduated cylinder to measure the total volume (ml) of urine collected. They 
recorded volume measured and the collection time (time-stamp) of the last void. A 
sample of the urine from each collection was transfeiTed into a pre-labelled 7ml
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sample vial with a fresh pipette. Urine samples were immediately stored in a freezer 
at< -20°C .
2.3.3 Plasma Melatonin Sampling -  Laboratory
Blood samples were collected to measure pineal melatonin secretion each day 
during most of the laboratory study. These measurements were used to: (1) calculate 
circadian phase, period and amplitude for individual subjects during laboratoiy 
assessments (Chapter 3); (2) assess the melatonin rhythm relative to circadian phase, 
time of day and scheduled wake and bed-rest (Chapter 4); and (3) to assess 
sleep/neurobehavioural function by circadian phase and elapsed time-in-bed 
(scheduled bed-rest) or time-awake (scheduled wake), respectively (Chapter 5).
2.3.3.1 Blood Collection System/Schedule
Plasma melatonin samples were collected from day 2 to day 37 of the 
laboratory protocol. An indwelling 18- to 20-gauge intravenous catheter was inserted 
into the subject’s forearm vein on day 2. The catheter was connected to a 12-foot 
small-lumen tube, which could be passed through a porthole to allow blood sampling 
outside the subject’s room during scheduled bed-rest so that the subject was not 
disturbed during sleep. Between samples, a solution of 0.45% saline with 5,000 
lU/liter of heparin was inflised at a rate of 44cc/hr to maintain patency. 
Approximately 1 ml of blood was aliquoted into a 3-ml vaccutainer containing the 
anticoagulant EDTA (ethylenediaminetetraacetic acid) for each sample taken. 
Samples were placed on ice for less than 45 minutes before being spun for 10 minutes 
in a centrifuge at +4 °C at 2,200-2,800 RPM. Plasma was transferred into a 2-ml
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aliquot tube and frozen at -20°C. Blood was sampled eveiy 60-120 minutes on 
baseline days and forced desynchrony days and eveiy 30 minutes on CR.
2.3.3.2 MST -  Light Exposure
Subjects were instructed to remain seated for ~9 hours total, including -1.5 
hours before, 6.5 hours during and -1.5 hours after the MST light exposure. Blood 
was sampled eveiy 10 minutes for 3 hours starting 1.5 hours before the room light 
intensity increased for the MST to capture any acute suppression of pineal melatonin 
after the light intensity increase. Blood sampling was reduced to eveiy 20 minutes 1.5 
hours after the room light intensity increased and continued for the remainder of the 
light exposure and 1.5 hours after the room light intensity was decreased to the dim 
light background setting.
2.3.4 Salivary Melatonin Sampling -  Laboratory
Salivary samples were obtained every 60 minutes from each subject during 
CRl (days 4 and 5), CR 2 (day 34 and 35) and on the light exposure MST day (day 
36) for melatonin assay. Subjects were asked to fill a 7ml plastic sample tube within 
five minutes. Samples were placed on ice for less than 45 minutes before being frozen 
at -20°C. Results for salivaiy melatonin are only reported here for one subject 22J2, 
since blood samples were no longer obtained after the FD protocol during CR2 and 
the light exposure MST day. Therefore, salivaiy samples were collected eveiy 30 
minutes during CR2 and the light exposure MST day for subject 22J2.
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2.3.5 Core Body Temperature Recording -  Laboratory
Core body temperature (CBT) was recorded continuously and used to assess 
the endogenous circadian phase and circadian period during the laboratoiy protocol as 
reported in chapter 3. Throughout the laboratory protocol, a disposable rectal 
thermistor (Yellow Springs Instrument Company, Yellow Springs, OH) was used to 
record CBT every minute except during bowel movements and showers. The 
thermistor marked by tape was inserted -1 0  cm into the rectum. A real-time, on-line 
data acquisition system was used to monitor CBT collection by via the rectal 
thermistor and room temperature by means of a pennanent air temperature thermistor 
attached to the wall inside the subject’s room. Technicians periodically asked subjects 
to check that the theimistor was inserted no less than the marked 1 0 cm length.
2.3.6 Neurobehavioural Assessments (Wake) -  Laboratory
Subjects completed neurobehavioural perfoimance assessments during 
scheduled wakefulness (Tights on’ to Tights out’) every 30-120 minutes beginning 
2.25 hours after scheduled wake time. Auditoiy versions of two computer-based 
perfoimance tasks and an alertness scale, known to be sensitive to circadian phase and 
time awake (Dijk et al., 1992; Wyatt et al., 1999; Wright Jr. et al., 2002; Hull et al., 
2003) were used. These include an auditoiy Karolinska Sleepiness Scale (a-KSS), a 
10-minute auditoiy Psychomotor Vigilance Task (a-PVT), a 6 -minute auditory 
Calculation Addition Task (a-ADD), and a Karolinska Drowsiness Test (KDT; wake- 
EEG data for test is not reported in this thesis). Only subjects who completed the 
entire laboratoiy protocol are included in the analysis of performance tasks.
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The Karolinska Sleepiness Scale, a 9-point Likert scale, was used to assess 
subjective sleepiness; “1 = very alert to 9 = sleepy -  great effort to keep awake -  
fighting sleep”. During this task the subject is asked to “rate their sleepiness based on 
the last five minutes before this scale”. Subjects were administered a-KSS via 
computer speakers approximately every 10-30 minutes during scheduled wakefulness 
starting 90 minutes after scheduled wake time, including administration before and 
after each neurobehavioural test. Subjects responded by typing a single number 
between 1 and 9 on a standard computer keyboard.
The a-PVT was used to measure sustained attention performance for each 
subject. During this timed task each subject was asked to maintain the fastest possible 
reaction time [RT, milliseconds (msec)] to a simple auditoiy tone. Subjects were not 
given feedback regarding any individual or overall response times. Subjects 
responded to the auditory stimulus by pressing a button. Subjects were instmcted to 
respond only upon hearing the auditoiy stimulus. The inter-stimulus interval varied 
randomly between 2 and 10 seconds. All ten subjects performed the a-PVT. The a- 
PVT was given eveiy two hours during scheduled wakefulness starting 2 hours after 
scheduled wake time.
The a-ADD task was used to assess working memoiy and cognitive 
throughput during scheduled wakefulness. During this timed task, a series of 
randomly generated 2 -digit pairings were verbally conveyed to the subject as an 
addition calculation set (i.e., fourteen plus twelve equals). In the allotted 6 -minutes, 
subjects were instructed to correctly summate each and as many 2 -digit pairings as 
fast as possible without compensating accuracy for speed. Subjects responded by 
typing the number on a standard keyboard number pad and pressing the ‘enter’ key. 
Before each response, subjects could “replay” each addition calculation pairing as
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many times as needed by pressing the keyboard ‘space bar.’ Subjects were instructed 
not to skip any addition calculation pairings (i.e., pressing ‘enter’ key without typing a 
2- or 3-digit number). After each response, the subject was automatically given a new 
2-digit pairing. Subjects performed the a-ADD task eveiy 2 hours during scheduled 
wakefulness following the a-PVT starting 2 hours after scheduled wake time. 
However, only 5 subjects perfonned the a-ADD during the test batteiy (22CS, 2306, 
2347, 23BP and 23CM). As a result, there were two test batteries, Battery-A (n=5; a- 
KSS + a-PVT + a-KSS + a-KDT + a-KSS) and Batteiy-B  (n=5; a-KSS + a-PVT + a- 
KSS + a-ADD + a-KSS + a-KDT + a-KSS).
2.3.7 Polysomnography Recordings (Sleep) -  Laboratory
Sleep-wake state during each subject’s scheduled bed-rest opportunities was 
measured and recorded by polysomnography (PSG) with an ambulatory TEMEC 
Instruments Vitaport (TEMEC, The Netherlands). PSG recordings were used to 
monitor the summation of cerebral action potentials, muscle activity and eye 
movements in order to determine sleep-wake states and sleep stage during scheduled 
bed-rest. PSG data were filtered at 35 Hz and digitized at 128 Hz. Surface electrodes 
(Beckman Instrument Co., Schiller Park, IL) were applied to each subject's face and 
head approximately 2 hours prior to scheduled bedtime (lights out) for all PSG 
recordings, including central and occipital placements for electroencephalogram 
(EEG), electrooculogram (EOG), electrocardiogram (ECG) and electromyogram 
(EMG) recording.
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2.4 Data Analysis
2.4.1 Urinary 6-Sulphatoxymelatonin (aMT6s)
All urine samples were assayed for aMT6 s at Stockgrand, Ltd. (Guildford, 
UK) by radioimmunoassay (RIA) using the method developed by Arendt and 
colleagues (1985) and modified by Aldhouse and Arendt (1988).
2.4.1.1 Urinary aMT6s Acrophase Calculation
Urinaiy aMT6 s assays results (ng/ml), total urine volume (ml) and duration 
(hr) of m ine collection for each sample were used to converted each sample value into 
nanograms per hour [(ng/hi*) = (ng/ml x ml)/hr]. A sinusoid curve [y =cos (2% x(x- 
24)/24)] was fitted to field and laboratoiy FD urinaiy aMT6 s (ng/hr) data for each 
-48-h and 56-h urine collection, respectively, to calculate the urinaiy aMT6 s 
acrophase clock time (([)aMT6s) and the standard eiTor around each estimate (SAS; 
program provided by Prof Derk-Jan Dijk).
2.4.1.2 Urinary aMT6s Period Estimation
Urinary aMT6 s acrophases derived from curve fitting analysis for each study 
condition were analysed by linear regression (y = ax + b) for each subject to calculate 
the period of urinary aMT6 s [xaMT6s = 24 + slope{b) h]. For each subject, the urinaiy 
aMT6 s acrophase estimates [clock time ± standard eiTor (se)j for each study condition 
were analysed by a weighted linear regression; the best-fit regression line was fitted 
through the acrophase estimates by day of study and clock time while weighting the 
standard eixor of each acrophase estimate (1/eiTor^). Period estimates for both 
regression analyses were considered significant if the 95% confidence inteiwal (95% 
Cl) did not include 24.00 h. The period estimates between each study condition were
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considered significantly different if the 95% Cl around the slope of regression line for 
both estimates did not cross each other. The period of urinary aMT6 s during the 
forced desynchrony was also measured using a non-orthogonal spectral analysis 
(NOSA) as described in section 2.4.4.
2.4.2 Plasma Melatonin
All plasma samples were assayed for melatonin at Phaiinasan, Inc. (Osceola, 
WI, USA) using a commercial radioimmunoassay kit (Elias USA, Inc., Osceola, WI) 
that uses I*^^-Melatonin as a tracer with a sensitivity of detection was 0.7 pg/ml. The 
intra-assay and inter-assay co-efficient of variation (CV%) was 8.9% and 10.3% at 
42.6 pg/ml (n = ll) and 83.7 pg/ml (n=10), respectively.
2.4.2.1 Melatonin Phase Calculations
Circadian phase, period and amplitude of plasma melatonin assay results 
(pg/ml) were assessed by calculating the time of 25% upward and downward crossing 
of daily melatonin profiles (Zeitzer et al., 1997), including the dim light melatonin 
onset (DLMOn25%), 25% dim light melatonin midpoint (DLMOmidpt25%), and 25% 
dim light melatonin offset (DLM0 ff2s%) time. The DLM0 n2s% and DLM0fÏ25% were 
defined as the time at which plasma melatonin levels exceeded or fell below 25% of 
the baseline frill amplitude (tiough to peak; amplitude x 2 ). The DLMOmidpt25% was 
half the distance between DLMOn25% and DLMOff25% clock times. The baseline 
amplitude was calculated by fitting a 3-harmonic regression model (Brown et al. 
1997) to the 24-h melatonin profile during the first constant routine. Melatonin data 
within the first 5 hours and the last 30 minutes of the CR were excluded fiom the 
analysis to reduce the influence of sleep at the beginning and postural changes (supine
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to semi-recumbent or semi-recumbent to supine) that occur at the beginning and end 
of the CR. If the melatonin profile began within the first 5 hours after schedule wake 
time to the constant routine, it was not used for the calculation of amplitude, thus the 
following 24-h melatonin profile was used. The CR2 amplitude was used instead of 
the CRl amplitude for one subject (1451-A previous study, Klerman et al., 1998; 
1451-B, current study) because CRl melatonin amplitude was insufficient to calculate 
D L M 025%.
In addition, the following characteristics o f the daily plasma melatonin profile 
during the forced desynchrony protocol were assessed: (I) duration above threshold 
(DAT) and (2) area under the curve (AUC). The DAT of the melatonin profile is the 
total duration of time between DLMOii25% and DLMOff25%. (DAT = (DLM0fl25%) -  
(DLMOn25%)] The AUC of the melatonin profile was calculated using the trapezoidal 
method (area of trapezoid (AUC) = area of rectangle [(Yi x (Xi~X2)] + area of 
triangle [(X1-X2) x ((Yi-Y2)/2 ))]; where Y = pg/ml and X = clock time).
2.4.2.2 Melatonin Period Estimation
Circadian period was calculated by linear regression analysis o f DLMOn25%, 
DLMOmidpt25%, and DLMOff25%. The best-fit regression lines were fitted through the 
calculated DLMOn25%, DLMOniidptOff25% and DLMOfÏ25% for each subject [period 
(t) = 24-h + slope of regression line] between CRl and CR2. The estimated period 
calculated from DLMOu25%, DLMOmidpt25%, and DLMOff25% was considered 
significant if the 95% confidence limits did not cross 24 h. The period of plasma 
melatonin during the forced desynchrony was also measured using a method (NOSA) 
described in section 2.4.4.
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2.4.2.3 Melatonin Suppression Test
Plasma melatonin levels on day 36 during the 6.5 hour bright-light exposure 
were compared with plasma melatonin levels at the corresponding clock times in dim 
light on day 35 during CR2 (Zeitzer et al., 2000b). Area under the curve (AUC) for 
plasma melatonin levels for days 35 (C R a u c )  and day 36 (L E a u c ) during 
corresponding clock times relative to the 6.5 hour light exposure was calculated using 
the trapezoidal method, as described above. Melatonin suppression was defined as the 
percentage of the difference between the C R a u c  and L E a u c  plasma melatonin levels 
during the coixesponding clock times of 6.5 hour light exposure. Percent suppression 
was determined by dividing the difference between the C R a u c  and L E a u c  plasma 
melatonin levels by C R au c:
CRauc"^ LEauc
% Suppression =   X 100
OR AUC
A MST was defined as ‘positive’ if  the L E a u c  plasma melatonin levels during 
the 6.5 hour light exposure on day 36 decreased by 33% or more (Czeisler et al., 
1995) relative to the C R a u c  plasma melatonin levels during CR at the coixesponding 
clock times on day 35. Subjects who; (1) exhibited melatonin suppression greater than 
33% [positive (+) MST] were categorized as NLP(+) blind subjects; (2) exhibited 
melatonin suppression less than 33% [negative (-) MST] were categorized as NLP(-) 
blind subjects, and (3) did not undergo a MST were categorized as NLP(<>) blind 
subjects.
2.4.3 Salivary Melatonin -  Melatonin Suppression Test
Saliva samples were assayed for melatonin at Pharmasan, Inc. (Osceola, WI, 
USA) using a commercial radioimmunoassay kit (Elias USA, Inc., Osceola, WI) that
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uses I^^^-Melatonin as a tracer with sensitivity of detection of 0.2 pg/ml. The inter­
assay co-efficient of variation was 8.87% and 10.25% at 1.81 pg/ml and 13.86 pg/ml, 
respectively, and the intra-assay co-efficient of variation was 1 1 .1% and 1 1 .2 % at 1 .6  
and 17.1 pg/ml, respectively. Salivary melatonin levels for subject 22J2 on day 36 
during the 6.5 hour bright-light exposure were compared with salivary melatonin 
levels at the corresponding clock times on day 35 (CR2) during CR in dim light using 
non-orthogonal spectral analysis (NOSA) as described in section 2.4.4.
2.4.4 Core Body Temperature -  Phase/Period Estimation
Daily core body temperature recorded during the laboratory protocol for each 
subject was edited to remove artefacts. Artefacts include data during times when the 
subject removed the thermistor for showers and bowel movements, the thermistor was 
broken or acute CBT decreases due to slight changes in the total insertion length of 
the thermistor in the rectum (<10cm) due to ambulatory movements. The CBT data 
were then analysed to calculate circadian period during the forced desynchrony 
protocol as described below.
A non-orthogonal spectral analysis (NOSA) technique was used to determine 
independently the circadian period of each subject’s urinary aMT6 s, plasma 
melatonin and CBT during the scheduled desynchrony protocol. This method takes 
into account the 28-h periodicity in the data resulting from the imposed rest-activity 
schedule and then searches for the best-fit periodicity in a wide circadian range 
between 20 and 30 hours (Brown and Czeisler, 1992; Czeisler et al., 1999). Eveiy 6 '^’ 
minute of CBT data and every available plasma melatonin and urinaiy aMT6 s data 
point between CRl and CR2 were used in the analysis. Data within the first 5 hours
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and the last 30 minutes of each CR for all three variables were excluded from 
analysis.
A model, including an endogenous component (x), an exogenous or evoked 
component (T) and a component resulting from the non-linear interaction between the 
endogenous (x) and evoked component (T) was fit to each subject’s CBT data. The 
endogenous component (x) refers to the intrinsic oscillation or period of the circadian 
pacemaker and the evoked component (T) refers to the external, evoked effects of the 
imposed 28-h forced desynchrony rest-activity schedule. One fundamental and one 
additional harmonic (Brown and Czeisler, 1992) was fitted to model the endogenous 
component and eight harmonics were fitted to model the evoked component, where as 
a fundamental and seven additional hannonics were fitted to model the evoked 
component. A parameter for serially correlated noise was also included in the model 
for CBT, but not for plasma melatonin and urinary aMT6 s. The NOSA analysis 
estimated (composite) the clock time of the first CBT minimum and plasma melatonin 
and urinary aMT6 s maximum during first CR before the start of the forced 
desynchrony days. The NOSA analysis also estimated the (composite) amplitude of 
the CBT, plasma melatonin and urinary aMT6 s rhythm across the forced 
desynchrony.
2.4.5 Neurobehavioural Assessments (Wake) -  Laboratory 
All available a-KSS, a-PVT and a-ADD data during the forced desynchrony were 
analyzed. The a-PVT output parameters included the median RT, mean RT, mean 
fastest 10% RT, mean slowest 10% RT, and the number of RT lapses in attention 
(RTs > 500 msec). Any a-PVT responses in the absence of the stimulus or RTs below 
100 msec were counted as anticipations and were not counted in the analysis. The a-
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ADD output parameters include the total number of attempted, correct and replayed 
addition calculation sets. Any a-PVT or a-ADD test that was inteiTupted or ended 
prematurely was not included in the analysis. A detailed description of analysis is 
reported in the methods section of chapter 5.
2.4.6 Polysomnography Recordings (Sleep) -  Laboratory
PSG recordings on 24-h baseline and 28-h FD days during scheduled bed-rest 
(16.00 -  24.00 h and 18.67 -  28.00 h, respectively) were scored visually in 30-second 
epochs by the investigator according to criteria established by Rechtschaffen and 
Kales (1968) for NREM. EEGs were derived from electrode placements on mastoid- 
referenced central scalp areas (C3-A2) and occipital scalp areas (01-A2). Both NREM 
stages three and four were defined as stage SWS. Both voluntaiy eye movements 
during PSG calibrations (asking subjects to direct the gaze of their eyes) prior to 
scheduled bedtime and sleep-related slow rolling and rapid eye movements during 
scheduled bed-rest were absent in all subjects, except subject 22CS. As a result, an 
epoch of sleep was scored as REM based on a modified criteria of Rechtschaffen and 
Kales (1968) in the remaining subjects described as follows: if (1) more than 50% of 
the epoch exhibited EEG characterized by mixed frequency and saw-toothed waves 
and (2) 100% of the epoch exhibited flat EMG signal, then the epoch was scored as 
REM, if not the epoch was scored as NREM-stage one. A blind-to-condition, 
secondaiy polysomnographic technician randomly selected and scored three PSG 
recordings for each subject using the criteria described above and compared the three 
recording to the coixesponding recordings scored by the investigator to determine the 
reliability of primaiy scoring for all sleep stages and wake (n=30, mean ± SD; 91 ± 3 
%). Only PSG recording during FD sleep opportunities were included in this analysis.
2 -3 3
However, the PSG recording for the first scheduled FD (9.33 h) sleep opportunity 
following CRl was not included in this analysis. In addition, PSG recordings that 
were missing both EEG and EMG channels for more than one hour of the entire sleep 
recording were excluded from analyses. A detailed description of analysis is reported 
in the methods section of chapter 5.
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Chapter 3
Assessments of Human 
Cireadian Period During 
Field and Foreed 
Desynehrony Conditions 
in NLP Blind Subjeets 
With and Without 
Cireadian Photoreeeption
CHAPTER 3 -  ASSESSMENTS OF HUMAN CIRCADIAN PERIOD DURING 
FIELD AND FORCED DESYNCHRONY CONDITIONS IN NLP 
BLIND SUBJECTS WITH AND WITHOUT CIRCADIAN 
PHOTORECEPTION
3.1 Introduction
Non-entrained blind subject with no conscious light perception (NLP) studied 
under uncontrolled field conditions exhibit a significantly longer average circadian 
period than sighted subjects studied under controlled laboratory forced desynchrony 
(LFD) conditions (-24.5 versus -24.2 h, respectively). It has been postulated that this 
discrepancy is related to: (1) a shortening of the observed period in sighted subjects 
assessed under LFD conditions due to aftereffects of entrainment; (2) the inclusion in 
the NLP blind group average of only those periods that were significantly different 
than 24-h (non-entrained); or (3) a lengthening of the observed period in non­
entrained NLP blind subjects due to exposure to unevenly or non-uniforinly 
distributed nonphotic time cues (i.e., sleep-wake state, rest-activity cycle, activity 
level and consumption of food, fluid and drugs/medications) across circadian phase 
(Czeisler et al., 1999). There are data which indicate that aftereffects of prior photic 
entrainment can alter the observed period under LFD in sighted subjects (Wright et 
al., 2006; Scheer et al., 2007). There are also field and LFD data that show that 
nonphotic time cues can shorten and entrain the non-24-h pacemaker in some 
“totally” blind individuals living in society (Kleiman et al., 1998), but there are no 
experimental field or LFD data supporting or refiiting the claim that exposure to 
nonphotic or photic time cues artificially lengthens the obseiwed period in NLP blind 
subjects living in society. It is possible that a lengthening of observed period may 
have occuiTed in a manner similar to that observed in sighted individuals studied 
under the classical-free-mnning studies (Wever, 1979; Czeisler et al., 1999).
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However, period estimates of NLP blind subjects are rarely accompanied by 
information regarding (1) the daily timing of their rest-activity or exposure to 
nonphotic time cues or the presence or absence of non-image-forming responses to 
light. Consequently, neither the uniformity of environmental or behavioural time cues 
across circadian phase dining these assessments nor their impact on observed period 
have ever been determined.
To addiess this question, the period of urinary 6-sulphatoxymelatonin 
(aMT6s) and the period of self-reported rest-activity, including the timing of bed-rest, 
naps and meal consumption, were measured in NLP blind subjects under similar field 
(Lockley et al., 1997a) and LFD (Klerman et al., 1998; Czeisler et al., 1999) 
assessments used to measure period in NLP blind and sighted subjects previously. 
Nonphotic or photic time cues were self-selected freely or with experimental 
prohibitions between two -1 -month field assessments [Field Free (FF) and Field 
Prohibited (FPl), respectively] and then experimentally removed, diminished or 
equally distributed across all circadian phases during a ~1-month LFD assessment. A 
comprehensive melatonin suppression test (Czeisler et al., 1995) was performed in 
laboratory following FD protocol to conflim whether the retina-RHT-SCN-pineal 
pathway was ftinctionally intact and to determine whether 24-h rhythms observed 
during field conditions were the result of photic entrainment. An additional - 1 -month 
field assessment [Field Prohibited (FP2)] was performed after the LFD condition. We 
hypothesized that the period of urinary aMT6s measured during the FF condition 
would be significantly longer compared to the period measured during both FP 
conditions and the LFD condition in NLP blind individuals without circadian 
photoreception (i.e., totally blind).
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3.2 Methods
3.2.1 Subjects
Twelve NLP blind subjects, 9 males and 3 females, ages 27 to 68 years (mean 
± SD, 47.8 ± 10.7) participated in the cunent study to assess human circadian period 
under field and laboratory conditions (see Table 2-1, Chapter 2). Self-reported 
daily/weekly/monthly consumption o f foreign substances varied amoung subjects (see 
Table 2-2, Chapter 2). All but one subject (23CM) reported daily consumption of 
caffeine. One subject (22K4) reported daily use and another subject (2306) reported 
inegular use of exogenous melatonin over the past year. Subject 22K4 ceased taking 
melatonin one month before the beginning of the (field) study, but subject 2306 
inadvertently took one melatonin pill (1.0 mg) on day 2 and day 6 of the first field 
study. Only one subject (22L5) engaged in exercise 2 to 4 times a week (33 bouts 
reported across 100 days). The exercise involved treadmill walking for ~ l-h  between 
the hours of 6:00 and 17:00 (mean clock time ± SD = 10:54 ± 3:22 h). Urine 
toxicology confirmed that all 12 subjects were drug-free at the beginning of the 
laboratoiy protocol. An additional abbreviated physical assessment upon admission to 
the laboratory protocol by a GCRC registered nurse and physician determined that 
each subject’s health status had not changed since their initial screening-physical 
examination -2  months earlier.
3.2,2 Protocol Schedule
Urine was collected and sampled every ~4 to 8 h over 48 h each week during 
field assessments and ~4 to 11 h daily during the laboratory assessment to measure 
urinary aMT6s, which were used to calculate the endogenous circadian phase and 
period during the following four segregated assessments (see Section 2.2 and Figure
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2-1, Chapter 2). (1) FIELD FREE (FF) (Lockley et ah, 1997); (2) a FIELD 
PROHIBITED-1 (FPl), (3) a LABORATORY FORCED DESYNCHORNY (LFD) 
(Czeisler et al., 1999), (4) and FIELD PROHIBITED-2 (FP2). A melatonin 
suppression test (MST) performed in the laboratory at the end of the FD protocol was 
used to deteraiine circadian photoreception status and test whether each individual 
had a Rmctional retina-retinohypothalamic tract-SCN-pineal pathway and (see Section 
2.2.3.7, Chapter 2). However, because two subjects, 22F1 and 22L5, were 
disempanelled on days 10 and 14 of the LFD protocol, respectively, neither was given 
the MST.
3.3 Analysis
3.3.1 Melatonin Suppression Test
The area under the curve (trapezoidal method) of plasma melatonin levels 
during the 6.5 h bright-light exposure (AUC-LE) on day 36 of the laboratory protocol 
was compared to the plasma melatonin levels during the corresponding clock times 
during CR#2 on day 35 (AUC-CR) to determine whether ocular light exposure 
elicited significant melatonin suppression. A ‘positive’ melatonin suppression test 
(MST) was defined as a greater than 33% decrease in AUC-LE compared to AUC-CR 
(Czeisler et a l, 1995) during the light exposiue. Subjects who had a positive MST 
were categorised as NLP(+), subjects with or without eyes who had a negative MST 
were categorised as NLP(-), and subjects who had no MST performed were 
categorised as NLP(<>).
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3.3.2 Periodicity of Endogenous Melatonin Rhythm
Urinaiy aMT6s concentrations were measured by radioimmunoassay (RIA) 
using the method developed by Arendt and colleagues (1985) and modified by 
Aldhous and Arendt (1988) (Stockgrand Ltd, SuiTey, UK). All urinaiy aMT6s assay 
results (ng/ml) were initially converted into nanograms per hour [(ng/hr) = (ml x 
ng/ml)/collection duration (h)]. aMT6s acrophase ((|)aMT6s = clock time ± standard 
error) or timing of each peak was calculated by fitting a sinusoid curve [y = cos (2ti x 
(x-24) / 24)] across aMT6s profiles for each -48-h field and ~56-h LFD collection.
To estimate the periodicity of urinaiy aMT6s (xaMT6s) for each subject during 
each study condition (FF, FPl, LFD and FP2), urinaiy aMT6s acrophases were fitted 
by weighted linear regression for each subject within each study condition. The best- 
fit slope of regression line (y = ax + b) was fitted tlnough the aMT6s acrophases within 
each condition for each subject while weighing the individual standard error (1/error^) 
of each calculated acrophase to determine period or the average daily change (h) in 
acrophase clock time during each condition [XaMT6s = 24 + slope(b) h]. The 95% 
confidence interval (95%CI) of the regression line was used to determine whether the 
slope of the line was significantly different from zero (or 24 h). Therefore, a subject’s 
aMT6s rhythm during field study conditions was classified as ‘entrained’ to the 24-h 
day if the 95% Cl included 24-h in the estimate or it was classified as ‘non-entrained’ 
to the 24-h day if the 95% Cl did not include 24-h in the estimate. The period of 
urinary aMT6s during the LFD condition was analyzed between CR#1 (day 5) and 
CR#2 (day 34). In addition, NOSA was used to calculate the period of urinary aMT6s 
(TaMTAs), plasma melatonin (Xm) and core body temperature (Xcbt) during the LFD 
condition for each subject (see section 2.4.4, Chapter 2). The NOSA calculated period 
of urinary aMT6s, plasma melatonin and core body temperature were compared by
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correlation analysis and averaged (FD-NOSA mean; intrinsic circadian period) within 
each subject.
First, to detennine whether observed period is lengthened in NLP blind 
subjects with no circadian photoreception under field conditions, weighted regression- 
derived period estimates of urinaiy aMT6s were first compared within each subject 
across study conditions. If the 95% Cl of the estimate in one condition did not exceed 
the 95% Cl of the estimate in another condition, then the observed periods between 
the two conditions were considered significantly different. A Student’s f-test was also 
used to determine whether the average circadian period between each condition for 
non-entrained NLP(-) blind subjects was significantly different (p<0.05).
Second, the FD-NOSA mean (intrinsic circadian period) was compared to the 
weighted regression-derived period estimates of urinary aMT6s (observed aMT6s 
circadian period) during each field condition and the FD condition by weighted linear 
regression (observed vs. intrinsic). The average change in observed period between 
each field condition and the intrinsic circadian period during the FD protocol was 
calculated for each NLP(-) subject, and then a Student’s C-test was used to determine 
whether the average change in obseiwed period between field and FD conditions in 
non-entrained NLP(-) blind subjects was significantly different (p<0.05).
Last, to detennine whether the length of the field assessment influenced the 
period estimate during field conditions, a weighted regression line was fit through all 
acrophases during the first two field conditions (FF+FPl) as part of a collective pre­
lab field assessment. The period of urinary aMT6s during the collective pre-lab field 
assessment was compared to the urinary aMT6s period during the LFD condition. In 
addition, the urinaiy aMT6s (weighted regression) period between the first half (lab 
days 4-19) and second half of the FD protocol (lab days 20-35) were compared for
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each subject to determine whether period significantly shortens or lengthens (i.e., 
after-effects) over the course of the LFD condition.
3.3.3 Periodicity of Behavioural Rhythms Linked to Rest-Activity
To determine the distribution and uniformity of exogenous time cues across 
circadian phase during each condition, the periodicity and average timing of each 
subject’s self-reported or scheduled rest-activity (T) were analysed. Rest-activity 
variables, including the clock times of the onset, midpoint and offset of bed-rest and 
naps, as well as clock times of the onsets of each major meal or consumption of a 
particular foreign substance, were fitted by linear regression. The 95% Cl was used to 
detennine whether the slope of the line was significantly different from the external 
24-h geophysical day (24-h or non-24-h) and the subject’s endogenous rhythm 
(synchronised or desynchronised), as well as to categorise the rest-activity rhythm 
relative to the endogenous rhythm. Therefore, if the 95% Cl of the individual 
subject’s I  estimate [T = 24 + slope(b) h] for more than 75% of behavioural rest- 
activity variables (1) included 24-h and exceeded the 95% Cl of the urinary aMT6s 
period estimate within a study condition, then T was considered a 24-h synchronised 
rhythm; (2) included 24-h and did not exceed the 95% Cl of the urinaiy aMT6s period 
estimate within a study condition, then I  was considered a 24-h desynchronised 
rhythm; (3) did not include 24 h, but exceed the 95% Cl of the urinaiy aMT6s period 
estimate within a study condition, then T was considered a non-24-h synchronised 
rhythm; and (4) did not include 24-h and did not exceed the 95% Cl of the urinaiy 
aMT6s period estimate within a study condition, then the T rhythm was considered 
non-24-h desynchronised rhythm.
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The length of each individual subject’s beat cycle period (xb) was also 
calculated [xb = (T x  XaMX6s) / (|T -  XaMT6s|)] for each study condition to determine the 
distribution of exposure to environmental and behavioural time cues across the range 
of circadian phases. The beat cycle is defined as the elapsed time it takes for the 
phases of two rhythms, which oscillate with different periods, to intersect or return to 
a given temporal phase relationship (xb = (j)T <i)XaMT6s)- For instance, an individual 
who exhibits a similar urinary aMT6s and rest-activity period has an undefined beat 
cycle period, since the two rhythms oscillate at the same period and thus maintain a 
relatively similar phase relationship. However, an individual who exhibits non- 
entrained lu’inary aMT6s period equal to 24.2 h and a rest-activity period equal to 24- 
h will has a beat cycle period equal to 2904 h or 121 days, since the two rhythms 
oscillate at different periods. Thus the individual subject’s beat cycle period (days) 
and the assessment duration (days; difference between day of last acrophase and day 
of first acrophase estimate) during each assessment will be used to determine the 
percentage of the distribution of environmental and behavioural time cues across the 
full range of circadian phases. The clock times for each variable were also averaged 
within and then across subjects within each group.
3.4 Results
3.4.1 Melatonin Suppression Test
Seven subjects were classified as NLP(-), tluee were classified as NLP(+), 
and the remaining two subjects were classified as NLP(<>) because they did not have 
a MST. The melatonin AUC-LE in seven NLP blind subjects, three without eyes
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Figure 3-1. Individual results of the melatonin suppression test (M ST). Melatonin levels (y- 
axis, pg/ml) on day 35 (CR2; open symbols) are superimposed over the melatonin levels 
across the corresponding 16 h (x-axis) on day 36 (MST; filled symbols) relative to 
scheduled wake time (0 h) on day 36 for each subject. Melatonin was measured under 
constant conditions in dim light on day 35 and before and after (<15 lux background 
lighting; gray shaded area) a 6 .5  h (10 .75  h for 23B P) bright white light exposure (>9500  
lux lighting, non-shaded area), which began 4 .75  h after scheduled wake time on day 36. 
Note: all figures depict plasma melatonin levels, except for subject 22J2 (salivary 
melatonin).
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(Figure 3-1, Column A) and four with two eyes (Figure 3-1, Column B), exhibited 
negative melatonin suppression (Figure 3-1, Column C). The average (± SD) 
percentage of suppression was -1.24 ± 16.6 % (n=7). The melatonin AUC-LE in three 
NLP blind subjects with at least one eye (Figure 3-1, Column C) exhibited positive 
melatonin suppression (subject = AUC%; 22J7 = +74.16 %; 22CS = +90.30 %; 23CM 
= +48.22%).
3.4.2 Period of Urinary aMT6s: Field vs. LFD Conditions
Table 3-1 and Figure 3-2 show the individual urinaiy aMT6s period estimates 
(weighted linear regression) for each subject under each study condition. Table 3-2 
shows the individual NOSA-derived period estimates for urinaiy aMT6s, plasma 
melatonin and core body temperature for each subject during the LFD condition. 
Urinaiy aMT6s rhythms were not classified as entrained for all three field assessments 
(FF, FP 1 and FP2) or through the first two field conditions in any of the seven NLP(-) 
subjects (see Figures 3-3.1 to 3-3.7). Urinaiy aMT6s rhythms were classified as 
entrained during all three field assessments (FF, FPl and FP2) in only two of three 
NLP(+) subjects (see Figures 3-3.8 to 3-3.10). Urinaiy aMT6s rhythms were 
classified as entrained during FF and FPl field assessments in one of the two 
NLP(<>) subjects (see Figures 3-3.11 to 3-3.12). The weighted linear regression 
derived period of urinary aMT6s was highly correlated to NOSA-derived period of 
urinary aMT6s (r=0.99), plasma melatonin (1=1.00) and CBT (i=1.00) under the LFD 
condition across all 10 subjects who completed the laboratoiy study.
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Figure 3-2. Circadian period (± 95% C I) of urinary aM T6s (weighted regression) under 
Field Free (open circles), Field Prohibited-1 (upward triangle), Laboratory Forced 
Desynchrony (filled circle) and Field Prohibited-2 (downward triangle) conditions in NLP 
blind subjects who had a negative [Top Panel; NLP(-)] and positive [Middle Panel; 
NLP(+)] melatonin suppression test and in NLP blind subjects for whom the melatonin 
suppression test was not performed [Bottom Panel; NLP(<>)].
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3.4.2.1 Rhythms in NLP(-) Blind Subjects
Approximately 80% of the urinaiy aMT6s period estimates in NLP(-) subjects 
across all field conditions were significantly different from 24-h and were classified 
as non-entrained. Non-entrained urinary aMT6s periods in NLP(-) subjects ranged 
between 24.1 and 24.9 h across all field conditions. Approximately 88% of the non- 
entrained urinary aMT6s periods in NLP(-) blind subjects observed during the three 
field assessments were comparable to the period observed during the LFD condition. 
The period of urinaiy aMT6s in NLP(-) subjects during the LFD condition ranged 
between 24.2 and 25.0 h. Furthennore, none of the NLP(-) subjects exhibited a 
significantly longer period under any field condition compared to the period obseiwed 
under the LFD condition.
The average circadian period (± SD) of urinaiy aMT6s in NLP(-) blind 
subjects (n=7) was 24.41 ± 0.20 h during the FF condition, 24.42 ± 0.32 h during the 
FPl condition, 24.45 ± 0.28 h during the LFD condition and 24.40 ±0.31 h during the 
FP2 condition. The average circadian period (± SD) of urinary aMT6s (n=7) during 
the collective field assessment (FF+FPl) was 24.41 ± 0.32 h. There was no significant 
difference (Student’s ^test; one-tail) in the observed period of urinary aMT6s 
between individual field conditions; FF and FPl (P=0.47), FF and FP2 (P=0.47), FPl 
and FP2 (P=0.40). In addition, there was no significant difference (Student’s ?-test; 
one-tail) in the period of urinaiy aMT6s between FF and LFD (P=0.16), FPl and LFD 
(P=0.21) or FP2 and LFD (P=0.21) conditions. However, there was a significant 
difference in the observed period of urinaiy aMT6s between the collective pre-lab 
field assessment (FF+FPl) and the LFD condition (P=0.01).
There was no significant difference in the average (±SD; Student’s ^-test: P < 
0.05) change in period between FF and FPl conditions (-0.01 ± 0.19 h; P = 0.91),
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SUBJECT#
Gender. Age 
Number of eyes 
MST results (+,-.<>)
Sludv conditions.
FF -  Field Free 
F P l -  Field Proh*biled-1 
LFD -  Let) 28 h FO 
FP2 -  Field P roh^ ted -2
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I aM T6e(t3S% Cn  
—  • condition transiinn
B
A C R O P H A S E S  O F URINARY aM T 6s 
& S E L F -R E P O R T E D  REST-ACTIVITY
CIRCADIAN PE R IO D  O F URINARY aM T 6s 
FO R  EACH STUDY CONDITION
i3 .e  34 .I B4.I !« .«  M .I & te  :# .#  l u  :# .e
t x e  i s .e  M .e  k i  i 4.« ae .e  a e .!  am e  am a  am e  
CIrced len  P e h o d  (h)
23 99 10  01
24 00 1 0 00 
28 00 1 0 00 
24 08 t  0.01
24 00 1 0 01 
24 00 1 0 00 
28 00 1 0 00 
24 OS t  0 01
24 02 18  01
24 00 1 0 00 
28 0 0 1 0  00 
24.08 1 0 01
24 O i l  0 08 24 02 1 0 08 24 03 l  0  11
28 0 0 1 0 0 0  28 00 1 0 OO 2800 i  0 00
Key for Figures 3-3.1 to 3-3.12 (following pages). Summary piots and tabie of urinary 
aM T6s and rest-activity data for FF, F P l, LFD and FP2 experimental conditions and 
individuai subjects. Panel A: subject information, study condition abbreviation, symboi key 
to raster plots and graph; Panel B: plot of subject’s weekly urinary aM T6s acrophases (± 
se) superimposed over a raster plot of their self-reported (field conditions) and imposed 
(laboratory protocol) rest-activity (see symbol key). Data are plotted by day of study (y- 
axis; left side), study condition (y-axis, right side) and double-plotted by clock time (x- 
axis). Note that seif-reported “sleep” data during scheduled bed-rest in the time-free 
laboratory protocol depicts only time between subject’s approximation of first sleep onset 
(duration of time to fall asleep after “lights out”) and last sleep offset (duration of time 
awake before “lights on”) reported in a post-sleep questionnaire after scheduled wake 
time; Panel C: plot of the observed circadian period (± 95% Ci; weighted regression) of 
urinary aM T6s (x-axis) for each condition (y-axis); Panel D: tabie reporting the observed 
period (± 95% C I) of urinary aM T6s and seif-reported (field conditions) and imposed 
(laboratory protocol) rest-activity measures (bed-rest, naps and meals) for FF, F P l, LFD  
and F P l conditions.
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FF and FP2 conditions (0.00 ± 0.17; h P = 0.95) or FPland FP2 conditions (0.01 ± 
0.07h; P = 0.70) conditions. There was no significant difference in the average change 
in period within subjects across field (FF, FPl and FP2) conditions (0.00 ± 0.11; h P = 
0.92). In addition, there was no significant difference in the average change in period 
between FF and LFD conditions (-0.05 ± 0.11 h; P = 0.22), FPl and LFD conditions 
(-0.05 ± 0.10; h P = 0.27) or FP2 and LFD conditions (-0.06 ± 0.10 h; P = 0.18). 
However, the average change in period within NLP(-) subjects between field 
conditions and the LFD condition was significantly slightly shorter than zero (-0.05 ± 
0.05 h; P = 0.03). In addition, the average change in period between the collective 
field assessment (FF+FPl) and the LFD condition was significantly shorter than zero 
(-0.06 d= 0.05 h; P = 0.02).
Figure 3-4 shows the relationship between weighted-linear-regression-derived 
(obseiwed) circadian period (xobs) of urinary aMT6s during all four assessments 
compared to the average NOSA-derived (intrinsic) circadian period (x) o f urinary 
aMT6s, plasma melatonin and CBT during the LFD condition for NLP(-) subjects. 
The observed circadian period o f urinary aMT6s and the average intrinsic circadian 
period during the LFD condition are similar and highly correlated (Figure 3-4A). The 
obseiwed circadian period of urinary aMT6s during FF, FPl and FP2 conditions 
exhibit a close relationship to the average intrinsic circadian period during the LFD 
condition. NLP(-) subjects with intrinsic circadian periods nearest to 24-h exhibited 
similar periods, while subjects with intrinsic circadian periods furthest from 24-h 
exhibited slightly shorter periods during the FF condition compared to the LFD 
condition (Figure 3-4B). In contrast, NLP(-) subjects with intrinsic circadian periods 
nearest to 24-h exhibited slightly shorter periods, while subjects with intrinsic 
circadian periods furthest from 24-h exhibited similar periods during the FPl
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Figure 3-4. Relationship between the average NOSA-derived (aM T6s, plasma melatonin, 
C BT) circadian period during LFD condition (T=28.0h ) and the urinary aM T6s circadian 
period (weighted-linear regression) during the LFD condition (A) and the FF (B), FP1 (0 )  
FP2 (D), FF+FP1 (E) field conditions. Symbols (error bars) represent the observed aM T6s  
period (± 95% C I) in individual NLP ( - )  subjects (n=7) plotted by urinary aM T6s circadian 
period (x-axis) and average NOSA-derived circadian period (y-axis). The solid diagonal 
black line represents the line of equality. The dashed line represents a linear fit of the 
data, and the dotted lines across 24.0 h represent the period of rest-activity.
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Figure 3-5. Average deviation from FD period in the period observed during field conditions 
(FF, F P l and FP2) relative to the initial phase angle (degrees; right y-axis) [or the timing of 
the aM T6s acrophase and out-of-bed during 1®‘ w eek of field condition during the first week  
of that field condition (hours; left y-axis)] in seven NLP ( - )  subjects. The seven data points in 
the graph do not represent individual N L P (-) subjects, nor does each subject contribute 
equally to each data point [7 (subjects) X 3 (field period estimate) = 21 (phase-angle/field  
periods)]. Data are plotted by average (± sem) deviation from FD period in the observed 
period during a field condition (where X <0 represents a shortening of period and X>0  
represents a lengthening of period) relative to the the mean initial phase angle [averaged 
every 3 consecutive phase angle points (when aM T6s acrophase occurs (1) at out-of-bed 
then Y=0 h, (2) before out-of-bed then Y <0 h and (3) after out-of-bed then Y >0 h] during the 
week of that field condition. Note that changes in period do not cover a full range of initial 
phase angles, such that extreme initial phase angles, where the f  ^ aM T6s acrophase of the 
field condition occurred 8 to 12 hours before or after out-of-bed (between -180° to -150° or 
150° to 180°), were not observed for any N L P (-) subjects. Therefore, there are no data 
showing whether a shortening or lengthening of period would occur at these extreme phase 
angles.
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condition compared to the LFD condition (Figure 3-4C). All NLP(~) subjects 
exhibited slightly shorter periods during the FP2 condition compared to the LFD 
condition (Figure 3-4D). In addition, all NLP(-) subjects exhibited slightly shorter 
periods during the collective field assessment (FF+FPl) compared to the LFD 
condition (Figure 3-4E). Significant changes in period occurred when the initial phase 
angle between the timing of the first aMT6s acrophase of the period assessment and 
the timing of average habitual wake time during the field condition were within 2 
hours of each other (Figure 3-5).
Only four NLP(-) subjects (1451, 22A6, 23BP and 22J2) exhibited any 
notable changes in observed period during field conditions compared to the LFD 
condition. These subjects also exhibited uiinary aMT6s periods nearest to 24-h during 
the LFD condition (24.2 -  24.3 h). Three NLP(-) subjects were classified as entrained 
during at least one of the three field assessments: 23BP during FF; 1451 during FPl 
and FP2; and 22J2 during FP2. However, the 95% Cl of their entrained period 
estimates crossed the 95% Cl of their period during the LFD condition, thus they were 
not significantly different than the period obseiwed during the LFD condition. 
Interestingly, two NLP(-) subjects, 22A6 and 23BP, exhibited a non-entiained urinary 
aMT6s period during one of the FP conditions (FPl and FP2, respectively) that was 
significantly shorter than the urinaiy aMT6s period under the LFD condition. In 
addition, subject 22A6 also exhibited a significantly shorter period during both FP 
conditions compared to the FF condition, but the urinaiy aMT6s period during FF and 
FP2 conditions was not significantly different than the period measured under LFD 
conditions. In contrast, three NLP(-) subjects (2306, 2347 and 22K4) were not 
classified as entrained during any field condition. These NLP(-) subjects also 
exhibited periods farthest from 24-h during the LFD condition (24.5, 24.7 and 25.0 h.
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respectively). The urinaiy aMT6s period estimates were not significantly different 
among any field conditions or between any field conditions and the LFD condition.
3.4.Z.2 Rhythms in NLP(+) Blind Subjects
Approximately 78% of the urinaiy aMT6s period estimates in NLP(+) subjects 
across all field conditions were indistinguishable from 24-h and were classified as 
entrained. Surprisingly, urinaiy aMT6s rhythms in only two NLP(+) subjects, 22CS 
(Figure 3-3.8) and 23CM (Figure 3-3.9), were classified as entrained during all thiee 
field assessments, while urinaiy aMT6s rhythms in subject 22J7 (Figure 3-3.10) were 
classified as non-entrained during both FF and FP2 conditions. Subject 22J7 exhibited 
a significantly longer circadian period (24.6 h) than subjects 22CS and 23CM, who 
exhibited the shortest periods (23.9 and 24,1 h, respectively) during the LFD 
condition. Subject 22J7’s non-entrained urinary aMT6s rhythms during both 
conditions were not significantly different than the observed circadian period during 
the LFD condition (24.6 h). Although subject 22J7 exhibited entrained urinary aMT6s 
rhythms during the FPl condition, the period observed during the collective field 
assessment (FF+FPl) suggests that the urinary aMT6s rhythms were not entrained 
during the FPl condition. Subject 22CS’s urinaiy aMT6s rhythm was entrained at an 
earlier clock hour (mean (j)aMT6s ± SD = 24.50 ±1.31 h), such that the phase angle of 
entrainment (±SD) between the average aMT6s acrophase and average offset of self­
selected bed-rest (out of bed) across each field assessment was -6.6 ± 1 . 9  h. In 
contrast, subject 23CM’s urinary aMT6s rhythm was entrained at a relatively noraial 
clock time (mean (j>aMT6s ± SD = 3.7 ± 1 . 8  h), such that the phase angle of 
entrainment (± SD) between the average aMT6s acrophase and average offset
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Figure 3-6. Relationship between the average NOSA-derived (aM T6s, plasma melatonin, 
C BT) circadian period during LFD condition (T=28.0h) and the urinary aM T6s circadian 
period (weighted-linear regression) during the LFD condition (A) and the FF (B), FP1 (0 )  
FP2 (D), FF+FP1 (E) field conditions. Symbols (error bars) represent the observed aM T6s  
period (± 95% C I) in individual NLP (+) subjects (n=3) plotted by urinary aMTBs circadian 
period (x-axis) and average NOSA-derived circadian period (y-axis). The solid diagonal 
black line represents the line of equality. The dashed line represents a linear fit of the 
data, and the dotted lines across 24.0 h reoresent the oeriod of rest-activitv.
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of self-selected bed-rest (out of bed) across each field assessment was -2.2 ± 1.2 h. 
There was no significant difference in aMT6 period between the 1st half and the 2nd 
half of the LFD condition in either NLP(+) or NLP (-) subjects (Figure 3-7).
Figure 3-6 shows the relationship between weighted linear regression derived 
(observed) circadian period (Xobs) of urinary aMT6s during all four assessments 
compared to the average NOSA-derived (intrinsic) circadian period (x) of urinary 
aMT6s, plasma melatonin and CBT during the LFD condition for each NLP(+) 
subject. The obseiwed circadian period of urinary aMT6s and the average intrinsic 
circadian period during the LFD condition were similar and highly coiTelated (Figure 
3-6A). Smprisingly, the observed circadian period of urinary aMT6s during FF, FPl 
and FP2 conditions exhibit a close relationship to the average intrinsic circadian 
period during the LFD condition. However this was mainly due to the non-entrained 
urinary aMT6s rhythms exhibited by subject 22J7. NLP(+) subjects 22CS and 23CM 
exhibited intrinsic circadian periods nearest to 24-h during the LFD condition and 
entrained urinary aMT6s rhythms during FF (Figuie 3-6B), FPl (Figure 3-6C) and 
FP2 (Figure 3-6D) conditions. However, NLP(+) subject 22J7 exhibited a non- 
entrained period during the FF and FP2 condition similar to that obseiwed during the 
LFD condition. This was flirther demonstrated when comparing the observed urinary 
periods during the collective field assessment (FF+FPl) with the LFD condition 
(Figure 3-6E).
3.4.2.3 Rhythms in NLP(<>) Blind Subjects
The urinary aMT6s rhythms in one of the two subjects who did not undergo a 
melatonin suppression test were classified as entrained during both field assessments. 
Subject 22F1 was classified as entrained during both FF and FP conditions and
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Period under Forced Desynchrony
Urinary aMT6s Circadian period (h)
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Figure 3-7. Circadian period (± 95% C I) of urinary aM T6s (weighted regression) during 
first half (filled circles) and second half (open circles) of Laboratory Forced Desynchrony 
in NLP blind subjects (y-axIs; ^exhibit positive melatonin suppression). Subject data are  
plotted from shortest to longest period.
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subject 22L5 was classified as non-entrained during both FF and FP conditions. 
Subject 22F l’s urinary aMT6s rhythm was entrained at a later than normal clock hour 
(mean (j)aMT6s ± SD = 9:06 ±1:41 h), such that the phase angle of entrainment (± 
SD) between the average aMT6s acrophase and average offset of self-selected bed­
rest (out of bed) across each field assessment was +3.0 ± 2.5 h. Subject 22 F l’s urinaiy 
aMT6 rhythms exhibited a period significantly longer than 24-h (24.35 ± 0.29 h) 
during one week under the LFD condition, and subject 22L5 exhibited a significantly 
period longer than 24-h (24.49 ±0.18 h) during approximately two weeks under the 
LFD condition. Individual urinary aMT6s period estimates were not significantly 
different among FF, FP or LFD conditions for either 22F1 or 22L5.
3.4.3 Period of Rest-activity Variables: Field vs. LFD Conditions
The periodicity of self-reported or scheduled rest-activity variables for all four 
study conditions are shown next to the period of urinaiy aMT6s in a table under the 
individual subject’s raster figures (Figures 3-3.1 to 3-3.12). Regardless of subjects or 
field condition, the rest-activity rhythm was not desynchronised to the 24-h day. In 
particular, the period of rest-activity was not significantly different from 24-h and not 
similar to the non-24-h period of the uiinary aMT6s rhythm in NLP(-) blind 
individuals. Therefore, the rest-activity rhythm was characterized as either a 24-h 
synchronised rhythm (entrained urinary aMT6s rhythm) or a 24-h desynchronised 
rhythm (non-entrained urinaiy aMT6s rhythm) across subjects and field conditions. In 
contrast, the period of the imposed 28 h rest-activity schedule during the LFD 
condition was significantly different from both 24-h and the period of each individual 
subject’s melatonin rhythm. Therefore, the rest-activity rhythm during the LFD 
condition was characterized as a non-24-h desynchronised rhythm for each subject.
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During ali field conditions, including the FF condition, NLP(-) subjects (n=7) 
reported bed-rest between late evening (-22:00) and later morning hours (-10:00), 
naps during mid-day between -11:00 and 19:00, and meals between morning (-6:00) 
and evening (-21:00) hours. During all field conditions, including the FF condition, 
NLP(+) subjects (n=3) reported bed-rest between late evening (-22:00) and early 
morning hours (-8:00), naps during mid-day between -15:00 and 18:00, and meals 
between morning (-6:00) and evening (-20:00) hours. During all field conditions, 
including the FF condition, NLP(<>) subjects (n=2) reported bed-rest between late 
evening (-23:00) and morning hours (-10:00), naps during mid-day between -11:00 
and 18:00, and meals between morning (-6:00) and evening (-20:00) hours.
3.4.3.1 Self-Reported Bed-rest
Table 3-3 shows the average clock time and duration of self-reported or 
scheduled bed-rest during field conditions and scheduled bed-rest during the LFD 
condition. The average (±SD) onset-to-offset clock times (duration) of self-reported 
bed-rest in NLP(-) subjects (n=7) were 23:20 ± 1:00 to 6:23 ± 0:59 (7.0 ± 0.8 h) 
during the FF condition, 22:30 ± 0:27 to 6:25 ± 0:31 (7.9 ± 0.3 h) during the 
FPl condition and 23:36 ± 1:14 to 7:29 ± 1:10 (7.9 ± 0.5 h) during the FP2 condition. 
The average (±SD) onset-to-offset clock times (duration) of self-reported bed-rest in 
NLP(+) subjects (n=3) were 24:13 ± 2:37 to 6:44 ±1:31 (6.8 ± 0.7 h) during the FF 
condition, 22:39 ± 0:08 to 6:56 ± 0:05 (8.3 ± 0.2 h) during the FPl condition and 
23:19 ± 0:07 to 7:14 ± 0:06 (7.9 ± 0.2 h) during the FP2 condition. Lastly, the average 
(±SD) onset-to-offset clock times (duration) of self-reported bed-rest in NLP(<>) 
subjects (n=2) were 23:36 ± 0:55 to 7:43 ± 0:11 (8.1 ± 0.7 h) during the FF condition 
and 23:25 ± 0:48 to 7:35 ± 1:08 (8.1 ± 0.3 h) during the single FP condition.
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3.4.3.2 Self-Reported Naps
Table 3-4 shows the average clock time and duration of self-reported naps 
during field conditions. All NLP(-) blind subjects reported naps dming the FF 
condition, but naps were not reported every day for any individual subject. The 
average (±SD) onset-to-offset clock times (duration) of self-reported naps were 14:58 
± 1:37 to 16:18 ± 1:19 (1.3 ± 0.7 h) in NLP(-) subjects during the FF condition. Four 
NLP(-) blind subjects reported sporadic naps during the FPl condition, and one 
subject (22J2) reported a nap nearly every day during the FPl condition. The average 
(±SD) onset-to-offset clock times of self-reported naps were 15:17 ± 1:22 to 16:13 ± 
1:00 (0.9 ± 0.6 h) in NLP(-) subjects dui'ing the FPl condition. Five NLP(-) blind 
subjects reported naps during the FP2 condition, but naps were not reported every day 
by any individual subject. The average (±SD) onset to offset clock times (duration) of 
self-reported naps were 13:14 ± 3:22 to 13:48 ± 3:18 (0.6 ± 0.4 h) in NLP(-) subjects 
during the FP2 condition. NLP(—) blind subjects reported fewer total naps during FPl 
(59 naps) and FP2 (63 naps) conditions compared to the FF condition (99 naps), but 
there was no significant difference (Smdent’s /-test; P<0.05) between the FF condition 
and the FPl (P=0.26) or FP2 (P=0.26) condition. However, the average nap duration 
was significantly shorter during the FPl (P=0.01) and FP2 (P=0.001) condition 
compared to the FF condition.
The two NLP(+) subjects who exhibited entrained urinary aMT6s rhythms 
during all field assessments reported the fewest naps. Subject 23CM reported 14 naps 
across all three field assessments (FF = 9 naps), and subject 22CS reported 11 naps 
across 60 days of study during the FF condition, no naps during the FPl condition and 
only 2 naps during the FP2 condition. The one NLP(+) subject who did not exhibit 
entrained urinary aMT6s rhythms during any field condition reported 26 naps during
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the FF condition, 9 naps during the FPl condition and 6 naps during the FP2 
condition (see table 3-4 for average clock times and duration).
The one NLP(<>) blind subject, 22F1, who exhibited abnormally entrained 
urinary aMT6s rhythms during both field assessments, reported fewer naps during the 
FF condition (19 naps) than during the single FP condition (49 naps). However, the 
average nap duration (±SD) during the FP condition (0.1 ± 0.1 h) was significantly 
shorter than during the FF condition (0.4 ± 0.6 h). Subject 22L5 reported fewer naps 
of shorter duration dining the single FP condition compared to the single FF 
condition.
3.4.3.3 Self-Reported Meals
Table 3-5 shows the average clock time of self-reported or scheduled meals 
during field conditions and scheduled bed-rest. During all field conditions, including 
the FF condition, NLP(-) subjects (n=5) reported meals between morning (-6:00) and 
evening (-21:00) hours. The average (±SD) clock times of self-reported breakfast, 
lunch and dinner in NLP(-) subjects was 7:48 ± 0:37, 12:54 ± 0:24 and 19:24 ± 0:54 
during the FF condition, 7:54 ± 1:12, 12:54 ± 0:12 and 19:19 ± 0:48 during the FPl 
condition and 8:07 ± 1:00, 13:00 ± 0:37 and 19:12 ± 1:00 during the FP2 condition.
Uniformity of external (environmental and behavioural) time cues linked to 
the self-selected or imposed rest-activity was dependent upon whether the individual 
subject exhibited photic entrainment, the length of the individual subject’s field 
assessment (-1 -month) and difference between the individual subject’s observed 
urinary aMT6s and rest-activity period. For instance, daily external time cues were 
not equally distributed across circadian phase during either field condition in four 
NLP(-) subjects (1451, 22A6, 23BP, 22J2) who exhibited urinaiy aMT6s periods
3-41
nearest to 24-h during the LFD condition (24.2 to 24.3 h). Daily external time cues 
were only distributed across 7 to 36% of the full range of circadian phases during 
field conditions. In addition, these four NLP(-) subjects did not complete a full beat 
cycle during the pre-lab field (FF+FPl) conditions before entering the laboratory for 
the FD protocol.
Daily external time cues were nearly equally distributed across circadian phase 
during both field conditions in NLP(-) subjects (2306, 2347, 22K4) whose urinary 
aMT6s exhibited periods furthest from 24-h during the LFD condition (24.5 to 25.0 
h). They were distributed across 34 to 89% of the full range of circadian phases 
during individual field conditions. In addition, the observed urinaiy aMT6s rhythms 
in these three subjects completed at least one full beat cycle during the pre-lab field 
(FF+FPl) conditions; 22K4 completed approximately two full beat cycles.
Daily external time cues were obviously not equally distributed across 
circadian phase during any field condition in the two NLP(+) subjects who exhibited 
entrained urinary aMT6s (22CS and 23CM), but they were distributed across 50 to 
60% of the fiill range of circadian phases in the NLP(+) subject (22J7) who exhibited 
non-entrained urinary aMT6s periods during FF and FP2 conditions. Daily external 
time cues were also not equally distributed across circadian phase during either field 
condition in the one NLP(<>) subject who exhibited entrained urinary aMT6s (22F1). 
However, daily external time cues were distributed across 42 to 100% of the full 
range of circadian phases in the NLP(<>) subject who exhibited non-entrained urinaiy 
aMT6s periods during both FF and FP conditions (22L5). The observed urinaiy 
aMT6s rhythms in subject 22L5 completed nearly two flill beat cycles during the FF 
condition, which is mainly attributed to the length of this individual’s field 
assessment.
3 -4 2
3.5 Discussion
In the cuiTent investigation, the range of periods obseiwed under the LFD 
condition in 7 totally blind subjects [NLP(-): no visual or circadian photoreception] 
was similar to the range of periods measured in previous field studies in other NLP 
blind subjects (Lockley et al., 1997a; Lockley et al., 2000; Hack et al., 2003). More 
importantly, the period obseiwed under any field condition was not significantly 
longer than the period observed under the LFD condition in any one of these totally 
blind subjects. This was particularly true in 3 totally blind subjects who’s urinaiy 
aMT6s rhythm exhibited a period equal to or significantly longer than 24.5 h under 
the LFD condition (or “longest-LFD” periods), especially one subject (22K4) who 
had previously been reported to exhibit a period closer to 25.0 h during similar field 
assessments [e.g., subject S45, XaMT6s (± 95%CI) reported in: Lockley et al., 2000, 
24.52 ± 0.34 h pre- and 24.91 ± 0.20 h post-melatonin administration; Hack et al., 
2003, 24.95 ± 0.05 h pre-melatonin administration]. This was also tiiie in 4 totally 
blind subjects who’s urinaiy aMT6s rhythm exhibited a period significantly shorter 
than 24.5 h under the LFD condition (or “shortest-LFD” periods).
Interestingly, among totally blind subjects, many of the periods observed 
across all field conditions were slightly shorter than the period observed under the 
LFD condition. For example, in totally blind subjects who exhibited the longest-LFD 
periods, some of the periods obseiwed dining field conditions were slightly, but not 
significantly shorter. However, in some totally blind subjects who exhibited the 
shortest-LFD periods, many o f the periods observed during field conditions were 
slightly or significantly shorter. In fact, over the first two field conditions, weekly 
urinaiy aMT6s acrophases displayed greater relative coordination in totally blind
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subjects with the shortest-LFD periods compared to subjects with the longest-LFD 
periods.
These data do not support the hypothesis that uncontrolled exposure to 
nonphotic (environmental and behavioural) time cues lengthens the observed period 
in non-entrained NLP blind individuals. This hypothesis was loosely based upon 
refuting evidence, which challenged the reliability of period estimates measured 
mostly in sighted individuals under the self-select conditions of the classical free- 
mnning studies (n=147; rest-activity period = 25.00 ± 20.50 h, 13 -  65 h and core 
body temperature period = 25.00 ± 0.50 h, 23.8 -  27.1 h; Wever, 1979) or under real- 
world conditions where there is no daily ocular exposure to a typical solar -12:12 LD 
cycle either as the result of geographical location (i.e., Antartica; Kenneway and Van 
Dorp, 1991) or non-24-h rest-activity behaviour (i.e., non-24-h sleep-wake syndrome; 
McArthur et al., 1996; Klerman, 2001; Hayakawa et al., 2005). However, non-24-h or 
atypical-daily light exposure could not account for a lengthening of period in a 
majority NLP blind individuals as it may in regards to “free-mnning” sighted 
subjects. For example, it is well established that the longer, near-25-h periods 
observed in “free-running” sighted individuals are artificially lengthened by self­
selected ocular light exposure (Klerman et al., 1996; Czeisler et al., 1999). This 
flirther demonstrated by observations made between sighted “nappers” and “non- 
nappers” studied under a free-running protocol, in which the period of body 
temperature rhythm in nappers was significantly shorter than the period in non- 
nappers (Campbell et al., 1993). The shorter period observed in nappers is not related 
to the effects of sleep per se, but is more directly related to changes in light-dark 
exposure associated with the timing of naps. In contrast, for most NLP blind 
individuals, particularly bilaterally enucleated subjects, environmental (solar and
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artificial) light is no longer a significant or relevant time cue, and it can no longer 
entrain the non-24-h period of the circadian pacemaker. As a result, periodic 
nonphotic stimuli, such as daily rest-activity behaviour, are the only significant and 
relevant time cues, but as these data show, they are much weaker than light and can 
only entrain the pacemaker to the 24-h day only within a narrow range of circadian 
periods nearer to 24-h. Interestingly, even though their endogenous melatonin rhythm 
was not entrained to their daily behaviour or the 24-h day, totally blind subjects 
maintained a relatively typical 24-h rest-night/active-day behaviour during all field 
assessments, like many (sighted) individuals living in society do. They did not exhibit 
a non-24-h rest-activity pattern, like that observed in sighted subjects living in 
isolation during the free-rmining protocols (i.e., without knowledge of time) or 
sighted individuals diagnosed with non-24-h sleep-wake syndrome living in society 
(i.e., with knowledge of time). Therefore, it may not be suiprising that a shortening, 
and not a lengthening of period was observed in these totally blind subjects, since 
they maintained a 24-h rest-activity pattern. Unfortunately, it cannot be determined 
which nonphotic time cue linked to rest-activity (i.e., sleep-wake state, activity levels, 
meal consumption) is responsible for the observed shortening of period. It is possible 
that sleep, independent of light is a significant nonphotic time cue. In previous field 
studies in NLP blind subjects, it has been reported that daytime naps, or sleep outside 
typical night time bed-rest, are more likely to occur in this particular population 
(Lockley et al., 1997a; Lockley et al., 1999). The occurrence o f daytime naps is 
usually related to the non-entrained or abnormally entrained melatonin rhythm, such 
that NLP blind individuals attempting to maintain a typical 24-h rest-activity schedule 
are more likely to report naps when the timing of the peak of melatonin occuis 
roughly during mid-day hours. The rest-activity patterns in some non-entrained NLP
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blind individuals may appear bimodal, such that the onset of one bout of sleep occurs 
in a nightly fashion and another occurs in a near circadian fashion each or every other 
day (Klein et al., 1993; Lockley et al., 1997a; Lockley et al,, 1999), but this may not 
be consistent across all non-entrained NLP blind individuals living in society. For 
example, social constraints, such as daytime employment, may impose restrictions, 
forcing the individual to maintain wakefulness, despite their feelings o f excessive 
sleepiness. Totally blind subjects in the cuiTent study reported varying numbers and 
durations of naps among field conditions, but the presence or absence of daytime 
napping did not produce any noticeable effects on the period observed during any 
field condition among totally blind subjects.
In general, nonphotic time cues were not distributed equally across circadian 
phase during any field assessments especially in subjects with periods less than 24.9 
h, yet the period during those assessments was not lengthened in any of the totally 
blind subjects. In a recent laboratory study examining the limits of entrainment to a 
weak synchronizer in sighted individuals, it was reported that the observed period 
significantly shortened or lengthened when subjects were scheduled to an imposed 
day length (24.0 or 24.6 h) that was less than or greater than their circadian period 
measured under forced desynchrony, respectively (Wright Jr et al., 2001). This may 
imply that exposure to 24-h-periodic nonphotic time cues, such as daily rest-activity, 
are more likely to shorten the observed period, when the endogenous period is slightly 
longer than 24 h.
The apparent entiainment of the urinary aMT6s rhythm during field 
assessments in some totally blind subjects is most likely due to insufficient power or 
assessment duration causing an error in the estimate and not a demonstration of tme 
circadian entrainment. Totally blind subjects did not exhibit entrainment continuously
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through the first two field assessments as it was obseiwed in two of the NLP(+) blind 
subjects. Moreover, most of the apparently entrained rhythms in some of the totally 
blind subjects occiuTed during field conditions when the peak of urinary aMT6s 
occurred at 1 to 3 hours after their average habitual wake time (i.e., abnoimal phase 
relationship). Half of NLP blind subjects previously reported to exhibit 24-h rhythms 
were categorised as “abnomially-entrained” (Lewy and Newsome, 1983; Sack et al., 
1992; Lockley et al., 1997b; Klerman et al., 1998). The timing of the minimum of 
core body temperature or the peak/onset of melatonin secretion in NLP blind subjects 
(i.e., CBT minimum -4.9 to +0.6 h relative to habitual wake time, Kleiinan et al., 
1998; melatonin peak +1.3 to +7.1 h relative to midnight, Lockley et al. 1997a) 
occurred outside the range observed in entrained sighted subjects (melatonin onset - 
4.47 to +0.55 h relative to habitual bed time, Wright Jr. et al., 2005). It is possible that 
the rhythms of NLP blind subjects categorised as abnormally-entrained are not truly 
entrained. It is possible that the study length or the sampling frequency of circadian 
phase was inadequate to detect non-entrained periods significantly different from 24-h 
(Lockley, 1997). An insufficient phase-estimate resolution (i.e., number of phase 
estimates and the number of days between phase estimates) may also explain the 
apparent 24-h rhythms observed in previous studies. For instance, there may be only 
one phase estimate per beat cycle (e.g., time it takes to go from a particular phase 
relationship back around to the same phase relationship). For example, if the period of 
the non-entrained melatonin rhythm in a NLP blind subject who maintains a typical 
24-h rest-activity schedule is longer than 24.5 h period, the melatonin rhythm will 
complete one full beat cycle in fewer days than if the period were shorter than 24.5 h. 
If the period of the melatonin rhythm is 25.0 h, the melatonin rhythm will complete 
one beat cycle in -25 days relative to the 24-h rest-activity rhythm, where as if the
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period of the melatonin rhythm is 24.2 h, the melatonin rhythm will complete one beat 
cycle in -122 days relative to the 24-h rest-activity rhythm. Therefore, if phase 
assessments were performed eveiy 4 weeks, the approximate clock time of each phase 
estimate relative to the 24-h day every four weeks would be similar in a NLP blind 
individuals whose melatonin rhythm exhibited a period of -25.0 h, but the 
approximate clock time of each phase estimate every four weeks relative to the 24-h 
day would occur -6  h later in the NLP blind individuals whose melatonin rhythm 
exhibits a period of 24.2 h. This may explain some of the 24-h or “entrained” rhythms 
that have been reported (i.e., Klerman et al., 1998).
In a previous report on nonphotic entrainment (Klerman et al., 1998), the 
apparent 24-h rhythms observed in most of the totally blind subjects (i.e., negative 
melatonin suppression test) was not due to photic entrainment. Interestingly, this 
report included results from various laboratory assessments of subject 1451, and he 
interestingly classified as both totally blind and entrained in society. Subject 1451 was 
studied during a 1-month forced desynchrony protocol similar to the one reported 
here. Over the course of the previous forced desynchrony protocol, the rhythms of 
CBT and melatonin for 1451 were delayed by 2.6 h, whereby the period (± SD) of the 
CBT rhythm was 24.10 ± 0.21 h. Based on this period estimate, a cumulative phase- 
delay (-8 hours) in the timing of the CBT minimum during a 2 % month outpatient 
assessment would have been expected. To further determine whether nonphotic 
stimuli were responsible for the apparent entrainment of subject 1451 in society, an 
additional inpatient study was perfoimed in which they assessed 1451’s melatonin 
rhythm during an imposed 23.8 h rest-activity schedule for 24 cycles, and then 
followed by a 24-h rest-activity stabilization schedule for 14 cycles. They reported 
that the CBT and melatonin rhythms phase-advanced after 10 days on the 23.8 h rest-
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activity schedule, and the phase-relationship of CBT and melatonin with respect to 
scheduled sleep episodes was maintained by the end of the protocol. This indicated 
that nonphotic time cues across a range circadian periods within -0.3 h around 24-h 
could cause significant phase shifts to maintain entrainment to the 24-h day. In the 
current study, in addition to 1451, the melatonin rhythm during the FD protocol in 
subjects 22A6 and 23BP exhibited a circadian period within 0.3 h of their observed 
24-h rest-activity (-24.2 and 24.3 h, respectively). The obseiwed period of the 
melatonin rhythm in these two subjects was shorter during certain field conditions 
(either FF or FP) compared to the circadian period during the LFD condition. The 
observed shortening of period was not directly related to the field condition. It 
appeared to be related more to the particular phase relationship between the melatonin 
rhythm and their rest-activity, which is consistent with changes in period previous 
reported (Klerman et al., 1998). For example, in 1451’s previous study on the 23.8 h 
day schedule, the onset of melatonin secretion did not begin to advance (i.e., shorten 
the observed period to 23.8 h) until approximately 10 cycle of the 23.8 h day when the 
phase-relationship between the melatonin rhythm and the scheduled sleep episode was 
slightly delayed.
In the earlier study, subject 1451 was entrained, and in the present study, the 
subject was not entrained in society. There are a few possible explanations for a lack 
of entrainment observed in 1451 in the current protocol. One explanation may be 
related to 145 Ts bilateral enucleation between LFD assessments. Bilateral 
enucleation has been shown to cause physiological changes in the circadian system, 
including to photic and nonphotic input pathways (Hannibal et al., 1997; Kaur and 
Rusak, 2007) and within the SCN itself (Cullen and Kaisennan-Abramof, 1976; Rea 
and Pickard, 2000; Lavialle et al., 2001; Nagai et al., 1992; Shibata et al., 1984). A
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study comparing the free-running circadian period of locomotor activity in bilaterally 
enucleated hamsters and intact controls (Yamazaki et a l, 2002) reported that 
enucleated hamsters had a broader distribution o f fi*ee-mnning circadian period of 
locomotor activity, suggesting that the eyes may feedback on or interact with the 
circadian pacemaker in generating the near-24-h signal Whether similar internal 
physiological changes obseiwed in rodents occurs in humans after bilateral 
enucleation is not definitively known. However, subject 1451 exhibited a significantly 
longer circadian period (h ± 95% Cl) during the same LFD protocol after (xmei =24.20 
± 0.03 h; xcbt =24.20 ± 0.05 h) compared to before (xmei =24,09 ± 0.02 h; xcbt =24.07 ± 
0.04 h) bilateral enucleation. Whether bilateral enucleation or the change in period 
observed after bilateral enucleation contributed to 1451’s non-entrained rhythms in 
society in the current study can not be ascertained.
Nonetheless, results from simulations of 1451’s data using light-based 
mathematical models of the circadian pacemaker incoiporating a nonphotic 
component (i.e., sleep-wake cycle) suggest that nonphotic stimuli could possibly 
entrain the human circadian pacemaker to day lengths (T) that have a ±0.3 h 
difference from the endogenous period (x) (St Hilaire et a l , 2007). In the cuixent 
study, the aMT6s period results during the field conditions for all the totally blind 
subjects, particularly those subjects with periods closest to 24-h during the LFD 
condition, suggest that the limits of entrainment to nonphotic time cues may be 
narrower than the proposed ±0.3 h. The aMT6s results also suggest that the strength 
of the nonphotic time cues, such as rest-activity, may not be sufficient to elicit 
significant phase-advances to entrain the circadian pacemaker to 24-h when the 
circadian period is greater than -24.1 h. During the assessment on the 23.8 h day 
length schedule, 1451 exercised for —15 minutes in the early part of every scheduled
3 -5 0
wake episode. Exercise has been shown to significantly phase-shift the circadian 
pacemaker in sighted subjects studied under extremely dim (<1 lux) light (Barger et 
al., 2004). It is possible that the human circadian pacemaker may be more sensitive to 
daily exercise compared to the rest-activity (i.e., sleep-wake) cycle. If bouts of 
exercise produce a larger amplitude phase-response-curve (PRC) compared to rest- 
activity, this could potentially increase the range of entrainment to a rest-activity 
schedule or day length that is ±0.3 h different from the endogenous period. The phase- 
advance shifts observed during 1451 assessment during the 23.8 h day schedule did 
not occur until ~10 days into the 23.8 h schedule, after a particular phase-relationship 
between the melatonin rhythm and the rest-activity schedule was reached, possibly 
when the advance-portion of the nonphotic PRC to exercise was exposed.
Two NLP(±) subjects with intact circadian photoreception (22CS and 23CM) 
exhibited entrained rhythms and also exhibited the shortest circadian periods under 
the LED condition. Suprisingly the third NLP(+) subject, 22J7 did not exhibit an 
entrained melatonin rhythm during field conditions despite possessing circadian 
photoreception. During the 22J7’s first field condition (FF), the melatonin rhythm 
exhibited significantly longer-than-24-h period, but interestingly, it was not 
significantly different the circadian period observed during the FF condition the LFD 
condition (-24.6 h). The most likely explanation for this discrepancy is that the 
subject wore opaque cosmetic scleral acrylic shells over her eyes. Although subject 
22J7 did not report the clock times that the shells were in or out of her eyes, she did 
report that she wore them during most of the day and night time hours during the field 
conditions and rarely removing the shells to momentarily clean them. Prior to 
admission to the 38-day inpatient laboratoiy protocol, subject 22J7 removed the shells 
and did not put them back in her eyes until after being discharged from the inpatient
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protocol. Although this subject attempted to maintain a typical 24-h rest-activity 
schedule during both the FP conditions, the cosmetic shells covering 22J7’s eyes most 
likely blocked ocular light exposure during the daytime. Blocking ocular light 
exposure would prevent daily light input to the clock, thus preventing the necessary 
phase-advance required each day to entrain the pacemaker to the 24-h day and 
causing non-entrained rhythms. A further field follow-up assessment of subject 22J7 
is necessaiy to determine whether timed light exposure without the cosmetic eye 
shells can entrain this subject in society. It would be especially advantageous to assess 
circadian period during LFD conditions once more in this individual after photic 
entrainment has been established to determine whether after-effects of entrainment 
would shorten the observed period upon release from entrainment into the LFD 
protocol. Despite this, this subject did not exhibit a significantly different period 
during field assessments.
3.6 Conclusion
These data demonstrate that the observed circadian period of uiinaiy aMT6s is 
not lengthened in totally blind subjects under uncontrolled field conditions, 
particularly in totally blind subjects who exhibited periods equal to or longer than 
24.5 h. These results indicate that exposure to nonphotic time cues in society are more 
likely to shorten the observed period in totally blind individuals in society rather than 
lengthen the period, par ticularly in totally blind individuals with periods nearer to 24- 
h and significantly less than 24.5 h. These results may explain the 24.0 h rhythms 
observed in -25 percent of NLP blind subjects in society. A shortening of period is 
more likely since most NLP blind subjects, particularly those who are employed 
during weekdays, attempt to maintain a typical 24 h, rather than a non-24-h rest-
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night/active-day schedule along with most of the 24-h “sighted” society. However, it 
should be noted that a shortening of period was not obseiwed in all totally blind 
subjects during field conditions or in eveiy field condition for any single subject. The 
latter suggests that changes in period as those observed in this investigation are 
dependent upon the presence of particular (yet to be identified) nonphotic time cues 
linked to rest-activity, as well as the phase relationship between the circadian 
melatonin rhythm and the rest-activity behaviour of the individual during field 
assessments. In addition, these data indicate that the range of entrainment to the 24-h 
day to nonphotic time cues linked to rest-activity is more naiTow then previously 
reported (within -0.3 h of 24 h), such that NLP blind subjects with periods equal to or 
less than 24.3 h did not exhibit entrainment to the 24-h day or rest-activity behaviour 
throughout all field conditions. Lastly, these data also demonstrate, once again, that 
light is the strongest environmental resetting stimulus of the human circadian 
pacemaker and that nonphotic time cues are much weaker than light.
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Chapter 4
Evoked Effeets of 
Rest-activity on the 
Human Melatonin Rhythm 
Under Forced Desynehrony 
Conditions: Dependence on 
Presence of Both Eyes.
CHAPTER 4 -  EVOKED EFFECTS OF REST-ACTIVITY ON THE HUMAN 
MELATONIN RHYTHM DURING FORCED DESYNCHRONY 
CONDITIONS: DEPENDENCE ON PRESENCE OF EYES
4.1 Introduction
The circadian pacemaker, the paired suprachiasmatic nuclei (SCN), drives 
circadian rhythms, such as the pineal melatonin rhythm, which is commonly used as a 
marker of the human circadian pacemaker. In sighted humans, the daily, nocturnal 
timing of melatonin secretion is maintained by ocular exposure to the solar 24-h light- 
dark (LD) cycle, and appropriately timed (nocturnal) ocular light exposure can 
suppress melatonin secretion and phase-shift the subsequent timing of nocturnal 
melatonin secretion the following day. Conversely, in a majority of blind humans with 
no conscious light perception (NLP), particularly bilaterally enucleated subjects, the 
timing of melatonin secretion usually occurs later each day, exhibiting a longer than 
24-h period, and the melatonin response to light is absent (Arendt et al., 1988; 
Lockley et al., 1997b; Czeisler et al., 1995; Klerman et al., 2002). The eyes serve a 
primary role for conveying photic information fi-om rod-cone photoreceptors via 
primary and accessoiy optic pathways to the occipital cortex for image-forming, 
conscious photoreception, but they also serve a vital, principal role for conveying 
photic information to the SCN via an distinct neural pathway for non-image-forming 
(NIF), circadian-photoreception. Environmental light that falls upon the retina is 
transduced into a neural signal by photosensitive retinal ganglion cells (pRGCs) and 
transmitted from the /?RGCs to the SCN via the retinohypothalamic tract (RHT). The 
specificity of this NIF pathway is underscored by the demonstration that a small 
percentage of NLP blind individuals, who still have at least one eye, exhibit 
significant light-induced melatonin suppression and phase shifts (Czeisler et al., 1995; 
Klerman et al., 2002).
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In previous reports in animals, it has been noted that the eyes may also act as a 
peripheral oscillator and may provide feedback to the circadian pacemaker 
independent of its major role of transmitting photic information to the SCN. For 
example, melatonin is rhythmically produced in the mammalian eyes in antiphase 
with the pineal melatonin secretion (Tosini and Menaker, 1996). In addition, bilateral 
enucleation has been reported to elicit: (1) reduced SCN inneiwation due to 
degeneration of the RHT and as well as indirect photic pathways, such as the GHT 
(Hannibal et al., 1997) and the IGL (Kaur and Rusak, 2007); (2) altered SCN 
innervation, morphology (Cullen and Kaisennan-Abramof, 1976; Rea and Pickard, 
2000; Lavialle et al., 2001; Nagai et al., 1992) and electrical activity (Shibata et al., 
1984); (3) altered pineal morphology (Dombrowski and McNulty, 1984a; 
Dombrowski and McNulty, 1984b); (4) diminished (Lee et al., 2003) and enhanced 
(Beaule and Amir, 2003) gene expression in the SCN; and (5) instability in the 
obseiwed average rest-activity period compared with sighted animals (Yamazaki et al., 
2002). Similar differences have been reported in anophthalmic mice that have a 
genetic mutation that inhibits the foimation of the eyes and retinal projections to the 
SCN during prenatal development (Silver, 1977; Laemle et al., 1993; Laemle and 
Ottenweller, 1998; Laemle et al., 2002; Wee et al., 2005). Other afferent SCN 
projections, such as the serotoninergic raphe nuclei, which receive indirect photic 
input and are also involved in the sleep-wake circuit, do not appear to be affected by 
the absence of eyes (Pickard et al., 1996; Graff et al., 2005). How bilateral 
enucleation affects the human circadian pacemaker and its afferents is unknown.
Nonphotic stimuli (sleep-wake state, activity level, posture changes) usually 
do not elicit marked changes to the human circadian melatonin rhythm that are near to 
or equivalent to the magnitude of those elicited by ocular light exposure. It is for this
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reason that the melatonin rhythm is considered the most reliable marker of the human 
circadian pacemaker. In laboratory assessments measuring the melatonin rhythm in 
sighted subjects during a forced desynchrony (FD) protocol, it has been reported that 
melatonin levels averaged across circadian phase are usually lower during scheduled 
wake compared to schedule bed-rest (sleep opportunities) and that melatonin levels 
averaged across by time o f day decrease during scheduled wake and increase during 
scheduled bed-rest (Wyatt et al., 1999; Dijk, 1999; Shanahan and Czeisler, 2000). A 
specific analysis of melatonin data pooled from multiple subjects studied during 20-h 
and 28-h FD protocols showed an interaction between the endogenous melatonin 
rhythm and the imposed LD/rest-activity schedule (Ritz-De Cecco, 2004). Melatonin 
secretion phase (dim light melatonin onset; DLMO), duration (time between DLMOn 
to DLMOff) and concentration levels (area under the curve between DLMOn to 
DLMOff; AUC) exhibited a significant modulation across different phase 
relationships with the non-24-h imposed schedule. The modulation of phase and 
amplitude observed in these assessments was consistent with the phase-dependent 
effects of light. For example, if the circadian peak o f melatonin pulse occuiTed nearer 
to scheduled wake time or nearer to scheduled bed time under FD conditions, DLMO 
was advanced or delayed, respectively, relative to the predicted phase (regression 
line) calculated by the overall period o f the melatonin rhythm across the study. In 
addition, if the melatonin pulse occurred during scheduled wake under FD conditions, 
melatonin levels were reduced compared to baseline levels during habitual bed-rest 
episodes. While it is more likely that the periodic exposure to photic (LD) rather than 
non-photic (rest-activity) cues across circadian phase is responsible for the observed 
modulation of the circadian melatonin rhythm in sighted subjects studied under FD 
conditions, there are no experimental data to confirm this.
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Although the relative duration and concentration levels of the melatonin 
rhythm has been shown to be similar between sighted and totally blind (i.e., no light 
or circadian photoreception) subjects under constant conditions, it has not been 
determined if the melatonin rhythm is similar under FD conditions. In addition, the 
effects of bilateral enucleation on the circadian pacemaker have not been assessed. In 
the current investigation, plasma melatonin was measured during the FD protocol to 
test the hypothesis that the daily profile, phase, duration and concentration levels of 
the circadian melatonin rhythm: (1) will exhibit significant light-induced modulation 
during the FD protocol in NLP blind subjects who have eyes and exhibit positive 
light-induced melatonin suppression similar to that observed in sighted subjects under 
the same FD conditions; (2) will not exhibit significant modulation during the FD 
protocol in either NLP blind subjects who have eyes or who are bilaterally enucleated 
(BE) and do not exhibit positive light-induced melatonin suppression.
4.2 Methods
4.2.1 Subjects
Plasma melatonin was assessed in 10 healthy, NLP blind subjects, 8 men and 
2 women (mean age ± SD = 48.1 ± 11.9 yrs, range 27-68 yrs) during the 28-h FD 
protocol (see section 2.3.3 for details regarding melatonin sampling). Subjects were 
separated into 3 groups (Table 4-1; also see Table 2-1) based on the presence or 
absence of eyes and positive melatonin suppression (Melatonin Suppression Test 
results; see Figure 3-1). Subjects were placed in the E-POS group, if they exhibited 
positive melatonin suppression (had at least 1 eye), and subjects who do not exhibited 
positive melatonin suppression were placed either in the E-NEG group, if they had 
eyes or the BE group, if they were bilaterally enucleated.
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Table 4-1 . List of NLP blind subjects among 3 experimental groups. Group assignment 
was based upon the presence or absence of eyes (>1) and positive melatonin 
suppression (M S I) . Note that 1451 was assessed before and after bilateral enucleation.
EXPERIMENTAL
GROUP
SUBJECT
NUMBER
AGE
(yrs)
CAUSE OF 
BLINDNESS
AGE OF 
NLP (yrs)
AGE OF 
ENUCLEATION
22J7 57 Retinal detachment -21 - -
E-POS 22CS 53 Retinitis pigmentosa -36 —
23CM 26 ROP at birth <14 14 (right eye)
1451-Before 34 Retinopathy -8 —
22A6 48 ROP at birth <1 -
E-NEG 22J2 52 ROP at birth <1 —
23BP 33 Measles: retinopathy 2 —
2347 68 Meningitis -8 —
1451-After 41 Retinopathy -8 38
BE 2306 53 Retinoblastoma 2 2
22K4 49 Ocular trauma 33 33
One subject, 1451, was studied during the same forced desynchrony protocol 
twice, ~4 years before (1451-Before, age 34; Klennan et al., 1998) and after (1451- 
After, age 41, current protocol) bilateral enucleation. Subject 1451 exhibited negative 
melatonin suppression before (subject no. 8; Czeisler et al., 1995) and after (subject 
no. 2; Klerman et al. 2002) the first forced desynchrony protocol prior to bilateral 
enucleation. As a result, subject 1451’s melatonin data was also included within and 
between group analyses for both E-NEG group (1451-Before) and BE group (1451- 
After), respectively. In addition, a specific analysis of subject 1451’s melatonin 
rhythm between forced desynchrony studies before and after bilateral enucleation was 
performed. This individual offers a rare opportunity to assess melatonin measuied 
continuously in a healthy blind individual before and after enucleation under strictly 
controlled, long-duration laboratoiy conditions. In summaiy (Table 4-1), 3 subjects 
are reported on in the E-POS group (mean age ± SD: 46 ± 16 y; Imale, 2 females), 5 
subjects (including 1451-Before) are reported on in the E-NEG group (47 ± 14 y; 5
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males) and 3 subjects (including 1451-After) are reported on in the BE group (48 ± 6 
y; 3 males). Age was not significantly different among the 3 groups (Student’s r-test; 
one-tailed: P>0.05),
4.2.2 Protocol Schedule
Subjects were studied independently in an environment free of time cues in the 
Intensive Physiology Monitoring Unit o f the General Clinical Research Center at 
Brigham and Women’s Hospital, Boston, MA. Subjects were first scheduled to three 
24-h baseline days (16:8; scheduled wakefulness and bed-rest) and on day 4 they 
remained awake for 40 h during a constant routine (CR) protocol. Subjects were then 
scheduled to live for over 4 weeks (24 cycles) on a 28-h day FD protocol (23 cycles 
for subject 1451-Before), in which scheduled wakefulness (18.66 h; <15 lux) and 
schedule bed-rest (9.33 h; 0 lux) occurred 4 h later each day relative to their habitual 
bed times (Figure 4-1; also see section 2.2.1.3). In the absence of a strong resetting 
stimulus, the circadian pacemaker continues to oscillate at its near-24-h period 
conciUTently with the imposed 28-h rest-activity schedule. The temporal relationship 
between the phases of the two oscillations (midpoint of bed-rest and peak/midpoint of 
melatonin rhythm) changes each cycle as a function of their disproportionate periods, 
such that the phase of imposed 28-h rest-activity rhythm is distributed across and 
superimposed over a full range of phases o f the near-24-h melatonin rhythm. Under 
these controlled experimental conditions, environmental and behavioural factors 
linked to the imposed 28-h bed-rest schedule (such as dim-light exposure, showers, 
activity, posture changes, sleep-wake state and food-fluid intake) occur periodically at 
different phases of the endogenous circadian melatonin rhythm.
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4.3 Analysis
4.3.1 Melatonin Levels
An analysis of daily melatonin profiles was perforaied to deteiinine how the 
individual subject’s endogenous period, the imposed 28-h rest-activity period and the 
interaction between the two affect the observed melatonin rhythm in NLP blind 
individuals. All available plasma melatonin data during the FD protocol, between 
scheduled wake time on day 6 to scheduled wake time on day 34, were included in 
these analyses (day 33 for 1451-Before). Each individual subject’s FD melatonin data 
was first normalised to account for inter-individual differences in peak melatonin 
secretion levels between subjects. FD melatonin levels were transfonned into a 
percentage o f  the baseline fitted  maximum (%BL fitted max). The baseline fitted 
maximum was calculated for each subject by fitting a 3-harmonic regression model 
(Brown et al. 1997) to the melatonin profile measured during the first CR on days 4 
and 5. However, the baseline fitted maximum for both 1451-Before and 1451-After 
BE was assessed during the second CR (on days 33-34 and days 34-35, respectively) 
due to an abnoimal melatonin profile (i.e., multiple outliers) during the first CR in 
each instance. The %BL fitted max melatonin values depict FD melatonin levels for 
each subject relative to the individual’s baseline fitted maximum measured under 
controlled CR conditions.
Nonnalised melatonin levels were averaged within subjects across time as a 
function of (1) the period of the individual subject’s endogenous circadian melatonin 
rhythm (C-cycle; Xm = -24-h), (2) the period of the (exogenous) imposed 28-h rest- 
activity rhythm (T-cycle; T = 28-h) and (3) the period of the individual subject’s beat 
cycle (B-cycle; Xy [T, Xm] = ( T x x,n ) / (|T -  Xm|). The latter refers to the elapsed time 
it takes for the phases o f two rhythms, which oscillate with different periods, to
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intersect or return to a similar temporal phase relationship. Therefore, the phase of the 
individual subject’s endogenous circadian rhythm, which oscillates with a near-24-h 
period, is defined as the NOSA predicted peak or midpoint (daily clock time relative 
to regression line of NOSA period estimate) of the melatonin rhythm ((j>Xm), and the 
phase of the exogenous rest-activity rhythm, which cycles at the imposed 28-h period, 
will be defined as the midpoint of scheduled bed-rest (cjiT) for this particular analysis.
4.3.1.1 Effects of 28 h Rest-Activity Period
To assess the effects of the imposed 28-h rest-activity period (T-cycle; T) on 
the melatonin rhythm, nonnalised melatonin data for each subject were divided into 
24 FD days (23 days for 1451-Before). Each melatonin sample time point (X^ei) for 
each subject was assigned a time point relative to the elapsed time in 28-h day 
[TID(h)n = Xmei -  (j)Tn], 0.00 to 27.99, where 0.00 equals the scheduled wake time ((})%) 
for each FD day (n). All FD melatonin data were then averaged in twelve 30° (-2.33 
h) bins starting at 0.00 h (centred at -1.20 h) within subjects and then averaged across 
subjects within each experimental group. In addition, melatonin data averaged by TID 
were assessed separately between elapsed time in wake episode (WAKE; eight bins 
between 0.00 to 18.67 h) and elapsed time in bed-rest episode (BED; four bins 
between 18.68 to 27.99 h). Data averaged by elapsed time in 28-h day and elapsed 
time in wake and bed-rest episodes were analysed by two-way repeated measures 
ANOVA within and between groups for the factor ‘T-CYCLE’. To compare 
melatonin levels between groups, all FD, WAKE and BED melatonin data were 
analysed by two-way repeated measures ANOVA between groups for the factors 
‘GROUP’ and ‘GROUP x T-CYCLE’.
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4.3.1.2 Effects of Circadian Period
To assess the effects of the endogenous circadian period (C-cycle; x) on the 
melatonin rhythm, normalised melatonin data for each subject were divided into 
circadian days (Figure 4-1). The total number of circadian days (complete cycles) 
during the FD protocol and the duration of the circadian day for each individual 
subject were relative to each individual’s melatonin NOSA calculated circadian (or C- 
cycle) period during the FD protocol. Each melatonin sample time point (Xmei) for 
each subject was assigned a circadian phase [CP° = (X^ei -  (|)m)/Tm) ^ 360°], 0 to 359°, 
where 0° equals the predicted NOSA fitted peak (^m). All FD melatonin data were 
then averaged in twelve 30° (-2 h) bins centred at CP 0° within each subject and then 
averaged across subjects within each experimental group. Data averaged by circadian 
phase were analysed by two-way repeated measures ANOVA within and between 
groups for the factor ‘C-CYCLE’. In addition, to assess the evoked effects of 
scheduled wakefiilness (WAKE) and bed-rest (BED) FD segments on the circadian 
melatonin rhythm, WAKE and BED melatonin data were averaged separately by 
circadian phase within each subject and then averaged across subjects within each 
group (WAKE-CP and BED-CP, respectively) and analysed separately by two-way 
repeated measures ANOVA for the factor ‘C-CYCLE’. To compare melatonin levels 
between WAKE and BED across circadian phase for each group, WAKE-CP and 
BED-CP were analysed by two-way repeated measures ANOVA within groups for 
the factor ‘WAKE x BED’. To compare melatonin levels between groups, all FD, 
WAKE and BED melatonin data were analysed separately by two-way repeated 
measures ANOVA within groups for the factors ‘GROUP’ and ‘GROUP x C- 
CYCLE’.
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Figure 4-1. Raster plot of laboratory protocol of one subject (2306) showing the changing 
phase relationship between the calculated (DLMO; open symbols) and predicted (N O SA  
regression line = ())MEL = C P 0°; dashed line and filled circle anchors) phase of the 
endogenous rhythm and the phase of the imposed rest-activity schedule (midpoint of bed­
rest =(j)T: diagonal white lines). Data are plotted by day of laboratory study on the y-axis 
and by habitual clock time double-plotted on the x-axis. The phase of endogenous 
circadian (dashed line) and imposed 28-h rest-activity (white line) rhythm intersect (the 
dashed and white line crisscross) when the predicted melatonin peak coincides within 4 
hours of the midpoint of scheduled bed-rest (BCP 0°; indicated along y-axis). This 
intersection occurs every - 8  days (one beat cycle). The length of the subject’s circadian 
day is tau (x) hours long (diagonal light-gray area). Daily calculated DLM Os (on, midpt, 
off) are superimposed over the 28-h rest-activity schedule showing their timing in the 
circadian day (TCD; arrows day 17, 18 and 19). Note that the day-to-day TC D  of DLM O  
changes relative to the beat cycle phase. For example, the timing of DLMOmidpt (open 
circles) occurs on, slightly before (phase-advanced) or slightly after (phase-delayed) the 
NOSA regression line on subsequent days at different phases of the beat cycle.
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4.3.1.3 Effects of Beat Cycle Period
To assess the magnitude of evoked effects on melatonin relative to the 
interaction between the circadian component and the imposed 28-h component, 
nonnalised melatonin data for each subject were first separated among six possible 
temporal phase relationships (beat cycle phases) between the midpoint of scheduled 
bed-rest and the predicted midpoint of the melatonin rhythm during the 28-h FD 
protocol. Beat cycle phase was determined by the period of each individual subject’s 
beat cycle or B-cycle (xb). The beat cycle period was calculated for each subject as a 
function of his or her individual circadian period (Xm) and the imposed 28-h rest- 
activity rhythm (T=28 h) using the following foimiila: xy [xmJl = ( T x Xm ) / (|T -  Xm|) 
(Klein et al., 1993; Klerman et al., 1996; Klennan et al., 1999). Each melatonin 
sample time point (Xmei) for each subject was assigned a beat cycle phase [BCP° = 
((Xmei -  (()b)/i:b) ^ 360°], 0 to 359°, where 0° equals the predicted intersection ((j)b) of 
the midpoint of scheduled bed-rest, which oscillates with an imposed period equal to 
28 h, and the midpoint (predicted peak) of the melatonin rhythm, which oscillates at 
the individual’s endogenous circadian period. Nonnalised melatonin data were then 
averaged in six, 60° (~4 h) bins centred at BCP 0° within each subject and then 
averaged across subjects within each group. Data averaged by beat cycle phase were 
analysed by two-way repeated measures ANOVA within groups for the factor ‘B- 
CYCLE’. To assess the evoked effects of the beat cycle period on the melatonin 
rhythm as a function of the (exogenous) imposed 28-h rest-activity period, normalised 
melatonin data within each 60° BCP (~4 h) bin were averaged across elapsed time in 
28-h day in twelve 30° (2.33 h) bins starting at TID 0.00 h (centred at TID -1.2 h) 
within each subject and then averaged across subjects within each group. Melatonin 
data were analysed by two-way repeated measures ANOVA within groups for the
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factor ‘T-CYCLE x B-CYCLE\ To assess the effects of the beat cycle period on the 
melatonin rhythm as a function of endogenous circadian period, normalised melatonin 
data within each 60° BCP (~4 h) bin were averaged across circadian phase in twelve 
30° bins centred at CP 0° within each subject and then averaged across subjects 
within each group. Melatonin data were analysed by two-way repeated measures 
ANOVA within groups for the factor ‘C-CYCLE x B-CYCLE’.
4.3.2 Melatonin Profile Characteristics
Melatonin profiles for each subject were separated into circadian days based 
on the subject’s individual circadian period. If 4 or more consecutive hours of 
melatonin samples were missing within a single circadian day, then all melatonin data 
within that circadian day were not used in the analysis. A total of 260 out of 306 
circadian days of melatonin were included in the analysis of phase, duration and 
concentrations.
4.3.2.1 Melatonin Phase, Duration and Concentrations
Cumulative changes in melatonin phase across days of the FD protocol occur 
as a function of the endogenous circadian period. Phase was measured to determine 
whether any systematic changes in daily timing occur to the calculated phase (DLMO; 
dim light melatonin onset) relative to the NOSA predicted phase (regression line) of 
the melatonin rhythms across different temporal phase relationships between the 
endogenous circadian rhythm and the imposed 28-h rest-activity schedule. Phase was 
calculated for each melatonin profile during each circadian day using thi*ee markers, 
including the timing (h) of the 25% dim light melatonin upward (onset; DLM0n2s%) 
and downward (offset; DLM0ff2s%) crossing, as well as the intennediate time point
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between them (midpoint; DLMOmidpt25%). The DLMOii25% and DLMO% 5% were 
defined as the clock time at which plasma melatonin levels rose above and fell below 
25% of the baseline full amplitude. The DLM0midpt25% was defined as the clock time 
half the distance between the timing of DLMOn25% and DLMOff25%. Clock times for 
each DLMO phase marker were converted into elapsed time in circadian day (TCD) 
by subtracting the DLMO clock time from the predicted start clock time for that 
circadian day (Figure 4-1). The TCD for each phase marker was transfonned into 
deviation from the mean (DFM) TCD.
Particular characteristics of melatonin profiles during the FD protocol were 
assessed to determine whether any cumulative and systematic changes occur to daily 
melatonin secretion/levels relative to the temporal relationship between the timing of 
melatonin rhythm and the imposed 28-h rest-activity schedule. For each melatonin 
profile the duration above threshold (DAT) and the area under the curve (AUC) of 
the daily plasma melatonin profile were calculated between the timing (h) of each 
profile’s DLMOn25% and DLM0ff25% using two markers. The DAT was defined as 
the duration of time (h) between DLMOu25% and DLMOff25% when melatonin levels 
were above the DLM02s% threshold. The AUC for each melatonin profile (pg/ml/h) 
was calculated using the trapezoidal method for melatonin values between 
DLMOn25% and DLM0ff^5%.
4.3.2.2 Assessment of Cumulative/Systematic Changes
To determine cumulative changes to the daily melatonin rhythm across days of 
the study, melatonin phase (DLMOn25%, DLM0midpt25%, DLM0ff25%), DAT and 
AUC were fitted by linear regression. Phase markers were expressed by 24-h habitual 
clock time (hour), and DAT and AUC were expressed as a percentage of their FD
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mean (%FD). The fitted linear regression for phase markers depicts the daily change 
in melatonin phase relative to the 24-h day or the circadian period o f the melatonin 
rhythm across the forced desynchrony (see Chapter 3). The slope of the regression 
line for both DAT and AUC across the FD protocol was considered significant if the 
95% confidence interval did not include zero.
To determine whether there were any systematic changes to the daily 
melatonin rhythm across the beat cycle, transformed DLMOs (DFM), DAT (%DFM) 
and AUC (%DFM) for each subject were assigned a beat cycle phase (BCP°), 0 to 
359°, where 0° equals the predicted intersection of the midpoint of scheduled bed­
rest, which oscillates with an imposed period equal to 28 h, and the midpoint of the 
melatonin rhythm (NOSA predicted peak), which oscillates at the individual subject’s 
endogenous circadian period. Normalised DLMO, DAT and AUC were then averaged 
in six 60° (~4 h) bins centred at BCP 0° within each subject and then averaged across 
subjects within each group. Each BCP° bin represents one of the six different 
temporal relationships between the phase of the imposed 28-h rest-activity schedule 
and the phase of the endogenous melatonin rhythm. To detemiine the magnitude of 
change in melatonin DLMO, DAT and AUC across the beat cycle, a non-linear 
sinusoid cuiwe [y = A+Bxsin(i5CP°+C); Ritz-De Cecco, 2004] was fit through each 
averaged DLMO, DAT and AUC variable across BCP° within each group. The 
amplitude of the sinusoid was considered significant if the 95% confidence interval 
(95% Cl) of the curve did not include zero.
4.3.3. Subject 1451: Before and After Bilateral Enucleation
Comparative analysis of the melatonin rhythm in one subject (1451) studied 
under the same experimental (FD) conditions before and after bilateral enucleation
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was performed. Comparisons of forced desynchi*ony melatonin data in subject 1451 
before and after bilateral enucleation include the circadian period of melatonin, 
overall melatonin levels across circadian phase, melatonin levels between WAKE and 
BED, melatonin levels across the beat cycle and melatonin phase, duration, and 
concentrations across the beat cycle (as described in sections 4.3.1 and 4.3.2).
4.4 Results 
4.4.1 Melatonin Levels
4.4.1.1 Baseline Melatonin
Across all subjects (n=l 1), the mean baseline fitted maximum of the melatonin 
profile during CR [pg/ml ± SD (range)] was 46.7 ± 23.2 (17.9 - 91.4) pg/ml, and there 
was no significant effect o f age on the baseline fitted maximum (slope = -0.1; 
P=0.83). The mean baseline fitted maximum was 48.9 ± 17.4 (33.3 - 67.7) pg/ml in 
the E-POS group, 49.9 ±31.2 (17.9 - 91.3) pg/ml in the E-NEG group and 39.3 ± 18.2 
(24.6 - 59.6) pg/ml in the BE group. The baseline fitted maximum was not 
significantly different among groups (ANOVA; P=0.84).
The phase relationship between the melatonin peak and habitual wake time to 
CRl varied widely across all subjects due to the majority of non-entrained rhythms 
across subjects and the timing of their admission to the laboratoiy study. The average 
duration between habitual wake time to CRl and the first obseiwed melatonin peak 
was 15.2 ± 7.4 (7.0 - 21.2) hours in the E-POS group, 12.75 ± 6.4 (5.0 - 20.1) hours in 
the E-NEG group and 9.1 ± 7.6 (3.8 - 17.8) hours in the BE group. The average 
duration between habitual wake time and the first melatonin peak was not significant 
different among groups (ANOVA; P=0.54).
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Table 4-2 . R esu lts o f two-way repeated  m easu re ANOVA within groups a n a ly ses  of
m elatonin %BL fitted m ax a s  a function of the e la p sed  time in 28-h day (T-cycle).
E-POS E-NEG BE
Melatonin factor ( n ^ ) (n = 5) (n = 3)
All-FD T-CYCLE F(11, 22) = 1.64; P = 0.15 F(11, 44) = 2.42; P <  0.05 F(11, 22)=  16.41; P <0.0001
WAKE T-CYCLE F(7. 14) = 1.42; P = 0.27 F(7, 28) = 1.13; P = 0.37 F(7. 14) = 4.36; P <  0.01
BED T-CYCLE F(3, 6) = 0.59; P = 0.64 F(3, 12) = 0.37; P = 0.78 F(3, 6) = 8.06; P< 0.05
4.4.1.2 Effects of T-Cycle; Within Groups
There were no significant effects on melatonin levels when averaged by the 
imposed rest-activity period in the E-POS group. However, there was a significant 
effect on melatonin levels for the factor ‘T-CYCLE’ across the FD protocol in the E- 
NEG and BE groups (Figure 4-2, Table 4-2). There were significant effects on 
melatonin levels for the factor ‘T-CYCLE’ during scheduled wakefulness (WAKE) 
and during scheduled bed-rest (BED) only in the BE group. Melatonin levels in the 
BE group rose across scheduled wakefulness above the DLM02s% threshold, then 
dropped below the DLM025% tlneshold during scheduled bed-rest. Melatonin levels 
stayed above the DLM02s% threshold in both the E-POS and the E-NEG groups.
4.4.1.3 Effects of T-Cycle: Between Groups
There were no significant effects for the factor ‘GROUP’ and no significant 
interaction for the factor ‘GROUP x T-CYCLE’ for melatonin levels overall, during 
scheduled wakefulness (WAKE) and bed-rest (BED) between the E-POS and E-NEG 
groups (Figure 4-2, Table 4-3). There was a significant effect for the factor ‘GROUP’ 
for melatonin levels during scheduled bed-rest (BED) between the BE group and the 
E-POS group. There was only a significant interaction for the factor ‘GROUP x T- 
CYCLE’ for melatonin levels overall and during scheduled wakefulness (WAKE) 
between the BE and the E-NEG groups.
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Figure 4-2. Average rest-activity cycle waveform of normalized melatonin data relative to 
the imposed 28-h rest-activity period for each subject group. Melatonin data are double­
plotted on the x-axis by elapsed time (h) in 28-h day (TID; 0.00 h = scheduled wake time. 
18.67 h = scheduled bed time) and are expressed on the y-axis as a percentage of the 
individual subject’s baseline fitted maximum during CR (%BL fitted max). Data are 
averaged (± sem) in and across subjects in ~2.33-h  bins (centred at T ID  1.2 h) within the 
E-PO S (filled symbols), E -N EG  (half-filled symbols) and BE (open symbols) groups. The 
horizontal dashed line in each panel indicates the D LM 0 2 s% threshold.
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Table 4-3 . R esu lts o f two-way repeated m easu re ANOVA b etw een  groups a n a ly ses  of
m elatonin %BL fitted m ax a s  a function of the im posed  28-h T-cycle.
Melatonin factor E-POS / E-NEG E-POS 1 BE E-NEG /  BE
All FD GROUP 
GROUP X T-CYCLE
F(1,6) = 0.03; P = 0.86 
F(11,66) =0.77; P = 0.67
F(1,4) = 3 .58:P  = 0.13 
F(11,44) = 1.60; P = 0.13
F(1,6) = 2 .2 9 ;P  = 0.18 
F(11,66) = 3.84 ;P < 0 .0 0 1
WAKE GROUP 
GROUP X T-CYCLE
F(1.6) = 0 .08;P  = 0.78 
F(7, 42) =1.46; P = 0.21
F(1.4) = 0.74; P = 0.43 
F(7, 28) =1.39; P = 0.25
F(1,6) = 0 .8 4 ;P  = 0.39 
F(7, 42) = 2.58 ; P < 0.05
BED GROUP 
GROUP X T-CYCLE
F(1,6) = 0.G0;P = 0.98 
F(3, 18) =0.26: P = 0.87
F(1, 4) = 22.16; P <  0.01 
F(3, 12) = 0.58; P = 0.51
F(1,6) = 4 .6 4 ;P  = 0.08 
F(3, 18) = 2 .34 ; P = 0.11
4.4.1.4 Effects of C-Cycle: Within Groups
As expected, the overall melatonin rhythm exhibited a robust circadian rhythm 
in each group during the forced desynchrony, even when assessed between scheduled 
wake and scheduled bed-rest. There was a significant effect for the factor ‘C-CYCLE’ 
on melatonin levels overall, during scheduled wakefiilness (WAKE) and during 
scheduled bed-rest (BED) within each group (Figure 4-3, Table 4-4). Visual 
inspection of melatonin levels within groups between WAKE and BED across 
circadian phase shows that melatonin levels were otheiivise reduced during BED 
compared with WAKE in each group. However, there was only a significant 
interaction for the factor ‘WAKE x BED’ in the BE group, and a similar trend in the 
E-POS group. In the E-POS group, peak melatonin levels (330, 0, 30 CP°) during 
BED were significantly lowered by almost 20% compared to the peak melatonin 
levels during WAKE. In addition, melatonin levels rose above and fell below the 
DLM025% threshold ~1 h or less later or earlier during BED compared with melatonin 
levels during WAKE. In the E-NEG group, peak melatonin levels (330, 0, 30 CP°) 
during BED were diminished compared with the peak melatonin levels during 
WAKE, but not significantly. In addition, melatonin levels rose above and fell below
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Figure 4-3. Average circadian waveform of normalized melatonin data between scheduled 
wakefulness and bed-rest relative to the individual subject’s endogenous circadian period 
for each subject group. Melatonin data are plotted on the x-axis by circadian phase (CP°; 
0° = predicted midpoint of melatonin) and are expressed on the y-axis as a percentage of 
the individual subject’s baseline fitted maximum during C R  (% BL fitted max). Data during 
scheduled wakefulness (upward triangle) and scheduled bed-rest (downward triangle) are  
averaged (± sem) in and across subjects in 30° ( - 2  h) bins (centred at 0°) within the E- 
POS (top panel; filled symbols), E -N EG  (middle panel; half-filled symbols) and BE 
(bottom panel; open symbols) groups. The horizontal dashed line in each panel indicates 
the DLM025% threshold.
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the DLM025% threshold only slightly later or earlier dming BED compared to 
melatonin levels during WAKE. In the BE group, peak melatonin levels (330, 0, 30 
CP”) during BED were lowered by almost 50% compared to the peak melatonin levels 
during WAKE. Moreover, melatonin levels at 300 and 60 CP” were also significantly 
reduced to levels at or below the DLM0 2 5 %, such that melatonin levels rose above and 
fell below the DLM025% threshold ~2-3 h later or earlier during BED compared to 
melatonin levels dui'ing WAKE.
Table 4-4. Results of two-way repeated measure A N O VA  within group analysis of %BL  
fitted max melatonin levels as a function of circadian phase. Melatonin levels overall, 
during both scheduled wakefulness (W AKE) and scheduled bed-rest (BED), were  
assessed across the circadian phase (C-Cycle). In addition, overall melatonin levels 
between W AKE and BED w ere compared while controlling for circadian phase in each  
group.
E-POS E-NEG BE
Melatonin factor (n=3) (n-5) (n=3)
Overall C-CYCLE F(11, 22) = 74.32; P <  0.0001 F(11, 44) = 244.34; P <  0.0001 F(11, 22) = 26.79; P <  0.0001
WAKE C-CYCLE F(11, 22) = 59.89; P < 0.0001 F(11, 44) = 144.81; P <  0.0001 F(11, 22) = 20.00; P <  0.0001
BED C-CYCLE F(11,22) = 46.88; P <  0.0001 F(11. 44) = 72.34: P <  0.0001 F(11, 22) = 30.00; P < 0.0001
Overall WAKE X BED F(11, 22) = 2.11; P = 0.07 F(11,44) = 0.11; P = 0.99 F{11, 22) = 8.37; P < 0.0001
4.4.1.5 Effects of C-Cycle: Between Groups
Melatonin levels overall averaged across circadian phase were lower than the 
baseline fitted maximum in all three groups. Melatonin levels overall averaged across 
circadian phase were relatively similar between groups, but peak melatonin levels 
(330, 0 and 30 CP”) in the BE group were slightly lower compared with the other two 
groups (Figure 4-4, Table 4-5). There was no significant effect for the factor
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‘GROUP’ on melatonin levels overall, yet there was a significant interaction for the 
factor ‘GROUP x C-CYCLE’ between the BE group and either the E-POS and the E- 
NEG groups. There was no significant interaction for the factor ‘GROUP x C- 
CYCLE’ on melatonin levels overall between the E-POS and the E-NEG groups. 
Overall melatonin levels averaged across circadian phase rose above and fell below 
the DLM025% threshold slightly later or earlier, respectively, in the BE group 
compared with the other two groups.
Melatonin levels during WAKE averaged across circadian phase were similar 
between groups (Figure 4-5, Table 4-5). There was no significant effect for the factor 
‘GROUP’ or a significant interaction for the factor ‘GROUP x C-CYCLE’ between 
any two groups. Peak melatonin levels (330, 0, 30 CP”) during WAKE were slightly 
higher in the E-POS group compared with the E-NEG and BE groups, but melatonin 
levels rose above and fell below the DLM0 2 5 % threshold at a similar circadian phase 
(285 and 75 CP”, respectively) in all three groups.
Table 4-5. Results of two-way repeated measure A N O VA  between groups comparison of 
%BL fitted max melatonin levels as a function of circadian phase. Melatonin levels 
overall, during both scheduled wakefulness (W AKE) and scheduled bed-rest (BED), were  
assessed across the circadian phase (C -Cycle) and assessed for comparison between 
groups.
Melatonin factor E-POS 1 E-NEG E-POS / BE E-NEG / BE
Overall GROUP 
GROUP X C-CYCLE
F(1, 6) = 0.001; P = 0.97 
F(11,66) =0.57; P = 0.84
F(1,4) = 2 .98 ;P  = 0.16 
F(11,44) = 2.04: P <  0.05
F(1,6) = 2.21 ;P  = 0.19 
F(11,66) = 2.22; P < 0 .0 5
WAKE GROUP 
GROUP X C-CYCLE
F(1,6) = 0 .06 ;P  = 0.B2 
F(11,66) =0.85; P = 0.59
F{1,4) = 0 .54 ;P  = 0.50 
F(11,44) =0.64; P = 0.78
F(1,6) = 0 .5 2 ;P  = 0.50 
F(11,66) = 0 .1 7 ;P  = 0.99
BED GROUP 
GROUP X C-CYCLE
F(1,6) = 0 .15 ;P  = 0.71 
F(11,66) =0.45; P = 0.93
F{1,4) = 26.47; P <  0.01 
F(11,44) =7.87; P < 0.0001
F(1,6) = 5 .0 6 ;P  = 0.07 
F(11, 66) = 9.39 ;P  <0.0001
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Figure 4-4. Average circadian waveform of normalized melatonin data relative to the 
individual subject’s endogenous circadian period for each subject group. Melatonin data 
are plotted on the x-axis by circadian phase (CP°; 0° = predicted midpoint of melatonin) 
and are expressed on the y-axis as a percentage of the individual subject’s baseline fitted 
maximum during C R  (% BL fitted max). Data are averaged (± sem) in and across subjects 
In 30° (~2 h) bins (centred at 0°) within the E -PO S (filled symbols), E -N EG  (half-filled 
symbols) and BE (open symbols) groups. The horizontal dashed line indicates the 
DLM025% threshold.
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In contrast, melatonin levels during BED averaged across circadian phase were 
markedly reduced in the BE group compared with both the E-POS and E-NEG groups 
(Figure 4-5, Table 4-5). There was a significant effect and a trend for the factor 
‘GROUP’ on melatonin levels during BED between the BE group and the E-POS and 
the E-NEG groups, respectively. In addition, there was a significant interaction for the 
factor ‘GROUP x C-CYCLE’ on melatonin levels during BED between the BE group 
and either the E-POS and E-NEG groups. Melatonin levels during BED averaged 
across circadian phase were similar between the E-POS and E-NEG groups; there was 
no significant effect for the factor ‘GROUP’ and no significant interaction for the 
factor ‘GROUP x C-CYCLE’ between the E-POS and E-NEG groups. Melatonin 
levels rose above and fell below the DLM0 2 5 % tlireshold at relatively the same 
circadian phase in the E-POS and E-NEG groups. In contrast, the BE group, peak 
melatonin levels (330, 0, and 30 CP“) during BED were lowered by almost %50 
compared with the peak melatonin levels during BED in the other two groups. 
Moreover, melatonin levels during BED in the BE group rose above and fell below 
the DLM025% threshold ~2-3 h later or earlier, respectively, relative to the timing that 
melatonin levels rose above and fell below the DLM0 2 5 % threshold in the other two 
groups.
Table 4-6. Results of two-way repeated measure A N O VA  within group analysis of %BL 
fitted max melatonin levels as a function of beat cycle phase. Melatonin levels were 
assessed across beat cycle phases (B-cycle) and beat cycle phase relative to circadian 
phase (C -Cycle) and elapsed time in 28-h day (T-Cycle) within each group.
Melatonin factor
E-POS
(n = 3)
E-NEG
(n = 5)
BE
(n = 3)
All FD B-CYCLE 
All FD C-CYCLE x B-CYCLE 
All FD T-CYCLE x B-CYCLE
F(5,10) = 1.69; P = 0.22 
F(55, 110) = 1.73; P <  0.01 
F(55, 110) = 28.89; P <  0.0001
F(5. 20) = 0.50; P = 0.78 
F(55, 220) = 1.24; P = 0.14 
F(55, 220) = 53.73; P < 0.0001
F(5,10) = 7.08; P <  0.01 
F{55, 110) = 7.18; P <  0.0001 
F(55, 110) = 17.80; P <  0.0001
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Figure 4-5. Average circadian waveform of normalized melatonin data during scheduled 
wakefulness and bed-rest relative to the individual subject's endogenous circadian period 
for each subject group. Melatonin data are plotted on the x-axis by circadian phase (CP°; 
0° = predicted midpoint of melatonin) and are expressed on the y-axis as a percentage of 
the individual subject’s baseline fitted maximum during CR (%BL fitted max). Data during 
scheduled wakefulness (top panel) and scheduled bed-rest (bottom panel) are averaged  
(± sem ) in and across subjects in 3 0 “ (~2 h) bins (centred at 0 “) within the E -PO S (filled 
symbols), E -N EG  (half-filled symbols) and BE (open symbols) groups. The horizontal 
dashed line in each panel indicates DLM025% threshold.
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4.4.1.6 Effects of B-Cycle: Within Groups
The average period (h ± SD) of the beat cycle overall (n = ll)  was 188.16 ± 
19.16 h. In other words, on average the phase of the exogenous rhythm (T-cycle = 28 
h) and the phase of endogenous circadian rhythm (C-cycle = t )  intersected 
approximately every 7.8 (24 h) days among subjects. The average period (h ± SD) of 
the beat cycle was 178.74 ± 17.87 h in the E-POS, 185.61 ± 13.39 h in the E- NEG 
and 201.84 ± 26.97 h in the BE groups. The average period of the beat cycle was not 
significantly different among groups (ANOVA; P=0.34).
There was no significant effect on melatonin levels for the factor ‘B-CYCLE’ 
in either the E-POS or the E-NEG groups (Figure 4-6; Table 4-6). Melatonin levels 
remained above the DLM025% threshold across beat cycle phases in both the E-POS 
and the E-NEG groups. Melatonin levels in the E-POS group exhibited some 
modulation across beat cycle phases, such that melatonin levels were lowest at 0 
BCP° and highest at 120 BCP". Melatonin levels in the E-NEG group were relatively 
flat across beat cycle phases, but there was a peak in melatonin levels observed at 0 
BCP°. There was a significant effect on melatonin levels for the factor ‘B-CYCLE’ in 
the BE group. Melatonin levels in the BE group exhibited robust modulation across 
beat cycle phases, such that melatonin levels fell below the DLM0 2 s% threshold 
between 240 and 300 BCP°, were lowest at 0 BCP°, rose above the DLM02s% 
threshold between 0 and 60 BCP° and were highest at 120 BCP°.
There was a significant interaction for the factor ‘T-CYCLE x B-CYCLE’ on 
melatonin levels in all three groups (Figure 4-7). This interaction is directly related to 
the ~4 h change in phase relationship between the phase of the imposed 28-h rest- 
activity rhythm (midpoint of scheduled bed-rest) and the phase of endogenous
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Figure 4-6. Average normalized melatonin data relative to the individual subject’s beat 
cycle period for each subject group. Melatonin data are double-plotted on the x-axis by 
beat cycle phase (BCP°; 0° = predicted intersection between the midpoint of the 
endogenous melatonin rhythm and the midpoint of scheduled bed-rest) and are 
expressed on the y-axis as a percentage of the individual subject’s baseline fitted 
maximum during C R  (% BL fitted max). D ata are averaged (± sem) in and across subjects 
in 60° (~4 h) bins (centered at 0°) within E -P O S  (top panel), E -N EG  (middle panel) and 
BE (bottom panel) groups. The horizontal dashed line in each panel indicates DLMOz5% 
threshold.
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Figure 4-7. Superimposed melatonin profiles (line/symbol) across each beat cycle phase 
relative to the imposed 28-h rest-activity period for the E-PO S (top panel), E -N EG  (middle 
panel) and BE (bottom panel) groups. Data are double-plotted on the x-axis by elapsed 
time (h) in 28-h day and are expressed on the y-axis as a percentage of each subject’s 
baseline fitted max during CR (%BL fitted m ax) for each beat cycle phase. Data are 
averaged (± sem) in and across subjects in -2 .3 3 -h  bins, and centred at T ID  -1 .2  h. The 
gray bar in each panel represents the 9.33-h scheduled bed-rest episode during the 28-h  
FD day. The horizontal dashed line in each panel indicates the D LM Ü 25% threshold.
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Figure 4-8. Relationship between average %BL melatonin levels during FD (dark gray 
line) and each beat cycle phase (line-symbol) in the E -PO S (left column), E -N EG  (middle 
column) and BE (right column) groups. Melatonin data are divided between 6 beat cycle 
phases (top to bottom graph; 0, 60, 120, 180, 240 and 300°) and are plotted on the x-axis 
by circadian phase (CP°; 0° = predicted midpoint of melatonin) and are expressed on the 
y-axis as a percentage of the individual subject’s baseline fitted maximum during CR  
(% BL fitted max). Data are averaged (± sem) in and across subjects in 30° (~2 h) bins 
(centred at 0°). The gray bars represent the mean (± SD ) onset/offset timing of scheduled 
bed-rest (9.33 h) relative to circadian phase; note that the midpoint of scheduled bed-rest 
occurs - 4  h later relative to midpoint of the melatonin rhythm (0°) at each subsequent 
beat cycle phase. The horizontal dashed line in each panel indicates the DLM02s% 
threshold.
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circadian rhythm (predicted peak of melatonin) during the imposed 28-h FD protocol. 
However, the modulation of melatonin profiles across beat cycle is much greater in 
the BE group compared with the other two groups. For instance, when the peak of 
melatonin occurs during scheduled wake, at least ~4 hours after scheduled wake time 
and before scheduled bedtime, melatonin levels are relatively similar to that observed 
in the other two groups. However, when the peak of melatonin occurs between the 
onset and offset scheduled bed-rest, melatonin levels are significantly reduced 
compared with melatonin levels during scheduled wake and compared with melatonin 
levels in the other two groups at any beat cycle phase. In addition, there was a 
significant interaction for the factor ‘C-CYCLE x B-CYCLE’ on melatonin levels in 
the E-POS and BE groups, but not in the E-NEG group (Figure 4-8).
4.4.2 Melatonin Profile Characteristics
4.4.2.1 Melatonin Phase, Duration and Concentrations
All three phase markers across days of the FD protocol (including or not 
including melatonin profiles during CR 1 and CR 2) exhibited a significant change in 
timing relative to the 24-h day based upon linear regression fits through each marker 
for individual subjects in each group. Not surprisingly, these are highly correlated to 
the NCSA calculated circadian period of the melatonin rhythm (data not shown). The 
actual day-to-day changes to melatonin phase, duration and concentrations relative to 
the circadian day are not predicted by NCSA, so phase and amplitude markers of the 
melatonin rhythm were assessed during the circadian day across the beat cycle. In the 
E-POS group, the average timing of DLMO phase markers in the circadian day (TCD; 
h ± SD) was as follows: DLMOn25%occurred at 6.91 ± 0.38 h (CP° = -283° or -77°), 
DLMOmidpt25% occurred at 12.06 ± 0.24 h (CP° = -359° or -1°) and DLMOff25%
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occurred at 17.21 ± 0.86 h (CP° = -76°). In the E-NEG group, the average timing of 
DLMO phase markers in the circadian day was as follows: DLM0n2s% occuned at 
7.08 ± 0.42 h (CP° = -285° or -75°), DLMOmidpt25% occurred at 12.22 ± 0.13 h (CP° 
= -1°) and DLMOff25% occurred at 17.37 ± 0.45 h (CP° = -76°). In the BE group, the 
average timing of DLMO phase markers in the circadian day was as follows: 
DLMOn25% occuned at 7.93 ± 0.06 h (CP° = -296° or -64°), DLM0midpt2s% 
occurred at 12.41 ± 0.15 h (CP° = -2°) and DLMOff2s% occurred at 16.88 ± 0.26 h 
(CP° = -67°). In the BE group, the DLMOu25% and DLM0ff2s% occur on average at a 
significantly later (P<0.05) and earlier (P<0.05) time in the circadian day respectively, 
compared with the E-POS and the E-NEG groups.
The average melatonin DAT (h ± SD) of the baseline CR melatonin profile 
and the mean across the FD protocol was 10.6 ± 0.7 and 10.4 ± 1.4 h in the E-POS 
group, 11.4 ± 2.0 and 10.2 ± 1.2 h in the E-NEG group and 11.5 ± 0.6 and 9.2 ± 1.7 h 
in the BE group, respectively. The average melatonin AUC (pg/ml/h ± SD) of the 
baseline CR melatonin profile and the mean across the FD protocol was 380.9 ± 143.1 
and 344.2 ± 150.5 pg/ml/h in the E-POS group, 356.4 ± 218.2 and 320.2 ± 195.2 
pg/ml/h in the E-NEG group and 287.3 ± 73.0 and 184.0 ± 72.5 pg/ml/h in the BE 
group. There was no significant difference among the three groups for melatonin 
DAT and AUC for baseline melatonin profiles during CR, yet there was a significant 
difference between the BE group and either the E-POS or the E-NEG groups for 
average melatonin DAT and AUC of melatonin profiles across the FD protocol 
(Figure 4-9).
Based upon a linear regression fit of the data, the melatonin DAT exhibited 
significant cumulative increase across days of the study in the BE group (slope=0.82;
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Figure 4-9. Average duration above (D LM O ) threshold (DAT; two top panels) during the 
constant routine (A) and across the forced desynchrony (B) protocol and area under the 
curve (AUC; two bottom panels) during the constant routine (C) and across the forced 
desynchrony (D) protocol for each experimental group. Data (±SD) are expressed on the 
y-axis in hours for DAT and pg/h/ml for A UC  for each experimental group (x-axis). P- 
values along lines indicate a significant difference between groups based on Student’s t- 
test. There was no significant difference among experimental groups for either baseline 
DAT or A U C  during the constant routine, and no significant difference between E-PO S  
and E -N EG  groups during the forced desynchrony. The BE group exhibited significant 
decreases in DAT and A UC compared to the E -PO S and E -N EG  groups during forced 
desynchrony.
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Figure 4-10. Daily melatonin secretion durations and concentrations across days of FD  
protocol (6-34) of individual subjects within each experimental group. The daily melatonin 
duration above threshold (DAT; left panels) and area under the curve (AUC; right panels) 
are expressed as a percentage of the individual subject’s forced desynchrony mean (y- 
axis) and are plotted by day of laboratory study (x-axis). The P-value in the lower right 
hand corner of each group’s plot indicates the significance of fitted linear regression line 
through group data to determine whether melatonin duration and concentration exhibit 
any cumulative changes across the FD protocol.
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P<0.01), but did not exhibit any significant cumulative changes across days of the 
study in either the E-POS or the E-NEG groups (Figure 4-10). In addition, the 
melatonin AUC exhibited a trend towards a cumulative increase across days of the 
study in both the E-POS and the BE groups, and did not exhibit any significant 
cumulative changes across days o f the study in the E-NEG group (Figure 4-10).
4.4.2.2 Effects of Beat Cycle
In the E-POS group, the amplitude of the sinusoid fitted through daily 
melatonin phase markers (DLMO-DFM) averaged across beat cycle phases was not 
significantly different from zero (Figure 4-11). In the E-POS group, daily DLMOs 
during the FD protocol changed little across the beat cycle relative to the mean timing 
in the circadian day. The amplitude of the sinusoid observed for DLMOs in the E- 
POS group was between 0.13 and 0.33 h and became successively smaller from 
DLMOn to DLMOmidpt to DLMOff. The minimum of the sinusoid (direction of 
greatest phase-delays) was 250 BCP“ for DLMOn, 245 BCP” for DLMOmidpt and 
225 BCP” for DLMOff. The amplitude of the sinusoid for daily melatonin duration 
(DAT-%DFM) was significantly different from zero across beat cycle phases, but not 
for daily melatonin concentrations (AUC-%DFM). The amplitude of the sinusoid 
observed for DAT in the E-POS group was relatively small, and all DAT points 
across the beat cycle were not significantly different from zero. Most AUC points 
were not significantly different from zero, but there was a significant -10%  reduction 
in AUC at 0 BCP” (midpoint of bed-rest occurring within -4  h of the predicted 
midpoint o f melatonin secretion).
In the E-NEG group, the amplitude of the sinusoid fitted through daily 
melatonin phase markers (DLMO-DFM) averaged across beat cycle phases was not
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Figure 4-11 (pg. 4-35). Average change in melatonin phase (DLM On, DLMOmidpt, 
DLM Off), duration above threshold (D AT) and area under the curve (A UC ) across the 
beat cycle in the E-PO S (left panel; filled symbols), E -N EG  (middle panel; half-filled 
symbols) and BE (right panel; open symbols) groups. Melatonin DLM O, DAT and AUC  
data are double-plotted by beat cycle phase on the x-axis. Melatonin phase markers 
DLM On (upward triangle), DLM Om idpt (circle) and DLM Off (downward triangle) are 
expressed as an average deviation from the mean (DFM , hour) of elapsed time in 
circadian day (TC D ) on the y-axis, where positive and negative values represent an 
earlier (phase-advanced) or later (phase-delayed) timing relative to the mean TC D . 
Melatonin DAT (diamonds) and A U C  (squares) are expressed as an average percentage 
of the deviation from the FD mean on the y-axis, where positive and negative values 
represent an increase or decrease, respectively, in melatonin secretion duration or 
concentration. Data are averaged (± sem) in and across subjects in ~4.0-h bins. A 
sinusoid is fitted (solid line curve) through DLM O, DAT and A U C  points, and the 
amplitude (±95%  C l) of the sinusoid is indicated above the curve (® P <0.05).
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significantly different from zero, except for DLMOmidpt (Figure 4-11). In the E- 
NEG group, daily DLMOs during the FD protocol also changed little across the beat 
cycle relative to the mean timing in the circadian day. The amplitude of the sinusoid 
observed for DLMOs in E-NEG group was between 0.17 to 0.20 h. In contrast to the 
E-POS group, the observed amplitude of the sinusoid was relatively similar among 
DLMOn, DLMOmidpt and DLMOff. The minimum of the sinusoid (direction of 
greatest phase-delays) was 320 BCP° for DLMOn, 290 BCP° for DLMOmidpt and 
255 BCP® for DLMOff. The amplitude of the sinusoid for daily melatonin 
concentrations (AUC-%DFM) was significantly different from zero across beat cycle 
phases, but not for daily melatonin duration (DAT-%DFM). The amplitude of the 
sinusoid observed for both DAT and AUC in the E-NEG group was relatively similar 
to that observed in the E-POS group. Most DAT points across the beat cycle were not 
significantly different from zero, except for a significant shortening or lengthening at 
60 and 120 BCP®, respectively. The AUC exhibited systematic modulation across beat 
cycle phases, such that levels were ~10% higher at -240 BCP® and lowest at 60 BCP®.
Conversely, in the BE group, the amplitude of the sinusoids fitted through 
DLMOff, DAT and AUC were significantly different from zero (Figure 4-11). In the 
BE group, timing of daily DLMOs changed considerably across the beat cycle relative 
to the mean timing in the circadian day. During certain beat cycle phases, the timing 
of DLMO was phase-advanced or phase-delayed by almost 1.0 to 2.0 h relative to the 
mean timing in the circadian day. In contrast to the other two groups, the amplitude of 
the sinusoid observed for DLMOs in the BE group was much greater between ±45 to 
60 minutes. Although not significant, the amplitude of the sinusoid for DLMOn and 
DLMOmidpt was relatively large. Most DLMOn and DLMOmidpt points fit well to 
the cuiwe, except for a large phase-delay o f -1.5 to 2.0 h at 300 BCP® (predicted peak
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o f melatonin coincided with the end o f scheduled bed-rest). This may explain the 
large 95% Cl for these measures and contributed to the lack o f significance. The 
observed amplitude o f the sinusoid was relatively similar among DLMOn, 
DLMOmidpt and DLMOff. The minimum o f the sinusoid (direction o f greatest phase- 
delays) was 290 BCP® for DLMOn, 250 BCP® for DLMOmidpt and 215 BCP® for 
DLMOff. The amplitude o f the sinusoid for daily melatonin duration (DAT-%DFM) 
and concentrations (AUC-%DFM) was approximately 5 to 6  times greater compared 
with that observed in either the E-POS or E-NEG group. Most DAT and AUC points 
across the beat cycle were significantly different from zero and fell along the sinusoid 
curve.
4.4.3 Subject 1451: Before and After Bilateral Enucleation
Significant changes were observed in the melatonin rhythm in subject 1451 
measured during a forced desynchrony protocol before and after bilateral enucleation. 
First, the circadian period (h ±  95% Cl) o f the melatonin rhythm was significantly 
longer after (24.20 ± 0.03 h) compared to before (24.09 ± 0.02 h) bilateral 
enucleation. The circadian period (h ±95%  Cl) o f core body temperature, which was 
measured concuiTently during each protocol assessment, confirmed the significantly 
longer period after (24.20 ± 0.05 h) compared with before (24.07 ± 0.04 h). Second, 
the NOSA (3-harmonic)-derived melatonin amplitude (half-max; pg/ml ± 95% Cl) 
under baseline conditions during CR2 was significantly higher in subject 1451 after 
(29.8 ± 6.5 pg/ml) compared with before (11.9 ±  0.9 pg/ml) bilateral enucleation. The 
NOSA-derived melatonin amplitude (pg/ml ± 95% Cl) across the entire FD protocol 
was also significantly higher in subject 1451 after (12.8 ± 1.2 pg/ml) compared with 
before (9.4 ± 0.8 pg/ml) bilateral enucleation. Average melatonin levels (pg/ml ± sem)
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Figure 4-12. Subject 1451’s melatonin time in 28-h day (T ID ) and circadian waveforms 
during forced desynchrony before and after bilateral enucleation. In each panel, 145Ts  
melatonin data before (half-filled symbols) and after (open symbols) bilateral enucleation 
are superimposed and expressed on the y-axis as a percentage of the individual subject's 
bas'eline fitted maximum during C R  (%BL fitted max). In panel A, melatonin data are 
double-plotted on the x-axis by elapsed time in 28-h day (TID; 0 .00 h = scheduled wake  
time, 18.67 h = scheduled bedtime) and averaged (± sem) in -2 .3 3 -h  bins (centred at TID  
-1 .2  h), and the gray bars indicate the 9.33-h  scheduled bed-rest episode. In panel B, 
melatonin data are plotted on the x-axis by circadian phase (C P “; 0° = predicted midpoint 
of melatonin) and averaged (± sem) in 30° ( - 2  h) bins (centred at 0°). The horizontal 
dashed line in each panel indicates the D LM 0 2 s% threshold.
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were significantly higher in subject 1451 after (14.45 ± 0.49 pg/ml) compared with 
before (8.63 ±  0.32 pg/ml) bilateral enucleation (ANOVA; P<0.0001). Average 
melatonin levels (pg/m ± sem) during scheduled wakefulness were significantly 
higher in 1451 after (16.45 ± 0.62 pg/ml) compared with before (9.00 ±  0.38 pg/ml) 
bilateral enucleation (ANOVA; P<0.0001). However, average melatonin levels (pg/ml 
±  sem) were not significantly different in subject 1451 before (7.94 ± 0.55pg/ml) and 
after (9.47 ±  0.66 pg/ml) bilateral enucleation, but showed a trend (ANOVA; P=0.07). 
Average melatonin DAT (h ±  sem) across the FD protocol was significantly shorter in 
1451 after (8.7 ± 0.4 h) compared with before (10.1 ± 0.3 h) bilateral enucleation 
(ANOVA; P<0.05). However, the average melatonin AUC (pg/ml/h ±  sem) was 
significantly higher in subject 1451 after (231.19 ± 16.94 pg/ml/h) compared with 
before (152.68 ± 6.11 pg/ml/h) bilateral enucleation (ANOVA; P<0.05).
The melatonin waveform relative to the time in the 28-h day was quite 
different in 1451 before and after bilateral enucleation (Figure 4-12A). Across the 28- 
h day, melatonin levels in 1451-Before remained above the DLM0 2 s% and varied by 
-20%  relative to the percentage o f the baseline fitted maximum. Melatonin levels 
were relatively flat across scheduled wakefulness, but did show a slight decline across 
scheduled bed-rest. In contrast, melatonin levels in 1451-After exhibited a robust 
variation across the 28-h day, rising and falling significantly between scheduled 
wakefulness and bed-rest, respectively. Across the 28-h day, melatonin levels in 
1451-After varied by -50%  relative to percentage o f the baseline fitted maximum. 
Melatonin levels during the FD after bilateral enucleation rose across the first half o f  
scheduled wakefulness, and remained significantly higher during the second half 
compared with before bilateral enucleation. Melatonin levels in 1451-After then
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Figure 4 -13. Subject 145T s  meiatonin circadian waveforms between scheduled 
wakefulness and scheduled bed-rest during forced desynchrony before and after bilateral 
enucleation, in each panel, 1451 's melatonin data before (Panel A; haif-filied symbols) 
and after (Panel B; open symbols) bilateral enucleation are expressed on the y-axis as a 
percentage of the individual subject’s baseline fitted max during C R  (% BL fitted max), in 
each panel, melatonin data are plotted on the x-axis by circadian phase (CP°; 0° = 
predicted midpoint of melatonin) averaged (± sem) in 30° (~2 h) bins (centred at 0°) 
during scheduled wakefulness (dark line, upward triangle) and scheduled bed-rest 
(downward triangle). The horizontal dashed line in each panel indicates the DLM025% 
threshold.
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declined sharply in the first 2.33 h o f scheduled bed-rest and remained low near to or 
just below the DLMO250/0 threshold.
The shape o f the circadian melatonin waveform was relatively the same in 
1451 before and after bilateral enucleation (Figure 4-12B). However, overall 
melatonin levels in 1451 were significantly higher (ANOVA; P>0.05) after bilateral 
enucleation at eveiy circadian phase (mean diff ±  SD = 5.92 ± 2.53; range = 3.14 to 
10.83 pg/ml), except CP 270° (P=0.06). Melatonin levels in 1451-Before remained 
below the DLM025% between 90 and 270 CP°, but surprisingly melatonin levels in 
1451-After remained below the DLM025% across a narrower range o f phases, only 
between 180 and 240 CP°.
The circadian melatonin waveform between scheduled wakefulness and bed­
rest was also altered in 1451 before and after bilateral enucleation (Figure 4-13). 
Melatonin levels in 1451-Before were relatively similar if  not slightly higher across 
circadian phase during scheduled bed-rest compared with scheduled wakefulness. In 
contrast, melatonin levels in 1451-After were significantly lower across circadian 
phase during scheduled bed-rest compared with scheduled wakefulness. However, 
melatonin levels during scheduled bed-rest were not significantly different across 
circadian phases in subject 1451 before and after bilateral enucleation, but melatonin 
levels were significantly elevated during scheduled wakefiilness at eveiy circadian 
phase (mean diff ± SD = 7.78 ± 4.34; range = 1.77 to 15.68 pg/ml), except phase 270° 
(P=0.37) in 1451 after bilateral enucleation.
Melatonin phase (DLMOs), duration (DAT) and concentrations (AUC) 
exhibited a larger variation across the beat cycle in subject 1451 after bilateral 
enucleation (Figure 4-14). In 1451-Before, daily DLMOs during the FD protocol 
changed little across the beat cycle relative to the mean timing in the
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Figure 4 -14  (pg. 4 -42). Average change in melatonin phase (DLM On, DLMOmidpt, 
DLMOff), duration above threshold (DAT) and area under the curve (AUC) across the 
beat cycle in subject 1451- before (left panel; haif-fiiied symbols) and after (right panel; 
open symbols) bilateral enucleation. Meiatonin DLM O, DAT and A UC  data are double­
plotted by beat cycle phase on the x-axis. Meiatonin phase markers DLM On (upward 
triangle), DLMOmidpt (circle) and DLM Off (downward triangle) are expressed as an 
average deviation from the mean (D FM , hour) of elapsed time in circadian day (TC D ) on 
the y-axis, where positive and negative values represent an earlier (phase-advanced) or 
later (phase-delayed) timing relative to the mean TC D . Melatonin DAT (diamonds) and 
A UC  (squares) are expressed as an average percentage of the deviation from the FD  
mean on the y-axis, where positive and negative values represent an increase or 
decrease, respectively, in melatonin secretion duration and concentration. Data are 
averaged (± sem) in ~4.0-h  bins. A  sinusoid is fitted (solid line curve) through DLM O , DAT  
and A U C  points and the amplitude (±95%  C l) of the sinusoid is indicated above the curve 
(" P<0.05).
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circadian day. The amplitude o f the sinusoid obseiTed for DLMOs in 1451-Before 
was between 0.08 to 0.33 h. The obseiwed amplitude became successively smaller 
from DLMOn to DLMOmidpt to DLMOff, but the amplitude o f the sinusoid was 
significantly different from zero for DLMOn and DLMOmidpt. The minimum o f the 
sinusoid (direction o f greatest phase-delays) was 245 BCP° for DLMOn, 240 BCP° 
for DLMOmidpt and 75 BCP° for DLMOff. The amplitude o f the sinusoid for daily 
melatonin concentrations (AUC-%DFM) was significantly different from zero across 
beat cycle phases, but not for daily melatonin duration (DAT-%DFM). The amplitude 
o f the sinusoid obseiwed for DLMOs, DAT and AUC was relatively similar to that 
observed in the E-NEG group, but the minimum o f the sinusoids was not. Most DAT 
points across the beat cycle were not significantly different from zero, except for a 
significant shortening or lengthening at 180 and 0 BCP“, respectively. The AUC 
exhibited systematic modulation across beat cycle phases, such that levels were - 10% 
higher at 0 BCP° and lowest at 180 BCP
In 1451-After, the timing o f daily DLMOs changed considerably across the 
beat cycle relative to the mean timing in the circadian day, but the amplitude o f the 
sinusoid was not significantly different from zero. During certain beat cycle phases, 
the timing o f DLMO was phase-advanced or phase-delayed up to 2 h relative to the 
mean timing in the circadian day. The amplitude o f the sinusoid observed for DLMOs 
in 1451-After was much greater between 1.10 to 1.48 h. DLMOn, DLMOmidpt and 
DLMOff exhibited large phase-delay o f -1 .5  to 2.0 h at 300 BCP° (predicted peak of 
melatonin coincided with the end o f scheduled bed-rest) and large phase-advances at 
0 or 60 BCP” (predicted peak o f melatonin coincided with the midpoint or beginning 
o f scheduled bed-rest, respectively). The large 95% Cl for these measures may have 
also contributed to the lack o f significance. The obseiwed amplitude o f the sinusoid
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was relatively similar between DLMOn, DLMOmidpt and DLMOff. The minimum of 
the sinusoid (direction o f greatest phase-delays) was 245 BCP” for DLMOn, 230 
BCP” for DLMOmidpt, 220 BCP” for DLMOff. The amplitude o f the sinusoid for 
daily melatonin concentrations (AUC-%DFM) was significantly different from zero, 
but the amplitude o f the sinusoid for melatonin daily duration (DAT-%DFM) was not. 
Most DAT points across the beat cycle were not significantly different from zero, 
except for a significant shortening or lengthening at 60 and 120 BCP”, respectively. 
The AUC exhibited systematic modulation across beat cycle phases, such that levels 
were -20%  higher at 120 BCP” and lower between 330 and 0 BCP”.
4.5 Discussion
4.5.1 Meiatonin Levais
Overall, the results show that melatonin levels were reduced rather than 
elevated during scheduled bed-rest in NLP subjects compared with melatonin 
waveforms obseiwed in sighted subjects. Interestingly, the observed melatonin rhythm 
in the BE group was significantly affected by the imposed rest-activity schedule 
compared with the two NLP blind groups who have eyes. Plasma melatonin levels 
during the FD protocol exhibited a robust circadian rhythm within each experimental 
group when averaged across circadian phase. Baseline melatonin levels during the CR 
were not significantly different among groups. However, when melatonin data were 
separated by scheduled wakefulness and bed-rest and then averaged across circadian 
phase, melatonin levels in the BE group were significantly lower during scheduled 
bed-rest compared with scheduled wakefulness. This effect was particularly evident 
- 2  h before and after the peak o f melatonin secretion between 300 (-60) and 60 CP”, 
such that at this circadian time melatonin levels were almost 50% lower during
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scheduled bed-rest compared with levels during scheduled wakefulness in the BE 
group. In addition, the circadian time at which melatonin levels during scheduled bed­
rest rose above and fell below the DLMO250/0 threshold occuned at a later and earlier 
circadian phase, respectively, compared with scheduled wakefulness. Furthermore, 
melatonin levels during scheduled wakefiilness across circadian phase were not 
significantly different among groups, but melatonin levels during scheduled bed-rest 
in the BE group were significantly lower compared with melatonin levels in the two 
NLP blind groups with eyes. The melatonin levels averaged across circadian phase 
dining scheduled bed-rest compared with scheduled wakefulness were not 
significantly different in the two NLP blind groups with eyes. These results indicate 
that the lower melatonin levels observed across circadian phase during scheduled bed­
rest compared with during scheduled wakefulness are not due to elevated melatonin 
levels during scheduled wakefulness. In addition, this further demonstrates that 
melatonin secretion in the BE group was significantly suppressed during scheduled 
bed-rest independent o f circadian control. The magnitude o f melatonin suppression 
observed is nearly equivalent to that induced by ocular light exposure (Czeisler et al., 
1995).
The observed effect o f the imposed rest-activity schedule on melatonin 
secretion in the BE group was also evident when melatonin levels were averaged by 
the period o f the 28-h day length. The time in 28-h day melatonin waveform was 
smaller compared with the circadian wavefonn in the BE group, yet it exhibited 
significant variation across the 28-h day. Melatonin levels increased across scheduled 
wakefulness and then fell sharply below the DLM0 2 5 % threshold just after and for the 
remainder o f scheduled bed-rest. Melatonin levels in the two NLP blind groups who
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have eyes also exhibited some variation across the 28-h day, however, melatonin 
levels remained above the DLM0 2 s% threshold.
The effect o f the imposed rest-activity schedule on the melatonin rhythm in 
the BE group is clearly demonstrated when melatonin levels were assessed across beat 
cycle phases, either relative to circadian phase or time in the 28-h day. In the BE 
group, melatonin levels averaged across beat cycle phase exhibited a robust 
oscillation. For instance, melatonin levels were significantly lower than the DLM025% 
threshold when the midpoint o f scheduled bed-rest coincided within 4 h o f the 
predicted peak o f the melatonin rhythm, and they were slightly higher than the 
DLM0 2 5 % thieshold when the midpoint o f scheduled bed-rest occurred ~ 1 2  h out o f  
phase with the predicted peak o f the melatonin rhythm. When the predicted peak of  
melatonin secretion in the BE group occurred within ~4 h o f onset o f scheduled bed­
rest, melatonin levels rose and fell at an earlier circadian phase, and when the 
predicted peak o f melatonin secretion in the BE group occurred within ~4 h o f the 
onset o f scheduled wakeflilness melatonin levels rose and fell at a later circadian 
phase.
4.5.2 Melatonin Phase, Duration and Concentrations
The differences between the BE group and both NLP blind groups who have 
eyes are further confimied by the results o f  melatonin phase, duration and 
concentration relative to the beat cycle. Melatonin phase, duration or concentrations 
in both NLP groups who have eyes did not show any consistent systematic changes 
across the beat cycle. However, the timing o f the three phase markers in the BE group 
changed dramatically relative to the mean timing within the circadian day as a 
function o f the beat cycle period. The timing o f calculated phase within the circadian
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day exhibited systematic phase-advances or phase-delays relative to changes in the 
temporal phase relationship between the predicted peak o f the melatonin rhythm and 
the midpoint o f scheduled bed-rest. The amplitude o f the fitted sinusoid was not 
significantly different from zero in DLMOii25% and DLMOmidpt25%, but this may be 
due to larger phase-advances versus phase-delays at one or two phases o f the beat 
cycle. For instance, when the midpoint o f scheduled bed-rest coincided with or 
occurred after the predicted midpoint o f  the melatonin rhythm between 0 and 240 
BCP°, the average DLM0 n2s% o f the melatonin rhythm exhibited little or no phase- 
advance, but when the midpoint o f scheduled bed-rest occurred ~4 h prior to the 
predicted midpoint o f  the melatonin rhythm at 300 BCP°, the average DLMOn25% of  
the melatonin rhythm exhibited veiy large phase-delay of up to -2 .0  h. In contrast, 
DLMOff25% exhibited a large phase-advance o f ~ 1  h when the midpoint o f scheduled 
bed-rest coincided with or occurred after the predicted midpoint o f the melatonin 
rhythm between 0 and 60 BCP°. However, when the midpoint o f scheduled bed-rest 
occurred - 4  h prior to the predicted midpoint o f the melatonin rhythm between 60 and 
300 BCP°, DLMOff25% exhibited small phase-delays o f only -3 0  min. Since the 
DLMOmidpt25% is an interaiediate point between DLMOn25% and DLM0ff25%, the 
uneven changes between phase advances and delays within and between DLM0 n2s% 
and DLMOff25% most likely contributed to the poorly fit sinusoid to DLM0midpt25% 
in the BE group.
Phase-advance and phase-delay shifts between phase markers occurred in 
parallel across the beat cycle phase in the E-POS group, but not in the BE or the E- 
NEG groups. In addition, the melatonin concentrations in the BE group were 
significantly altered across the beat cycle, particularly at the beat cycle phases where 
the greatest phase-advances or phase-delays were observed in both DLMOn25% and
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DLMOff25%. These two observations indicate that the altered changes in timing of  
melatonin phase markers during the circadian day were the direct result o f significant 
reductions in circadian melatonin concentrations apparently induced during scheduled 
bed-rest episodes. For instance, when the midpoint o f scheduled bed-rest occurred 
within ~  4 h o f the predicted midpoint o f the melatonin rhythm, melatonin levels 
between 300, 0 and 60 BCP° remained above the DLM025% threshold (DAT) for 
shorter duration o f time and were lower (AUC) compared to baseline. These beat 
cycle phases coiiespond to the beat cycle phase that DLM0 n25% and DLMOff25% 
exhibit the greatest phase shifts. In contrast, when the midpoint o f scheduled bed-rest 
occuned - 8  to 12 h out o f phase with the predicted midpoint o f the melatonin rhythm 
the amplitude at 120, 180 and 240 BCP°, melatonin levels remained above the 
DLM025% threshold (DAT) for a much longer duration o f time and they were higher 
(AUC). These beat cycle phases correspond to the beat cycle phase at which either, 
DLMOii25% and DLMOff25% exhibit the smallest phase shifts.
4.5.3 Subject 1451: Before and After Bilateral Enucleation
One (1451) o f three bilaterally enucleated subjects studied was assessed under 
the same protocol conditions before and after bilateral enucleation. Compared with 
the melatonin rhythm in subject 1451’s assessment before bilateral enucleation, the 
melatonin rhythm after bilateral enucleation exhibited: ( 1) a significantly longer 
circadian period; (2 ) significantly higher levels overall compared to before bilateral 
enucleation; and (3) altered secretion levels relative to the temporal phase relationship 
between the circadian melatonin rhythm and the imposed 28-h rest-activity rhythm.
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4.6 Conclusion
Significant systematic modulation o f the melatonin rhythm under FD 
condition in NLP blind subjects was dependent upon the presence o f eyes and 
independent o f photic input to the pacemaker. The magnitude o f modulation was 
much greater in bilaterally enucleated subjects compared with NLP groups with eyes, 
as well as compared with sighted subjects studied under similar FD conditions. 
However, the timing of daily phase, duration and concentrations changed at opposite 
phase relationships between the melatonin rhythms and imposed rest-activity cycle 
compared with that observed in sighted subjects. Nonphotic-induced alterations in 
human circadian period and amplitude o f  this magnitude have never been obseiwed 
before in healthy subjects under these controlled laboratoiy conditions. These data 
suggest that bilateral enucleation dismpts circadian organization by altering the 
human circadian pacemaker’s output and/or sensitivity to nonphotic time cues. These 
data indicate that the human eyes interact with the circadian pacemaker independent 
o f its role as the primary photic transducer. In general, the mammalian eye(s) may act 
as peripheral oscillator(s), which helps stabilise endogenous rhythmicity.
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Chapter 5
Homeostatic and Circadian 
Regulation of Sleep and 
Neurobehavioural Function 
in NLP Blind Individuals
CHAPTER 5 -  HOMEOSTATIC AND CIRCADIAN REGULATION OF SLEEP 
AND NEUROBEHAVIOURAL FUNCTION IN NLP BLIND 
INDIVIDUALS
5.1 Introduction
The two-process model o f sleep-wake regulation describes a sleep-wake 
dependent or homeostatic (Process S) component and a circadian (Process C) 
component (Borbély, 1982; Daan et al., 1984; Dijk et al., 1987b; Acheimann and 
Borbély, 1990; Achermann and Borbély, 2003). Under Process S, sleep propensity 
and wakefulness are driven by the amount o f prior time awake and prior time asleep, 
respectively. For example, sleep pressure rises as the duration of time-awake 
increases and dissipates during sleep. Under Process C, sleep propensity and 
wakefulness are driven by circadian timing independent o f the prior duration of sleep 
and wake via the circadian pacemaker. The forced desynchrony (FD) protocol (20, 28, 
42.85 h) has been used to separate homeostatic and circadian components to assess 
the individual contribution o f each to sleep-wake regulation in sighted humans (Dijk 
et al., 1992; Johnson et al., 1992; Dijk and Czeisler, 1994; Dijk and Czeisler, 1995; 
Dijk et al., 1999; Dijk, 1999; Wyatt et al., 1999; Dijk et al., 2001; Wright Jr. et al., 
2002; Hull et al., 2003; Klerman et al., 2004; Wyatt et al., 2004; Wyatt et al., 2006). 
During the FD protocol, scheduled sleep opportunities and wake episodes occur 
across a full range o f circadian phases o f the melatonin rhythm while minimizing the 
amount o f prior wakefulness. As first described in reports from FD protocol 
assessments in sighted subjects, sleep and neurobehavioural fiinction are regulated by 
a non-linear interaction between homeostatic and circadian components (Dijk and 
Czeisler, 1994; Dijk and Czeisler, 1995). Under entrained conditions, homeostatic and 
circadian processes interact such that the circadian drive for wake counteracts 
elevated homeostatic sleep pressure in the latter half o f the subjective day, promoting
5-1
optimal alertness levels across the day. Furthermore, sleep continuity across an 8 -h 
episode in bed is promoted by a diminished circadian drive for wake or elevated 
circadian drive for sleep in the latter half o f the subjective night when homeostatic 
sleep pressure has dissipated. Moreover, when sleep initiation is scheduled across a 
full range o f circadian phases, the magnitude o f circadian effects on the amount o f  
wakefulness during the hours o f a scheduled sleep opportunity is dependent upon the 
sleep-dependent component (i.e., time asleep across time-in-bed).
The hypothalamic suprachiasmatic nuclei (SCN), the site o f the primary 
circadian pacemaker in mammals, endogenously generate precise near-24-hour 
rhythmicity. The SCN control the daily timing and amplitude o f  a range o f  
physiological and behavioural rhythms, such as pineal melatonin secretion and sleep- 
wake states. Complete SCN lesions abolish daily melatonin secretion (Klein and 
Moore, 1979) and consolidated sleep-wake rhythmicity (Mistlberger et al., 1983; 
Tobler et al., 1983; Trachsel et al., 1992; Edgar et al., 1993). Daily light-dark 
exposure entrains the human melatonin rhythm and sleep-wake cycle to the 24-h day. 
Under entrained conditions, sleep is usually consolidated during the subjective night 
when melatonin is high, and wakefulness is consolidated during the subjective day 
when melatonin is low. Photic input to the SCN is mediated through a non-image- 
forming (NIF) pathway from a subset o f photosensitive-melanopsin-containing retinal 
ganglion cells (jpRGCs) via the retinohypothalamic tract (RHT). The specificity o f this 
NIF pathway is underscored by the demonstration that a small percentage o f blind 
subjects with no conscious light perception (NLP), who still retain at least one eye, 
exhibit significant light-induced melatonin suppression and phase-shifts (Czeisler et 
al., 1995; Klerman et a l, 2002).
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/>RGCs are also known to innervate the ventrolateral preoptic nucleus 
(VLPO), an area o f the brain heavily involved in sleep-wake regulation (Lu et a l, 
1999). The timing o f sleep and wakefulness is significantly affected by light input to 
the circadian pacemaker, yet ocular light exposure may also have direct effects on 
sleep-wake circuits, like the VLPO, which receive photic input. For example, 
exposure to DD (Gonzalez and Aston-Jones, 2006) or blinding via bilateral 
enucleation (Ibuka et a l, 1977) in rodents has been reported to decrease the amplitude 
o f the sleep-wake rhythm, exposure to the dark during the light-activity phase o f a 24 
h LD cycle has been reported to increase REM sleep propensity (Trachsel et al., 1986; 
Benca et a l, 1998), daily exposure to short LD cycles can increase REM sleep 
propensity in darkness (Deboer et al., 2007) and long-duration light exposure has been 
reported to increase NREM sleep (AlfOldi et al., 1991; Miller et al., 1998). In another 
study, rats exposed to a 22-h LD cycle exhibited out-of-phase gene expression 
between dorsomedial and ventrolateral subdivision o f the SCN and dual locomotor 
activity with different periods, a 22-h rhythm superimposed over a longer than 24-h 
rhythm (de la Iglesia et al., 2004; Cambras et al., 2007). In this study, it was suggest 
that ocular light exposure dining the 22-h LD cycle desynchronised or separated the 
dual oscillators within the SCN, and that REM and SWS are not regulated by the 
same oscillator. It was concluded that REM sleep (not responsive to light) is regulated 
by endogenous circadian timing by dorsomedial SCN cells and that SWS (responsive 
to light) is driven by retino-recipient, ventrolateral SCN cells.
It is well established that a majority o f NLP blind humans living in society 
exhibit nonentrained melatonin rhythms and suffer from a non-24-h sleep-wake 
disorder due to the absence o f light input to the circadian pacemaker (Okawa et al., 
1987; Arendt et al., 1988; Nakagawa et a l, 1992; Klein et a l, 1993; Lockley et a l.
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1997a; Lockley et al., 1997b; Tabandeh et al., 1998; Leger et al., 1999a; Leger et al., 
1999b; Lockley et al., 1999b; Hack et al., 2003). This sleep-wake disorder is usually 
characterized by a periodic or cyclic dismption o f both sleep during bed-rest during 
the subjective night and neurobehavioural function, such as alertness and vigilance, 
during the subjective day despite an individual’s attempts to maintain a typical 24-h 
rest-activity schedule (i.e., rest-sleep during the night and active-wake during the 
day). These field observations suggest that homeostatic and circadian regulation of  
sleep-wake function is intact in NLP blind individuals. However, NLP blind subjects 
have not been assessed under the same strict experimental FD conditions as sighted 
subjects. As a result, it has not been definitively determined whether the individual 
contribution of homeostatic and circadian processes or an interaction between the two 
processes remains intact in NLP blind subjects as observed in sighted subjects despite 
the lack of light input or absence o f eyes. In the current investigation, 
neurobehavioural wake function using auditory computer-based tests and sleep using 
polysomnography were measured in NLP blind subjects during a 28-h FD protocol 
across all NLP blind subjects and between NLP blind groups (described in Chapter 4).
5.2 Methods
5.2.1 Subjects
Plasma melatonin, sleep and neurobehavioural function were assessed in 10 
healthy, NLP blind subjects (see Table 2-1 for subject details), 8 men and 2 women 
(mean age ± SD = 48.1 ±  11.9 yrs, range 27-68 yrs) during the 28-h FD protocol (see 
section 2.2.3 for protocol details). The first analysis o f the data included all 10 
subjects. A second analysis was conducted among the 3 NLP blind groups based upon 
the presence or absence o f eyes and positive melatonin suppression (MST results; see
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Figure 3-1). Subjects were placed in the E-POS group, if  they exhibited positive 
melatonin suppression (had at least I eye), and subjects who do not exhibited positive 
melatonin suppression were placed either in the E-NEG group, if  they had eyes or the 
BE group, if  they were bilaterally enucleated.
5.2.2 Protocol Schedule
Subjects were studied independently in an environment free o f time cues in the 
Intensive Physiology Monitoring Unit o f the General Clinical Research Center at 
Brigham and Women’s Hospital, Boston, MA for 38-days (see section 2.2.3 and 
Figure 2-1). Subjects were first scheduled to three baseline days (16:8; scheduled 
wakefulness and bed-rest) and then remained awake for 40 h during a constant routine 
protocol starting on day 4. Following a 9.33-h recovery sleep episode, subjects were 
scheduled to a live on a 28 h FD protocol for 4 weeks (24 cycles), in which scheduled 
wakefulness (00.00-18.66 h; <15 lux) and scheduled bed-rest (18.67-27.99 h; 
darkness) occurred 4 hours later each day relative to their habitual 24-h bed time 
schedule.
5.2.3 Melatonin Rhythm
Plasma melatonin was used as a marker o f the circadian component. An 
indwelling 18- to 2 0 -gauge intravenous catheter was inserted into the subject’s 
forearm vein on day 2. Plasma melatonin samples were collected every 60-120 min 
from day 2 to day 37 o f the 38-day inpatient protocol. The catheter was connected to a 
12 -foot small-lumen tube, which could be passed through a porthole to allow blood 
sampling outside the subject’s room during scheduled bed-rest so that the subject was
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not disturbed during sleep (see sections 2.3.3.1 and 2.4.2 for details regarding 
melatonin sampling and assay analyses).
5.2.4 Neurobehavioural Assessments -  Scheduled Wakefulness
Subjects completed neurobehavioiiral perfoimance assessments during 
scheduled wakefulness (00.00 -  18.67 h) eveiy 30-120 minutes beginning 2.25 h after 
scheduled wake time on 28 h FD days. Auditoiy versions o f visual computer-based 
tests, known to be sensitive to circadian phase and time awake (Dijk et al., 1992; 
Wyatt et al., 1999; Hull et al., 2003) were used, including an auditory Karolinska 
Sleepiness Scale (a-KSS), a 10-minute auditory Psychomotor Vigilance Task (a- 
PVT), and a 6 -minute auditory Addition Calculation Task (a-ADD).
5.2.4.1 Karolinska Sleepiness Scale
The a-KSS is a 9-point Likert scale used to assess subjective alertness. When 
the a-KSS is verbally presented, subjects are asked to rate their alertness/sleepiness on 
a scale from 1 to 9 ( 1 =  veiy alert to 9 = sleepy -  great effort to keep awake -  fighting 
sleep) based on the prior 5 minutes before the scale was presented. The a-KSS was 
given approximately every 30 minutes during scheduled wakefulness, before and after 
an entire test battery and between tests.
5.2.4.2 Psychomotor Vigilance Task
The a-PVT was used to measure auditory vigilance performance. During this 
timed-task each subject was asked to maintain the fastest possible reaction time [RT, 
milliseconds (msec)] to a simple auditoiy stimulus (recurring phone ring). Subjects 
responded to the auditory stimulus by pressing a button on a hand-held box as quickly
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as possible. The interstimulus interval varied randomly between 2 and 10 seconds. 
The a-PVT output parameters that were analysed include the median RT (msec) and 
the number o f lapses in attention (lapse = RTs > 500 msec).
5.2.4.3 Addition Calculation Task
Following the a-PVT 5 o f 10 subjects performed the a-ADD task, which was 
used to assess cognitive performance and working memoiy. During this timed-task 
the computer verbally presents a series o f randomly generated pairs o f 2 -digit 
numbers as an addition calculation problem (i.e., “23 + 45 equals”). The subject is 
asked to listen to the addition problem and correctly summate as many pairs o f 2 -digit 
numbers as fast as possible without sacrificing accuracy for speed. Subjects responded 
by typing their answers on a keyboard. Subjects were automatically given a new 
pairing after each response. Subjects could replay the current addition problem 
(pressing a key) as many times as they needed before responding with an answer, but 
they could not skip any presentations. The a-ADD test was scored according the total 
number o f addition calculations attempted (cognitive performance) and replayed 
(working memoiy) during the 6  minutes allowed.
5.2.5 Polysomnography Assessments -  Scheduled Bed-rest
5.2.5.1 Polysomnography (PSG) Recordings
PSG was recorded with an ambulatory TEMEC Instruments Vitaport 
(TEMEC, The Netherlands) for all scheduled sleep opportunities (scheduled bed-rest). 
PSG recordings were used to monitor the summation o f cerebral action potentials, 
muscle activity and eye movements in order to deteimine sleep-wake state and sleep 
stages during scheduled bed-rest. All data were filtered at 35 Hz and digitized at 128
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Hz. Surface electrodes (Beckman Instmment Co., Schiller Park, IL) were applied to 
the subject's face and head prior to scheduled bed time (lights out) for all PSG 
recordings, including central (C3-A2 and C4—A l) and occipital (0 1 -A 2  and 0 2 -A 1)  
derivations for electroencephalogram (EEG), electrooculogram (EOG), 
electrocardiogram (EGG) and electromyogram (EMG) recording.
5.2.5.2 PSG Sleep Stage Scoring
PSG recordings during each 9.33-h scheduled bed-rest episode across the FD 
protocol were scored visually in 30-second epochs by the investigator (JTH) 
according to criteria established by Rechtschaffen and Kales (1968). EEGs were 
derived from electrode placements on mastoid-referenced central C3-A2 and occipital 
0 1 -A 2 . Epochs scored as NREM stages 3 and 4 were categorised as Slow Wave 
Sleep (SWS).
Voluntary eye movements during PSG calibrations (asking subjects to direct 
the gaze o f their eyes) prior to scheduled bed time and sleep-related slow rolling eye 
movements and rapid eye movements during any PSG recording were absent in all 
subjects, except subject 22CS. As a result, an epoch o f PSG recording was scored as 
REM sleep based on the criteria o f Rechtschaffen and Kales (1968) in the absence o f  
eye movements in the EOG for 9 o f 10 subjects. A secondary polysomnographic 
technician blinded to the study condition randomly selected and scored three PSG 
recordings for each subject and compared them with those scored by the investigator 
to determine the reliability o f primary scoring (n=30, mean ± st dev; 91 ± 3 %). Each 
subject’s first 9.33-h PSG recording following the 40 h CR was excluded from these 
analyses due to the potential confounding effects o f sleep deprivation on recovery
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sleep. In addition, PSG recordings missing both EEG and EMG channels for more 
than one hour o f the entire sleep recording were excluded from these analyses.
5.2.5.3 Sleep Duration/Latencies
Total sleep time (TST), sleep latency and REM latency were calculated for 
each individual scheduled PSG recording for each subject. TST (minutes) is the total 
number o f 30-sec epochs scored as sleep (REM-NREM) multiplied by two. Sleep 
latency was defined as the elapsed time (min) between scheduled "lights out" and the 
first three continuous epochs o f Stage 1 sleep or the first epoch o f any other stage o f  
sleep. REM sleep latency was defined as the elapsed time (min) between sleep onset 
and the first epoch o f REM sleep. Average sleep or wake bout duration (min) between 
sleep-to-wake or wake-to-sleep transitions during scheduled bed-rest was expressed 
as the mean sleep- or wake- “state-duration-after-transition” (SDAT), respectively. 
Sleep-SDAT is defined as the duration o f time asleep after any transition from wake- 
to-sleep (one 30-sec epoch o f any stage o f sleep), and Wake-SDAT is defined as the 
duration o f time awake after any transition from sleep-to-wake.
5.2.6 Analysis
5.2.6.1 Melatonin Rhythm
Nonorthogonal spectral analysis (NOSA) o f each subject’s plasma melatonin 
data collected during the FD protocol between CRl and CR2 were used to estimate 
the individual’s intrinsic circadian period and the clock time o f the melatonin peak 
during CR l. Each plasma melatonin sample during the FD protocol was assigned: (1) 
a circadian phase (CP; varying from 0 to 359°) based upon the clock time of the 
sample relative to the melatonin maximum (CP 0°) and the circadian period estimated
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by NOSA; (2) a time o f 28-h day (TOD; vary from 0.00 to 27.99 h) based upon the 
time the sample was taken relative to scheduled wake time (TOD 0.00 h); and (3) a 
beat cycle phase (BCP; vaiying from 0 to 359°), based upon the clock time o f the 
sample relative to predicted intersection (BCP 0°) between the midpoint o f scheduled 
bed-rest (T=28 h) and the fitted peak o f the melatonin rhythm ( t )  [also see Figure 4-1 
and section 4.3.1.3]. Each o f the subjects’ melatonin data were normalised by a z- 
score transformation and averaged within and then across subjects by circadian phase 
in 30° (~2-h) bins centred at CP 0° and by elapsed- time-awake and time-in-bed in
2.33 h bins centred at TOD -1 .2  h. Melatonin data were separated by beat cycle phase 
in 60° (-4-h) bins centred at BCP 0° and then averaged within and across subjects by 
TOD in -2.33-h bins centred at TOD -1 .2  h by beat cycle phase. Statistical 
significance was assessed with repeated measures ANOVA.
S.2.6.2 Neurobehavioural Measures (Wake)
All neurobehavioural data were first transformed into deviation from the 
individual subject’s FD mean to account for interindividual differences. Each 
neurobehavioural test for each subject was then assigned: ( 1) a circadian phase (0  to 
359°, where 0° equals the NOSA predicted melatonin peak); (2) an elapsed-time- 
awake during scheduled wake episode o f the 28-h day (0 .0 0  to 18.66 h, where 0 .0 0  h 
equals scheduled wake time/light on); and (3) a beat cycle phase [0 to 359°, where 0° 
equals predicted intersection between the midpoint o f scheduled bed-rest (T=28 h) and 
the fitted peak o f the melatonin rhythm (%)]. Data were averaged within and then 
across subjects by circadian phase in 30° (~2-h) bins centred at CP 0° and elapsed- 
time-awake in -2 -h  bins centred at TOD -1 .2  h. In addition, neurobehavioural data 
were separated by beat cycle phase in 60° (-4-h) bins centred at BCP 0° and then
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averaged within and across subjects by elapsed time in 28-h day in - 2 -h bins centred 
at TOD -1 .2  h for each beat cycle phase. Statistical significance was assessed with 
repeated measures ANOVA.
5.2.6.3 PSG Measures (Bed-rest)
Total sleep time, sleep latency and REM latency (minutes) for each individual 
sleep recording were assigned a circadian phase (0° to 359°, where 0° equals the 
NOSA predicted melatonin peak) based upon the clock time o f the beginning o f the 
scheduled sleep opportunity (i.e., lights out) relative to the melatonin maximum (CP 
0°) and the circadian period estimated by NOSA. Total sleep time, sleep latency and 
REM latency were averaged by circadian phase in 60° (-4-h) bins centred at CP 0°.
Each 30-sec epoch was assigned; (1) a circadian phase (0 to 359°, where 0° 
equals the NOSA predicted melatonin peak); (2) an elapsed time-in-bed (TIB; 0.00 -
9.33 h) dming scheduled bed-rest (18.67 to 27.99 h, where 18.67 h equals scheduled 
bed time/light out); and (3) a beat cycle phase [0 to 359°, where 0° equals predicted 
intersection between the midpoint o f scheduled bed-rest (T=28 h) and the fitted peak 
o f  the melatonin rhythm ( t ) ] .  The total number o f epochs scored in the PSG recording 
and the total the nmnber o f epochs scored as Wake, as individual stages o f sleep 
(REM sleep, SWS, Stage 2 sleep and Stage 1 sleep) and as any stage o f sleep was 
summed within subjects by circadian phase (30° bins centred at CP 0°), by elapsed- 
time-in-bed (-2-h  bins centred at TIB -1 .2  h), and by beat cycle phase (60° bins 
centred at BCP 0°) and elapsed time-in-bed (-2-h  bins centred at TIB -1 .2  h).
Total recording time (TRT; the total number o f epochs in the PSG recording) 
and total time awake (total number o f epochs scored as Wake) were used to express 
Wake as percentage o f total recording time (Wake %TRT = total awake time total
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recording time) for each circadian, elapsed time-in-bed and BCPxTIB bin. The total 
number o f epochs scored as any stage o f  sleep was used to express the total number o f  
epochs scored as REM sleep, SWS, Stage 2 sleep or Stage 1 sleep as a percentage o f  
TST (Stage %TST = total time in an individual stage o f sleep ^ total sleep time) for 
each circadian, elapsed-time-in-bed and BCPxTIB bin. Wake %TRT and stages o f  
sleep %TST were then averaged across subjects by circadian phase, elapsed time-in- 
bed and BCPxTIB. Statistical significance was assessed with repeated measures 
ANOVA.
SDAT data were assigned: (1) a circadian phase (0° to 359°, where 0° equals 
the NOSA predicted melatonin peak); (2) an elapsed-time-in-bed during scheduled 
bed-rest o f the 28 h day (18.67 to 27.99 h, where 18.67 h equals scheduled bed 
time/light out); and (3) a beat cycle phase [0° to 359°, where 0° equals predicted 
intersection between the midpoint o f  scheduled bed-rest (T=28 h) and the fitted peak 
o f the melatonin rhythm (x)]. The clock time o f the first epoch o f sleep or wake after 
the transition from wake-to-sleep or sleep-to-wake, respectively, was used to assign 
circadian phase, elapsed-time-in-bed and beat cycle phase to sleep and wake SDAT 
data. Sleep and wake SDAT (minutes) were averaged within and then across subjects 
by circadian phase, elapsed-time-in-bed and BCPxTIB. Statistical significance was 
assessed with repeated measures ANOVA.
An additional analysis was conducted to determine whether a non-linear 
interaction between homeostatic and circadian components exists in NLP blind 
individuals (n=10). Wake %TRT was averaged within and then across subjects by 
both circadian phase and elapsed-time-in-bed. In addition, the same analysis was 
conducted to determine whether a non-linear interaction between homeostatic and 
circadian components exist among NLP blind groups, those who retain circadian
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photoreception (E-POS) and totally blind with eyes (E-NEG) and without eyes (BE). 
Statistical significance was assessed with repeated measures ANOVA.
5.3 Results
5.3.1 Neurobehavioural Measures: NLP Blind (n=10)
As expected the melatonin rhythm (Figure 5-1 A) exhibited a robust variation 
across circadian phase [F(l 1,99) = 514.45; P < 0.0001], but melatonin levels averaged 
across scheduled wakefulness were flat (P=0.10). There was a robust circadian 
variation across most measures o f neurobehavioural function. Neurobehavioural 
function was optimal ~4 h prior to the onset o f melatonin secretion and declined after 
the onset o f melatonin (270-300°). Neurobehavioural function was worst ~4 h (90°) 
after the peak o f melatonin, but improved thereafter across circadian phases when 
melatonin levels are lowest (120-240°). In addition, most measures o f  
neurobehavioural function declined as a fimction of elapsed-time-awake during 
scheduled wakefulness, but the amplitude o f this variation across time-awake was 
much smaller than that observed across circadian phase (Figure 5-1; Table 5-1).
For the a-KSS, there were significant main effects o f circadian phase and 
elapsed-time-awake on subjective alertness (Figure 5-lB). For the a-ADD, there,were 
significant main effects o f  circadian phase and elapsed-time-awake on the number of  
addition calculations attempted (Figure 5-1C). There was also a significant main 
effect o f elapsed-time-awake on the number o f addition calculations replayed (Figure 
5 -ID), but no significant effect o f circadian phase. For the a-PVT, there was a 
significant main effect o f circadian phase on both median RT (Figure 5 -IE) and 
number o f lapses (Figure 5 -IF), and both displayed a trend for elapsed-time-awake 
(P=0.07).
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Figure 5-1. Plasma melatonin and neurobehavioural function (scheduled wakefulness) 
across circadian phase and time awake in NLP blind subjects. Data are double-plotted by 
circadian phase (left column) and plotted by elapsed-tim e-awake (right column). Melatonin 
and neurobehavioural data (A) were averaged (± sem ) in and across subjects by circadian 
phase (degrees) in 30° (-2 -h ) bins (centred at 0°) and by elapsed-tim e-awake (hours) in 
-2 .3 3 -h  bins (centred at 1.2 h). Melatonin (A) data are expressed as a z-score 
transformation and neurobehavioural measures, including subjective alertness (B) on the 
a-K SS (n=10), number of calculations attempted (C) and replayed (D ) on the a-ADD (n=5) 
and auditory median reaction time (E) and number of lapses (F) on the a -P V T  (n=10) are 
expressed as deviation from the subject’s FD mean (y=0; horizontal dash lines) on y-axis. 
Values below mean indicate impaired neurobehavioural function. The area between the 
two vertical dashed lines (left column) indicates when melatonin levels were above the 
mean.
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Table 5-1. Analysis of neurobehavioural measures (scheduled wakefulness) assessed 
across circadian phase, time aw ake and beat cycle phase in NLP blind subjects. 
Neurobehavioural measures, including subjective alertness (a-KSS; n=10), cognitive 
performance and working memory (a-ADD; n=5) and auditory vigilance (a-PVT; n=10).
Measure Circadian
Phase
Elapsed 
Time Awake
Beat Cycle 
Phase
a - K S S
Alertness
F(11,99) = 13.83; P <  0.0001 F(8.72) = 8.67; P < 0.0001 F(40,360) = 9.09, P < 0.0001
a -A D D
it- A ttem pted
F(11,44) = 4.03; P <  0.001 F(7,28) = 3.97; P < 0.01 F(35,140) = 2.09; P <  0.01
a -A D D
#  R eplayed
F(11,44)=  1.55; P = 0.15 F(7,28) = 4.30; P < 0.01 F(35,140)= 1.46, P = 0.07
a -P V T
Median R T
F(11,99) = 8.40; P <  0.0001 F(7,63) = 1.99; P = 0.07 F(35,315) = 3.68; P <  0.0001
a -P V T
# of L apses
F(11,99) = 11.14; P <  0.0001 F(7,63) = 2.01; P = 0.07 F(35,315) = 4.42; P <  0.0001
There was a significant interaction between beat cycle phase and elapsed-time- 
awake for all neurobehavioural measures (Figure 5-2; Table 5-1), except for number 
o f addition calculations replayed on the a-ADD (figure not shown). Subjective 
alertness (Figure 5-2A) and measures o f cognitive perfonnance (Figure 5-2B) and 
auditory vigilance (Figure 5-2C) were optimal across -1 8  h o f scheduled wakeflilness 
when the peak of the melatonin pulse occurred during the middle o f scheduled bed­
rest (BCP 0°). Subjective alertness and measures o f cognitive performance (Figure 5- 
2B) and auditory vigilance (Figure 5-2C) were also optimal for -4 -6  h during the first 
third o f scheduled wakefulness regardless o f whether the timing (beat cycle phase) o f  
the melatonin pulse occurred during scheduled wakefulness. However, the onset o f  
significant neuiobehavioural impaiiment obseiwed during different beat cycle phases 
was dependent upon the timing o f the melatonin pulse. If the onset o f melatonin 
secretion occurred during the last third o f scheduled wakefulness, then 
neurobehavioural function remained optimal for up to 14-16 h o f scheduled 
wakefulness (BCP 60“), but if  the onset o f melatonin secretion occuiTed during the
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Figure 5-2. Interaction between beat cycle phase (BCP) and elapsed-tim e-awake on 
neurobehavioural function (scheduled wakefulness) during FD protocol. a-K SS (A; n=10), 
a-A D D  (B; n=5) and a-P V T  (0 ; n=10) data (filled circles) are superimposed over melatonin 
data (waveform filled downward diagonal pattern) plotted by BCP, varying from 0 to 300° 
(top to bottom panels), and time of 28-h day, varying from 0.00 to 27 .99  h (x-axis in each 
panel; 0 .00  h = lights on). Neurobehavioural data are expressed on the y-axis (each BCP  
panel) as deviation from the subject’s FD mean (horizontal dash lines) and are averaged  
(± sem ) in and across subjects by BCP in 60° ( -4 -h )  bins [centred at BCP 0°. where BCP  
0° is defined as the predicted intersection between the peak of the subject’s melatonin 
rhythm (t )  and the midpoint of scheduled bed-rest (T=28 h)] and elapsed-tim e-awake in ~2  
h bins (centred at ~2  h after lights on). Note that at each subsequent beat cycle phase the 
melatonin pulse occurs ~4 h earlier, and that circadian phase and time awake change 
concurrently during scheduled wakefulness.
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first third of scheduled wakefulness, then neurobehavioural function declined after 
only 6 h o f scheduled wakefulness (BCP 180“). Most measures of neurobehavioural 
function across elapsed-time-awake were lowest in assessments performed at or up to 
6 h after the peak of the melatonin pulse, but this was only tme in assessments 
performed at least 4-6 h after scheduled wake time (BCP 60-300“). Interestingly, 
when peak melatonin levels occur in the first third of scheduled wakefulness (BCP 
240 to 300“), most measures of neurobehavioural function are lowest in the first half 
of scheduled wakefulness after only 6-8 h elapsed-time-awake, but some measures of 
neurobehavioural function (a-ADD and a-PVT) improve to optimal levels in the 
second half of scheduled wakefulness even after 14-18 h elapsed-time-awake.
5.3.2 PSG Assessments: NLP Blind (n=10)
Table 5-2 shows a summaiy (mean ± sem) for 229 PSG recordings included in 
this analysis. There was a significant age-related decrease in overall mean sleep 
efficiency across all NLP blind subjects as analysed by regression analysis (slope ± 
95%CI, -0.005 ± 0.004; P < 0.05), which is consistent with prior reports in sighted 
subjects. Regarding sleep propensity and continuity (Figure 5-3), there was a 
significant main effect of circadian phase on sleep latency [F(4,45) = 4.69; P < 0.01], 
REM latency [(4,45) == 5.02; P < 0.001] and total sleep time [F(4,45) = 28.11; P < 
0.0001]. When scheduled bed-rest is initiated at circadian phases when melatonin 
levels are lowest, sleep latency and REM latency remain long; however when it is 
initiated 2-4 h after the melatonin peak, sleep latency and REM latency are shortest. 
In addition, when scheduled bed-rest is initiated ~8-10 h after the peak of melatonin, 
total sleep time is shortest, but if it is initiated -8-10 h before the peak of melatonin, 
total sleep time is longest.
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Table 5-2. Sum m ary of all available PSG  recordings for ail NFL blind su b jects (n=10).
VARIABLE NLP BLIND (n=io) 
mean ± sem
Age 48.1 ± 3 .7
Sleep Latency (min) 6.9 ± 0 .7
R EM  Latency (min) 65.2 ±  5,1
T R T  (min) 558.4  ± 0.7
Wakefulness (min) 153.5 ± 14.9
T S T  (min) 405 .0  ± 14.7
Sleep efficiency (% ) 72 .5  ± 2.7
Stage 1 (% TST) 15.6 ± 1.5
Stage 2 (% TS T) 59.3 ± 3 .1
SW S (% TS T) 10.1 ± 2 .8
REM  sleep (% TS T) 14.9 ± 1.1
Most PSG-defined sleep-wake state and sleep structure exhibited significant 
variation across circadian phase and elapsed-time-in-bed dui'ing scheduled bed-rest 
(Figure 5-4; Table 5-3). There were significant main effects of circadian phase and 
elapsed-time-in-bed on Wake %TRT (Figure 5-4B). Wake %TRT during bed-rest was 
lowest at the peak of melatonin secretion, it increased across those circadian phases 
when melatonin levels were lowest and peaked ~2 h before the onset of melatonin 
secretion. In addition, Wake %TRT was relatively low in the first two quarters of 
elapsed-time-in-bed, and then exhibited a linear increase across the last two quarters 
of elapsed-time-in-bed. There was a significant main effect of circadian phase, but no 
significant effect of elapsed-time-in-bed on REM %TST (Figure 5-4C). REM %TST 
gradually increased across circadian phases when melatonin levels were above the 
mean, peaked ~2 h after the peak of melatonin secretion, and remained relatively low 
across circadian phases when melatonin levels were lowest. REM %TST was 
relatively flat across elapsed-time-in-bed. There were significant main effects of
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Figure 5-3. Plasma melatonin and sleep propensity and duration (scheduled bed-rest) in 
NLP blind individuals (n=10) during the FD protocol. Data are double plotted by circadian 
phase relative to the individual subject’s circadian period during the FD protocol. 
Melatonin data (A) w ere averaged (± sem) in and across subjects by circadian phase 
(degrees) in 30“ (-2 -h ) bins (centred at 0°) and are expressed by z-score transformation 
on the y-axis. The clock time of scheduled lights-out for each sleep opportunity was  
assigned a circadian phase. Sleep latency (B), R EM  latency (C) and total sleep time (D) 
for each sleep opportunity were averaged (± sem ) in and across subjects by circadian 
phase in 60“ ( -4 -h ) bins (centred at O'*) and are expressed as mean duration in minutes. 
Therefore, total sleep time is plotted at the circadian phase at which sleep latency is 
assessed (i.e., the average sleep latency is relatively longer and average total sleep time 
is longer within the 9 .33  h sleep opportunity if schedule bed-rest began at -240® prior to 
the onset of melatonin secretion compared to if bed-rest began at -6 0 °  after the peak of 
melatonin secretion). The area between the two vertical dashed lines indicates when 
melatonin levels were above the mean.
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circadian phase and elapsed-time-in-bed on SWS %TST (Figure 5-4D), stage 2 %TST 
(Figure 5-4E) and stage 1 %TST (Figure 5-4F). SWS %TST dming bed-rest was 
relatively low across circadian phases when melatonin levels were above the mean 
and remained relatively high across circadian phases when melatonin levels were 
lowest. In addition, SWS %TST was highest in the first two quarter of elapsed-time- 
in-bed, and then exhibited a linear decline across the remaining three quarters of 
elapsed-time-in-bed. Stage 2 %TST gradually decreased across circadian phases when 
melatonin levels were above the mean, was lowest ~4 h after the peak of melatonin 
secretion, and remained relatively high across circadian phases when melatonin levels 
were lowest. Stage 1 %TST gradually increased across circadian phases when 
melatonin levels were above the mean, peaked ~4 h after the peak of melatonin 
secretion, and remained relatively low across circadian phases when melatonin levels 
were lowest.
Table 5-3. A N O VA  analyses of PSG-derived variables across circadian phase and 
elapsed-time-in-bed in NLP blind subjects (n=10). PSG-derived variables include sleep 
stages expressed as a percentage of total sleep time (% TST), wakefulness during 
scheduled bed-rest expressed as a percentage of total recording time (% TR T) and w ake- 
and sleep- ‘state-duration-after-transition’ (SD AT) expressed as the mean duration 
(minutes) awake or asleep following S -to-W  or W -to-S  transitions, respectively.
Variable Circadian
Phase
Eiapsed 
Time in Bed
Interaction
(B-Cycie)
stage 1 (%TST) F(11,99) = 6.90; P< 0.0001 F(3,27) = 22.27; P < 0.0001 F(55,495) = 0.45; P = 0.96
Stage 2 (%TST) F(11,99) = 2.15; P < 0.05 F(3,27) = 5.96; P < 0.01 F(55,495)= 1.45; P = 0.13
SWS (%TST) F(11,99) = 4.27; P< 0.0001 F(3,27) = 16.43; P< 0.0001 F(55,495) = 1.52; P = 0.11
REM (%TST) F(11,99) = 17.44; P< 0.0001 F(3,27) = 0.31; P = 0.82 F(35,140) = 2.88; P< 0.001
Wake (%TRT) F(11,99)= 17.44; P< 0.001 F(3,27) = 75.86; P < 0.0001 F(35,140) = 11.43; P< 0.001
Sleep-SDAT (min) F(11,99) = 1.23; P = 0.28 F(3,27) = 13.54; P< 0.0001 F(15,495)= 1.35, P = 0.18
Awake-SDAT (min) F(11,99)= 10.01; P <0.0001 F(3,27) = 19.88; P< 0.0001 F(15,135) = 5.04; P< 0.0001
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Figure 5-4. Plasma melatonin and PSG  variables (scheduled bed-rest) during the FD 
protocol in NLP blind subjects (n=10). Data are double plotted by circadian phase (left 
column) and plotted by elapsed-time-in-bed (right column). Melatonin and PSG  data are 
averaged (± sem) in and across subjects by circadian phase (degrees) in 30° (~2 h) bins 
(centred at 0°) and by elapsed-time-in-bed (hours) in quarter ( -2 .3 3  h) bins (centred at 
-1 .2  h after lights out). Melatonin data (A) are expressed as a z-score transformation. 
W ake (B) during scheduled bed-rest is expressed as a percentage of total recording time 
(% TR T). REM sleep (C), Slow W ave Sleep (D), Stage 2 sleep (E) and Stage 1 sleep (F) 
are expressed as a percentage of total sleep time (% TS T). The area between the two 
vertical dashed lines (left column) indicates when melatonin levels were above the mean.
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Figure 5-5. Plasma melatonin and PSG-derived Sieep and W ake state-duration-after- 
transition (SD A T) across circadian phase and eiapsed-time-in-bed in NLP blind subjects 
(n=10). Melatonin (A), W ake-S D A T  (B) and S ieep-SDA T (C ) are doubie-plotted by 
circadian phase (ieft column) and by elapsed-time-in-bed (right column) on the x-axis. 
Data are averaged (± sem ) in and across subjects by circadian phase (degrees) in 30° (~2  
h) bins and by elapsed-time-in-bed (hours) in quarter ( -2 .3 3  h) bins. Melatonin data are  
expressed as a z-score transformation. W ake-S D A T and S ieep-SDA T data are expressed  
on the y-axis as the mean duration of time (minutes) awake or asleep relative to the 
circadian phase or quarter of time-in-bed that subjects transitioned from sleep-to-wake or 
wake-to-sleep, respectively. The area between the two vertical dashed lines indicates 
when melatonin levels were above the mean.
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There were significant main effects of circadian phase and elapsed-time-in- 
bed on Wake-SDAT (Figure 5-5B; Table 5-3). If  subjects awoke from sleep at the 
peak of melatonin secretion during scheduled bed-rest, the mean duration of 
wakefulness before falling back to sleep was shortest. The mean duration of wake 
bouts during scheduled bed-rest lengthened when awakenings from sleep occurred 
later and later across circadian phases where melatonin levels were lowest (CP 90 to 
240°). The mean duration of wake bouts during scheduled bed-rest was longest when 
subjects awoke from sleep -2-4  h before the onset of melatonin secretion. In addition, 
the mean duration of wakefulness before falling back to sleep was shortest if subjects 
awoke from sleep in the first quarter of elapsed-time-in-bed. The mean duration of 
wakefiilness before falling back to sleep increased in a linear fashion if subjects 
awoke from sleep later and later during subsequent quarters of elapsed-time-in-bed. 
There was a significant main effect of elapsed-time-in-bed, but no significant effect of 
circadian phase on Sieep-SDAT (Figure 5-5C; Table 5-3). Following an awakening 
during scheduled bed-rest, the mean duration of sleep bouts after falling back to sleep 
was similar regardless of the circadian phase during which subjects fell back to sleep. 
However, the mean duration of sleep bouts was longest when the transition from wake 
to sleep occurred in the first quarter following an awakening and shortest when the 
transition from wake to sleep occuned in the last quarter of elapsed-time-in-bed. The 
mean duration of sleep bouts after falling back to sleep decreased markedly in a linear 
fashion when the tiansition from wake to sleep following an awakening occurred later 
and later during subsequent quarters of elapsed-time-in-bed.
There was no significant interaction between beat cycle phase and elapsed- 
time-in-bed on NREM stage 1, stage 2 and SWS sleep (%TST) during the FD 
protocol (Table 5-3). In particular, SWS %TST only exhibited elapsed-time-in-bed
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Figure 5-6. Interaction between beat cycle phase (BCP) and elapsed-time-in-bed on PSG - 
derived variables during FD protocol. SW S  (A), R EM  sleep (B), W ake (C ) PSG  data (filled 
columns) during scheduled bed-rest (gray bars) are superimposed over melatonin data 
(waveform filled downward diagonal pattern) plotted by BCP, varying from 0 to 300° (top to 
bottom panels), and time of 28-h day, varying from 0.00 to 27.99 h (x-axis in each panel; 
18.67 h = lights out). SW S and REM  sleep are expressed as a percentage of total sieep 
time (% TS T) and W ake is expressed as a percentage of total recording time (% TR T) on 
the y-axis (each BCP panel). PSG  data are averaged (± sem) in and across subjects by 
BCP in 60° (~4-h) bins [centred at BCP 0°, where BCP 0° is defined as the predicted 
intersection between the peak of the subject’s melatonin rhythm (x) and the midpoint of 
scheduled bed-rest (T=28 h)j and elapsed-time-in-bed in quarter (-2 .3 3 -h ) bins (centred at 
-1 .2  h after lights out). Note that the melatonin pulse occurs - 4  h earlier across 
subsequent BCPs, and that circadian phase and time-in-bed change concurrently during 
scheduled bed-rest.
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dependent changes across the beat cycle, SWS%TST was always highest in the first 
quarter and declined across the remaining quarters of elapsed-time-in-bed at each beat 
cycle phase (Figure 5-6A). In addition, there was a significant interaction between 
beat cycle phase and elapsed-time-in-bed REM %TST (Figure 5-6B) and Wake 
%TRT (Figure 5-6C) during the FD protocol. REM %TST mostly exhibited 
circadian-dependent changes across the beat cycle. REM %TST was usually highest 
during the quarter of sleep that coincided just after the peak of melatonin secretion 
independent of the elapsed-time-in-bed. However, unlike SWS and REM sleep, Wake 
%TRT exhibited both circadian and elapsed-time-in-bed dependent changes across 
the beat cycle, particularly in the last two quarters of time in bed. For example, if the 
peak of the melatonin rhythm coincided with the midpoint of scheduled bed-rest, 
Wake %TRT remained relatively low across all quarters of time in bed. However, if 
the peak of the melatonin rhythm occuned 2-10 h prior to the onset of scheduled bed­
rest, Wake %TRT increased significantly in either the last or last two quarters of time 
in bed. Wake %TRT in the first two quarters of time in bed exhibited little or no 
variation across beat cycle phases.
There was a significant interaction between beat cycle phase and elapsed-time- 
in-bed on Wake-SDAT (Table 5-3; Figure 5-7A). As with Wake %TRT, Wake-SDAT 
exhibited both circadian and elapsed-time-in-bed dependent changes across the beat 
cycle, particularly in the last two quarters of time in bed. For example, if subjects 
awoke during any quarter of time in bed when the peak of the melatonin rhythm 
coincided with midpoint of scheduled bed-rest, the average wake duration remained 
relatively short across all quarters of time in bed. However, if subjects woke during 
the third or last quarter of time in bed when the peak of the melatonin rhythm 
occurred 2-10 h prior to the onset of scheduled bed-rest, the average wake duration
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Figure 5-7. Interaction between beat cycle phase (BCP) and elapsed-time-in-bed (TIB) on 
PSG-derived W ake/S ieep ‘state-duration-after-transition’ (SDAT) in NLP blind subjects 
(n=10). W ake- (A) and S ieep-SDA T (B) data (filled columns) during scheduled bed-rest 
(gray bars) are superimposed over meiatonin data (waveform filled downward diagonal 
pattern) plotted by BCP, varying from 0 to 30 0 “ (top to bottom panels), and time of 28 h 
day, varying from 0.00 to 27 .99 h (x-axis in each panei; 18.67 h = lights out). SDAT data 
are averaged (± sem) in and across subjects by BCP in 60 “ ( -4  h) bins [centred at BCP 0 “, 
where BCP 0 “ is the predicted intersection between the peak of the subject’s melatonin 
rhythm (x) and the midpoint of scheduled bed-rest (T=28 h)] and TIB in quarter ( -2 .3 3  h) 
bins (centred at -1 .2  h after lights out). W ake- and S ieep-SDAT data are expressed as the 
mean duration of time (minutes) awake or asleep on the y-axis (each BCP panei) relative 
to the BCP and quarter of TIB in which subjects transitioned from sieep-to-wake or wake- 
to-sleep, respectively. Note that the melatonin pulse occurs - 4  h earlier across 
subsequent BCPs, and that circadian phase and time-in-bed change concurrently during 
scheduled bed-rest.
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was 5-20 minutes longer than the average wake duration in the first quarter of time in 
bed. In addition, there was significant interaction between beat cycle phase and 
elapsed time in bed for Wake-SDAT, but there was no significant interaction between 
beat cycle phase and elapsed-time-in-bed on Sieep-SDAT (Table 5-3). Wake-SDAT 
remained low and exhibited no variation in the first two quarters o f bed-rest across 
beat cycle phases, but it exhibited significantly more variation in the latter two 
quarters of bed-rest across beat cycle phases (Figure 5-7A). In contrast, Sieep-SDAT 
consistently exhibited an elapsed-time-in-bed decline across all quarters of bed-rest, 
regardless o f beat cycle phase, such that the average duration of sleep bouts between 
awakenings was always longest in the first quarter and shortened across the remaining 
quarters of elapsed-time-in-bed at each beat cycle phase (Figure 5-7B).
There was a significant interaction between circadian phase and elapsed-time- 
in-bed [F(33,297) = 6.19; P <0.0001] for Wake %TRT (Figure 5-8C). High sleep 
efficiency was maintained across all circadian phases in the first two quarters of 
scheduled bed-rest. However, sleep consolidation was worst when the end of 
scheduled bed-rest occuiTed prior to the onset o f melatonin secretion, and was best 
when the end of scheduled bed-rest occurred just after the peak of melatonin 
secretion. The variation in the amount o f wakefulness during bed-rest changes as a 
function of both circadian phase and time-in-bed. However, the magnitude of 
circadian timing on the amount of wakefiilness diu'ing bed-rest is not significant until 
the second half of the sleep episode when sleep pressure is reduced. The 3- 
dimensional temporal shape and amplitude of the variation in the amount of 
wakefiilness obseiwed in young (Figure 5-8A) and older (Figure 5-8B) sighted adult 
subjects is quite similar in these NLP blind individuals (Figure 5-8C).
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Figure 5-8. Quasl-3-D  representation of wakefulness in scheduled sleep episodes as a 
function of circadian phase of the core body tem perature cycle and time in sleep episode 
in older (A) and young (B) sighted subjects (Adapted from Dijk et al., 1999) and as a 
function of circadian phase of the melatonin rhythm and time in bed in NLP blind subjects 
(C ). Data are plotted per 30 circadian deg and per fifth of the sieep episode (112 min) for 
older and young sighted subjects and per quarter of the sieep episode (140 min) in the 
blind subjects. All data are plotted at the midpoint of the bins. The mean approximate 
corresponding times of day during entrainment in (sighted) young and older people 
(according to Duffy et al. 1998) are also indicated.
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5.3.3 Neurobehavioural/PSG; NLP Blind Groups
NLP blind subjects were assessed in separate experimental groups: (1) those 
NLP blind subjects who retain circadian photoreception (E-POS); (2) totally blind 
subjects with eyes (E-NEG); or (3) bilaterally enucleated (BE) subjects. There was no 
significant difference in average age among groups, and no significant differences in 
overall sleep variables averaged across each FD PSG recording within and across 
subjects in each experimental group (Table 5-4). The average age of E-NEG group 
was slightly older than the other two groups, and not suiprisingly this group had the 
lowest average SWS and sleep efficiency. The average age for each group was greater 
than 40 y, and so the average values across sleep variables are reasonable compared 
with the sleep in older sighted subjects.
Table 5-4. Sum mary and between groups comparisons (ANO VA single factors) of ail 
available PSG  recordings for NPL blind subjects who exhibit circadian photoreception (E- 
PO S) or totally blind subjects with eyes (E -N E G ) or bilaterally enucleated (BE).
Variable E-POS (n=3) 
mean ± sem
E-NEG (n=4) 
mean ± sem
BE (n=3) 
mean ± sem P
Age (yrs) 45.7 ± 9.4 50.3 ± 7.2 47.7 ± 3.5 0.90
SLEEP latency (min) 6.8 ± 1.8 7.0 ± 1.1 6.8 ± 1.1 0.99
REM latency (min) 65.7 ± 8.9 71.4 ± 10.7 56.2 ±4 .1 0.52
TRT (min) 558.2 ± 0.7 557.6 ± 1.5 559.8 ±0 .1 0.40
Wakefulness (min) 116.3 ± 2 8 .3 184.0 ± 2 3 .8 150.0 ±8 .1 0.17
TST (min) 441.8 ± 2 8 .5 373.6 ± 22.6 409.9 ±8 .1 0.15
Sieep efficiency (%) 79.2 ±5 .1 67.0 ± 4.2 73.2 ± 1.4 0.17
Stage 1 (% TST) 16.4 ± 2 .0 15.5 ± 4 .4 15.1 ± 1.3 0.96
Stage 2 (% TST) 54.7 ± 4.6 66.6 ± 3.5 54.2 ±6 .1 0.15
SWS (% TST) 13.2 ± 6 .7 4.4 ± 1.8 14.7 ± 5 .7 0.28
REM sleep (% TST) 15.7 ±3 .3 13.4 ± 1.3 16.0 ± 0 .9 0.60
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Subjective alertness (a-KSS) and median reaction time (a-PVT) were assessed 
for wake neurobehavioural function, and SWS (%TST), REM (%TST) and Wake 
(%TRT) were assessed for sleep-wake states during bed-rest in the within-group 
analyses. Most neurobehavioural and PSG-derived variables assessed for the within 
groups analyses exhibited significant effects of circadian phase (Table 5-5; Figure 5- 
9). In each experimental group there was a significant main effect of circadian phase 
on subjective alertness (a-KSS), median reaction time (a-PVT), SWS and Wake. 
There was significant main effect of circadian phase on REM sleep in only the E- 
NEG group and a trend in the E-POS group, but each group exhibited a peak in REM 
sleep between 2 and 4 hours after the peak of the melatonin rhythm. The amplitude of 
variation in subjective alertness, median reaction time and Wake (%TRT) across 
circadian phase was similar between groups. The amount and amplitude of variation 
in SWS across circadian phase was similar between the E-POS group and the BE 
group. The amount of SWS was significantly less across circadian phase in the E- 
NEG group than in the other two groups [F(2,33) = 3.28; P<0.0001].
Table 5-5. A N O VA  analyses of neurobehavioural measures subjective sleepiness and 
auditory vigilance (scheduled wakefulness) and PSG-derived variables (Scheduled bed­
rest) across circadian phase in NLP blind subjects who retain circadian photoreception 
(E -P O S ) and totally blind subjects with eyes (E -N E G ) or bilaterally enucleated (BE).
Variable E-POS (n=3) E-NEG (n=4) BE (n=3)
a-PVT
Median R T (msec)
F(11,22) = 16.04; P <0.001 F(11,33) = 2.48; P< 0.05 F(11,22) = 2.36; P < 0.05
a-KSS
Subjective Alertness
F(11,22) = 6.20; P< 0.001 F(11,33) = 6.30; P < 0.0001 F(11,22) = 4.98; P< 0.001
SWS (%TST) F(11,22) = 2.26; P< 0.05 F(11,33)= 3.38; P< 0.01 F(11,22) = 4.02; P< 0.001
REM (%TST) F(11,22) = 2.03; P = 0.08 F(11,33) = 3.08; P< 0.01 F(11,22) = 1.46; P = 0.21
WAKE (%TRT) F(11,22) = 3.80; P <0.01 F(11,33) = 7.38; P< 0.0001 F(11,22) = 4.75; P< 0.0001
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Figure 5-9. Assessm ent of sleep and wake during scheduled bed-rest and 
neurobehavioural function during scheduled wakefulness across circadian phase among 
NLP blind groups. Data for E -P O S  (left column), E -N EG  (middle column) and BE (right 
column) NLP blind groups are double plotted by circadian phase relative to the period of 
the individual subject’s melatonin rhythm during the FD protocol. Data are averaged (± 
sem) in and across subjects by circadian phase (degrees) in 30° (-2 -h ) bins (centred at 
0°). For PSG-derived variables during scheduled bed-rest (filled columns). W ake (A) is 
expressed as a percentage of total recording time (% TR T) and REM  sleep (B) and SW S  
(0 )  are expressed as a percentage of total sleep time (% TST), For measures of 
neurobehavioural function during scheduled wakefulness (filled circles), alertness on the 
a-K SS (D ) and median reaction time (m sec) on the a-P V T (F) are expressed as a 
deviation from the subject’s FD mean.
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Only some neurobehavioural and PSG-derived variables assessed for the 
within-group analyses exhibited significant sleep-wake dependent effects of elapsed- 
time-awake or elapsed-time-in-bed (Table 5-6; Figure 5-10). There was no significant 
effect of time-awake on median reaction time in any group, but there was a trend in 
the BE group. Although each group exhibited a decrease across the scheduled wake 
episode, there was only a significant main effect of time-awake on subjective 
alertness in the E-POS and BE group. Similarly, each group exhibited a linear decline 
in SWS (%TST) across quarters of bed-rest. There was a significant main effect of 
time-in-bed on SWS (%TST) in the E-NEG and BE groups, and a trend in the E-POS 
groups. There was no effect of time-in-bed on REM sleep (%TST) in any group, but 
there was a significant main effect of time-in-bed on Wake (%TRT) in each 
experimental group. In each group. Wake (%TRT) exhibited a linear increase across 
quarters of bed-rest. The amplitude of variation in subjective alertness and median 
reaction time was slightly greater in the BE group than in the other two groups.
Table 5-5. A N O VA  analyses of neurobehavioural measures of subjective sleepiness and 
auditory vigilance (scheduled wakefulness) across elapsed-tlm e-awake and PSG-derived  
variables (scheduled bed-rest) across elapsed-time-ln-bed in NLP blind subjects who 
retain circadian photoreception (E -P O S ) and totally blind subjects with eyes (E -N EG ) or 
bilaterally enucleated (BE).
VARIABLE E-POS (n=3) E-NEG (n=4) BE (n=3)
a-PVT
Median RT (msec)
F(8,16) = 1.85; P =0.16 F(8,24) = 1.20; P = 0.34 F{8,16) = 2.69; P = 0.05
a-KSS
Subjective Alertness
F(8,16) = 5.09; P <0.01 F(8,24) = 0.97; P = 0.48 F(8,16) = 9.94; P< 0.0001
SWS (%TST) F(3,6) = 4.07; P = 0.07 F(3,9) = 5.06; P <0.05 F(3,6) = 11.14; P <0.01
REM (%TST) F(3,6) = 0.54; P = 0.67 F(3,9) = 0.29; P = 0.83 F{3,6) = 0.03; P = 0.99
WAKE (%TRT) F(3,6) = 8.09; P < 0.05 F(3,9) = 67.01; P <0.0001 F(3.6) = 35.04; P <0.001
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Figure 5-10. Assessment of neurobehavioural function during scheduled wakefulness and 
of sleep and wake during scheduled bed-rest across elapsed time-wake and time-ln-bed, 
respectively, among NLP blind groups. Data during scheduled wake and bed-rest (gray 
bars) for E -POS (left column), E -N EG  (middle column) and BE (right column) NLP blind 
groups are plotted and are averaged (± sem) In and across subjects in by elapsed-tlme- 
wake or elapsed-tlme-in-bed (~2-h) bins (centred at 1.2 h). For each NLP blind group 
during scheduled wakefulness, median reaction time (msec) on the a-P V T (A) and 
alertness on the a-KSS (B) are expressed as a deviation from the subject’s FD mean. For 
each NLP blind group during scheduled bed-rest, SW S  (C) is expressed as a percentage 
of total sleep time (% TST) and wake (D ) Is expressed as a percentage of total recording 
time (% TR T).
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Figure 5-11. Quasi-3-D  representation of wakefulness in scheduled sleep episodes as a 
function of circadian phase of the melatonin rhythm and time in bed in E -PO S  (A) E -N EG  
(B) and BE (C ) NLP blind subjects. Data are plotted by circadian phase (degrees) in 30° 
(~2 h) bins and per quarter (2 .33 h) of elapsed-time-in-bed (140 min). All data are plotted 
at the midpoint of the bins.
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There was a significant interaction between circadian phase and elapsed-time- 
in-bed on Wake %TRT in all three experimental NLP blind groups [E-POS group, 
F(33,66) = 2.53; P < 0.001 (Figure 5-llA ); E-NEG group, F(33,99)^2.77; P<0.0001 
(Figure 5-1 IB); BE group F(33,66)=2.21; P < 0.01 (Figure 5-11C)]. The variation in 
the amount of wakefulness during bed-rest changed as a frmction of both circadian 
phase and time-in-bed as observed in sighted subjects under the same experimental 
conditions. In each experimental NLP blind group, sleep efficiency was higher across 
all circadian phases in the first two quarters than in the last two quarters of scheduled 
bed-rest. Sleep was less consolidated when scheduled bed-rest ended just prior to the 
onset of melatonin secretion and more consolidated when scheduled bed-rest ended 
just after the peak of the melatonin rhythm.
5.4 Discussion
These data provide for the first time direct quantitative evidence that the 
propensity to wake from sleep in NLP blind individuals results from the same 
interaction of sleep-dependent and circadian processes obsei*ved in sighted subjects 
(Dijk and Czeisler, 1994; Dijk and Czeisler, 1995; Dijk et al., 1999; Dijk et al., 2001; 
Kleiman et al., 2004). They show how the variation in sleep propensity, structure, 
duration, and consolidation is influenced by these processes. These data also provide 
for the first time direct quantitative evidence that neurobehavioural function, 
including subjective alertness, cognitive performance and vigilance, is regulated by 
the individual processes of and the interaction between wake-dependent and circadian 
components observed in sighted subjects (Johnson et al., 1992; Wyatt et a l, 1999; 
Wright Jr. et a l, 2002; Hull et a l , 2003; Wyatt et a l, 2004; Wyatt et a l, 2006). Last, 
these data demonstrate that the sleep-wake dependent and circadian processes
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function independent of photic input and confirm the first findings from FD 
assessments in sighted subjects, showing that sleep-wake dependent or circadian 
modulation of sleep and wake variables in sighted subjects are not masked by light.
5.4.1 Neurobehavioural Function During Wake
The results from neurobehavioural assessments in NLP blind individuals are 
relatively consistent with results from neurobehavioural assessments in sighted 
individuals studied under the same FD conditions (Johnson et al., 1992; Wyatt et al., 
1999; Wright Jr. et al., 2002; Hull et al., 2003; Wyatt et al., 2004; Wyatt et al., 2006). 
Measures of neurobehavioural flmction varied as a function of both time awake and 
circadian phase in NLP blind individuals. Subjective alertness was highest and 
cognitive-working memoiy and vigilance performance was optimal at the beginning 
and then decreased across the scheduled wake episode. Subjective alertness and 
cognitive-working memory and vigilance perfonnance exhibited robust circadian 
variation. Subjective alertness was highest and cognitive and vigilance (but not 
working memory) performance declined when assessments occuned after the onset of 
melatonin secretion when melatonin levels were rising. Subjective alertness was 
lowest and cognitive-working memory and vigilance perfonnance was worst when 
neurobehavioural assessments occuned after the peak of melatonin secretion when 
melatonin levels were falling. Neurobehavioural measures increased or improved 
across circadian phases when melatonin levels were lowest, and were optimal when 
assessed prior to the onset of melatonin secretion. The latter observation further 
confiims the existence of the wake maintenance zone (Strogatz et al., 1987), a 
pronounced, circadian wake-promoting temporal-region also reported in sighted 
subjects under FD (Dijk and Czeisler, 1994).
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In general, the magnitude of wake-dependent and circadian modulation on 
neurobehavioural ftmction was relatively similar among NLP blind groups, 
particularly totally blind (i.e., no conscious or circadian photoreception). These 
findings show that neither image- or non-image forming photic input drives or masks 
wake-dependent and circadian components. In the analysis of all NLP blind subjects, 
subjective alertness was usually high in the first 4 to 6 h o f scheduled wakefulness 
regardless of the circadian phase that scheduled wake episodes started. However, 
subjective alertness significantly declined in the latter part of scheduled wake 
episodes, particularly when the onset of melatonin occuned in the middle of 
scheduled wake episodes. This finding illustrates the same interaction between wake- 
dependent and circadian components on subjective alertness, which shows once again 
that the magnitude of circadian effects on subjective alertness is not significant in the 
first few hours after waking, but increases as time-awake progresses.
The magnitude of variation on cognitive (i.e., number of attempts in 6 min) 
and working-memoiy perfonnance in NLP blind subjects was similar between wake- 
dependent and circadian components. Unfortunately, assessments among NLP blind 
groups could not be performed since only 5 of 10 NLP subjects performed this task. 
Despite this, it is possible to assume that the regulation of this type of 
neurobehavioural function remains intact despite the lack o f photic input, as was 
obseiwed in other measures. Interestingly, there was a weak circadian modulation of 
working-memoiy (replay; a-ADD task), yet there was a significant wake-dependent 
decline observed. This is similar to a previous finding of working-memoiy from FD 
results using a different task called Probed Memory Recall (Wyatt et al., 1999). The 
lack of robust circadian modulation on working-memoiy may be due to the fact that 
subjects were more likely to answer addition calculation problems (respond) without
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replaying them across most circadian phases, but were only significantly more likely 
to replay them across a naiTow range of circadian phase beginning more than 4 to 6 
hours after the onset of melatonin secretion. The delayed decline in working-memory 
across circadian phase is interesting since cognitive perfonnance, which is optimal 
(i.e., greatest number of attempts) prior to the onset of melatonin secretion, starts to 
significantly decline right after the onset of melatonin. In general, decrements in 
cognitive performance (number of attempts) mainly result from a slowing in response 
times during the 6 minute a-ADD task. The longer it takes to respond on each addition 
problem the fewer attempts will be made in the allotted time. A slowing in response 
time could be related to a diminished summation capability (i.e., efficiency of adding 
paired, 2-digit numbers) or working-memory capacity (i.e., duration of time one can 
hold paired, 2-digit numbers in memoiy while attempting to summate them). These 
data suggest that summation capability begins to decline at an earlier circadian phase 
than working-memoiy capacity. Therefore, the deterioration observed in cognitive 
perfonnance in the first part of biological night may be primarily caused by slower 
response times resulting from the impairment of summation capability alone. 
Furthermore, the greatest impairment obseiwed in cognitive perfonnance in the latter 
part of biological night may be caused by even slower response times resulting from 
impainnent in both summation capability and working-memoiy capacity. In contrast, 
cognitive performance and working-memoiy on the a-ADD task exhibited a similar 
the wake-dependent variation, which suggests that summation capability and 
working-memoiy capacity decline at the same rate as time-awake progress. In 
addition, cognitive performance usually optimal in the first 4-6 hours of scheduled 
wakefulness regardless o f the circadian phase that scheduled wakefulness started. 
However, cognitive perfonnance significantly worsened in the latter part of some
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scheduled wake episodes, particularly when the onset of melatonin occmred in the 
middle of scheduled wakefulness.
It should be noted that auditoiy vigilance in NLP blind subjects exhibited a 
robust, significant circadian modulation, but showed no pronounced wake-dependent 
decline. The amplitude of variation for auditory vigilance perfonnance (i.e., median 
RT and number of lapses) was much greater across circadian phase than across time 
awake. This observation is not consistent with those made for visual vigilance 
performance on the visual psychomotor vigilance test (v-PVT) in sighted subjects 
studied under the FD protocol (Wyatt et al., 1999; Wright Jr. et al., 2002; Wyatt et al., 
2004; Wyatt et al., 2006). Wake-dependent and circadian variations of visual 
vigilance perfonnance observed in sighted subjects are robust and exhibit relatively 
similar amplitudes. This particular difference between blind-auditoiy and sighted- 
visual vigilance performance suggests that auditoiy vigilance-attention is not as 
sensitive to the wake-dependent process as it is to the circadian process even after ~16 
h awake. Wake-dependent decrements observed in auditoiy vigilance usually were 
dependent upon the phase of the melatonin rhythm that the scheduled wake episode 
started. As like subjective alertness and cognitive performance, auditory vigilance was 
unaffected and usually optimal in the first 4- 6 hours of scheduled wakefiilness 
regardless of the circadian phase that scheduled wakefulness started. However, 
auditory vigilance was usually affected and significantly worsened in the latter part of 
scheduled wake episodes, particularly when the onset of melatonin occurred in the 
middle of scheduled wakefulness. Alternatively, the absence of a pronounced wake- 
dependent decline in auditoiy vigilance compared with visual-vigilance may be due to 
the different modality used to assess vigilance. For example, while performing the v- 
PVT, sighted subjects must keep their eyes open and direct their focus onto the centre
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of the computer screen to detect the stimulus. A wake-dependent increase in eye blink 
rate and a wake-dependent and circadian phase-related increase in the incidence of 
slow eye movements (SEMs) or tendency to fall asleep (Cajochen et al., 1999) can 
impede a sighted subject’s ability to see the target stimulus, which potentially causes 
an increase in reaction time and number of lapses in attention across 16 h time awake. 
In contrast, certain auditoiy stimuli, such as bells, whistles and phone-rings, are 
commonly used in society as alerts or alanns for the very purpose of eliciting acute 
responses or shifts in attention and even transitions from sleep to wake (i.e., alarm 
clocks). The audible phone-ring is capable o f arousing an individual from sleep and 
alerting them to respond. For example, if  sighted subjects fail to respond to the visual 
stimulus after 10 seconds (i.e., eyes diverted or closed) during the v-PVT, the same 
audible phone-ring used on the a-PVT task signals the subject to respond. In this 
respect, the audible phone-ring on the a-PVT acts more like as an alerting signal 
rather than a more subtle, neutral auditory tone. As a result, the continuous audible 
phone-ring used on the a-PVT may reduce the average reaction time and the number 
of lapses in attention compared with the v-PVT. Thus, the absence of a pronounced 
wake-dependent decline in auditory vigilance/attention in NLP blind subjects may be 
due to a masking effect related to the profound alerting effects of the auditory 
stimulus used in this version of the a-PVT.
Since time-awake and circadian phase change concurrently during FD 
scheduled wake episodes the interaction of these two processes was assessed. 
Neurobehavioural function was significantly affected by the interaction between 
wake-dependent and circadian processes. Wake-dependent variation in 
neurobehavioural function was dependent upon when the start of scheduled 
wakefiilness occurred relative to the melatonin rhythm. For example, when scheduled
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wake episodes started near the offset o f melatonin secretion, neurobehavioural 
function was optimal across the entire ~18-h wake episode. However, when the onset 
o f melatonin occurred near the start o f or during scheduled wake episodes, 
neurobehavioural function was diminished in the latter part of the ~18-h scheduled 
wake episode. In addition, when the melatonin pulse occurred in the middle of 
scheduled wakefulness, neinobehavioural function was worst ~2 to 4 h after the peak 
melatonin secretion, even after only 6 to 8 h of scheduled wakefulness. In general, the 
findings from assessments of neurobehavioural function in NLP blind individuals 
provides definitive evidence that the intmsion of excessive daytime sleepiness, which 
may lead to an increase in the incidence of naps during the subjective day in 
nonentrained and abnonnally entrained NLP blind individuals, is directly caused by 
the interaction between wake-dependent and circadian processes when endogenous 
circadian timing (i.e., melatonin rhythm) is desynchronized or misaligned with an 
NLP blind individual’s 24-h rest-night/activity-day.
5.4.2 Sleep-Wake States During Bed-rest
In NLP blind subjects, sleep latency and duration varied relative to the 
circadian phase of the melatonin rhythm that scheduled sleep episodes started. Sleep 
latencies exhibited the same paradoxical variation described in sighted subjects under 
FD (Dijk and Czeisler, 1994). Sleep latencies were longest when the beginning of the 
scheduled sleep episodes started shortly before the onset of melatonin secretion, 
which is usually the typical habitual bed-time o f entrained sighted humans. Sleep 
latencies decrease after the onset of melatonin secretion and were shortest when 
scheduled sleep episodes started shortly after the peak of melatonin secretion. In 
addition, total sleep duration within individual scheduled sleep episodes was longest
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when scheduled sleep episodes started shortly before the onset of melatonin secretion. 
Total sleep duration decreased within individual scheduled sleep episodes when these 
episodes started after the onset of melatonin secretion and were shortest when 
scheduled sleep episodes started after the offset of melatonin secretion.
The amount and circadian and time-in-bed variation of NREM stage I, stage 
2 and SWS in NLP blind subjects was relatively similar to that reported in sighted 
subjects, but usually more similar to that in older subjects (Dijk and Czeisler, 1994; 
Dijk and Czeisler, 1995; Dijk et al., 1999; Dijk et al., 2001; Kleiman et al., 2004). 
This is not surprising since 5 of the 10 subjects were over the age of 50 years, and 
only 2 of the 10 subjects were under the age of 40 years. The circadian and sleep- 
dependent variation in the percentage of NREM stage 1 sleep in NLP blind subjects 
was relatively similar to that obseiwed in older sighted subjects during the FD 
protocol. However, the percentage of NREM stage 2 sleep was slightly higher across 
circadian phase than that observed in both young and sighted subjects, perhaps 
because of the results from two male subjects (22A6, age 48 and 2347, age 68) whose 
average SWS %TST was less than 5%, suggesting an age-related increase in stage 2. 
This may also be due to the modified scoring criteria for REM sleep in the absence of 
rapid eye movements, which overestimated the number of epochs scored as stage 2. 
The amount of SWS (stage 3 and 4) in NLP blind subjects was relatively similar to 
that observed in older sighted subjects. SWS also exhibited a pronounced sleep- 
dependent decline during bed-rest independent of the circadian phase that sleep was 
initiated and the lack of visual or circadian photoreception or the presence of eyes.
The amount and circadian and time-in-bed variation of REM sleep in NLP 
blind subjects was relatively similar to that reported in older sighted subjects (Dijk 
and Czeisler, 1994; Dijk and Czeisler, 1995; Dijk et al., 1999; Dijk et al., 2001;
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Klerman et al., 2004). REM sleep exhibited a robust circadian variation in NLP blind 
subjects, peaking ~2 h after the melatonin peak, but there was no sleep-dependent 
increase observed across successive quarters of time-in-bed. The amount o f REM 
sleep remained relatively level across the quarters of time-in-bed. Interestingly, the 
amount of REM sleep across circadian phase was less than that observed in sighted 
subjects. This observation could be related to the absence of rapid eye movements in 
most NLP blind subjects’ PSG EOG channels, and may explain the greater stage 2 
sleep across circadian phase than that observed in sighted subjects. In this respect, the 
modified PSG scoring criteria for REM sleep may have been somewhat stringent. 
Within individual NL blind groups, REM sleep was somewhat noisy and lost 
significance across circadian phase, yet an underlying circadian modulation is still 
evident in the data. The amount of REM sleep across quarters of time in bed was 
significantly influenced by the timing of the melatonin rhythm within the scheduled 
28-h day. For example, when the peak of melatonin secretion occurred near the 
midpoint of the scheduled bed-rest, the amount of REM sleep was relatively lower in 
the first quarter of time-in-bed, increasing across subsequent quarters o f scheduled 
bed-rest. However, when the peak of melatonin secretion occurred I to 8 h prior to the 
start of scheduled bed-rest, the amount of REM sleep was relatively higher in the first 
quarter or half of time-in-bed, declining across subsequent quarters o f scheduled bed­
rest.
REM latency also showed a robust circadian variation in NLP blind subjects. 
The amplitude of REM latencies in young and old sighted subjects was similar, but 
older sighted subjects exhibited shorter latencies than that observed in young sighted 
subjects. The circadian amplitude of REM latencies in NLP blind subjects was greater 
than young and older subjects, such that the longest latencies were similar to that
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observed in young sighted and the shortest latencies were similar to that observed in 
the older sighted subjects. REM latencies were shortest -2  h after the peak of 
melatonin secretion, which is consistent with those of sighted subjects.
Sleep consolidation during scheduled sleep episodes was significantly 
modulated by circadian and sleep-dependent processes in NLP blind individuals, 
regardless of photic input. The amount of wakefiilness was lowest in the first half and 
then exhibited a pronounced linear increase across in the latter half of the scheduled 
sleep episode. In addition, the amount of wakefiilness during bed-rest was highest 
when scheduled sleep episodes coincided shortly before the onset of melatonin 
secretion, further confirming a “wake maintain zone” (Strogatz et al., 1987). The 
amount of wakefiilness within scheduled sleep episodes declined relatively rapidly 
across circadian phases shortly after the onset of the melatonin secretion. It was 
lowest shortly after the peak of melatonin secretion and increased gradually during the 
biological day across circadian phases when melatonin levels are lowest. The 
magnitude of the sleep-dependent rise and circadian modulation on the amount of 
wakefulness within scheduled sleep episodes was similar and no different from that 
observed in sighted subjects.
The duration of wake-bouts after awakening from sleep during bed-rest 
exhibited the same sleep-dependent rise and circadian modulation in NLP blind 
individuals as that described in young and older sighted subjects studied under FD 
(Dijk et al., 2001; Klerman et al., 2004). The duration of wake-bouts after awakening 
from sleep was shortest during the first half of scheduled sleep episodes and when 
scheduled sleep episodes coincided near the peak of melatonin secretion. The duration 
of wake-bouts was higher in the second half of scheduled sleep episodes and 
increased gradually when scheduled sleep episodes coincided across circadian phases
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when melatonin levels were lowest, exhibiting the longest duration of wake-bouts 
shortly before the onset of melatonin secretion. In addition, the duration of sleep- 
bouts (i.e., sleep onsets following awakenings) showed a pronounced sleep-dependent 
decline across time-in-bed during scheduled sleep episodes, yet there was no circadian 
modulation. The latter is mainly due to the ability of subjects to initiate sleep at any 
circadian phase under sufficient sleep pressure, which is determined by the duration 
of prior wakefulness. The consistent sleep-dependent decline in the duration of sleep- 
bouts regardless of the circadian phase that the scheduled sleep episode starts is 
parallel to the sleep-dependent decline obseiwed in SWS. The duration of sleep-bouts 
was longest in the fist half and lowest in the second half o f scheduled sleep episodes. 
In contrast, sleep-dependent effects on the duration of wake-bouts following 
awakenings from sleep were more apparent in the latter part of scheduled sleep 
episodes, particularly when scheduled bed-rest started near or after the peak of 
melatonin secretion.
The final and most important finding of these analyses is that sleep and 
wakefulness in NLP blind subjects, even in the absences of conscious light perception 
or circadian photoreception, is regulated by the same interaction of sleep-dependent 
and circadian processes on the amount of wakefulness during bed-rest observed in 
sighted subjects during FD. The amount of wakefulness during bed-rest was relatively 
low in the first half of scheduled bed-rest regardless of the circadian phase that the 
scheduled sleep episode started. The magnitude of circadian modulation on the 
amount of wakefulness during bed-rest was not significant until the second half of 
scheduled bed-rest. For example, when the scheduled sleep episode started near or 
after the peak of melatonin secretion, the amount of wakefulness in latter half of 
scheduled bed-rest significantly increased. Nonentrained or abnonnally entrained
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NLP individuals are more likely than sighted individuals to report cyclic or daily 
intmsions of wakefulness on sleep during the night or excessive sleepiness on wake 
function during the day despite their attempts to maintain a typical 24 h rest- 
night/activity-day schedule. The cuiTent analyses demonstrate that this sleep-wake 
dismption results from (1) the circadian drive for wake or sleep relative to the 
nonentrained or the abnormally entrained (phase-delayed or advance-advanced) 
melatonin rhythm and (2) the wake-dependent build up of sleep pressure during wake 
and its decline during sleep.
5.5 Conclusion
Circadian and sleep-wake dependent processes are intact and regulate sleep 
and neurobehavioural function in NLP blind individuals by the same interaction 
observed in sighted subjects independent of photic input, thus confirming the findings 
in sighted subjects. The cyclic or daily sleep-wake disorder described in nonentrained 
or abnonnally entrained NLP blind individuals is (1) mainly caused by the irregular or 
adverse temporal organization between these two processes, resulting from circadian 
desynchrony or misalignment with the 24 h rest-night/activity-day related to blindness 
and (2) is not caused by a diminished contribution of either process resulting from 
blindness. Entraining the circadian pacemaker to the 24-h day/rest-activity cycle 
would treat this circadian sleep disorder. In general, this sleep-wake disorder is related 
to, but not an inevitable condition of total blindness.
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Chapter 6
General Discussion
CHAPTER 6 -  GENERAL DISCUSSION
6.1 Rationale
In general, the issues suiTounding the potential confounding effects of light on 
measurements and observations made in sighted subjects under FD conditions suggest 
that: (I) the average period in sighted subjects under FD conditions may not be an 
accurate representation of all sighted subjects; and (2) that sighted subjects under 
these conditions may not be ideal controls for measuring circadian period, 
determining the independent impact of nonphotic time cues on the human circadian 
system or understanding homeostatic and circadian processes in sleep-wake 
regulation. In the current study, NLP blind subjects were assessed under the same 
experimental FD conditions to address these issues and to also make comparisons 
with period measured under field conditions. In addition, for ~3 weeks prior to the 
admission to the inpatient FD study, sighted subjects were asked to modify their daily 
rest-activity regime. Modifications included maintaining a same nightly 8-h “time-in- 
bed” schedule and refraining from day time napping, heavy exercise and intake of 
foreign substances, such as caffeine, nicotine, over-the-counter medications and 
alcohol. Therefore, NLP blind subjects were first assessed during a ~1-month field 
assessment in which rest-activity was uncontrolled and not experimentally influenced, 
but were then assessed again during a ~1-month field assessment and asked to modify 
their daily rest-activity regime in the same manner until their admission to the 
inpatient FD protocol and also during a ~1-month assessment starting the day after 
discharge from the inpatient FD protocol.
The primaiy aim of this study was to provide empirical evidence for or against 
the suggestion that the discrepancy between the average circadian period in sighted 
and NLP blind subjects is also due to a systematic lengthening of observed period in
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nonentrained NLP blind subjects measured under field conditions. The lengthening of 
obsei*ved period is believed to be related to uncontrolled exposure to nonphotic and, to 
a lesser extent, photic time cues linked to the individual’s self-selected rest-activity. 
The strict FD conditions solve this issue by removing, diminishing or 
equally/uniformly distributing both photic and nonphotic time cues across circadian 
phase. Therefore, the period estimates measured in NLP blind subjects under FD 
conditions serve as the experimental (within-subject) control for period estimates 
measured during field conditions. In addition, both period estimates measured under 
FD conditions and the results of the melatonin suppression test (perfonned at the end 
of the FD protocol) serve to distinguish between endogenous period or 
photic/nonphotic entrainment during field conditions when a 24-h melatonin rhythm 
is observed. Furthermore, melatonin data and sleep and neurobehavioural variables 
measured in “totally” blind subjects (i.e., no light or circadian photoreception) sei-ve 
as a control for comparisons between the same observations made in sighted subjects 
and NLP blind subjects with circadian photoreception.
6.2 Field Studies in NLP Blind: Period Estimates and Relative Coordination
In the cuiTent investigation, the observed period of the melatonin rhythm in 
nonentrained totally blind subjects was not systematically lengthened under field 
conditions. In fact, the observed period was slightly shorter under field conditions 
compared to the FD condition, but this was only the case among totally blind subjects 
who exhibited periods significantly less than 24.5 h during the FD condition. The 
observed shortening of period of the melatonin rhythm did not result in stable 
entrainment; either the period estimate was significantly shorter than the circadian 
period measured under FD conditions, but still significantly different from 24 h, or the
6-2
timing of urinaiy aMT6s acrophase appeared similar over at least two weeks of the 
field assessment, but then continued to change each week thereafter as function of the 
period measured during the FD condition. Interestingly, these observations only 
occurred at a particular, atypical phase-relationship between the 24-h rest-activity and 
the non-24-h melatonin rhythm (i.e., aMT6s acrophases occurring ~2 hours after 
habitual wake (out of bed) during or between different field conditions). As a result, 
the melatonin rhythm in these totally blind subjects exhibited relative coordination 
across the first two field conditions. Relative coordination occurs when two 
concurrent rhythms, oscillating with different periods, interact, such that the 
oscillation of one rhythm affects the oscillation of the other. Although in-bed and out- 
of-bed clock times were highly variable between subjects during the Field-Free 
condition, all subjects maintained a relatively typical 24-h rest-activity rhythm during 
each field condition, especially during the Field-Prohibited condition. The results 
indicate that the strength of unknown nonphotic time cues linked to this 24-h rest- 
activity behaviour was sufficient to shorten the observed period of the circadian 
melatonin rhythm, but not sufficient enough to entrain it, even in subjects who 
exhibited periods closest to 24 h (i.e., 1451 and 22A6; x = -24.2 h). In general, the 
data suggest that the pacemaker’s range of entrainment to nonphotic time cues, at 
least those typically linked to rest-activity behaviour (i.e., food intake, social contact 
and bed-rest during night active during the day), is quite narrow.
The relative coordination exhibited by the melatonin rhythm against 24-h rest- 
activity behaviour in these few totally blind subjects is reminiscent of a phenomenon, 
called phase trapping, a term that was originally used to describe a characteristic of 
the relative coordination observed between the timing of the sleep-wake cycle and the 
endogenous CBT rhythm in internally synchronised and spontaneously
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desynchronised free-running subjects (Ki'onauer et al., 1982). The sleep-wake cycle 
usually exhibited period significantly longer than the period observed in the CBT 
rhythm during spontaneous internal desynchrony. Under those conditions, phase 
trapping signified that “the oscillator reflected by the temperature rhythm was able to 
constrain the oscillator controlling the sleep-wake cycle in such a way that their 
phases on average move together; yet it was unable to constrain a precise phase 
relationship” (Ki'onauer et al., 1982). In the cunent study, the period of the rest- 
activity rhythm was 24 h during field conditions, and significantly shorter than the 
period of the melatonin rhythm under FD conditions in totally blind subjects. In some 
cases (i.e., 22A6, 23BP and 22F1) the timing of night time bed-rest exhibited similar 
phase-trapping between successive weeks when the peak of melatonin exhibited a 
similar phase relationship and then a slightly delayed phase relationship relative to the 
offset o f bed-rest. The timing of the offset o f bed-rest appeared to delay with the 
melatonin rhythm. However, the timing o f the bed-rest episode in some totally blind 
subjects would advance by several hours relative to the peak of the melatonin rhythm 
and also relative to the average timing of bed-rest in the week prior. This abrupt shift 
in rest-activity mainly occurred during the transitions between field free and 
prohibited conditions. Under these conditions, phase trapping appeared to signify that 
the oscillation of rest-activity, as well as the nonphotic time cues linked to it (i.e., 
sleep-wake, posture, meal intake), is able to constrain the circadian oscillation 
controlling the melatonin rhythm and in such a way that their phases on average move 
together, yet it was unable to constrain a precise, stable phase relationship. It should 
be noted that the pronounced effects of light on the circadian pacemaker and the 
interaction between homeostatic and circadian processes on sleep-wake regulation 
were not yet fully understood around the time of the free-running studies being
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conducted in sighted subjects. The influences of light and circadian and homeostatic 
processes may explain why the rest-activity rhythms, not the CBT rhythms appear to 
be phase trapped in desynchonrised “free-running” sighted subjects. This difference 
may also be due to the longer or shorter period o f the rest-activity rhythm relative to 
the period of the endogenous rhythm between “fiee-running” sighted subjects and 
nonentrained totally blind subjects, respectively. However, the difference in period 
observed in rest-activity rhythm between the two is mainly due to knowledge of the 
time of day.
The changes in period observed in totally blind subjects in the current study do 
not support a previous report regarding the potential effects of nonphotic time cues on 
the period in nonentrained NLP blind individuals living in society (Emens et al., 
2005). In this prior report, melatonin secretion was measured for 3 to 6 months, for 
over a 24 h duration approximately eveiy two or more weeks in a group of blind 
individuals (n=5). Linear regression of all day and clock time each bi-weekly DLMOs 
was used to calculate an overall period estimate for the entire assessment for each 
subject. The nonentrained melatonin rhythm for each subject exhibited a period of 
-24.3 h and appeared to exhibit relative coordination across the entire assessment. It 
was suggested that the relative coordination observed in these 5 nonentrained NLP 
blind subjects was the direct result of both a shortening and a lengthening of period. 
The authors depicted the timing of when period shortened or lengthened across a 
curve relative to the overall period estimate, in which deviations of individual two- 
point period estimates (interpolation between two successive DLMOs) from the 
subject’s overall period estimate (linear regression) were plotted by the average 
DLMO clock time across the 24-h day. Across the cuiwe, a lengthening of the two- 
point period estimates was greatest when the average timing between DLMOs
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occurred near -1 5 :00pm, a shortening of the two-point period estimates was greatest 
when the average timing between DLMOs occuixed near -2:00am and no changes in 
period were observed when the average timing between DLMOs occurred at -5:00am 
and 8:00pm. There are numerous problems with the methods and analyses which lead 
to their inteipretation (i.e., tau response ciuwe) of the data, including: (1) the use the 
two-point interpolation method to estimate period. These period estimates are highly 
questionable, particularly since the reliability of this method for calculating period 
was and has not been tested or verified with any controls; (2) the use of the individual 
subject’s overall linear-regression-derived period estimate as the control with which 
to compare and calculate changes in period. By using this period estimate, the authors 
assume that the underlying intrinsic period of the melatonin rhythm merely lies 
between the two-point period variability across the study and that a phase response 
curve to the nonphotic time cues, which they imply cause the obseiwed changes in 
period, exhibits equal delayed and advanced phase-shifts; (3) the use of clock time as 
the environmental marker for assessing changes in period. Comparing and plotting 
point-to-point changes in period relative to clock time, and not relative to the 
individual subject’s rest-activity, does not provide any information about the timing of 
the subject’s rest-activity (i.e., nonphotic time cues) relative to circadian phase, unless 
each subject was keeping the same rigorous rest-activity schedule; (5) period 
measurements in blind subjects who were taking different prescription medications. 
There are possible confounds (i.e., phase-shifting effects) related to the potential 
effects of these medications that most subjects were reportedly taking, and moreover 
there is no indication of the clock times that these subjects used these medications; (6) 
no melatonin suppression test was performed in any of the 5 subjects. This test would 
deteiinine whether any of the blind subjects with at least one eye had retained
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circadian photoreception to mle out any possible effects of light (i.e., results of 
subject 22J7 in the current study).
6.3 Abnormal Distribution of Periods in NLP Blind Subjects
In the current study, the specific nonphotic time cues (or time cue), which are 
responsible for the observed shortening of period at a particular phase relationship, 
are not known. However, the data indicate that they are closely linked to the 
individual’s daily rest-activity regime, especially since a shortening of period 
occurred consistently around a particular phase relationship between the two rhythms 
in subjects with periods closer to 24 h. It is for this veiy reason that the term “free- 
running” has not been used to categorize or characterize nonentrained blind 
individuals living in society in this thesis. In essence, most blind subjects assessed 
while living in society are exposed to 24-h or near-24-h time cues (personal 
communication, CA Czeisler), and therefore, the pacemaker is not running in an 
environment completely free of periodic stimuli. A phase-dependent shortening of 
period in totally blind subjects with periods closer to 24 h would presumably be more 
likely rather than a lengthening, since the only significant time cue is their 24-h rest- 
activity behaviour.
The latter point is o f great significance in regards to the abnormal distribution 
o f the individual periods of nonentrained NLP blind subjects. First, many assessments 
o f period in NLP blind subjects were only conducted for over a month or a slightly 
longer duration. Depending on the observed period of the individual subject, either 
-24-h or non-24-h rhythm, circadian phase was not always assessed across a complete 
range of phase-relationships (i.e., beat cycle) between the nonentrained melatonin 
rhythm and rest-activity rhythm. This means that the phase relationship between the
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endogenous circadian rhythm and daily rest-activity only changed by up to 12 h 
across the assessment for subjects who exhibited periods between -24  h and 24.5 h. In 
addition, period assessments may have occuned during those phase relationships that 
the pacemaker is sensitive to nonphotic time cues (assuming all NLP blind subjects 
were “totally” blind), thus causing a shortening of period. This shortening of period 
across a certain range of circadian periods nearer to 24 h may possibly explain the 
apparent 24-h rhythms, or the rhythms categorised as “entrained”, in small proportion 
of NLP blind subjects that have been studied. It may also possibly explain the 
abnormal distribution of previously reported periods in nonentrained NLP blind 
subjects. Across this distribution, there are two distinct peaks in the number of 
subjects who exhibited periods near 24.4 and 24.7 h (see Figure 6-1 A). These two 
peaks in the distribution are relatively conserved within reports from two research 
groups (see Figure 1-8 A and B in Chapter 1). It is possible that the peak around -24.4 
h across the distribution of periods may be the result of a shortening o f period in many 
of the subjects, thus causing a shift in the number subjects with periods closer to 24 h.
In the current study, the maximum average change in period under all field 
assessments relative to the circadian period under the FD condition was 
approximately -0.11 ± 0.03 h, which occurred when aMT6s acrophase occurred -2  
hours after habitual wake (out o f bed) time during the month of the period assessment. 
If  individual periods that are less than 24.5 h across the distribution of nonentrained 
NLP blind periods are adjusted by +0.1 h, a nonnal-distribution with a single peak at 
-24.5 h is produced without significantly changing the range of periods and the 
average period (Figure 6-IB). The “adjusted” distribution of nonentrained NLP blind 
periods is more typical that previously reported in other mammal species, as well as 
sighted humans under FD conditions. Unfortunately, information regarding the timing
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Figure 6-1. The distribution of individual circadian periods in non-entrained NLP blind 
humans (n=67) measured in society under uncontrolled field conditions as reported in the 
literature (A) and after adjusting ±0.1 h the those periods that were within ±0 .5  h of 24-h 
(B). Therefore, periods originally reported between 24.0 and 24.5 h were adjusted by +0.1 
h to compensate for a probable nonphotic induced shortening of the observed period and 
one subject with a period between 23.5  and 24.0 h (23.9 h) was adjusted by -0.1 h to 
compensate for a probable nonphotic induced lengthening of the observed period toward 
24-h. Note that the distribution of "adjusted" periods in the bottom histogram does not 
exhibit two peaks as observed in the distribution of the “reported" periods in the top the 
histogram. In addition, the adjustment did not significantly alter the average (±S D ) period.
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of rest-activity relative to the melatonin rhythm during previous field assessments in 
most of these NLP blind subjects did not accompany the estimates of period. Some of 
these assessments may have occurred across a range of phase relationships in which 
rest-activity does not evoke any changes in the observed period. As a result, this 
global +0.1 h adjustment applied to individual periods less than 24.5 h in the 
distribution is mostly likely an inaccurate assumption, but it is possible some of the 
periods less than 24.5 h represent underestimations of period in this population.
6.4 The Role of the Eyes in Circadian Organization
Blinding, particularly bilateral enucleation resulting from disease or trauma, 
and increases the risk of developing a circadian rhythm sleep disorders due to the lack 
of photic entrainment. The human circadian melatonin rhythm has usually be reported 
to be minimally affected by nonphotic time cues, such as meals, posture, sleep, and 
activity which usually elicit significant evoked effects on the core body temperature 
rhythm. In the cuiTent study, the rest-activity/sleep-wake cycle had a major impact on 
amplitude of the melatonin rhythm in bilaterally enucleated subjects compared to 
intact NLP blind subjects with and without circadian photoreception. The current 
findings suggest that the eye may have some residual function in the organization and 
stability of the circadian system, independent of its role in transmitting photic 
information to the pacemaker. Melatonin levels were significantly reduced during 
scheduled bed-rest in enucleated subjects, yet melatonin levels during scheduled 
wakefulness were relatively the same between intact and enucleated subjects. In 
addition, one totally blind individual studied on the same FD protocol before and after 
bilateral enucleation exhibited these systematic changes in the melatonin rhythm 
relative to the imposed non-24-h rest-activity schedule after bilateral enucleation, but
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before bilateral enucleation. This subject also exhibited a significantly longer 
circadian period during the FD protocol after bilateral enucleation compared to 
before.
The differences in the melatonin data during the FD protocol between the NLP 
blind groups suggests that bilateral enucleation may change the sensitivity of human 
circadian pacemaker to nonphotic time cues, but does not affect the overall function 
of the circadian system. The circadian system (i.e., afferent degeneration, gene 
expression within the core, receptor sites at the core) must go through some level of 
reorganization after bilateral enucleation. The systematic phase and amplitude 
changes to the melatonin rhythm observed during the FD protocol in the bilaterally 
enucleated subjects may be directly related to this reorganization. This can only be 
concluded based on the fact that systematic changes of this magnitude have not been 
obseiwed in the melatonin rhythm of either sighted or blind humans with eyes studied 
under the same conditions. For instance, the eyes and the SCN, as well as the SCN 
and the pineal, are directly connected through a distinct neural pathways (i.e., the 
RHT and the PVN-SCG, respectively). The timing and amplitude of nocturnal 
melatonin secretion is modulated by the pacemaker and is affected by active 
communication from the eyes tr iggered by ocular light exposure when an individual is 
awake during the night. The cunent data may suggest that the eyes may also 
communicate to the SCN or interfere with excitatory or inhibitory inputs from other 
SCN afferents (i.e., raphe nuclei) when an individual is asleep and melatonin levels 
are rising. After bilateral enucleation, the SCN may no longer receives this residual 
ocular input, or may be it is more sensitive to inputs from other afferents since those 
afferents no longer receive ocular inhibition or disinhibition during sleep, thus altering 
the circadian output signal to the pineal and affecting melatonin secretion. The affect
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presumably of sleep on melatonin secretion after bilateral enucleation appears to be 
benign, and only represents masking.
6.5 Sleep-Disorders in the Blind
In studies which reported rest-activity, most, if not all, nonentrained NLP 
blind subjects exhibited a relatively typical 24-h bed-rest schedule. However, many 
times the characteristics of the sleep-wake disturbance or pattern in NLP blind 
individuals are categorised as “Non-24-hour Sleep-wake Syndrome.” According to 
the International Classification of Sleep Disorders (ICSD-R), “non-24-hour sleep- 
wake syndrome consists of a chronic steady pattern comprising one- to two-hour daily 
delays in sleep onset and wake times in an individual living in society.” This 
definition mainly describes the sleep-wake patterns observed in a small proportion of 
sighted individuals living in society. The sleep-wake patterns in these sighted 
individuals usually recur on a greater than 24-h basis, such that the onset of sleep or 
activity usually occur an hour or two later each day. However, this pattern is mainly 
the result of going to bed, turning off the lights and closing the eyes an hour or two 
later each day. Strangely, this pattern of sleep-wake behaviour is similar to the pattern 
of behaviour observed in sighted subjects during the classical free-running studies 
despite the knowledge of clock time. The period of rest-activity or sleep-wake 
behaviour is usually longer than 24 h and the period of endogenous rhythms, such as 
the melatonin or CBT rhythm, is usually longer than 24 h or equal to the period of the 
longer-than-24-h rest-activity behaviour. In this case, sighted individuals diagnosed 
with non-24-h sleep-wake syndrome go to bed later and wake up later each day, thus 
they self-select a longer-than-24-h LD cycle. The delay portion of the PRC to light in 
sighted individuals diagnosed with non-24-h sleep-wake syndrome is most likely
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exposed each day due to the longer-than-24-h day length they live on. The chief 
disturbance of this non-24-h sleep-wake pattern is the daily/weekly change in sleep- 
wake timing relative to the 24-h social order. In this respect, sighted individuals who 
exhibit non-24-h sleep-wake syndrome do not usually exhibit internal desynchrony or 
cyclic sleep-wake disturbance like that described in many NLP blind individuals. The 
greatest disturbance in sighted individuals diagnosed with non-24-h sleep-wake 
syndrome is that their non-24-h sleep-wake pattern interferes with their ability to 
function in the 24-h day society.
The non-24-hour sleep-wake syndrome classification does distinguish between 
two possible causes of this sleep disorder, an extrinsic or intrinsic type. The extrinsic 
type is a sleep disorder believed to be socially or environmentally (i.e., light) induced, 
which is an accurate characterisation of sighted individuals with this sleep disorder. 
However, the intrinsic type of this syndrome is described as a sleep disorder that is 
due to “an abnonnal circadian pacemaker or its entrainment mechanism,” which is not 
a completely accurate statement. The cuiTent findings from the analyses in NLP blind 
subjects, such as the circadian period o f the melatonin rhythm, and in particular, sleep 
and neurobehavioural function show that the circadian pacemaker and both 
homeostatic and circadian processes of sleep regulation are functionally intact and 
exhibit no abnomialities. It is the lack of photic entrainment to 24-h day and rest- 
activity which causes the sleep-wake disturbances in totally blind individuals. Use of 
the current classification of non-24-h sleep-wake syndrome for totally blind 
individuals could lead to misconceptions regarding the underlying causes of this 
particular type of sleep-wake disturbance. In addition, other circadian sleep disorders, 
such as advanced- and delayed sleep phase syndrome do not account for abnormally 
entrained totally blind individuals, such that light therapy would not benefit most NLP
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blind individuals and would require an entirely different treatment, such a daily 
melatonin administration. The day-to-day timing of the wake-maintenance and sleep 
propensity driven by the circadian pacemaker nonentrained blind individuals changes 
as a function of the period of non-24-h melatonin rhythm and typical 24 rest- 
night/active-day that they usually attempt to maintain. There is only 1 NLP blind 
individual reported in the literature who exhibited non-24-h sleep-wake syndrome 
similar to that usually observed in sighted individuals with this disorder. The 
periodicity of his rest-activity behaviour was equivalent to the period of (24.9 h) the 
CBT rhythm and other overt rhythms (Miles et al., 1977).
In totally blind individuals, daily rest-activity behaviour is the only significant, 
relevant time cue that may affect circadian timing. The 24-h day may only indirectly 
influence the periodicity of a totally blind individual’s behaviour via certain social 
cues, such as obligations to family members, a weekly-5-day work schedule or the 
social order maintained by entrained sighted individual (i.e., most public or private 
services are only open during the day time). Social constraints may impose a 24-h 
rest-activity schedule for many or most totally blind individuals, but the cyclic sleep- 
wake disturbances can place constraints on the individual ability to function with the 
24 society. As the timing of circadian sleep-wake propensity changes relative to “in 
bed” and “out o f bed” time, a majority of blind individuals may experience a week or 
more of restful sleep at night and alert-wakefulness during the day time, but this is 
usually followed by weeks to months of disturbed sleep at night (i.e., insomnia) and 
excessive day time sleepiness.
Finally, one interesting observation made in the cunent study regarding non- 
24-h sleep-wake syndrome was the case of the female NLP blind individual (22J7) 
who exhibited light-induced melatonin suppression, yet during her field assessments
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she exhibited a nonentrained melatonin rhythm as well as a non-24-h sleep-wake 
pattern similar to that observed in totally blind subjects. This particular subject wore a 
scleral shell prosthesis in both eyes for reasons related to her profession, and her 
profession did not require her to work at regular hours. A scleral shell prosthesis is 
usually worn for cosmetic reasons to cover a blind, damaged, or disfigured eye in 
individuals who still retain vision in the other eye. A scleral shell prosthesis is a thin 
hard acrylic shell-like artificial eye, they are generally opaque, and they cover the 
entire surface of the eye to give the eye a natural appearance while matching the 
colour and size with the healthy eye. Presumably the scleral shells do not allow any or 
a sufficient amount of light through them. Subject 22J7’s natural left eye had a 
generally healthy appearance (comea/pupil were clear, no cataract or scaring), while 
her natural right eye was disfigured and shmnlcen, a condition called Phthisis bulbi. 
Reportedly subject 22J7 wore the scleral shell prostheses day and night, eveiy day, 
and only removed them periodically for a few minutes to clean them. As a result of 
wearing them during the field assessments, she incidentally was blocking daily light 
input to the circadian pacemaker, thereby causing the nonentrained melatonin rhythm 
and consequently the non-24-hour sleep-wake pattern. This may indicate that a small 
percentage of NLP blind individuals who retain intact circadian photoreception or 
even legally blind individuals (i.e., have light perception, but minimal visual acuity) 
may also wear scleral shells which may also perpetuate cyclic circadian misalignment 
which may lead to this sleep-wake disorder.
Due to the significant differences in signs, symptoms and behavioural patterns 
generally observed between blind and sight individuals reported or diagnosed with 
non-24-h sleep-wake syndrome, it is recommended that the International 
Classification of Sleep Disorders compose two distinct diagnostic terms, including
6-15
individual definitions, signs, symptoms, typical sleep-wake patterns, causes, diagnosis 
procedures and evaluations and possible treatments relative to whether: (1) the 
individual exhibits periodic/cyclic sleep and wake disturbances due to a lack of 
circadian photic entrainment to the 24-h day/rest-activity related to either blindness or 
insufficient environmental light (e.g.. Cyclic Sleep-Wake Syndrome); or (2) whether 
the individual exhibits non-24-h rest-activity behaviour and difficulty maintaining a 
24-h schedule in society (e.g., Non-24-h Rest-Activity Behaviour). It would not be 
necessaiy to distinguish between the two conditions by whether the individual is blind 
or sighted. Based on the findings in Chapter 5, homeostatic and circadian processes of 
sleep-wake regulation fimction independent of conscious or circadian photic input, yet 
preferred timing and optimal sleep-wake function is dependent upon daily photic 
input to the pacemaker even in sighted humans. For sighted individuals, extreme 
alterations in the ratio of solar LD, such as experienced in mid-summer and mid­
winter months in Antarctica or the Arctic, or periodic, day-to-day alterations in the 
timing of LD, such as experienced under weekly schedules for shift-workers can 
potentially cause circadian related sleep-wake disturbances. It would be advantageous 
to assess the daily LD and light level exposure and circadian rhythms and sleep in 
certain patient groups, such as those with Alzheimer’s Disease, schizophrenia or 
bipolar disorder, and determine whether their LD exposure are typical and/or light 
levels sufficient and whether the LD/light and circadian/sleep information gathered 
can be used to indicate, identify and help facilitate treatment for a particular sleep 
disorder within these patient groups. In addition, more effort needs to be placed 
toward educating the medical field regarding circadian rhythm sleep disorders, as well 
as implementing similar or abbreviated field assessments (i.e., diaries, melatonin
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assessments) to determine the underlying nature of the sleep-wake disturbance so that 
a proper diagnosis and treatment can be attained.
6.6 Final Comments
It is strongly recommended as a result of the findings presented in this thesis 
that all reports of circadian phase and period in NLP blind individuals should be 
accompanied by reports of the daily timing of nonphotic time cues, such as meals, 
exercise and rest-activity. An accurate assessment and inteipretation of field data 
collected can not be accomplished without having empirical data related to phase 
relationships between the subject endogenous circadian rhythm and their rest-activity 
behaviour. The absence of such infonnation is equivalent to reporting the effects of 
light without at least providing the type or timing of the light exposure. Gathering 
these behavioural data will also help detennine the strength of particular nonphotic 
time cues and identify those cues that have the strongest effects on the pacemaker. 
Preferably, field assessments should be carried out for at least 3 months, so that the 
melatonin rhythm can be measured across a complete range of phase relationships 
with the individual’s rest-activity. However, one significant factor that impedes the 
interpretation of periods measured under field conditions is having a reliable control 
condition, like the forced desynchrony protocol. Unfortunately, these long-duration 
inpatient studies require the work o f many people and more costly compared to field 
assessments. Despite this, field assessments are still necessaiy, particular for the 
purpose of determining the prevalence of circadian sleep-wake disorders in the blind 
population and bringing such findings to the attention of the both the medical and 
sleep community.
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